id
stringlengths 7
10
| query
stringlengths 559
87.6k
| answer
stringlengths 16
1.58k
| text
stringlengths 288
87.3k
|
|---|---|---|---|
edtsum2838 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ARLINGTON, Va.--(BUSINESS WIRE)--FLIR Systems, Inc. (NASDAQ: FLIR) announced it has won an additional $15.4 million contract to deliver its FLIR Black Hornet 3 Personal Reconnaissance Systems (PRS) to the U.S. Army. The advanced nano-unmanned aerial vehicles (UAVs) are being used to augment squad and small unit-level surveillance and reconnaissance capabilities as part of the Armys Soldier Borne Sensor (SBS) program. In late 2018, the U.S. Army began acquiring Black Hornet 3s to support the SBS effort. Since then, it has placed orders totaling more than $85 million for the FLIR nano-UAV. Extremely light and well suited for operations in contested environments, nearly silent, and with a flight time up to 25 minutes, the combat-proven, pocket-sized Black Hornet PRS transmits live video and HD still images back to the operator. Its information feed provides soldiers with immediate covert situational awareness to help them perform missions more effectively. FLIR has delivered more than 12,000 Black Hornet nano-UAVs to defense and security forces worldwide. Unmanned systems like our Black Hornet provide enhanced standoff and safety to troops in harms way, which is critical as militaries intensify their plans for multi-domain operations, said Roger Wells, VP and general manager of Unmanned Systems & Integrated Solutions at FLIR. Were honored the Black Hornet plays an integral part in the Armys Soldier Borne Sensor program. Every new order is a testament to the difference this technology can make on the battlefield and renews our commitment to advancing the science. The award-winning Black Hornet is designed and built by FLIR in Norway. Deliveries will begin midyear 2021. To learn more about the FLIR Black Hornet PRS, visit flir.com/products/black-hornet-prs/ About FLIR Systems, Inc. Founded in 1978, FLIR Systems is a world-leading technology company focused on intelligent sensing solutions for defense and industrial applications. Our vision is to be The Worlds Sixth Sense, creating and advancing technologies to help professionals make better, faster decisions that save lives and livelihoods. For more information, please visit www.flir.com and follow @flir. Forward Looking Statements The statements in this release by Roger Wells and the other statements in this release about the contract and order described above are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates, and projections about FLIR's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including the following: the ability to manufacture and deliver the systems referenced in this release, changes in pricing of FLIR's products, changing demand for FLIR's products, product mix, the impact of competitive products and pricing, constraints on supplies of critical components, excess or shortage of production capacity, the ability of FLIR to manufacture and ship products in a timely manner, FLIR's continuing compliance with U.S. export control laws and regulations, and other risks discussed from time to time in FLIR's Securities and Exchange Commission filings and reports. In addition, such statements could be affected by general industry and market conditions and growth rates, and general domestic and international economic conditions. Such forward-looking statements speak only as of the date on which they are made and FLIR does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release, or for changes made to this document by wire services or Internet service providers.
Answer: | FLIR Wins Additional $15.4M Contract for Black Hornet Nano-UAV Systems for U.S. Army Soldier Borne Sensor Program Total Value of Army SBS Orders for Black Hornets Now Tops $85 Million | ARLINGTON, Va.--(BUSINESS WIRE)--FLIR Systems, Inc. (NASDAQ: FLIR) announced it has won an additional $15.4 million contract to deliver its FLIR Black Hornet 3 Personal Reconnaissance Systems (PRS) to the U.S. Army. The advanced nano-unmanned aerial vehicles (UAVs) are being used to augment squad and small unit-level surveillance and reconnaissance capabilities as part of the Armys Soldier Borne Sensor (SBS) program. In late 2018, the U.S. Army began acquiring Black Hornet 3s to support the SBS effort. Since then, it has placed orders totaling more than $85 million for the FLIR nano-UAV. Extremely light and well suited for operations in contested environments, nearly silent, and with a flight time up to 25 minutes, the combat-proven, pocket-sized Black Hornet PRS transmits live video and HD still images back to the operator. Its information feed provides soldiers with immediate covert situational awareness to help them perform missions more effectively. FLIR has delivered more than 12,000 Black Hornet nano-UAVs to defense and security forces worldwide. Unmanned systems like our Black Hornet provide enhanced standoff and safety to troops in harms way, which is critical as militaries intensify their plans for multi-domain operations, said Roger Wells, VP and general manager of Unmanned Systems & Integrated Solutions at FLIR. Were honored the Black Hornet plays an integral part in the Armys Soldier Borne Sensor program. Every new order is a testament to the difference this technology can make on the battlefield and renews our commitment to advancing the science. The award-winning Black Hornet is designed and built by FLIR in Norway. Deliveries will begin midyear 2021. To learn more about the FLIR Black Hornet PRS, visit flir.com/products/black-hornet-prs/ About FLIR Systems, Inc. Founded in 1978, FLIR Systems is a world-leading technology company focused on intelligent sensing solutions for defense and industrial applications. Our vision is to be The Worlds Sixth Sense, creating and advancing technologies to help professionals make better, faster decisions that save lives and livelihoods. For more information, please visit www.flir.com and follow @flir. Forward Looking Statements The statements in this release by Roger Wells and the other statements in this release about the contract and order described above are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates, and projections about FLIR's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including the following: the ability to manufacture and deliver the systems referenced in this release, changes in pricing of FLIR's products, changing demand for FLIR's products, product mix, the impact of competitive products and pricing, constraints on supplies of critical components, excess or shortage of production capacity, the ability of FLIR to manufacture and ship products in a timely manner, FLIR's continuing compliance with U.S. export control laws and regulations, and other risks discussed from time to time in FLIR's Securities and Exchange Commission filings and reports. In addition, such statements could be affected by general industry and market conditions and growth rates, and general domestic and international economic conditions. Such forward-looking statements speak only as of the date on which they are made and FLIR does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release, or for changes made to this document by wire services or Internet service providers. |
edtsum2842 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN JOSE, Calif.--(BUSINESS WIRE)--Xperi Holding Corporation (NASDAQ: XPER) today announced that Robert Andersen, Chief Financial Officer, will present at the Sidoti & Company Virtual Conference on Wednesday, March 24, 2021 at 11:30am PT / 2:30pm ET. This session will be webcast and interested parties can view the event on Xperis Investor Relations website at investor.xperi.com. Management will also be hosting one-on-one and group meetings during the conference. About Xperi Holding Corporation Xperi invents, develops, and delivers technologies that enable extraordinary experiences. Xperi technologies, delivered via its brands (DTS, HD Radio, IMAX Enhanced, Invensas, TiVo), and by its startup, Perceive, make entertainment more entertaining, and smart devices smarter. Xperi technologies are integrated into billions of consumer devices, media platforms, and semiconductors worldwide, driving increased value for partners, customers and consumers. Xperi, DTS, IMAX Enhanced, Invensas, HD Radio, Perceive, TiVo and their respective logos are trademarks or registered trademarks of affiliated companies of Xperi Holding Corporation in the United States and other countries. All other company, brand and product names may be trademarks or registered trademarks of their respective companies. XPER C
Answer: | Xperi to Present at Sidoti & Company Virtual Conference | SAN JOSE, Calif.--(BUSINESS WIRE)--Xperi Holding Corporation (NASDAQ: XPER) today announced that Robert Andersen, Chief Financial Officer, will present at the Sidoti & Company Virtual Conference on Wednesday, March 24, 2021 at 11:30am PT / 2:30pm ET. This session will be webcast and interested parties can view the event on Xperis Investor Relations website at investor.xperi.com. Management will also be hosting one-on-one and group meetings during the conference. About Xperi Holding Corporation Xperi invents, develops, and delivers technologies that enable extraordinary experiences. Xperi technologies, delivered via its brands (DTS, HD Radio, IMAX Enhanced, Invensas, TiVo), and by its startup, Perceive, make entertainment more entertaining, and smart devices smarter. Xperi technologies are integrated into billions of consumer devices, media platforms, and semiconductors worldwide, driving increased value for partners, customers and consumers. Xperi, DTS, IMAX Enhanced, Invensas, HD Radio, Perceive, TiVo and their respective logos are trademarks or registered trademarks of affiliated companies of Xperi Holding Corporation in the United States and other countries. All other company, brand and product names may be trademarks or registered trademarks of their respective companies. XPER C |
edtsum2845 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, May 27, 2020 /PRNewswire/ -- The "Asia-Pacific Augmented Reality Market 2019-2025" report has been added to ResearchAndMarkets.com's offering Asia-Pacific's augmented reality (AR) market is estimated to grow significantly at a CAGR of 39.4% during the forecast period.Increasing adoption of AR for different applications such as entertainment, automotive, healthcare, telecommunication, infrastructure in public and private sectors is one of the major factors that contribute towards the growth of the AR market in the Asia-Pacific region. Along with the growing application of AR, the growing investments by the government and private institutions for the development of startups based on AR is further making a considerable contribution towards the growth of the AR market in the region.The major factor responsible for the increasing market share in the region includes the presence of a large customer base, a considerable increase in smartphone users, along with the rising startups in AR and VR technology. Apart from major market players operating in the region Octagon Studio, EXA VR Park, ZipMatch, TaKanto, Hiverlab, and VizioFly among others are some small companies that offer products based on AR technology.Octagon is a multimedia company that produces AR products and solutions for mobile and wearable devices. The key products of the company include 4D AR educational flashcards, which have images that pop up when they are viewed through a mobile app. China is the largest smartphone market in number, followed by India. Apart from India, China, Japan, South Korea, and Australia are expected to be the major contributors to the market.This report covers: A comprehensive research methodology of the Asia-Pacific augmented reality market. A detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the Asia-Pacific augmented reality market. Insights about market determinants which are stimulating the Asia-Pacific augmented reality market. Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. Key Topics Covered 1. Report Summary1.1. Research Methods and Tools1.2. Market Breakdown1.2.1. By Segments1.2.2. By Geography2. Market Overview and Insights2.1. Scope of the Report2.2. Analyst Insight & Current Market Trends2.2.1. Key Findings2.2.2. Recommendations2.2.3. Conclusion2.3. Rules & Regulations3. Competitive Landscape3.1. Company Share Analysis3.2. Key Strategy Analysis3.3. Key Company Analysis3.3.1. Overview3.3.2. Financial Analysis3.3.3. SWOT Analysis3.3.4. Recent Developments4. Market Determinants4.1. Motivators4.2. Restraints4.3. Opportunities5. Market Segmentation5.1. Asia-Pacific Augmented Reality Market by Device Type5.1.1. Head-Mounted5.1.2. Head-Up5.1.3. Handheld5.2. Asia-Pacific Augmented Reality Market by Technology5.2.1. Monitor Based Technology5.2.2. Near Eye Based Technology5.3. Asia-Pacific Augmented Reality Market by Component5.3.1. Hardware5.3.2. Software5.4. Asia-Pacific Augmented Reality Market by Application5.4.1. Individual5.4.2. Commercials5.4.3. Others (Automotive, Defense, Tourism, Healthcare, Apparels & Accessories)6. Regional Analysis6.1. China6.2. Japan6.3. India6.4. Rest of Asia-Pacific7. Company Profiles7.1. Wikitude GmbH7.2. Wayray AG7.3. Thales Group7.4. Seiko Epson Corp.7.5. Rokid Corp. Ltd.7.6. Qualcomm Technologies Inc.7.7. Niantic Inc.7.8. Microsoft Corp.7.9. Lumus Ltd.7.10. Intellectsoft LLCFor more information about this report visit https://www.researchandmarkets.com/r/wvjkew Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | Asia-Pacific Augmented Reality (AR) Market Outlook, 2025 | DUBLIN, May 27, 2020 /PRNewswire/ -- The "Asia-Pacific Augmented Reality Market 2019-2025" report has been added to ResearchAndMarkets.com's offering Asia-Pacific's augmented reality (AR) market is estimated to grow significantly at a CAGR of 39.4% during the forecast period.Increasing adoption of AR for different applications such as entertainment, automotive, healthcare, telecommunication, infrastructure in public and private sectors is one of the major factors that contribute towards the growth of the AR market in the Asia-Pacific region. Along with the growing application of AR, the growing investments by the government and private institutions for the development of startups based on AR is further making a considerable contribution towards the growth of the AR market in the region.The major factor responsible for the increasing market share in the region includes the presence of a large customer base, a considerable increase in smartphone users, along with the rising startups in AR and VR technology. Apart from major market players operating in the region Octagon Studio, EXA VR Park, ZipMatch, TaKanto, Hiverlab, and VizioFly among others are some small companies that offer products based on AR technology.Octagon is a multimedia company that produces AR products and solutions for mobile and wearable devices. The key products of the company include 4D AR educational flashcards, which have images that pop up when they are viewed through a mobile app. China is the largest smartphone market in number, followed by India. Apart from India, China, Japan, South Korea, and Australia are expected to be the major contributors to the market.This report covers: A comprehensive research methodology of the Asia-Pacific augmented reality market. A detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the Asia-Pacific augmented reality market. Insights about market determinants which are stimulating the Asia-Pacific augmented reality market. Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. Key Topics Covered 1. Report Summary1.1. Research Methods and Tools1.2. Market Breakdown1.2.1. By Segments1.2.2. By Geography2. Market Overview and Insights2.1. Scope of the Report2.2. Analyst Insight & Current Market Trends2.2.1. Key Findings2.2.2. Recommendations2.2.3. Conclusion2.3. Rules & Regulations3. Competitive Landscape3.1. Company Share Analysis3.2. Key Strategy Analysis3.3. Key Company Analysis3.3.1. Overview3.3.2. Financial Analysis3.3.3. SWOT Analysis3.3.4. Recent Developments4. Market Determinants4.1. Motivators4.2. Restraints4.3. Opportunities5. Market Segmentation5.1. Asia-Pacific Augmented Reality Market by Device Type5.1.1. Head-Mounted5.1.2. Head-Up5.1.3. Handheld5.2. Asia-Pacific Augmented Reality Market by Technology5.2.1. Monitor Based Technology5.2.2. Near Eye Based Technology5.3. Asia-Pacific Augmented Reality Market by Component5.3.1. Hardware5.3.2. Software5.4. Asia-Pacific Augmented Reality Market by Application5.4.1. Individual5.4.2. Commercials5.4.3. Others (Automotive, Defense, Tourism, Healthcare, Apparels & Accessories)6. Regional Analysis6.1. China6.2. Japan6.3. India6.4. Rest of Asia-Pacific7. Company Profiles7.1. Wikitude GmbH7.2. Wayray AG7.3. Thales Group7.4. Seiko Epson Corp.7.5. Rokid Corp. Ltd.7.6. Qualcomm Technologies Inc.7.7. Niantic Inc.7.8. Microsoft Corp.7.9. Lumus Ltd.7.10. Intellectsoft LLCFor more information about this report visit https://www.researchandmarkets.com/r/wvjkew Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum2849 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, March 16, 2020 /PRNewswire/ -- The "Global Preclinical Stage Partnering Terms & Agreements in Pharma & Biotech 2014-2020" report has been added to ResearchAndMarkets.com's offering. Global Preclinical Stage Partnering Terms & Agreements in Pharma & Biotech 2014-2020 provides a detailed understanding and analysis of how, why and what terms companies enter preclinical stage partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Trends in preclinical stage dealmaking in the biopharma industry since 2014 Analysis of preclinical stage deal structure Access to headline, upfront, milestone and royalty data Case studies of real-life preclinical stage deals Access to over 1,400 preclinical stage deals The leading preclinical stage deals by value since 2014 Most active preclinical stage dealmakers since 2014 The leading preclinical stage partnering resources This report provides details of the latest preclinical agreements announced in the healthcare sector.Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.This report contains a comprehensive listing of over 1,400 preclinical stage partnering deals announced since 2014 including financial terms, where available, including links to online deal records of actual preclinical partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.The initial chapters of this report provide an orientation of preclinical stage deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of why companies partner preclinical stage compounds/products. Chapter 3 provides an overview of preclinical stage deals strategy and deal structure including numerous case studies. Chapter 4 provides an overview of the various payment strategies used in preclinical stage deals. Chapter 5 provides a review of preclinical stage deal making since 2014. Deals activity is reviewed by year, stage of development at signing, therapeutic area, technology type, as well as most active dealmakers. Chapter 6 provides a detailed analysis of preclinical stage payment terms including headline, upfront, milestone and royalty rates. Chapter 7 provides a review of the leading preclinical stage deal by headline value. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand. Chapter 8 provides a comprehensive listing of the top 25 most active preclinical stage dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand. Chapter 9 provides a comprehensive and detailed review of preclinical stage partnering deals signed and announced since 2014, where a contract document is available in the public domain. Chapter 10 provides a comprehensive directory of preclinical stage partnering deals since 2014. The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.The report also includes numerous tables and figures that illustrate the trends and activities in preclinical stage partnering and deal making since 2014.In addition, a comprehensive appendix of all preclinical deals since 2014 is provided organized by partnering company A-Z, deal type, therapy focus and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of preclinical stage products and compounds.Analyzing actual contract agreements allows assessment of the following: What are the precise rights granted or optioned? What is actually granted by the agreement to the partner company? What exclusivity is granted? What is the payment structure for the deal? How aresalesand payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Companies Mentioned 1ST Biotherapeutics 2A 3B Pharmaceuticals 3DMed 3SBio 4D Molecular Therapeutics 4SC 23andMe A*STAR Agency for Science Technology and Research AB-Biotics AB Biosciences Abbott Laboratories Abbvie AbClon Ab E Discovery Abeona Therapeutics Abide Therapeutics ABL Bio Abpro Abzena Accelovance AccuGenomics Acetylon Pharmaceuticals Achaogen Achieve Life Science AC Immune Aclaris Therapeutics ACT Biotech Acticor Biotech Actinium Pharmaceuticals Acucela AcuraStem Acurx Pharmaceuticals AdAlta Adaptimmune Adapt Pharma ADC Therapeutics Addex Therapeutics Adimab Aduro BioTech Advaita Advanced Accelerator Applications Advanced BioScience Laboratories Advaxis Aerie Pharmaceuticals Aevi Genomic Medicine AffaMed Therapeutics Affigen Affinium Pharmaceuticals Affinivax AFFiRiS AGC Biologics Agenus Bio Agilvax Agios Pharmaceuticals AgonOx AGTC AIMM Therapeutics Ajinomoto Akaal Pharma Akcea Therapeutics Akebia Therapeutics Akeso Biopharma AKESOgen Akston Biosciences Albert Einstein College of Medicine Alderley Analytical Aldeyra Therapeutics Alector Alexion Pharmaceuticals AliveGen Alivio Therapeutics Alkahest Alkermes Allergan Alligator Bioscience Allogene Therapeutics Alma Bio Therapeutics Almirall Alnylam Pharmaceuticals Alphamab Alpine Immune Sciences ALS Association ALS Biopharma Altamira Pharma Altasciences Alteogen Alzheimer's Association Alzheimer's Drug Discovery Foundation Alzheimers Research UK Amarantus BioSciences amcure American Foundation for AIDS Research (amfAR) American National Multiple Sclerosis Society Amgen Amicus Therapeutics AmorChem Amorsa Therapeutics AmpliPhi Biosciences and over 1,850 more! For more information about this report visit https://www.researchandmarkets.com/r/a9y9cu Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | Preclinical Stage Partnering Deals in Pharma & Biotech, 2014-2020 - Access to 1,400+ Deal Records; Leading Deals by Value, Most Active Dealmakers | DUBLIN, March 16, 2020 /PRNewswire/ -- The "Global Preclinical Stage Partnering Terms & Agreements in Pharma & Biotech 2014-2020" report has been added to ResearchAndMarkets.com's offering. Global Preclinical Stage Partnering Terms & Agreements in Pharma & Biotech 2014-2020 provides a detailed understanding and analysis of how, why and what terms companies enter preclinical stage partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Trends in preclinical stage dealmaking in the biopharma industry since 2014 Analysis of preclinical stage deal structure Access to headline, upfront, milestone and royalty data Case studies of real-life preclinical stage deals Access to over 1,400 preclinical stage deals The leading preclinical stage deals by value since 2014 Most active preclinical stage dealmakers since 2014 The leading preclinical stage partnering resources This report provides details of the latest preclinical agreements announced in the healthcare sector.Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.This report contains a comprehensive listing of over 1,400 preclinical stage partnering deals announced since 2014 including financial terms, where available, including links to online deal records of actual preclinical partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.The initial chapters of this report provide an orientation of preclinical stage deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of why companies partner preclinical stage compounds/products. Chapter 3 provides an overview of preclinical stage deals strategy and deal structure including numerous case studies. Chapter 4 provides an overview of the various payment strategies used in preclinical stage deals. Chapter 5 provides a review of preclinical stage deal making since 2014. Deals activity is reviewed by year, stage of development at signing, therapeutic area, technology type, as well as most active dealmakers. Chapter 6 provides a detailed analysis of preclinical stage payment terms including headline, upfront, milestone and royalty rates. Chapter 7 provides a review of the leading preclinical stage deal by headline value. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand. Chapter 8 provides a comprehensive listing of the top 25 most active preclinical stage dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand. Chapter 9 provides a comprehensive and detailed review of preclinical stage partnering deals signed and announced since 2014, where a contract document is available in the public domain. Chapter 10 provides a comprehensive directory of preclinical stage partnering deals since 2014. The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.The report also includes numerous tables and figures that illustrate the trends and activities in preclinical stage partnering and deal making since 2014.In addition, a comprehensive appendix of all preclinical deals since 2014 is provided organized by partnering company A-Z, deal type, therapy focus and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of preclinical stage products and compounds.Analyzing actual contract agreements allows assessment of the following: What are the precise rights granted or optioned? What is actually granted by the agreement to the partner company? What exclusivity is granted? What is the payment structure for the deal? How aresalesand payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Companies Mentioned 1ST Biotherapeutics 2A 3B Pharmaceuticals 3DMed 3SBio 4D Molecular Therapeutics 4SC 23andMe A*STAR Agency for Science Technology and Research AB-Biotics AB Biosciences Abbott Laboratories Abbvie AbClon Ab E Discovery Abeona Therapeutics Abide Therapeutics ABL Bio Abpro Abzena Accelovance AccuGenomics Acetylon Pharmaceuticals Achaogen Achieve Life Science AC Immune Aclaris Therapeutics ACT Biotech Acticor Biotech Actinium Pharmaceuticals Acucela AcuraStem Acurx Pharmaceuticals AdAlta Adaptimmune Adapt Pharma ADC Therapeutics Addex Therapeutics Adimab Aduro BioTech Advaita Advanced Accelerator Applications Advanced BioScience Laboratories Advaxis Aerie Pharmaceuticals Aevi Genomic Medicine AffaMed Therapeutics Affigen Affinium Pharmaceuticals Affinivax AFFiRiS AGC Biologics Agenus Bio Agilvax Agios Pharmaceuticals AgonOx AGTC AIMM Therapeutics Ajinomoto Akaal Pharma Akcea Therapeutics Akebia Therapeutics Akeso Biopharma AKESOgen Akston Biosciences Albert Einstein College of Medicine Alderley Analytical Aldeyra Therapeutics Alector Alexion Pharmaceuticals AliveGen Alivio Therapeutics Alkahest Alkermes Allergan Alligator Bioscience Allogene Therapeutics Alma Bio Therapeutics Almirall Alnylam Pharmaceuticals Alphamab Alpine Immune Sciences ALS Association ALS Biopharma Altamira Pharma Altasciences Alteogen Alzheimer's Association Alzheimer's Drug Discovery Foundation Alzheimers Research UK Amarantus BioSciences amcure American Foundation for AIDS Research (amfAR) American National Multiple Sclerosis Society Amgen Amicus Therapeutics AmorChem Amorsa Therapeutics AmpliPhi Biosciences and over 1,850 more! For more information about this report visit https://www.researchandmarkets.com/r/a9y9cu Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum2856 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ATLANTA, May 8, 2020 /PRNewswire/ --Tropical Smoothie Cafe, a leading national fast-casual concept known for its better-for-you-smoothies and food with a tropical twist, announced today its One Million Smoothie Giveaway for guests nationwide. Coming off the heels of donating over 200,000 smoothies in April to the frontline heroes in the COVID-19 pandemic, Tropical Smoothie Cafe's new goal is to spread even more sunshine by giving away 1 million free smoothies to guests across the country. "We were humbled by the incredible response to the 200,000 smoothies our franchisees donated to frontline heroes nationwide," said Charles Watson, Tropical Smoothie Cafe, LLC CEO. "The smiles we saw and stories we heard inspired us to think bigger and explore how we could do even more to support the communities we serve. Our guests have always told us our smoothies provide a refreshing, momentary escape and we figured everyone could use a little escape right now. So, we decided to extend our smoothie giveaway to everyone in America by offering 1,000,000 free smoothies." In support of National Nurses Appreciation Month in May, Tropical Smoothie Cafe also pledged to donate $100,000 to the American Nurses Foundation's COVID-19 Response Fund upon reaching its goal of giving away 1,000,000 smoothies. "The support Tropical Smoothie Cafe already gave to nurses and other healthcare professionals is tremendous. We appreciate them doing even more by giving away 1 million smoothies and making a generous donation to the American Nurses Foundation Coronavirus Response Fund for Nurses," said Kate Judge, executive director, American Nurses Foundation. "Their donation will help the Foundation support critical areas where frontline nurses need immediate and ongoing support like mental wellness, direct financial assistance and national advocacy." In support of Tropical Smoothie Cafe's ongoing efforts to promote social distancing, guests can only participate by visiting www.FreeSmoothies.com, where they can sign up to receive a single-use promo code, redeemable online only, for one free smoothie. Once the online order is placed, smoothies can be picked up at the designated Tropical Smoothie Cafe location. Free smoothies cannot be requested directly at the cafe for the safety of our guests and crews. All offers are subject to applicable terms and conditions. About Tropical Smoothie CafTropical Smoothie Cafe is a national fast-casual cafe concept inspiring a healthier lifestyle with more than 850 locations nationwide. Serving better-for-you smoothies, wraps, sandwiches, and flatbreads, Tropical Smoothie Cafe also offers upgraded app technology and enhanced mobile ordering capabilities to further elevate the digital and dine-in cafe experience and emphasize the brand's focus on convenience. The rapidly growing franchise has received numerous accolades including rankings in QSR's Best Franchise Deals, Entrepreneur's Franchise 500 and Forbes' Best Franchises, as well as Franchise Times' Top 200+. In 2019, the brand was recognized amongst Fast Casual's Top 100 Movers and Shakers, Nation's Restaurant News' Top 200 and Top 10 Fastest Growing Chains, Franchise Times Fast and Serious, Restaurant Business America's Favorite Chains, as well as being chosen as NRAEF's Restaurant Neighbor Award Winner. SOURCE Tropical Smoothie Cafe Related Links http://www.FreeSmoothies.com
Answer: | Tropical Smoothie Cafe Announces 1 Million Smoothie Giveaway Nationwide Leading Fast Casual Concept Continues Spreading Sunshine across the Country by Giving Back to Local Communities | ATLANTA, May 8, 2020 /PRNewswire/ --Tropical Smoothie Cafe, a leading national fast-casual concept known for its better-for-you-smoothies and food with a tropical twist, announced today its One Million Smoothie Giveaway for guests nationwide. Coming off the heels of donating over 200,000 smoothies in April to the frontline heroes in the COVID-19 pandemic, Tropical Smoothie Cafe's new goal is to spread even more sunshine by giving away 1 million free smoothies to guests across the country. "We were humbled by the incredible response to the 200,000 smoothies our franchisees donated to frontline heroes nationwide," said Charles Watson, Tropical Smoothie Cafe, LLC CEO. "The smiles we saw and stories we heard inspired us to think bigger and explore how we could do even more to support the communities we serve. Our guests have always told us our smoothies provide a refreshing, momentary escape and we figured everyone could use a little escape right now. So, we decided to extend our smoothie giveaway to everyone in America by offering 1,000,000 free smoothies." In support of National Nurses Appreciation Month in May, Tropical Smoothie Cafe also pledged to donate $100,000 to the American Nurses Foundation's COVID-19 Response Fund upon reaching its goal of giving away 1,000,000 smoothies. "The support Tropical Smoothie Cafe already gave to nurses and other healthcare professionals is tremendous. We appreciate them doing even more by giving away 1 million smoothies and making a generous donation to the American Nurses Foundation Coronavirus Response Fund for Nurses," said Kate Judge, executive director, American Nurses Foundation. "Their donation will help the Foundation support critical areas where frontline nurses need immediate and ongoing support like mental wellness, direct financial assistance and national advocacy." In support of Tropical Smoothie Cafe's ongoing efforts to promote social distancing, guests can only participate by visiting www.FreeSmoothies.com, where they can sign up to receive a single-use promo code, redeemable online only, for one free smoothie. Once the online order is placed, smoothies can be picked up at the designated Tropical Smoothie Cafe location. Free smoothies cannot be requested directly at the cafe for the safety of our guests and crews. All offers are subject to applicable terms and conditions. About Tropical Smoothie CafTropical Smoothie Cafe is a national fast-casual cafe concept inspiring a healthier lifestyle with more than 850 locations nationwide. Serving better-for-you smoothies, wraps, sandwiches, and flatbreads, Tropical Smoothie Cafe also offers upgraded app technology and enhanced mobile ordering capabilities to further elevate the digital and dine-in cafe experience and emphasize the brand's focus on convenience. The rapidly growing franchise has received numerous accolades including rankings in QSR's Best Franchise Deals, Entrepreneur's Franchise 500 and Forbes' Best Franchises, as well as Franchise Times' Top 200+. In 2019, the brand was recognized amongst Fast Casual's Top 100 Movers and Shakers, Nation's Restaurant News' Top 200 and Top 10 Fastest Growing Chains, Franchise Times Fast and Serious, Restaurant Business America's Favorite Chains, as well as being chosen as NRAEF's Restaurant Neighbor Award Winner. SOURCE Tropical Smoothie Cafe Related Links http://www.FreeSmoothies.com |
edtsum2858 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BRIDGEWATER, N.J., May 7, 2020 /PRNewswire/ --Declutter and personalize your home with the touch of a button. Today, Brother is excited to unveil the P-touch Home Personal Label Maker as the newest addition to the P-touch family of label makers. With easy-to-use features, intuitive menus, and one-touch keys for personalization, the P-touch Home is a portable solution built to transform your home into a functional and attractive space. P-touch Home Personal Label Maker by Brother Simplifies Family and Home Organization Exclusive to the P-touch Home are built-in home organization templates for a variety of needs and items, including food prep, linen closet and clothing storage, child and baby items and more. The templates provide an effortless and creative way to organize and declutter your entire home no matter your family's needs. P-touch Home also stores up to 30 labels to help save time on reprinting; perfect for labeling baby bottles, lunchboxes and more. "Home organization has transformed from a necessary evil in the past, to a hobby that allows individuals to organize and personalize their home," said Jacquie Hunter, Director of Labeling Product Marketing at Brother. "We developed the P-touch Home specifically with that in mind and are excited to deliver our consumers a labeling solution dedicated to home, kitchen and childcare organization." The P-touch Home offers 14 fonts, 10 font styles, 97 frames, and over 600 symbols and emojis, making it easy to customize and personalize your home based on your dcor and style. Get started with your favorite home organization projects right out of the box as the P-touch Home comes with six AAA batteries and a standard roll of Black on Clear Brother Genuine P-touch Laminated TZe Label Tape. Alphabetically-organized spice racks, clutter-free kids' rooms, and personalized pet palaces have never been easier. The P-touch Home is compatible with Brother Genuine P-touch TZe Label Tapes in four different widths and an assortment of colors with several print color options. P-touch Laminated TZe Label Tapes are temperature and water resistant. They can go from the freezer, to the microwave, to the dishwasher, making them a must-have for families on the go. The Brother P-touch Home retails for $44.99. Both the P-touch Home and Brother Genuine P-touch TZe Label Tapes are available to purchase from PtouchHomeByBrother.com. About Brother International Corporation Brother International Corporation has earned its reputation as a premier provider of home office and business products, home appliances for the sewing and crafting enthusiast as well as industrial solutions that revolutionize the way we live and work. Brother International Corporation is a wholly-owned subsidiary of Brother Industries Ltd. With worldwide sales exceeding $6 billion, this global manufacturer was started more than 100 years ago. Bridgewater, New Jersey is the corporate headquarters for Brother in the Americas. It has fully integrated sales, marketing services, manufacturing, research and development capabilities located in the U.S. In addition to its headquarters, Brother has facilities in California, Illinois and Tennessee, as well as subsidiaries in Canada, Brazil, Chile, Argentina, Peru and Mexico. For more information, visit www.brother.com.Media Contact: Ashley GuidoManager, Public Relations and Influencer Marketing[emailprotected](908) 252-3077SOURCE Brother International Corporation Related Links http://www.brother-usa.com
Answer: | Organization, Meet Home: New P-touch Home by Brother Simplifies Family and Home Organization With One-Touch Options | BRIDGEWATER, N.J., May 7, 2020 /PRNewswire/ --Declutter and personalize your home with the touch of a button. Today, Brother is excited to unveil the P-touch Home Personal Label Maker as the newest addition to the P-touch family of label makers. With easy-to-use features, intuitive menus, and one-touch keys for personalization, the P-touch Home is a portable solution built to transform your home into a functional and attractive space. P-touch Home Personal Label Maker by Brother Simplifies Family and Home Organization Exclusive to the P-touch Home are built-in home organization templates for a variety of needs and items, including food prep, linen closet and clothing storage, child and baby items and more. The templates provide an effortless and creative way to organize and declutter your entire home no matter your family's needs. P-touch Home also stores up to 30 labels to help save time on reprinting; perfect for labeling baby bottles, lunchboxes and more. "Home organization has transformed from a necessary evil in the past, to a hobby that allows individuals to organize and personalize their home," said Jacquie Hunter, Director of Labeling Product Marketing at Brother. "We developed the P-touch Home specifically with that in mind and are excited to deliver our consumers a labeling solution dedicated to home, kitchen and childcare organization." The P-touch Home offers 14 fonts, 10 font styles, 97 frames, and over 600 symbols and emojis, making it easy to customize and personalize your home based on your dcor and style. Get started with your favorite home organization projects right out of the box as the P-touch Home comes with six AAA batteries and a standard roll of Black on Clear Brother Genuine P-touch Laminated TZe Label Tape. Alphabetically-organized spice racks, clutter-free kids' rooms, and personalized pet palaces have never been easier. The P-touch Home is compatible with Brother Genuine P-touch TZe Label Tapes in four different widths and an assortment of colors with several print color options. P-touch Laminated TZe Label Tapes are temperature and water resistant. They can go from the freezer, to the microwave, to the dishwasher, making them a must-have for families on the go. The Brother P-touch Home retails for $44.99. Both the P-touch Home and Brother Genuine P-touch TZe Label Tapes are available to purchase from PtouchHomeByBrother.com. About Brother International Corporation Brother International Corporation has earned its reputation as a premier provider of home office and business products, home appliances for the sewing and crafting enthusiast as well as industrial solutions that revolutionize the way we live and work. Brother International Corporation is a wholly-owned subsidiary of Brother Industries Ltd. With worldwide sales exceeding $6 billion, this global manufacturer was started more than 100 years ago. Bridgewater, New Jersey is the corporate headquarters for Brother in the Americas. It has fully integrated sales, marketing services, manufacturing, research and development capabilities located in the U.S. In addition to its headquarters, Brother has facilities in California, Illinois and Tennessee, as well as subsidiaries in Canada, Brazil, Chile, Argentina, Peru and Mexico. For more information, visit www.brother.com.Media Contact: Ashley GuidoManager, Public Relations and Influencer Marketing[emailprotected](908) 252-3077SOURCE Brother International Corporation Related Links http://www.brother-usa.com |
edtsum2860 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Real-Time Payments Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering. The real-time payments market is expected to register a CAGR of 29.8% during the forecast period 2021-2026. The real-time payments typically focus on low-value retail payment systems (RPS); they differ from real-time gross settlement systems (RTGS) and distributed ledger payment systems. In addition to meeting the demands and expectations, real-time payments have generated interest from the regulators, competition authorities and payment service providers alike. Regulators believe that instant payments will expand access to banking services, support economic growth, provide alternatives to Visa/Mastercard networks and reduce the use of cash and cheques. The increased penetration of smartphones has meant that currently, customer expectations are high. Individuals expect to be able to make a payment anywhere and at any time, including during evening hours, weekends and on public holidays. They also want to be able to pay for and receive their purchases as fast as possible. Suppliers, on the other hand, want the certainty of payment as soon they release their goods and services. These demands have come into place due to the increased adoption rates of smartphones. The reliance on traditional banking has fallen dramatically in the past, with customers demanding more convenience and flexibility. There has been an emergence of new fin-tech payment providers. This has led to a huge boost to the real-time payments market. Lack of Interoperability has affected the market adversely. It has caused the uneasiness amongst the users and thus, restricted the adoption rates of the technology. Key Market Trends Bank Led Operating Organisations are Expected to Experience a Major Market Growth Competitive Landscape With the consumer preferences changing rapidly, the market has become a lucrative option and thus, have attracted huge amount of investments. Due to the huge growth potential, the market is moving towards fragmentation due to the new entrants. The service providers are engaging in partnerships to promote product innovation. Key Topics Covered: 1 INTRODUCTION 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Introduction to Market Drivers and Restraints 4.3 Market Drivers 4.3.1 Increased Smartphone Penetration 4.3.2 Falling Reliance on Traditional Banking 4.4 Market Restraints 4.4.1 Lack of Interoperability 4.5 Industry Attractiveness - Porter's Five Force Analysis 4.6 Technology Snapshot 4.6.1 By Hours of Operation 4.6.1.1 24*7 4.6.1.2 Business Hours 5 MARKET SEGMENTATION 5.1 By Transaction Types 5.1.1 P2B 5.1.2 B2B 5.1.3 P2P 5.2 By Type of Operating Organization 5.2.1 Bank Led 5.2.2 No-bank Led 5.3 By End-user Industry 5.3.1 IT & Telecommunications 5.3.2 Retail 5.3.3 BFSI 5.3.4 Utilities 5.3.5 Other End-user Industries 5.4 Geography 6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 ACI Worldwide, Inc. 6.1.2 Fiserv, Inc. 6.1.3 Paypal Holdings Inc. 6.1.4 Mastercard Inc. 6.1.5 FIS Global 6.1.6 VISA Inc. 6.1.7 Apple Inc. 7 INVESTMENT ANALYSIS 8 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/we3wot
Answer: | Global Real-Time Payments Market Report 2021-2026: Bank Led Operating Organisations are Expected to Experience a Major Market Growth - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Real-Time Payments Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering. The real-time payments market is expected to register a CAGR of 29.8% during the forecast period 2021-2026. The real-time payments typically focus on low-value retail payment systems (RPS); they differ from real-time gross settlement systems (RTGS) and distributed ledger payment systems. In addition to meeting the demands and expectations, real-time payments have generated interest from the regulators, competition authorities and payment service providers alike. Regulators believe that instant payments will expand access to banking services, support economic growth, provide alternatives to Visa/Mastercard networks and reduce the use of cash and cheques. The increased penetration of smartphones has meant that currently, customer expectations are high. Individuals expect to be able to make a payment anywhere and at any time, including during evening hours, weekends and on public holidays. They also want to be able to pay for and receive their purchases as fast as possible. Suppliers, on the other hand, want the certainty of payment as soon they release their goods and services. These demands have come into place due to the increased adoption rates of smartphones. The reliance on traditional banking has fallen dramatically in the past, with customers demanding more convenience and flexibility. There has been an emergence of new fin-tech payment providers. This has led to a huge boost to the real-time payments market. Lack of Interoperability has affected the market adversely. It has caused the uneasiness amongst the users and thus, restricted the adoption rates of the technology. Key Market Trends Bank Led Operating Organisations are Expected to Experience a Major Market Growth Competitive Landscape With the consumer preferences changing rapidly, the market has become a lucrative option and thus, have attracted huge amount of investments. Due to the huge growth potential, the market is moving towards fragmentation due to the new entrants. The service providers are engaging in partnerships to promote product innovation. Key Topics Covered: 1 INTRODUCTION 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Introduction to Market Drivers and Restraints 4.3 Market Drivers 4.3.1 Increased Smartphone Penetration 4.3.2 Falling Reliance on Traditional Banking 4.4 Market Restraints 4.4.1 Lack of Interoperability 4.5 Industry Attractiveness - Porter's Five Force Analysis 4.6 Technology Snapshot 4.6.1 By Hours of Operation 4.6.1.1 24*7 4.6.1.2 Business Hours 5 MARKET SEGMENTATION 5.1 By Transaction Types 5.1.1 P2B 5.1.2 B2B 5.1.3 P2P 5.2 By Type of Operating Organization 5.2.1 Bank Led 5.2.2 No-bank Led 5.3 By End-user Industry 5.3.1 IT & Telecommunications 5.3.2 Retail 5.3.3 BFSI 5.3.4 Utilities 5.3.5 Other End-user Industries 5.4 Geography 6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 ACI Worldwide, Inc. 6.1.2 Fiserv, Inc. 6.1.3 Paypal Holdings Inc. 6.1.4 Mastercard Inc. 6.1.5 FIS Global 6.1.6 VISA Inc. 6.1.7 Apple Inc. 7 INVESTMENT ANALYSIS 8 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/we3wot |
edtsum2871 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HERNDON, Va.--(BUSINESS WIRE)--ePlus inc. (NASDAQ NGS: PLUS news) today announced its sponsorship of Check Points virtual Women in IT event in support of the drive to engage more women in STEM fields, including cyber security. The event, which will take place online on Tuesday, September 15, 2020 from 12:00 - 1:30 PM ET, will bring together a panel of female leaders to connect and consider how organizations are navigating today's uncharted waters and how they will adapt in the months ahead. The panel will feature special guest speaker, Erin Brockovich, an iconic environmental activist, consumer advocate, real-life inspiration for the Oscar-winning film Erin Brockovich, and New York Times bestselling author. The event will also include dialogue around: It is a well-known fact that there is a shortage of women in STEM fields and, as a leading IT integrator, ePlus has an important role to play in helping to address that issue, said Elaine Marion, CFO. We are committed to helping to drive interest, learning, engagement and diversity in technology, and as Check Points Americas Cloud Partner of the Year, we are proud of our partnership with Check Point as well as our sponsorship of the Women in IT event. Two charities have been selected as beneficiaries of the event. Check Point will donate $5 to either Girls Who Code or Dress for Success on behalf of each event attendee. Please click here to register for the event. About ePlus inc. ePlus is a leading consultative technology solutions provider that helps customers imagine, implement, and achieve more from their technology. With the highest certifications from top technology partners and lifecycle services expertise across key areas including security, cloud, data center, collaboration, networking and emerging technologies, ePlus transforms IT from a cost center to a business enabler. Founded in 1990, ePlus has more than 1,500 associates serving a diverse set of customers in the U.S., Europe, and Asia-Pac. The Company is headquartered at 13595 Dulles Technology Drive, Herndon, VA, 20171. For more information, visit www.eplus.com, call 888-482-1122, or email [email protected]. Connect with ePlus on Facebook, LinkedIn, Twitter and Instagram. ePlus, Where Technology Means More. ePlus, Where Technology Means More, and ePlus products referenced herein are either registered trademarks or trademarks of ePlus inc. in the United States and/or other countries. The names of other companies, products, and services mentioned herein may be the trademarks of their respective owners. Statements in this press release that are not historical facts may be deemed to be forward-looking statements. Actual and anticipated future results may vary materially due to certain risks and uncertainties, including, without limitation, risks related to COVID-19, including but not limited to its possible effects on the availability of and demand for our products and services, our ability to efficiently and flexibly manage our business amid uncertainties related to COVID-19, and its impact on the economy, possible adverse effects resulting from financial market disruption and fluctuations in foreign currency rates, and general slowdown of the U.S. economy such as our current and potential customers delaying or reducing technology purchases or put downward pressure on prices, increasing credit risk associated with our customers and vendors, reduction of vendor incentive programs, and restrictions on our access to capital necessary to fund our operations; our ability to consummate and integrate acquisitions; the possibility of goodwill impairment charges in the future; significant adverse changes in, reductions in, or losses of relationships with major customers or vendors; the demand for and acceptance of, our products and services; our ability to adapt our services to meet changes in market developments; our ability to implement comprehensive plans to achieve customer account coverage for the integration of sales forces, cost containment, asset rationalization, systems integration and other key strategies; our ability to reserve adequately for credit losses; our ability to secure our electronic and other confidential information or that of our customers or partners; future growth rates in our core businesses; our ability to protect our intellectual property; the impact of competition in our markets; the possibility of defects in our products or catalog content data; our ability to adapt to changes in the IT industry and/or rapid change in product standards; our ability to realize our investment in leased equipment; our ability to hire and retain sufficient qualified personnel; and other risks or uncertainties detailed in our reports filed with the Securities and Exchange Commission. All information set forth in this press release is current as of the date of this release and ePlus undertakes no duty or obligation to update this information.
Answer: | ePlus Sponsors Check Point Women in IT: Breaking the Glass Ceiling Event to Support Female Achievement in Cyber Security | HERNDON, Va.--(BUSINESS WIRE)--ePlus inc. (NASDAQ NGS: PLUS news) today announced its sponsorship of Check Points virtual Women in IT event in support of the drive to engage more women in STEM fields, including cyber security. The event, which will take place online on Tuesday, September 15, 2020 from 12:00 - 1:30 PM ET, will bring together a panel of female leaders to connect and consider how organizations are navigating today's uncharted waters and how they will adapt in the months ahead. The panel will feature special guest speaker, Erin Brockovich, an iconic environmental activist, consumer advocate, real-life inspiration for the Oscar-winning film Erin Brockovich, and New York Times bestselling author. The event will also include dialogue around: It is a well-known fact that there is a shortage of women in STEM fields and, as a leading IT integrator, ePlus has an important role to play in helping to address that issue, said Elaine Marion, CFO. We are committed to helping to drive interest, learning, engagement and diversity in technology, and as Check Points Americas Cloud Partner of the Year, we are proud of our partnership with Check Point as well as our sponsorship of the Women in IT event. Two charities have been selected as beneficiaries of the event. Check Point will donate $5 to either Girls Who Code or Dress for Success on behalf of each event attendee. Please click here to register for the event. About ePlus inc. ePlus is a leading consultative technology solutions provider that helps customers imagine, implement, and achieve more from their technology. With the highest certifications from top technology partners and lifecycle services expertise across key areas including security, cloud, data center, collaboration, networking and emerging technologies, ePlus transforms IT from a cost center to a business enabler. Founded in 1990, ePlus has more than 1,500 associates serving a diverse set of customers in the U.S., Europe, and Asia-Pac. The Company is headquartered at 13595 Dulles Technology Drive, Herndon, VA, 20171. For more information, visit www.eplus.com, call 888-482-1122, or email [email protected]. Connect with ePlus on Facebook, LinkedIn, Twitter and Instagram. ePlus, Where Technology Means More. ePlus, Where Technology Means More, and ePlus products referenced herein are either registered trademarks or trademarks of ePlus inc. in the United States and/or other countries. The names of other companies, products, and services mentioned herein may be the trademarks of their respective owners. Statements in this press release that are not historical facts may be deemed to be forward-looking statements. Actual and anticipated future results may vary materially due to certain risks and uncertainties, including, without limitation, risks related to COVID-19, including but not limited to its possible effects on the availability of and demand for our products and services, our ability to efficiently and flexibly manage our business amid uncertainties related to COVID-19, and its impact on the economy, possible adverse effects resulting from financial market disruption and fluctuations in foreign currency rates, and general slowdown of the U.S. economy such as our current and potential customers delaying or reducing technology purchases or put downward pressure on prices, increasing credit risk associated with our customers and vendors, reduction of vendor incentive programs, and restrictions on our access to capital necessary to fund our operations; our ability to consummate and integrate acquisitions; the possibility of goodwill impairment charges in the future; significant adverse changes in, reductions in, or losses of relationships with major customers or vendors; the demand for and acceptance of, our products and services; our ability to adapt our services to meet changes in market developments; our ability to implement comprehensive plans to achieve customer account coverage for the integration of sales forces, cost containment, asset rationalization, systems integration and other key strategies; our ability to reserve adequately for credit losses; our ability to secure our electronic and other confidential information or that of our customers or partners; future growth rates in our core businesses; our ability to protect our intellectual property; the impact of competition in our markets; the possibility of defects in our products or catalog content data; our ability to adapt to changes in the IT industry and/or rapid change in product standards; our ability to realize our investment in leased equipment; our ability to hire and retain sufficient qualified personnel; and other risks or uncertainties detailed in our reports filed with the Securities and Exchange Commission. All information set forth in this press release is current as of the date of this release and ePlus undertakes no duty or obligation to update this information. |
edtsum2877 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that Cigna has added EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% as a preferred brand on its commercial formulary, effective May 15, 2021. We are pleased to announce the addition of EYSUVIS to Cignas preferred formulary, reflecting a significant expansion of our commercial coverage and important progress toward our goal of securing broad patient access, said Todd Bazemore, Chief Operating Officer of Kala Pharmaceuticals. We look forward to continuing to engage with other commercial and Medicare Part D health plans as we execute on our strategy to optimize coverage, with the goal of delivering EYSUVIS as the preferred prescription therapy for the millions of people in the United States who suffer from dry eye disease flares. EYSUVIS was approved in October 2020 as the first and only prescription therapy indicated specifically for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. EYSUVIS became commercially available in the United States in January 2021 and is available through both national and regional U.S. pharmaceutical distribution centers, as well as local retail pharmacies or home delivery. About EYSUVIS EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% is approved for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. EYSUVIS utilizes Kala's proprietary AMPPLIFY mucus-penetrating particle (MPP) Drug Delivery Technology to enhance penetration of loteprednol etabonate (LE) into target tissue of the ocular surface. EYSUVIS was approved by the FDA on October 26, 2020. Kala believes that EYSUVIS' broad mechanism of action, rapid onset of relief of both signs and symptoms, favorable tolerability and safety profile and the potential to be complementary to existing therapies, offer a differentiated product profile for the treatment of dry eye disease, including the management of dry eye flares. EYSUVIS Important Safety Information EYSUVIS, as with other ophthalmic corticosteroids, is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. The initial prescription and each renewal of the medication order should be made by a physician only after examination of the patient with the aid of magnification, such as slit lamp biomicroscopy, and, where appropriate, fluorescein staining. Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, as well as defects in visual acuity and fields of vision. Corticosteroids should be used with caution in the presence of glaucoma. Renewal of the medication order should be made by a physician only after examination of the patient and evaluation of the IOP. Use of corticosteroids may result in posterior subcapsular cataract formation. Use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infections. In acute purulent conditions, corticosteroids may mask infection or enhance existing infection. Use of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Use of ocular corticosteroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex). Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local corticosteroid application. Fungus invasion must be considered in any persistent corneal ulceration where a corticosteroid has been used or is in use. The most common adverse drug reaction following the use of EYSUVIS for two weeks was instillation site pain, which was reported in 5% of patients. Please see full Prescribing Information at www.eysuvis.com About Kala Pharmaceuticals, Inc. Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery. The Company also has a pipeline of preclinical development programs targeted to address unmet medical needs, including both front and back of the eye diseases. For more information on Kala, please visit www.kalarx.com. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, that involve substantial risks and uncertainties, including statements regarding EYSUVIS, the Company continuing to engage with commercial and Medicare Part D health plans as it executes on its strategy to optimize managed care coverage, and the Companys goal of delivering EYSUVIS as the preferred prescription therapy for the millions of people in the United States who suffer from dry eye disease flares. All statements, other than statements of historical facts, contained in this press release, including statements regarding the Companys strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words anticipate, believe, continue could, estimate, expect, intend, may, plan, potential, predict, project, should, target, will, would, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company may not actually achieve the plans, intentions or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements as a result of various risks and uncertainties including, but not limited to: the impact of extraordinary external events, such as the current pandemic health event resulting from the novel coronavirus (COVID-19), and their collateral consequences, including disruption of the activities of the Companys sales force and the market for EYSUVIS and INVELTYS; whether the Company will be able to successfully implement its commercialization plans for EYSUVIS and INVELTYS; whether the market opportunity for EYSUVIS and INVELTYS is consistent with the Companys expectations and market research; the Companys ability execute on the commercial launch of EYSUVIS on the timeline expected, or at all, including obtaining Commercial and Medicare Part D payor coverage; whether the Company will be able to generate its projected net product revenue on the timeline expected, or at all; whether the Company's cash resources will be sufficient to fund the Company's foreseeable and unforeseeable operating expenses and capital expenditure requirements for the Company's expected timeline; other matters that could affect the availability or commercial potential of EYSUVIS and INVELTYS; and other important factors, any of which could cause the Company's actual results to differ from those contained in the forward-looking statements, discussed in the Risk Factors section of the Companys Annual Report on Form 10-K, most recently filed Quarterly Report on Form 10-Q and other filings the Company makes with the Securities and Exchange Commission. These forward-looking statements represent the Companys views as of the date of this release and should not be relied upon as representing the Companys views as of any date subsequent to the date hereof. The Company does not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Answer: | Kala Pharmaceuticals Announces Preferred Position for EYSUVIS on Cigna -- Commercial formulary coverage effective May 15, 2021 -- | WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that Cigna has added EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% as a preferred brand on its commercial formulary, effective May 15, 2021. We are pleased to announce the addition of EYSUVIS to Cignas preferred formulary, reflecting a significant expansion of our commercial coverage and important progress toward our goal of securing broad patient access, said Todd Bazemore, Chief Operating Officer of Kala Pharmaceuticals. We look forward to continuing to engage with other commercial and Medicare Part D health plans as we execute on our strategy to optimize coverage, with the goal of delivering EYSUVIS as the preferred prescription therapy for the millions of people in the United States who suffer from dry eye disease flares. EYSUVIS was approved in October 2020 as the first and only prescription therapy indicated specifically for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. EYSUVIS became commercially available in the United States in January 2021 and is available through both national and regional U.S. pharmaceutical distribution centers, as well as local retail pharmacies or home delivery. About EYSUVIS EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% is approved for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. EYSUVIS utilizes Kala's proprietary AMPPLIFY mucus-penetrating particle (MPP) Drug Delivery Technology to enhance penetration of loteprednol etabonate (LE) into target tissue of the ocular surface. EYSUVIS was approved by the FDA on October 26, 2020. Kala believes that EYSUVIS' broad mechanism of action, rapid onset of relief of both signs and symptoms, favorable tolerability and safety profile and the potential to be complementary to existing therapies, offer a differentiated product profile for the treatment of dry eye disease, including the management of dry eye flares. EYSUVIS Important Safety Information EYSUVIS, as with other ophthalmic corticosteroids, is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. The initial prescription and each renewal of the medication order should be made by a physician only after examination of the patient with the aid of magnification, such as slit lamp biomicroscopy, and, where appropriate, fluorescein staining. Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, as well as defects in visual acuity and fields of vision. Corticosteroids should be used with caution in the presence of glaucoma. Renewal of the medication order should be made by a physician only after examination of the patient and evaluation of the IOP. Use of corticosteroids may result in posterior subcapsular cataract formation. Use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infections. In acute purulent conditions, corticosteroids may mask infection or enhance existing infection. Use of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Use of ocular corticosteroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex). Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local corticosteroid application. Fungus invasion must be considered in any persistent corneal ulceration where a corticosteroid has been used or is in use. The most common adverse drug reaction following the use of EYSUVIS for two weeks was instillation site pain, which was reported in 5% of patients. Please see full Prescribing Information at www.eysuvis.com About Kala Pharmaceuticals, Inc. Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery. The Company also has a pipeline of preclinical development programs targeted to address unmet medical needs, including both front and back of the eye diseases. For more information on Kala, please visit www.kalarx.com. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, that involve substantial risks and uncertainties, including statements regarding EYSUVIS, the Company continuing to engage with commercial and Medicare Part D health plans as it executes on its strategy to optimize managed care coverage, and the Companys goal of delivering EYSUVIS as the preferred prescription therapy for the millions of people in the United States who suffer from dry eye disease flares. All statements, other than statements of historical facts, contained in this press release, including statements regarding the Companys strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words anticipate, believe, continue could, estimate, expect, intend, may, plan, potential, predict, project, should, target, will, would, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company may not actually achieve the plans, intentions or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements as a result of various risks and uncertainties including, but not limited to: the impact of extraordinary external events, such as the current pandemic health event resulting from the novel coronavirus (COVID-19), and their collateral consequences, including disruption of the activities of the Companys sales force and the market for EYSUVIS and INVELTYS; whether the Company will be able to successfully implement its commercialization plans for EYSUVIS and INVELTYS; whether the market opportunity for EYSUVIS and INVELTYS is consistent with the Companys expectations and market research; the Companys ability execute on the commercial launch of EYSUVIS on the timeline expected, or at all, including obtaining Commercial and Medicare Part D payor coverage; whether the Company will be able to generate its projected net product revenue on the timeline expected, or at all; whether the Company's cash resources will be sufficient to fund the Company's foreseeable and unforeseeable operating expenses and capital expenditure requirements for the Company's expected timeline; other matters that could affect the availability or commercial potential of EYSUVIS and INVELTYS; and other important factors, any of which could cause the Company's actual results to differ from those contained in the forward-looking statements, discussed in the Risk Factors section of the Companys Annual Report on Form 10-K, most recently filed Quarterly Report on Form 10-Q and other filings the Company makes with the Securities and Exchange Commission. These forward-looking statements represent the Companys views as of the date of this release and should not be relied upon as representing the Companys views as of any date subsequent to the date hereof. The Company does not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. |
edtsum2878 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ST. LOUIS, Dec. 23, 2020 /PRNewswire/ --Ameren Missouri, a subsidiary of Ameren Corporation (NYSE: AEE), has closed on the acquisition of the company's first wind energy center, a 400-megawatt (MW) project in northeast Missouri. The purchase of the High Prairie Renewable Energy Center in Adair and Schuyler counties is the first of two planned investments in Missouri-based wind generation, which will add 700 MW of clean energy to the grid. "This is just the beginning, as Ameren Missouri lays the foundation for a transformational advancement toward more renewable wind and solar generation in the coming years, cutting carbon emissions and driving job creation and economic growth," said Marty Lyons, chairman and president of Ameren Missouri. "Ameren Missouri is committed to clean. Expanding Missouri-based wind energy generation helps us move toward our goal of net-zero carbon emissions by 2050." The High Prairie Renewable Energy Center is the first of many renewable energy additions anticipated by Ameren Missouri. The company recently released plans to invest approximately $4.5 billion in 3,100 MW of renewable generation by 2030. This includes $1.2 billion for the planned acquisitions of this energy center and a 300 MW energy center in Atchison County, Missouri. "All of our customers, no matter where they live, are benefitting from additional clean energy on the grid as a result of this acquisition," said Ajay Arora, chief renewable development officer at Ameren Missouri. "These turbines use some of the latest technology that harnesses more wind at an affordable price. It's also very gratifying to see this project built in our state, where families will receive a host of economic benefits for years to come." The wind facility was constructed by an affiliate of Terra-Gen LLC. The energy center consists of 175 wind turbines that are among the most technologically advanced in the state. Ameren Missouri anticipates the energy center will produce enough energy to power the equivalent of 120,000 homes in 2021. "It's exciting to see how northeast Missouri is making a major contribution to providing cleaner energy for the entire state," said Carolyn Chrisman, executive director of Kirksville Regional Economic Development (K-REDI). "Besides providing sustainable energy, it is helping to grow the economy of our region from not only construction jobs, but ongoing operations that will provide long term good paying jobs for many years to come!" Ameren Missouri has been providing electric and gas service for more than 100 years, and the company's electric rates are among the lowest in the nation. Ameren Missouri's mission is to power the quality of life for its 1.2 million electric and 132,000 natural gas customers in central and eastern Missouri. The company's service area covers 64 counties and more than 500 communities, including the greater St. Louis area. For more information, visit Ameren.com/Missouri or follow us on Twitter at @AmerenMissouri or Facebook.com/AmerenMissouri. Forward-Looking StatementsStatements in this release not based on historical facts are considered "forward-looking" and, accordingly, involve risks and uncertainties that could cause actual results to differ materially from those discussed. Although such forward-looking statements have been made in good faith and are based on reasonable assumptions, there is no assurance that the expected results will be achieved. These statements include (without limitation) statements as to future expectations, beliefs, plans, projections, strategies, objectives, events, conditions, and financial performance. In connection with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, we are providing this cautionary statement to identify important factors that could cause actual results to differ materially from those anticipated. The following factors, in addition to those discussed under Risk Factors in Ameren's Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, and elsewhere in this release and in our other filings with the Securities and Exchange Commission, could cause actual results to differ materially from management expectations suggested in such forward-looking statements: regulatory, judicial, or legislative actions, and any changes in regulatory policies and ratemaking determinations that may change regulatory recovery mechanisms; the length and severity of the COVID-19 pandemic, and its impacts on our business continuity plans and our results of operations, financial position, and liquidity, including but not limited to changes in customer demand resulting in changes to sales volumes, customers' payment for our services and their use of deferred payment arrangements, future regulatory or legislative actions that could require suspension of customer disconnections and/or late fees, among other things, for an extended period of time, the health and welfare of our workforce and contractors, supplier disruptions, delays in the completion of construction projects, which could impact our planned capital expenditures and expected planned rate base growth, Ameren Missouri's ability to recover any forgone customer late fee revenues or incremental costs, our ability to meet customer energy-efficiency program goals and earn performance incentives related to those programs, increased data security risks as a result of the transition to remote working arrangements for a significant portion of our workforce, and our ability to access the capital markets on reasonable terms and when needed; the effect on Ameren Missouri of any customer rate caps pursuant to Ameren Missouri's election to use the plant-in-service accounting regulatory mechanism, including an extension of use beyond 2023, if requested by Ameren Missouri and approved by the Missouri Public Service Commission; the effects of changes in federal, state, or local laws and other governmental actions, including monetary, fiscal, and energy policies; the effects of changes in federal, state, or local tax laws, regulations, interpretations, or rates, including as a result of amendments or technical corrections to the Tax Cuts and Jobs Act of 2017, and challenges to the tax positions taken by us, if any; the effects on energy prices and demand for our services resulting from technological advances, including advances in customer energy efficiency, electric vehicles, electrification of various industries, energy storage, and private generation sources, which generate electricity at the site of consumption and are becoming more cost-competitive; the effectiveness of Ameren Missouri's customer energy-efficiency programs and the related revenues and performance incentives earned under its Missouri Energy Efficiency Investment Act programs; our ability to align overall spending, both operating and capital, with frameworks established by our regulators and to recover these costs in a timely manner in our attempt to earn our allowed return on equity; the cost and availability of fuel, such as low-sulfur coal, natural gas, and enriched uranium used to produce electricity; the cost and availability of purchased power, zero emission credits, renewable energy credits, and natural gas for distribution; and the level and volatility of future market prices for such commodities and credits, including our ability to recover the costs for such commodities and credits and our customers' tolerance for any related price increases; the effectiveness of our risk management strategies and our use of financial and derivative instruments; the ability to obtain sufficient insurance, including insurance for Ameren Missouri's nuclear and coal-fired energy centers, or, in the absence of insurance, the ability to recover uninsured losses from our customers; the impact of cyberattacks on us or our suppliers, which could, among other things, result in the loss of operational control of energy centers and electric and natural gas transmission and distribution systems and/or the loss of data, such as customer, employee, financial, and operating system information; business and economic conditions, which have been affected by, and will be affected by the length and severity of, the COVID-19 pandemic, including the impact of such conditions on interest rates; disruptions of the capital markets, deterioration in our credit metrics, or other events that may have an adverse effect on the cost or availability of capital, including short-term credit and liquidity; the actions of credit rating agencies and the effects of such actions, including any impacts on our credit ratings that may result from the economic conditions of the COVID-19 pandemic; the inability of our counterparties to meet their obligations with respect to contracts, credit agreements, and financial instruments; the impact of weather conditions and other natural phenomena on us and our customers, including the impact of system outages; the construction, installation, performance, and cost recovery of generation, transmission, and distribution assets; the effects of failures of electric generation, electric and natural gas transmission or distribution, or natural gas storage facilities systems and equipment, which could result in unanticipated liabilities or unplanned outages; the operation of Ameren Missouri's Callaway Energy Center, including planned and unplanned outages, and decommissioning costs; Ameren Missouri's ability to recover the remaining investment, if any, and decommissioning costs associated with the retirement of an energy center, as well as the ability to earn a return on that remaining investment and those decommissioning costs; the impact of current environmental laws and new, more stringent, or changing requirements, including those related to the New Source Review provisions of the Clean Air Act, carbon dioxide and the implementation of the Affordable Clean Energy Rule, other emissions and discharges, cooling water intake structures, coal combustion residuals, and energy efficiency, that could limit or terminate the operation of certain of Ameren Missouri's energy centers, increase our operating costs or investment requirements, result in an impairment of our assets, cause us to sell our assets, reduce our customers' demand for electricity or natural gas, or otherwise have a negative financial effect; the impact of complying with renewable energy standards in Missouri; Ameren Missouri's ability to acquire wind, solar, and other renewable energy generation facilities and recover its cost of investment and related return in a timely manner, which is affected by the ability to obtain all necessary project approvals; the ability of developers to meet contractual commitments and complete projects timely, which is dependent upon the availability of necessary materials and equipment, including those that are affected by the disruptions in the global supply chain caused by the COVID-19 pandemic; and Ameren Missouri's ability to obtain a certificate of convenience and necessity from the Missouri Public Service Commission or any other required approvals for the addition of renewable resources, retirement of energy centers, and new or continued customer energy-efficiency programs; the availability of federal production and investment tax credits related to renewable energy and Ameren Missouri's ability to use such credits; the cost of wind, solar, and other renewable generation and storage technologies; and our ability to obtain timely interconnection agreements with the Midcontinent Independent System Operator, Inc. or other regional transmission organizations at an acceptable cost for each facility; advancements in carbon-free generation and storage technologies, and constructive federal and state energy and economic policies with respect to those technologies; labor disputes, work force reductions, changes in future wage and employee benefits costs, including those resulting from changes in discount rates, mortality tables, returns on benefit plan assets, and other assumptions; the impact of negative opinions of us or our utility services that our customers, investors, legislators, or regulators may have or develop, which could result from a variety of factors, including failures in system reliability, failure to implement our investment plans or to protect sensitive customer information, increases in rates, negative media coverage, or concerns about environmental, social, and/or governance practices; the effects of strategic initiatives, including mergers, acquisitions, and divestitures; legal and administrative proceedings; and acts of sabotage, war, terrorism, or other intentionally disruptive acts. New factors emerge from time to time, and it is not possible for management to predict all of such factors, nor can it assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained or implied in any forward-looking statement. Given these uncertainties, undue reliance should not be placed on these forward-looking statements. Except to the extent required by the federal securities laws, we undertake no obligation to update or revise publicly any forward-looking statements to reflect new information or future events. SOURCE Ameren Corporation Related Links http://www.ameren.com
Answer: | Ameren Missouri takes largest step yet toward net-zero carbon goal with acquisition of its first wind energy center in northeast Missouri Customers now receiving more clean energy than ever before | ST. LOUIS, Dec. 23, 2020 /PRNewswire/ --Ameren Missouri, a subsidiary of Ameren Corporation (NYSE: AEE), has closed on the acquisition of the company's first wind energy center, a 400-megawatt (MW) project in northeast Missouri. The purchase of the High Prairie Renewable Energy Center in Adair and Schuyler counties is the first of two planned investments in Missouri-based wind generation, which will add 700 MW of clean energy to the grid. "This is just the beginning, as Ameren Missouri lays the foundation for a transformational advancement toward more renewable wind and solar generation in the coming years, cutting carbon emissions and driving job creation and economic growth," said Marty Lyons, chairman and president of Ameren Missouri. "Ameren Missouri is committed to clean. Expanding Missouri-based wind energy generation helps us move toward our goal of net-zero carbon emissions by 2050." The High Prairie Renewable Energy Center is the first of many renewable energy additions anticipated by Ameren Missouri. The company recently released plans to invest approximately $4.5 billion in 3,100 MW of renewable generation by 2030. This includes $1.2 billion for the planned acquisitions of this energy center and a 300 MW energy center in Atchison County, Missouri. "All of our customers, no matter where they live, are benefitting from additional clean energy on the grid as a result of this acquisition," said Ajay Arora, chief renewable development officer at Ameren Missouri. "These turbines use some of the latest technology that harnesses more wind at an affordable price. It's also very gratifying to see this project built in our state, where families will receive a host of economic benefits for years to come." The wind facility was constructed by an affiliate of Terra-Gen LLC. The energy center consists of 175 wind turbines that are among the most technologically advanced in the state. Ameren Missouri anticipates the energy center will produce enough energy to power the equivalent of 120,000 homes in 2021. "It's exciting to see how northeast Missouri is making a major contribution to providing cleaner energy for the entire state," said Carolyn Chrisman, executive director of Kirksville Regional Economic Development (K-REDI). "Besides providing sustainable energy, it is helping to grow the economy of our region from not only construction jobs, but ongoing operations that will provide long term good paying jobs for many years to come!" Ameren Missouri has been providing electric and gas service for more than 100 years, and the company's electric rates are among the lowest in the nation. Ameren Missouri's mission is to power the quality of life for its 1.2 million electric and 132,000 natural gas customers in central and eastern Missouri. The company's service area covers 64 counties and more than 500 communities, including the greater St. Louis area. For more information, visit Ameren.com/Missouri or follow us on Twitter at @AmerenMissouri or Facebook.com/AmerenMissouri. Forward-Looking StatementsStatements in this release not based on historical facts are considered "forward-looking" and, accordingly, involve risks and uncertainties that could cause actual results to differ materially from those discussed. Although such forward-looking statements have been made in good faith and are based on reasonable assumptions, there is no assurance that the expected results will be achieved. These statements include (without limitation) statements as to future expectations, beliefs, plans, projections, strategies, objectives, events, conditions, and financial performance. In connection with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, we are providing this cautionary statement to identify important factors that could cause actual results to differ materially from those anticipated. The following factors, in addition to those discussed under Risk Factors in Ameren's Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, and elsewhere in this release and in our other filings with the Securities and Exchange Commission, could cause actual results to differ materially from management expectations suggested in such forward-looking statements: regulatory, judicial, or legislative actions, and any changes in regulatory policies and ratemaking determinations that may change regulatory recovery mechanisms; the length and severity of the COVID-19 pandemic, and its impacts on our business continuity plans and our results of operations, financial position, and liquidity, including but not limited to changes in customer demand resulting in changes to sales volumes, customers' payment for our services and their use of deferred payment arrangements, future regulatory or legislative actions that could require suspension of customer disconnections and/or late fees, among other things, for an extended period of time, the health and welfare of our workforce and contractors, supplier disruptions, delays in the completion of construction projects, which could impact our planned capital expenditures and expected planned rate base growth, Ameren Missouri's ability to recover any forgone customer late fee revenues or incremental costs, our ability to meet customer energy-efficiency program goals and earn performance incentives related to those programs, increased data security risks as a result of the transition to remote working arrangements for a significant portion of our workforce, and our ability to access the capital markets on reasonable terms and when needed; the effect on Ameren Missouri of any customer rate caps pursuant to Ameren Missouri's election to use the plant-in-service accounting regulatory mechanism, including an extension of use beyond 2023, if requested by Ameren Missouri and approved by the Missouri Public Service Commission; the effects of changes in federal, state, or local laws and other governmental actions, including monetary, fiscal, and energy policies; the effects of changes in federal, state, or local tax laws, regulations, interpretations, or rates, including as a result of amendments or technical corrections to the Tax Cuts and Jobs Act of 2017, and challenges to the tax positions taken by us, if any; the effects on energy prices and demand for our services resulting from technological advances, including advances in customer energy efficiency, electric vehicles, electrification of various industries, energy storage, and private generation sources, which generate electricity at the site of consumption and are becoming more cost-competitive; the effectiveness of Ameren Missouri's customer energy-efficiency programs and the related revenues and performance incentives earned under its Missouri Energy Efficiency Investment Act programs; our ability to align overall spending, both operating and capital, with frameworks established by our regulators and to recover these costs in a timely manner in our attempt to earn our allowed return on equity; the cost and availability of fuel, such as low-sulfur coal, natural gas, and enriched uranium used to produce electricity; the cost and availability of purchased power, zero emission credits, renewable energy credits, and natural gas for distribution; and the level and volatility of future market prices for such commodities and credits, including our ability to recover the costs for such commodities and credits and our customers' tolerance for any related price increases; the effectiveness of our risk management strategies and our use of financial and derivative instruments; the ability to obtain sufficient insurance, including insurance for Ameren Missouri's nuclear and coal-fired energy centers, or, in the absence of insurance, the ability to recover uninsured losses from our customers; the impact of cyberattacks on us or our suppliers, which could, among other things, result in the loss of operational control of energy centers and electric and natural gas transmission and distribution systems and/or the loss of data, such as customer, employee, financial, and operating system information; business and economic conditions, which have been affected by, and will be affected by the length and severity of, the COVID-19 pandemic, including the impact of such conditions on interest rates; disruptions of the capital markets, deterioration in our credit metrics, or other events that may have an adverse effect on the cost or availability of capital, including short-term credit and liquidity; the actions of credit rating agencies and the effects of such actions, including any impacts on our credit ratings that may result from the economic conditions of the COVID-19 pandemic; the inability of our counterparties to meet their obligations with respect to contracts, credit agreements, and financial instruments; the impact of weather conditions and other natural phenomena on us and our customers, including the impact of system outages; the construction, installation, performance, and cost recovery of generation, transmission, and distribution assets; the effects of failures of electric generation, electric and natural gas transmission or distribution, or natural gas storage facilities systems and equipment, which could result in unanticipated liabilities or unplanned outages; the operation of Ameren Missouri's Callaway Energy Center, including planned and unplanned outages, and decommissioning costs; Ameren Missouri's ability to recover the remaining investment, if any, and decommissioning costs associated with the retirement of an energy center, as well as the ability to earn a return on that remaining investment and those decommissioning costs; the impact of current environmental laws and new, more stringent, or changing requirements, including those related to the New Source Review provisions of the Clean Air Act, carbon dioxide and the implementation of the Affordable Clean Energy Rule, other emissions and discharges, cooling water intake structures, coal combustion residuals, and energy efficiency, that could limit or terminate the operation of certain of Ameren Missouri's energy centers, increase our operating costs or investment requirements, result in an impairment of our assets, cause us to sell our assets, reduce our customers' demand for electricity or natural gas, or otherwise have a negative financial effect; the impact of complying with renewable energy standards in Missouri; Ameren Missouri's ability to acquire wind, solar, and other renewable energy generation facilities and recover its cost of investment and related return in a timely manner, which is affected by the ability to obtain all necessary project approvals; the ability of developers to meet contractual commitments and complete projects timely, which is dependent upon the availability of necessary materials and equipment, including those that are affected by the disruptions in the global supply chain caused by the COVID-19 pandemic; and Ameren Missouri's ability to obtain a certificate of convenience and necessity from the Missouri Public Service Commission or any other required approvals for the addition of renewable resources, retirement of energy centers, and new or continued customer energy-efficiency programs; the availability of federal production and investment tax credits related to renewable energy and Ameren Missouri's ability to use such credits; the cost of wind, solar, and other renewable generation and storage technologies; and our ability to obtain timely interconnection agreements with the Midcontinent Independent System Operator, Inc. or other regional transmission organizations at an acceptable cost for each facility; advancements in carbon-free generation and storage technologies, and constructive federal and state energy and economic policies with respect to those technologies; labor disputes, work force reductions, changes in future wage and employee benefits costs, including those resulting from changes in discount rates, mortality tables, returns on benefit plan assets, and other assumptions; the impact of negative opinions of us or our utility services that our customers, investors, legislators, or regulators may have or develop, which could result from a variety of factors, including failures in system reliability, failure to implement our investment plans or to protect sensitive customer information, increases in rates, negative media coverage, or concerns about environmental, social, and/or governance practices; the effects of strategic initiatives, including mergers, acquisitions, and divestitures; legal and administrative proceedings; and acts of sabotage, war, terrorism, or other intentionally disruptive acts. New factors emerge from time to time, and it is not possible for management to predict all of such factors, nor can it assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained or implied in any forward-looking statement. Given these uncertainties, undue reliance should not be placed on these forward-looking statements. Except to the extent required by the federal securities laws, we undertake no obligation to update or revise publicly any forward-looking statements to reflect new information or future events. SOURCE Ameren Corporation Related Links http://www.ameren.com |
edtsum2887 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, May6, 2020 /PRNewswire/ -- American Finance Trust, Inc. (Nasdaq: AFIN) ("AFIN" or the "Company"), a real estate investment trust focused on acquiring and managing a diversified portfolio of primarily service-oriented1 and traditional retail and distribution related commercial real estate properties in the U.S., announced today its financial and operating results for the first quarter ended March31, 2020. First Quarter 2020 Highlights Revenue increased 4% to $74.6 million as compared to $71.5 million for the first quarter 2019 Net loss attributable to common stockholders was $9.2 million, or $0.08 per diluted share, compared to a net loss of $3.2 million, or $0.03 per diluted share, for the first quarter 2019 Cash net operating income ("NOI") grew by 6% to $59.0 million compared to $55.7 million for the first quarter 2019 Funds from Operations ("FFO") was $23.7 million, or $0.22 per diluted share compared to $26.8 million, or $0.25 per diluted share, for the first quarter 2019 Adjusted Funds from Operations ("AFFO") was $25.2 million, or $0.23 per diluted share, compared to $26.3 million or $0.25 per diluted share in the prior year first quarter Announced a dividend change to be paid beginning in April for the second quarter to $0.21 per share per quarter, or $0.85 per share on an annualized basis, expected to strengthen AFIN's cash flow by $6.8 million per quarter Closed on the acquisition of 31 properties for an aggregate contract purchase price of $90.0 million2 at a 7.4% weighted average cash capitalization rate3 and a weighted-average capitalization rate4 of 8.4% Total multi-tenant occupancy increased to 87.3% from 85.0% year-over-year High quality portfolio with 66% of tenants in single-tenant portfolio and 44% of the top 10 tenants5 in multi-tenant portfolio rated as investment grade or implied investment grade6 Annual rent escalators7 averaging 1.3% per year in 80.9% of leases provide contractually embedded rent growth Ample Liquidity8 of $215.0 million after borrowing an additional $153 million under credit facilities in March to enhance financial flexibility in response to COVID-19 Collected over 79% of cash rent due in April, including 92% in single tenant portfolio, with rent deferral amendments approved for 4% of the unpaid cash rent, while 16% of lease deferrals are in negotiation (see additional details in April Rents section below) CEO Comments Michael Weil, Chief Executive Officer, commented, "Our first quarter results highlight the strong momentum we had coming into this year. Going forward, we continue to have a high degree of confidence in our long-term outlook, reflecting the resilience and capabilities of our team and the financial strength of our portfolio. I am proud of the focused effort and proactive communications we took in early March to create direct dialog with our tenants in response to the unprecedented COVID-19 pandemic. This led to tremendous success, as we collected over 79% of the rents due in April during the month, including 97% of the rent payable from the top 20 tenants in our portfolio." Financial Results Three Months Ended March 31, (In thousands, except per share data) 2020 2019 Revenue from tenants $ 74,564 $ 71,541 Net loss attributable to common stockholders $ (9,153) $ (3,227) Net loss per common share (a) $ (0.08) $ (0.03) FFO attributable to common stockholders $ 23,690 $ 26,760 FFO per common share (a) $ 0.22 $ 0.25 AFFO attributable to common stockholders $ 25,237 $ 26,303 AFFO per common share (a) $ 0.23 $ 0.25 (a) All per share data based on 108,364,082 and 106,076,588 diluted weighted-average shares outstanding for the three months ended March31, 2020 and 2019, respectively. Real Estate Portfolio The Company's portfolio consisted of 848 net lease properties located in 46 states and the District of Columbia and comprised 18.9 million rentable square feet as of March31, 2020. Portfolio metrics include: 94.7% leased, up from 94.0% at the end of first quarter 2019, with 8.9 years remaining weighted-average lease term9 80.9% of leases have contractual rent increases of 1.3% on average based on annualized straight-line rent10 66% of single-tenant portfolio and 30% of multi-tenant anchor tenants annualized straight-line rent derived from investment grade or implied investment grade tenants 80% retail properties, 11% distribution properties and 9% office properties (based on an annualized straight-line rent) 69% of the retail portfolio focused on either service or experiential retail11 giving the company strong alignment with "e-commerce resistant" real estate Since 2017, dispositions averaged six years of remaining lease term while new acquisitions on average have 16 years remaining on their lease term as we continue to cycle out assets with short remaining lease terms and acquire long-term service-oriented retail assets 2.3% increase in multi-tenant occupancy, year over year Property Acquisitions During the three months ended March31, 2020, the Company acquired 31 properties for an aggregate contract purchase price of $90.0 million at a weighted average capitalization rate of 8.4%. Since 2017, 78% of all acquisitions have been properties leased to service retail tenants12. Subsequent to March 31, 2020, the Company completed one property acquisition for a contract purchase price of $6.9 million. The Company's acquisition pipeline as of April 15, 2020 includes 34 properties for an aggregate contract purchase price of $37.8 million. There can be no assurance that these acquisitions will be completed on current terms, or at all. Property Dispositions The Company sold two properties during the first quarter of 2020 for $3.8 million, of which approximately $1.3 million was used to repay related mortgage debt. Capital Structure and Liquidity Resources As of March31, 2020, the Company had a total borrowing capacity under its credit facility of $522.4 million. Of this amount, $483.1 million was outstanding under this facility as of March31, 2020 and $39.3 million remained available for future borrowing13. As of March31, 2020, the Company had $175.7 million of cash and cash equivalents. The Company's net debt14 to gross asset value15 was 38.8%, with net debt of $1.6 billion. The Company's percentage of fixed rate debt was 73.2% as of March31, 2020. The Company's total combined debt had a weighted-average interest rate costof 4.2%16, resulting in an interest coverage ratio of 2.8 times17. Dividend On March 30, 2020, the Company announced that its Board of Directors approved an annualized dividend of $0.85per share. The Company pays dividends monthly, and the change went into effect for the dividend which the Company declared inApril 2020. Subsequent Events Short-term Stockholder Rights Plan On April 13, 2020 the Company announced that its Board of Directors had approved a short-term stockholder rights plan to protect the long-term interests of the Company due to the substantial volatility in the trading of the Company's Class A common stock that has resulted from the ongoing COVID-19 pandemic. April Rents18 For the month of April, AFIN collected over 79% of the cash rents that were due across the portfolio, including 97% of the cash rent payable from the top 20 tenants19 in the portfolio and 92% of the cash rent payable in the single tenant portfolio. Of the April cash rent remaining, rent deferral amendments have been approved for 4% of the unpaid cash rent, while another 16% of rent deferrals are currently in negotiation. The remaining 1% generally represents tenants that have paid partial April cash rent but where the Company has not agreed to, or commenced negotiations regarding, any formal deferral arrangements. The typical deferral amendment defers payment of approximately 30% of the rent due for 3 months and is repaid within the first half of 2021. Footnotes/Definitions 1 Service retail is defined as single-tenant retail properties leased to tenants in the retail banking, restaurant, grocery, pharmacy, gas/convenience, healthcare, and auto services sectors 2 Represents the contract purchase price and excludes acquisition costs which are capitalized per GAAP. 3 Cash capitalization rate is a rate of return on a real estate investment property based on the expected, annualized cash rental income during the first year of ownership that the property will generate under its existing lease. Cash capitalization rate is calculated by dividing the annualized cash rental income the property will generate (before debt service and depreciation and after fixed costs and variable costs) and the purchase price of the property. The weighted-average cash capitalization rate is based upon square feet. 4 Capitalization rate is a rate of return on a real estate investment property based on the expected, annualized straight-line rental income that the property will generate under its existing lease. Capitalization rate is calculated by dividing the annualized straight-lined rental income the property will generate (before debt service and depreciation and after fixed costs and variable costs) and the purchase price of the property. The weighted-average capitalization rate is based upon square feet. 5 Percentage of single-tenant portfolio tenants and top 10 tenants based on annualized straight-line rent as of March 31, 2020. 6 As used herein, investment grade includes both actual investment grade ratings of the tenant or guarantor, if available, or implied investment grade. Implied investment grade may include actual ratings of tenant parent, guarantor parent (regardless of whether or not the parent has guaranteed the tenant's obligation under the lease) or by using a proprietary Moody's analytical tool, which generates an implied rating by measuring a company's probability of default. Ratings information is as of March31, 2020. Single-tenant portfolio tenants are 44.3% actual investment grade rated and 21.5% implied investment grade rate. Anchor tenants in the multi-tenant portfolio are 19.7% actual investment grade rated and 10.6% implied investment grade rated. 7 Based on annualized straight-line rent as of March31, 2020. Contractual rent increases include fixed percent or actual increases, or CPI-indexed increases. 8 Liquidityincludesthe amount available for future borrowings under the Company's credit facility of $39.3 million andcashandcashequivalents. In accordance with the Company's credit facility, the Company is permitted to pay distributions in an aggregate amount not exceeding 105% of MFFO (as defined in the Company's credit facility) for any applicable period (commencing with the period of two consecutive fiscal quarters ended on September 30, 2019) if, as of the last day of the period, the Company is able to satisfy a maximum leverage ratio after giving effect to the payments and also has a combination of cash, cash equivalents and amounts available for future borrowings under the credit facility of not less than $60.0 million. The Company satisfied these requirements and relied on this exception for all applicable periods (including the period ended March 31, 2020). The Company also expects it will rely on this exception in future periods. 9 Theweighted-averageremainingleaseterm(years)isbasedonannualized straight-line rent as of March31, 2020. 10 Annualized straight-line rent is calculated using the most recent available lease terms as of March31, 2020. 11 Experiential retail is defined as multi-tenant properties leased to tenants in the restaurant, discount retail, entertainment, salon/beauty, and grocery sectors, among others. 12 Based on acquisitions during the period from January 1, 2017 through March 31, 2020 excluding the multi-tenant properties acquired in the American Realty Capital Retail Centers of America, Inc. ("RCA") merger in February 2017. Weighted by annualized straight-line rent as of March 31, 2020. 13 The borrowing capacity and availability for future borrowings under the Company's credit facility is based on the borrowing base thereunder, which is the pool of eligible otherwise unencumbered real estate assets as March31, 2020. 14 Total debt of $1.8 billion less cash and cash equivalents of $175.7 million as of March31, 2020. Excludes the effect of deferredfinancingcosts,net,mortgagepremiums,net and includes the effect of cash and cash equivalents. 15Defined as the carrying value of total assets plus accumulated depreciation and amortization as of March31, 2020. 16 Weightedbasedontheoutstandingprincipalbalanceofthedebt. 17 The interest coverage ratio is calculated by dividing adjusted EBITDA by cash paid for interest (interestexpenselessamortization of deferred financing costs, net, and change in accrued interestandamortizationofmortgagepremiums on borrowings) for the quarter ended March31, 2020. 18 This information may not be indicative of any future period. The impact of the COVID-19 pandemic on the Company's rental revenue for the second quarter of 2020 and thereafter cannot be determined at present. The ultimate impact on our future results of operations and liquidity will depend on the overall length and severity of the COVID-19 pandemic, which management is unable to predict. With respect to ongoing negotiations of rent deferrals, there can be no assurance that these negotiations will be successful and will lead to formal rent deferral agreements on favorable terms, or at all. With respect to the other remaining unpaid amounts, there can be no assurance the Company will be successful in its efforts to collect or defer these amounts on a timely basis, or at all. 19 Top 20 tenants based on April cash rents Webcast and Conference Call AFIN will host a webcast and call on May 7, 2020 at 11:00 a.m. ET to discuss its financial and operating results. This webcast will be broadcast live over the Internet and can be accessed by all interested parties through the AFIN website, www.americanfinancetrust.com, in the "Investor Relations" section. Dial-in instructions for the conference call and the replay are outlined below. To listen to the live call, please go to AFIN's "Investor Relations" section of the website at least 15 minutes prior to the start of the call to register and download any necessary audio software. For those who are not able to listen to the live broadcast, a replay will be available shortly after the call on the AFIN website at www.americanfinancetrust.com. Live Call Dial-In (Toll Free): 1-888-317-6003 International Dial-In: 1-412-317-6061 Canada Dial-In (Toll Free): 1-866-605-3851 Participant Elite Entry Number: 4922290 Conference Replay* Domestic Dial-In (Toll Free): 1-877-344-7529 International Dial-In: 1-412-317-0088 Canada Dial-In (Toll Free): 1-855-669-9658 Conference Number: 10141883 *Available one hour after the end of the conference call through August 7, 2020. About American Finance Trust, Inc. American Finance Trust, Inc. (Nasdaq: AFIN) is a publicly traded real estate investment trust listed on the Nasdaq focused on acquiring and managing a diversified portfolio of primarily service-oriented and traditional retail and distribution related commercial real estate properties in the U.S. Additional information about AFIN can be found on its website at www.americanfinancetrust.com. Supplemental Schedules The Company will file supplemental information packages with the Securities and Exchange Commission (the "SEC") to provide additional disclosure and financial information. Once posted, the supplemental package can be found under the "Presentations" tab in the Investor Relations section of AFIN's website at www.americanfinancetrust.com and on the SEC website at www.sec.gov. Important Notice The statements in this press release that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words "anticipates," "believes," "expects," "estimates," "projects," "plans," "intends," "may," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of the Company's control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include the potential adverse effects of the ongoing global COVID-19 pandemic, including actions taken to contain or treat COVID-19, on the Company, the Company's tenants and the global economy and financial markets and that any potential future acquisition is subject to market conditions and capital availability and may not be identified or completed on favorable terms, or at all, as well as those risks and uncertainties set forth in the Risk Factors section of the Company's Annual Report on Form 10-K for the year ended December 31, 2019 filed on February 27, 2020 and all other filings with the SEC after that date, as such risks, uncertainties and other important factors may be updated from time to time in the Company's subsequent reports. Further, forward looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statement to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results, unless required to do so by law. Accounting Treatment of Rent Deferrals The Company currently anticipates that the majority of the concessions granted to its tenants as a result of the COVID-19 pandemic will be rent deferrals with the original lease term unchanged and collection of deferred rent deemed probable. The Company's revenue recognition policy requires that it must be probable that the Company will collect virtually all of the lease payments due and does not provide for partial reserves, or the ability to assume partial recovery. In light of the COVID-19 pandemic, the FASB and SEC agreed that for leases where the total lease cash flows will remain substantially the same or less than those after the COVID-19 related effects, companies may choose to forgo the evaluation of the enforceable rights and obligations of the original lease contract as a practical expedient and account for rent concessions as if they were part of the enforceable rights and obligations of the parties under the existing lease contract. As a result, we do not expect rental revenue used to calculate Net Income and Nareit FFO to be significantly impacted by deferrals. In addition, since we currently believe that these amounts are collectible, we would not plan to adjust from AFFO the amounts recognized under GAAP relating to rent deferrals. Contacts: Investors and Media: Email: [emailprotected] Phone: (866) 902-0063 American Finance Trust, Inc. Consolidated Balance Sheets (In thousands. except share and per share data) March 31,2020 December 31,2019 (Unaudited) ASSETS Real estate investments, at cost: Land $ 705,761 $ 685,889 Buildings, fixtures and improvements 2,739,793 2,681,485 Acquired intangible lease assets 448,642 448,175 Total real estate investments, at cost 3,894,196 3,815,549 Less: accumulated depreciation and amortization (554,271) (529,052) Total real estate investments, net 3,339,925 3,286,497 Cash and cash equivalents 175,745 81,898 Restricted cash 18,192 17,942 Deposits for real estate acquisitions 1,140 85 Deferred costs, net 16,934 17,467 Straight-line rent receivable 49,272 46,976 Operating lease right-of-use assets 18,841 18,959 Prepaid expenses and other assets (including $659 and $503 due from related parties as of March 31, 2020 and December 31, 2019, respectively) 20,142 19,188 Assets held for sale 5,937 1,176 Total assets $ 3,646,128 $ 3,490,188 LIABILITIES AND STOCKHOLDERS' EQUITY Mortgage notes payable, net $ 1,309,513 $ 1,310,943 Credit facility 483,147 333,147 Below market lease liabilities, net 82,624 84,041 Accounts payable and accrued expenses (including $473 and $1,153 due to related parties as of March 31, 2020 and December 31, 2019, respectively) 53,333 26,817 Operating lease liabilities 19,305 19,318 Deferred rent and other liabilities 8,685 10,392 Dividends payable 3,619 3,300 Total liabilities 1,960,226 1,787,958 7.50% Series A cumulative redeemable perpetual preferred stock, $0.01 par value, liquidation preference $25.00 per share, 8,796,000 shares authorized, 7,719,689 and 6,917,230 issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 77 69 Common stock, $0.01 par value per share, 300,000,000 shares authorized, 108,475,266 and 108,475,266 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 1,085 1,085 Additional paid-in capital 2,634,953 2,615,089 Distributions in excess of accumulated earnings (972,019) (932,912) Total stockholders' equity 1,664,096 1,683,331 Non-controlling interests 21,806 18,899 Total equity 1,685,902 1,702,230 Total liabilities and equity $ 3,646,128 $ 3,490,188 American Finance Trust, Inc. Consolidated Statements of Operations (Unaudited) (In thousands, except share and per share data) Three Months Ended March 31, 2020 2019 Revenue from tenants $ 74,564 $ 71,541 Operating expenses: Asset management fees to related party 6,905 6,038 Property operating expense 12,282 12,836 Impairment of real estate investments 823 Acquisition, transaction and other costs [1] 452 854 Equity-based compensation [2] 3,211 3,021 General and administrative 5,328 6,061 Depreciation and amortization 34,335 32,086 Total operating expenses 62,513 61,719 Operating income before gain on sale of real estate investments 12,051 9,822 Gain on sale of real estate investments 1,440 2,873 Operating income 13,491 12,695 Other (expense) income: Interest expense (19,106) (18,440) Other income 72 2,545 Total other expense, net (19,034) (15,895) Net loss (5,543) (3,200) Net loss attributable to non-controlling interests 9 3 Preferred stock dividends (3,619) (30) Net loss attributable to common stockholders $ (9,153) $ (3,227) Basic and Diluted Net Loss Per Share: Net loss per share attributable to common stockholders Basic and Diluted $ (0.08) $ (0.03) Weighted-average shares outstanding Basic and Diluted 108,364,082 106,076,588 _______ [1] For the three months ended March31, 2020 and 2019, includes litigation costs related to AFIN's 2017 merger with American Realty Capital - Retail Centers of America, Inc. (the "Merger") of $0.3 million and $0.3 million, respectively. [2] For the three months ended March31, 2020 and 2019, includes expense related to the Company's restricted common shares of $0.2 million and $0.3 million, respectively. American Finance Trust, Inc. Quarterly Reconciliation of Non-GAAP Measures (Unaudited) (In thousands) Three Months Ended March 31, 2020 2019 Adjusted EBITDA Net loss $ (5,543) $ (3,200) Depreciation and amortization 34,335 32,086 Interest expense 19,106 18,440 Impairment of real estate investments 823 Acquisition, transaction and other costs [1] 452 854 Equity-based compensation [2] 3,211 3,021 Gain on sale of real estate investments (1,440) (2,873) Other income (72) (2,545) Adjusted EBITDA 50,049 46,606 Asset management fees to related party 6,905 6,038 General and administrative 5,328 6,061 NOI 62,282 58,705 Amortization of market lease and other intangibles, net (992) (1,839) Straight-line rent (2,265) (1,196) Cash NOI $ 59,025 $ 55,670 Cash Paid for Interest: Interest expense $ 19,106 $ 18,440 Amortization of deferred financing costs, net and change in accrued interest (1,712) (1,329) Amortization of mortgage discounts and premiums on borrowings 560 794 Total cash paid for interest $ 17,954 $ 17,905 _______ [1] For the three months ended March31, 2020 and 2019, includes litigation costs related to the Merger of $0.3 million and $0.3 million, respectively. [2] For the three months ended March31, 2020 and 2019, includes expense related to the Company's restricted common shares of $0.2 million and $0.3 million, respectively. American Finance Trust, Inc. Quarterly Reconciliation of Non-GAAP Measures (Unaudited) (In thousands) Three Months Ended March 31, Three Months Ended December 31, 2020 2019 2019 Net loss attributable to common stockholders (in accordance with GAAP) $ (9,153) $ (3,227) $ (4,827) Impairment of real estate investments 823 Depreciation and amortization 34,335 32,086 31,802 Gain on sale of real estate investments (1,440) (2,873) (4,519) Proportionate share of adjustments for non-controlling interest to arrive at FFO (52) (49) (44) FFO attributable to common stockholders 23,690 26,760 22,412 Acquisition, transaction and other costs [1] 452 854 3,022 Litigation cost reimbursements related to the Merger [2] (9) (1,833) (316) Amortization of market lease and other intangibles, net (992) (1,839) (1,307) Straight-line rent (2,265) (1,196) (2,847) Amortization of mortgage premiums on borrowings (560) (794) (1,344) Equity-based compensation [3] 3,211 3,021 3,211 Amortization of deferred financing costs, net and change in accrued interest 1,712 1,329 2,394 Proportionate share of adjustments for non-controlling interest to arrive at AFFO (2) 1 (5) AFFO attributable to common stockholders $ 25,237 $ 26,303 $ 25,220 _______ [1] Primarily includes prepayment costs incurred in connection with early debt extinguishment as well as litigation costs related to the Merger. [2] Included in "Other income" in the Company's consolidated statement of operations. [3] Includes expense related to the amortization of the Company's restricted common shares and LTIP Units. Non-GAAP Financial Measures This release discusses the non-GAAP financial measures we use to evaluate our performance, including Funds from Operations ("FFO"), Adjusted Funds from Operations ("AFFO"), Adjusted Earnings before Interest, Taxes, Depreciation and Amortization ("Adjusted EBITDA"), Net Operating Income ("NOI") and Cash Net Operating Income ("Cash NOI"). While NOI is a property-level measure, AFFO is based on our total performance and therefore reflects the impact of other items not specifically associated with NOI such as, interest expense, general and administrative expenses and operating fees to related parties. Additionally, NOI as defined herein, does not reflect an adjustment for straight-line rent but AFFO does. A description of these non-GAAP measures and reconciliations to the most directly comparable GAAP measure, which is net income, is provided below. Adjustments for unconsolidated partnerships and joint ventures are calculated to exclude the proportionate share of the non-controlling interest to arrive at FFO, AFFO and NOI attributable to stockholders. Caution on Use of Non-GAAP Measures FFO, AFFO, Adjusted EBITDA, NOI and Cash NOI should not be construed to be more relevant or accurate than the current GAAP methodology in calculating net income or in its applicability in evaluating our operating performance. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP measures. Other REITs may not define FFO in accordance with the current National Association of Real Estate Investment Trusts ("NAREIT"), an industry trade group, definition (as we do), or may interpret the current NAREIT definition differently than we do, or may calculate AFFO differently than we do. Consequently, our presentation of FFO and AFFO may not be comparable to other similarly titled measures presented by other REITs. We consider FFO and AFFO useful indicators of our performance. Because FFO and AFFO calculations exclude such factors as depreciation and amortization of real estate assets and gains or losses from sales of operating real estate assets (which can vary among owners of identical assets in similar conditions based on historical cost accounting and useful-life estimates), FFO and AFFO presentations facilitate comparisons of operating performance between periods and between other REITs in our peer group. As a result, we believe that the use of FFO and AFFO, together with the required GAAP presentations, provide a more complete understanding of our performance, including relative to our peers and a more informed and appropriate basis on which to make decisions involving operating, financing, and investing activities. However, FFO and AFFO are not indicative of cash available to fund ongoing cash needs, including the ability to pay cash dividends. Investors are cautioned that FFO and AFFO should only be used to assess the sustainability of our operating performance excluding these activities, as they exclude certain costs that have a negative effect on our operating performance during the periods in which these costs are incurred. Funds from Operations and Adjusted Funds from Operations Funds from Operations Due to certain unique operating characteristics of real estate companies, as discussed below, the NAREIT, an industry trade group, has promulgated a performance measure known as FFO, which we believe to be an appropriate supplemental measure to reflect the operating performance of a REIT. FFO is not equivalent to net income or loss as determined under GAAP. We calculate FFO, a non-GAAP measure, consistent with the standards established over time by the Board of Governors of NAREIT, as restated in a White Paper and approved by the Board of Governors of NAREIT effective in December 2018 (the "White Paper"). The White Paper defines FFO as net income or loss computed in accordance with GAAP, excluding depreciation and amortization related to real estate, gains and losses from sales of certain real estate assets, gain and losses from change in control and impairment write-downs of certain real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity. Adjustments for consolidated partially-owned entities (including our Operating Partnership) and equity in earnings of unconsolidated affiliates are made to arrive at our proportionate share of FFO attributable to our stockholders. Our FFO calculation complies with NAREIT's definition. The historical accounting convention used for real estate assets requires straight-line depreciation of buildings and improvements, and straight-line amortization of intangibles. We believe that, because real estate values historically rise and fall with market conditions, including inflation, interest rates, unemployment and consumer spending, presentations of operating results for a REIT using historical accounting for depreciation and certain other items may be less informative. Historical accounting for real estate involves the use of GAAP. Any other method of accounting for real estate such as the fair value method cannot be construed to be any more accurate or relevant than the comparable methodologies of real estate valuation found in GAAP. Nevertheless, we believe that the use of FFO, which excludes the impact of real estate related depreciation and amortization, among other things, provides a more complete understanding of our performance to investors and to management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses, and interest costs, which may not be immediately apparent from net income. Adjusted Funds from Operations In calculating AFFO, we start with FFO, then we exclude certain income or expense items from AFFO that we consider to be more reflective of investing activities, such as fees related to the Listing, non-cash income and expense items and the income and expense effects of other activities that are not a fundamental attribute of our day to day operating business plan, such as amounts related to litigation arising out of the Merger. These amounts include legal costs incurred as a result of the litigation, portions of which have been and may in the future be reimbursed under insurance policies maintained by us.Insurance reimbursements are deducted from AFFO in the period of reimbursement. We believe that excluding the litigation costs and subsequent insurance reimbursements related to litigation arising out of the Merger helps to provide a better understanding of the operating performance of our business. Other income and expense items also include early extinguishment of debt and unrealized gains and losses, which may not ultimately be realized, such as gains or losses on derivative instruments and gains and losses on investments. In addition, by excluding non-cash income and expense items such as amortization of above-market and below-market leases intangibles, amortization of deferred financing costs, straight-line rent, vesting and conversion of the Class B Units and share-based compensation related to restricted shares and the 2018 OPP from AFFO, we believe we provide useful information regarding those income and expense items which have a direct impact on our ongoing operating performance. In calculating AFFO, we exclude certain expenses which under GAAP are characterized as operating expenses in determining operating net income (loss). All paid and accrued merger, acquisition and transaction related fees and certain other expenses negatively impact our operating performance during the period in which expenses are incurred or properties are acquired will also have negative effects on returns to investors but are not reflective of our on-going performance. Further, under GAAP, certain contemplated non-cash fair value and other non-cash adjustments are considered operating non-cash adjustments to net income (loss). In addition, as discussed above, we view gains and losses from fair value adjustments as items which are unrealized and may not ultimately be realized and not reflective of ongoing operations and are therefore typically adjusted for when assessing operating performance. Excluding income and expense items detailed above from our calculation of AFFO provides information consistent with management's analysis of our operating performance. Additionally, fair value adjustments, which are based on the impact of current market fluctuations and underlying assessments of general market conditions but can also result from operational factors such as rental and occupancy rates, may not be directly related or attributable to our current operating performance. By excluding such changes that may reflect anticipated and unrealized gains or losses, we believe AFFO provides useful supplemental information. By providing AFFO, we believe we are presenting useful information that can be used to better assess the sustainability of our ongoing operating performance without the impact of transactions or other items that are not related to the ongoing performance of our portfolio of properties. AFFO presented by us may not be comparable to AFFO reported by other REITs that define AFFO differently. Furthermore, we believe that in order to facilitate a clear understanding of our operating results, AFFO should be examined in conjunction with net income (loss) as presented in our consolidated financial statements. AFFO should not be considered as an alternative to net income (loss) as an indication of our performance or to cash flows as a measure of our liquidity or ability to pay dividends. Adjusted Earnings before Interest, Taxes, Depreciation and Amortization, Net Operating Income and Cash Net Operating Income. We believe that Adjusted EBITDA, which is defined as earnings before interest, taxes, depreciation and amortization adjusted for acquisition and transaction-related expenses, fees related to the Listing, other non-cash items such as the vesting and conversion of the Class B Units, expense related to our multi-year outperformance agreement with the Advisor and including our pro-rata share from unconsolidated joint ventures, is an appropriate measure of our ability to incur and service debt. Adjusted EBITDA should not be considered as an alternative to cash flows from operating activities, as a measure of our liquidity or as an alternative to net income as an indicator of our operating activities. Other REITs may calculate Adjusted EBITDA differently and our calculation should not be compared to that of other REITs. NOI is a non-GAAP financial measure used by us to evaluate the operating performance of our real estate. NOI is equal to total revenues, excluding contingent purchase price consideration, less property operating and maintenance expense. NOI excludes all other items of expense and income included in the financial statements in calculating net income (loss). We believe NOI provides useful and relevant information because it reflects only those income and expense items that are incurred at the property level and presents such items on an unleveraged basis. We use NOI to assess and compare property level performance and to make decisions concerning the operations of the properties. Further, we believe NOI is useful to investors as a performance measure because, when compared across periods, NOI reflects the impact on operations from trends in occupancy rates, rental rates, operating expenses and acquisition activity on an unleveraged basis, providing perspective not immediately apparent from net income (loss). NOI excludes certain items included in calculating net income (loss) in order to provide results that are more closely related to a property's results of operations. For example, interest expense is not necessarily linked to the operating performance of a real estate asset. In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort operating performance at the property level. NOI presented by us may not be comparable to NOI reported by other REITs that define NOI differently. We believe that in order to facilitate a clear understanding of our operating results, NOI should be examined in conjunction with net income (loss) as presented in our consolidated financial statements. NOI should not be considered as an alternative to net income (loss) as an indication of our performance or to cash flows as a measure of our liquidity or our ability to pay dividends. Cash NOI, is a non-GAAP financial measure that is intended to reflect the performance of our properties. We define Cash NOI as NOI excluding amortization of above/below market lease intangibles and straight-line adjustments that are included in GAAP lease revenues. We believe that Cash NOI is a helpful measure that both investors and management can use to evaluate the current financial performance of our properties and it allows for comparison of our operating performance between periods and to other REITs. Cash NOI should not be considered as an alternative to net income, as an indication of our financial performance, or to cash flows as a measure of liquidity or our ability to fund all needs. The method by which we calculate and present Cash NOI may not be directly comparable to the way other REITs present Cash NOI. SOURCE American Finance Trust, Inc. Related Links http://www.americanfinancetrust.com
Answer: | American Finance Trust Announces First Quarter 2020 Results | NEW YORK, May6, 2020 /PRNewswire/ -- American Finance Trust, Inc. (Nasdaq: AFIN) ("AFIN" or the "Company"), a real estate investment trust focused on acquiring and managing a diversified portfolio of primarily service-oriented1 and traditional retail and distribution related commercial real estate properties in the U.S., announced today its financial and operating results for the first quarter ended March31, 2020. First Quarter 2020 Highlights Revenue increased 4% to $74.6 million as compared to $71.5 million for the first quarter 2019 Net loss attributable to common stockholders was $9.2 million, or $0.08 per diluted share, compared to a net loss of $3.2 million, or $0.03 per diluted share, for the first quarter 2019 Cash net operating income ("NOI") grew by 6% to $59.0 million compared to $55.7 million for the first quarter 2019 Funds from Operations ("FFO") was $23.7 million, or $0.22 per diluted share compared to $26.8 million, or $0.25 per diluted share, for the first quarter 2019 Adjusted Funds from Operations ("AFFO") was $25.2 million, or $0.23 per diluted share, compared to $26.3 million or $0.25 per diluted share in the prior year first quarter Announced a dividend change to be paid beginning in April for the second quarter to $0.21 per share per quarter, or $0.85 per share on an annualized basis, expected to strengthen AFIN's cash flow by $6.8 million per quarter Closed on the acquisition of 31 properties for an aggregate contract purchase price of $90.0 million2 at a 7.4% weighted average cash capitalization rate3 and a weighted-average capitalization rate4 of 8.4% Total multi-tenant occupancy increased to 87.3% from 85.0% year-over-year High quality portfolio with 66% of tenants in single-tenant portfolio and 44% of the top 10 tenants5 in multi-tenant portfolio rated as investment grade or implied investment grade6 Annual rent escalators7 averaging 1.3% per year in 80.9% of leases provide contractually embedded rent growth Ample Liquidity8 of $215.0 million after borrowing an additional $153 million under credit facilities in March to enhance financial flexibility in response to COVID-19 Collected over 79% of cash rent due in April, including 92% in single tenant portfolio, with rent deferral amendments approved for 4% of the unpaid cash rent, while 16% of lease deferrals are in negotiation (see additional details in April Rents section below) CEO Comments Michael Weil, Chief Executive Officer, commented, "Our first quarter results highlight the strong momentum we had coming into this year. Going forward, we continue to have a high degree of confidence in our long-term outlook, reflecting the resilience and capabilities of our team and the financial strength of our portfolio. I am proud of the focused effort and proactive communications we took in early March to create direct dialog with our tenants in response to the unprecedented COVID-19 pandemic. This led to tremendous success, as we collected over 79% of the rents due in April during the month, including 97% of the rent payable from the top 20 tenants in our portfolio." Financial Results Three Months Ended March 31, (In thousands, except per share data) 2020 2019 Revenue from tenants $ 74,564 $ 71,541 Net loss attributable to common stockholders $ (9,153) $ (3,227) Net loss per common share (a) $ (0.08) $ (0.03) FFO attributable to common stockholders $ 23,690 $ 26,760 FFO per common share (a) $ 0.22 $ 0.25 AFFO attributable to common stockholders $ 25,237 $ 26,303 AFFO per common share (a) $ 0.23 $ 0.25 (a) All per share data based on 108,364,082 and 106,076,588 diluted weighted-average shares outstanding for the three months ended March31, 2020 and 2019, respectively. Real Estate Portfolio The Company's portfolio consisted of 848 net lease properties located in 46 states and the District of Columbia and comprised 18.9 million rentable square feet as of March31, 2020. Portfolio metrics include: 94.7% leased, up from 94.0% at the end of first quarter 2019, with 8.9 years remaining weighted-average lease term9 80.9% of leases have contractual rent increases of 1.3% on average based on annualized straight-line rent10 66% of single-tenant portfolio and 30% of multi-tenant anchor tenants annualized straight-line rent derived from investment grade or implied investment grade tenants 80% retail properties, 11% distribution properties and 9% office properties (based on an annualized straight-line rent) 69% of the retail portfolio focused on either service or experiential retail11 giving the company strong alignment with "e-commerce resistant" real estate Since 2017, dispositions averaged six years of remaining lease term while new acquisitions on average have 16 years remaining on their lease term as we continue to cycle out assets with short remaining lease terms and acquire long-term service-oriented retail assets 2.3% increase in multi-tenant occupancy, year over year Property Acquisitions During the three months ended March31, 2020, the Company acquired 31 properties for an aggregate contract purchase price of $90.0 million at a weighted average capitalization rate of 8.4%. Since 2017, 78% of all acquisitions have been properties leased to service retail tenants12. Subsequent to March 31, 2020, the Company completed one property acquisition for a contract purchase price of $6.9 million. The Company's acquisition pipeline as of April 15, 2020 includes 34 properties for an aggregate contract purchase price of $37.8 million. There can be no assurance that these acquisitions will be completed on current terms, or at all. Property Dispositions The Company sold two properties during the first quarter of 2020 for $3.8 million, of which approximately $1.3 million was used to repay related mortgage debt. Capital Structure and Liquidity Resources As of March31, 2020, the Company had a total borrowing capacity under its credit facility of $522.4 million. Of this amount, $483.1 million was outstanding under this facility as of March31, 2020 and $39.3 million remained available for future borrowing13. As of March31, 2020, the Company had $175.7 million of cash and cash equivalents. The Company's net debt14 to gross asset value15 was 38.8%, with net debt of $1.6 billion. The Company's percentage of fixed rate debt was 73.2% as of March31, 2020. The Company's total combined debt had a weighted-average interest rate costof 4.2%16, resulting in an interest coverage ratio of 2.8 times17. Dividend On March 30, 2020, the Company announced that its Board of Directors approved an annualized dividend of $0.85per share. The Company pays dividends monthly, and the change went into effect for the dividend which the Company declared inApril 2020. Subsequent Events Short-term Stockholder Rights Plan On April 13, 2020 the Company announced that its Board of Directors had approved a short-term stockholder rights plan to protect the long-term interests of the Company due to the substantial volatility in the trading of the Company's Class A common stock that has resulted from the ongoing COVID-19 pandemic. April Rents18 For the month of April, AFIN collected over 79% of the cash rents that were due across the portfolio, including 97% of the cash rent payable from the top 20 tenants19 in the portfolio and 92% of the cash rent payable in the single tenant portfolio. Of the April cash rent remaining, rent deferral amendments have been approved for 4% of the unpaid cash rent, while another 16% of rent deferrals are currently in negotiation. The remaining 1% generally represents tenants that have paid partial April cash rent but where the Company has not agreed to, or commenced negotiations regarding, any formal deferral arrangements. The typical deferral amendment defers payment of approximately 30% of the rent due for 3 months and is repaid within the first half of 2021. Footnotes/Definitions 1 Service retail is defined as single-tenant retail properties leased to tenants in the retail banking, restaurant, grocery, pharmacy, gas/convenience, healthcare, and auto services sectors 2 Represents the contract purchase price and excludes acquisition costs which are capitalized per GAAP. 3 Cash capitalization rate is a rate of return on a real estate investment property based on the expected, annualized cash rental income during the first year of ownership that the property will generate under its existing lease. Cash capitalization rate is calculated by dividing the annualized cash rental income the property will generate (before debt service and depreciation and after fixed costs and variable costs) and the purchase price of the property. The weighted-average cash capitalization rate is based upon square feet. 4 Capitalization rate is a rate of return on a real estate investment property based on the expected, annualized straight-line rental income that the property will generate under its existing lease. Capitalization rate is calculated by dividing the annualized straight-lined rental income the property will generate (before debt service and depreciation and after fixed costs and variable costs) and the purchase price of the property. The weighted-average capitalization rate is based upon square feet. 5 Percentage of single-tenant portfolio tenants and top 10 tenants based on annualized straight-line rent as of March 31, 2020. 6 As used herein, investment grade includes both actual investment grade ratings of the tenant or guarantor, if available, or implied investment grade. Implied investment grade may include actual ratings of tenant parent, guarantor parent (regardless of whether or not the parent has guaranteed the tenant's obligation under the lease) or by using a proprietary Moody's analytical tool, which generates an implied rating by measuring a company's probability of default. Ratings information is as of March31, 2020. Single-tenant portfolio tenants are 44.3% actual investment grade rated and 21.5% implied investment grade rate. Anchor tenants in the multi-tenant portfolio are 19.7% actual investment grade rated and 10.6% implied investment grade rated. 7 Based on annualized straight-line rent as of March31, 2020. Contractual rent increases include fixed percent or actual increases, or CPI-indexed increases. 8 Liquidityincludesthe amount available for future borrowings under the Company's credit facility of $39.3 million andcashandcashequivalents. In accordance with the Company's credit facility, the Company is permitted to pay distributions in an aggregate amount not exceeding 105% of MFFO (as defined in the Company's credit facility) for any applicable period (commencing with the period of two consecutive fiscal quarters ended on September 30, 2019) if, as of the last day of the period, the Company is able to satisfy a maximum leverage ratio after giving effect to the payments and also has a combination of cash, cash equivalents and amounts available for future borrowings under the credit facility of not less than $60.0 million. The Company satisfied these requirements and relied on this exception for all applicable periods (including the period ended March 31, 2020). The Company also expects it will rely on this exception in future periods. 9 Theweighted-averageremainingleaseterm(years)isbasedonannualized straight-line rent as of March31, 2020. 10 Annualized straight-line rent is calculated using the most recent available lease terms as of March31, 2020. 11 Experiential retail is defined as multi-tenant properties leased to tenants in the restaurant, discount retail, entertainment, salon/beauty, and grocery sectors, among others. 12 Based on acquisitions during the period from January 1, 2017 through March 31, 2020 excluding the multi-tenant properties acquired in the American Realty Capital Retail Centers of America, Inc. ("RCA") merger in February 2017. Weighted by annualized straight-line rent as of March 31, 2020. 13 The borrowing capacity and availability for future borrowings under the Company's credit facility is based on the borrowing base thereunder, which is the pool of eligible otherwise unencumbered real estate assets as March31, 2020. 14 Total debt of $1.8 billion less cash and cash equivalents of $175.7 million as of March31, 2020. Excludes the effect of deferredfinancingcosts,net,mortgagepremiums,net and includes the effect of cash and cash equivalents. 15Defined as the carrying value of total assets plus accumulated depreciation and amortization as of March31, 2020. 16 Weightedbasedontheoutstandingprincipalbalanceofthedebt. 17 The interest coverage ratio is calculated by dividing adjusted EBITDA by cash paid for interest (interestexpenselessamortization of deferred financing costs, net, and change in accrued interestandamortizationofmortgagepremiums on borrowings) for the quarter ended March31, 2020. 18 This information may not be indicative of any future period. The impact of the COVID-19 pandemic on the Company's rental revenue for the second quarter of 2020 and thereafter cannot be determined at present. The ultimate impact on our future results of operations and liquidity will depend on the overall length and severity of the COVID-19 pandemic, which management is unable to predict. With respect to ongoing negotiations of rent deferrals, there can be no assurance that these negotiations will be successful and will lead to formal rent deferral agreements on favorable terms, or at all. With respect to the other remaining unpaid amounts, there can be no assurance the Company will be successful in its efforts to collect or defer these amounts on a timely basis, or at all. 19 Top 20 tenants based on April cash rents Webcast and Conference Call AFIN will host a webcast and call on May 7, 2020 at 11:00 a.m. ET to discuss its financial and operating results. This webcast will be broadcast live over the Internet and can be accessed by all interested parties through the AFIN website, www.americanfinancetrust.com, in the "Investor Relations" section. Dial-in instructions for the conference call and the replay are outlined below. To listen to the live call, please go to AFIN's "Investor Relations" section of the website at least 15 minutes prior to the start of the call to register and download any necessary audio software. For those who are not able to listen to the live broadcast, a replay will be available shortly after the call on the AFIN website at www.americanfinancetrust.com. Live Call Dial-In (Toll Free): 1-888-317-6003 International Dial-In: 1-412-317-6061 Canada Dial-In (Toll Free): 1-866-605-3851 Participant Elite Entry Number: 4922290 Conference Replay* Domestic Dial-In (Toll Free): 1-877-344-7529 International Dial-In: 1-412-317-0088 Canada Dial-In (Toll Free): 1-855-669-9658 Conference Number: 10141883 *Available one hour after the end of the conference call through August 7, 2020. About American Finance Trust, Inc. American Finance Trust, Inc. (Nasdaq: AFIN) is a publicly traded real estate investment trust listed on the Nasdaq focused on acquiring and managing a diversified portfolio of primarily service-oriented and traditional retail and distribution related commercial real estate properties in the U.S. Additional information about AFIN can be found on its website at www.americanfinancetrust.com. Supplemental Schedules The Company will file supplemental information packages with the Securities and Exchange Commission (the "SEC") to provide additional disclosure and financial information. Once posted, the supplemental package can be found under the "Presentations" tab in the Investor Relations section of AFIN's website at www.americanfinancetrust.com and on the SEC website at www.sec.gov. Important Notice The statements in this press release that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words "anticipates," "believes," "expects," "estimates," "projects," "plans," "intends," "may," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of the Company's control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include the potential adverse effects of the ongoing global COVID-19 pandemic, including actions taken to contain or treat COVID-19, on the Company, the Company's tenants and the global economy and financial markets and that any potential future acquisition is subject to market conditions and capital availability and may not be identified or completed on favorable terms, or at all, as well as those risks and uncertainties set forth in the Risk Factors section of the Company's Annual Report on Form 10-K for the year ended December 31, 2019 filed on February 27, 2020 and all other filings with the SEC after that date, as such risks, uncertainties and other important factors may be updated from time to time in the Company's subsequent reports. Further, forward looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statement to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results, unless required to do so by law. Accounting Treatment of Rent Deferrals The Company currently anticipates that the majority of the concessions granted to its tenants as a result of the COVID-19 pandemic will be rent deferrals with the original lease term unchanged and collection of deferred rent deemed probable. The Company's revenue recognition policy requires that it must be probable that the Company will collect virtually all of the lease payments due and does not provide for partial reserves, or the ability to assume partial recovery. In light of the COVID-19 pandemic, the FASB and SEC agreed that for leases where the total lease cash flows will remain substantially the same or less than those after the COVID-19 related effects, companies may choose to forgo the evaluation of the enforceable rights and obligations of the original lease contract as a practical expedient and account for rent concessions as if they were part of the enforceable rights and obligations of the parties under the existing lease contract. As a result, we do not expect rental revenue used to calculate Net Income and Nareit FFO to be significantly impacted by deferrals. In addition, since we currently believe that these amounts are collectible, we would not plan to adjust from AFFO the amounts recognized under GAAP relating to rent deferrals. Contacts: Investors and Media: Email: [emailprotected] Phone: (866) 902-0063 American Finance Trust, Inc. Consolidated Balance Sheets (In thousands. except share and per share data) March 31,2020 December 31,2019 (Unaudited) ASSETS Real estate investments, at cost: Land $ 705,761 $ 685,889 Buildings, fixtures and improvements 2,739,793 2,681,485 Acquired intangible lease assets 448,642 448,175 Total real estate investments, at cost 3,894,196 3,815,549 Less: accumulated depreciation and amortization (554,271) (529,052) Total real estate investments, net 3,339,925 3,286,497 Cash and cash equivalents 175,745 81,898 Restricted cash 18,192 17,942 Deposits for real estate acquisitions 1,140 85 Deferred costs, net 16,934 17,467 Straight-line rent receivable 49,272 46,976 Operating lease right-of-use assets 18,841 18,959 Prepaid expenses and other assets (including $659 and $503 due from related parties as of March 31, 2020 and December 31, 2019, respectively) 20,142 19,188 Assets held for sale 5,937 1,176 Total assets $ 3,646,128 $ 3,490,188 LIABILITIES AND STOCKHOLDERS' EQUITY Mortgage notes payable, net $ 1,309,513 $ 1,310,943 Credit facility 483,147 333,147 Below market lease liabilities, net 82,624 84,041 Accounts payable and accrued expenses (including $473 and $1,153 due to related parties as of March 31, 2020 and December 31, 2019, respectively) 53,333 26,817 Operating lease liabilities 19,305 19,318 Deferred rent and other liabilities 8,685 10,392 Dividends payable 3,619 3,300 Total liabilities 1,960,226 1,787,958 7.50% Series A cumulative redeemable perpetual preferred stock, $0.01 par value, liquidation preference $25.00 per share, 8,796,000 shares authorized, 7,719,689 and 6,917,230 issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 77 69 Common stock, $0.01 par value per share, 300,000,000 shares authorized, 108,475,266 and 108,475,266 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 1,085 1,085 Additional paid-in capital 2,634,953 2,615,089 Distributions in excess of accumulated earnings (972,019) (932,912) Total stockholders' equity 1,664,096 1,683,331 Non-controlling interests 21,806 18,899 Total equity 1,685,902 1,702,230 Total liabilities and equity $ 3,646,128 $ 3,490,188 American Finance Trust, Inc. Consolidated Statements of Operations (Unaudited) (In thousands, except share and per share data) Three Months Ended March 31, 2020 2019 Revenue from tenants $ 74,564 $ 71,541 Operating expenses: Asset management fees to related party 6,905 6,038 Property operating expense 12,282 12,836 Impairment of real estate investments 823 Acquisition, transaction and other costs [1] 452 854 Equity-based compensation [2] 3,211 3,021 General and administrative 5,328 6,061 Depreciation and amortization 34,335 32,086 Total operating expenses 62,513 61,719 Operating income before gain on sale of real estate investments 12,051 9,822 Gain on sale of real estate investments 1,440 2,873 Operating income 13,491 12,695 Other (expense) income: Interest expense (19,106) (18,440) Other income 72 2,545 Total other expense, net (19,034) (15,895) Net loss (5,543) (3,200) Net loss attributable to non-controlling interests 9 3 Preferred stock dividends (3,619) (30) Net loss attributable to common stockholders $ (9,153) $ (3,227) Basic and Diluted Net Loss Per Share: Net loss per share attributable to common stockholders Basic and Diluted $ (0.08) $ (0.03) Weighted-average shares outstanding Basic and Diluted 108,364,082 106,076,588 _______ [1] For the three months ended March31, 2020 and 2019, includes litigation costs related to AFIN's 2017 merger with American Realty Capital - Retail Centers of America, Inc. (the "Merger") of $0.3 million and $0.3 million, respectively. [2] For the three months ended March31, 2020 and 2019, includes expense related to the Company's restricted common shares of $0.2 million and $0.3 million, respectively. American Finance Trust, Inc. Quarterly Reconciliation of Non-GAAP Measures (Unaudited) (In thousands) Three Months Ended March 31, 2020 2019 Adjusted EBITDA Net loss $ (5,543) $ (3,200) Depreciation and amortization 34,335 32,086 Interest expense 19,106 18,440 Impairment of real estate investments 823 Acquisition, transaction and other costs [1] 452 854 Equity-based compensation [2] 3,211 3,021 Gain on sale of real estate investments (1,440) (2,873) Other income (72) (2,545) Adjusted EBITDA 50,049 46,606 Asset management fees to related party 6,905 6,038 General and administrative 5,328 6,061 NOI 62,282 58,705 Amortization of market lease and other intangibles, net (992) (1,839) Straight-line rent (2,265) (1,196) Cash NOI $ 59,025 $ 55,670 Cash Paid for Interest: Interest expense $ 19,106 $ 18,440 Amortization of deferred financing costs, net and change in accrued interest (1,712) (1,329) Amortization of mortgage discounts and premiums on borrowings 560 794 Total cash paid for interest $ 17,954 $ 17,905 _______ [1] For the three months ended March31, 2020 and 2019, includes litigation costs related to the Merger of $0.3 million and $0.3 million, respectively. [2] For the three months ended March31, 2020 and 2019, includes expense related to the Company's restricted common shares of $0.2 million and $0.3 million, respectively. American Finance Trust, Inc. Quarterly Reconciliation of Non-GAAP Measures (Unaudited) (In thousands) Three Months Ended March 31, Three Months Ended December 31, 2020 2019 2019 Net loss attributable to common stockholders (in accordance with GAAP) $ (9,153) $ (3,227) $ (4,827) Impairment of real estate investments 823 Depreciation and amortization 34,335 32,086 31,802 Gain on sale of real estate investments (1,440) (2,873) (4,519) Proportionate share of adjustments for non-controlling interest to arrive at FFO (52) (49) (44) FFO attributable to common stockholders 23,690 26,760 22,412 Acquisition, transaction and other costs [1] 452 854 3,022 Litigation cost reimbursements related to the Merger [2] (9) (1,833) (316) Amortization of market lease and other intangibles, net (992) (1,839) (1,307) Straight-line rent (2,265) (1,196) (2,847) Amortization of mortgage premiums on borrowings (560) (794) (1,344) Equity-based compensation [3] 3,211 3,021 3,211 Amortization of deferred financing costs, net and change in accrued interest 1,712 1,329 2,394 Proportionate share of adjustments for non-controlling interest to arrive at AFFO (2) 1 (5) AFFO attributable to common stockholders $ 25,237 $ 26,303 $ 25,220 _______ [1] Primarily includes prepayment costs incurred in connection with early debt extinguishment as well as litigation costs related to the Merger. [2] Included in "Other income" in the Company's consolidated statement of operations. [3] Includes expense related to the amortization of the Company's restricted common shares and LTIP Units. Non-GAAP Financial Measures This release discusses the non-GAAP financial measures we use to evaluate our performance, including Funds from Operations ("FFO"), Adjusted Funds from Operations ("AFFO"), Adjusted Earnings before Interest, Taxes, Depreciation and Amortization ("Adjusted EBITDA"), Net Operating Income ("NOI") and Cash Net Operating Income ("Cash NOI"). While NOI is a property-level measure, AFFO is based on our total performance and therefore reflects the impact of other items not specifically associated with NOI such as, interest expense, general and administrative expenses and operating fees to related parties. Additionally, NOI as defined herein, does not reflect an adjustment for straight-line rent but AFFO does. A description of these non-GAAP measures and reconciliations to the most directly comparable GAAP measure, which is net income, is provided below. Adjustments for unconsolidated partnerships and joint ventures are calculated to exclude the proportionate share of the non-controlling interest to arrive at FFO, AFFO and NOI attributable to stockholders. Caution on Use of Non-GAAP Measures FFO, AFFO, Adjusted EBITDA, NOI and Cash NOI should not be construed to be more relevant or accurate than the current GAAP methodology in calculating net income or in its applicability in evaluating our operating performance. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP measures. Other REITs may not define FFO in accordance with the current National Association of Real Estate Investment Trusts ("NAREIT"), an industry trade group, definition (as we do), or may interpret the current NAREIT definition differently than we do, or may calculate AFFO differently than we do. Consequently, our presentation of FFO and AFFO may not be comparable to other similarly titled measures presented by other REITs. We consider FFO and AFFO useful indicators of our performance. Because FFO and AFFO calculations exclude such factors as depreciation and amortization of real estate assets and gains or losses from sales of operating real estate assets (which can vary among owners of identical assets in similar conditions based on historical cost accounting and useful-life estimates), FFO and AFFO presentations facilitate comparisons of operating performance between periods and between other REITs in our peer group. As a result, we believe that the use of FFO and AFFO, together with the required GAAP presentations, provide a more complete understanding of our performance, including relative to our peers and a more informed and appropriate basis on which to make decisions involving operating, financing, and investing activities. However, FFO and AFFO are not indicative of cash available to fund ongoing cash needs, including the ability to pay cash dividends. Investors are cautioned that FFO and AFFO should only be used to assess the sustainability of our operating performance excluding these activities, as they exclude certain costs that have a negative effect on our operating performance during the periods in which these costs are incurred. Funds from Operations and Adjusted Funds from Operations Funds from Operations Due to certain unique operating characteristics of real estate companies, as discussed below, the NAREIT, an industry trade group, has promulgated a performance measure known as FFO, which we believe to be an appropriate supplemental measure to reflect the operating performance of a REIT. FFO is not equivalent to net income or loss as determined under GAAP. We calculate FFO, a non-GAAP measure, consistent with the standards established over time by the Board of Governors of NAREIT, as restated in a White Paper and approved by the Board of Governors of NAREIT effective in December 2018 (the "White Paper"). The White Paper defines FFO as net income or loss computed in accordance with GAAP, excluding depreciation and amortization related to real estate, gains and losses from sales of certain real estate assets, gain and losses from change in control and impairment write-downs of certain real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity. Adjustments for consolidated partially-owned entities (including our Operating Partnership) and equity in earnings of unconsolidated affiliates are made to arrive at our proportionate share of FFO attributable to our stockholders. Our FFO calculation complies with NAREIT's definition. The historical accounting convention used for real estate assets requires straight-line depreciation of buildings and improvements, and straight-line amortization of intangibles. We believe that, because real estate values historically rise and fall with market conditions, including inflation, interest rates, unemployment and consumer spending, presentations of operating results for a REIT using historical accounting for depreciation and certain other items may be less informative. Historical accounting for real estate involves the use of GAAP. Any other method of accounting for real estate such as the fair value method cannot be construed to be any more accurate or relevant than the comparable methodologies of real estate valuation found in GAAP. Nevertheless, we believe that the use of FFO, which excludes the impact of real estate related depreciation and amortization, among other things, provides a more complete understanding of our performance to investors and to management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses, and interest costs, which may not be immediately apparent from net income. Adjusted Funds from Operations In calculating AFFO, we start with FFO, then we exclude certain income or expense items from AFFO that we consider to be more reflective of investing activities, such as fees related to the Listing, non-cash income and expense items and the income and expense effects of other activities that are not a fundamental attribute of our day to day operating business plan, such as amounts related to litigation arising out of the Merger. These amounts include legal costs incurred as a result of the litigation, portions of which have been and may in the future be reimbursed under insurance policies maintained by us.Insurance reimbursements are deducted from AFFO in the period of reimbursement. We believe that excluding the litigation costs and subsequent insurance reimbursements related to litigation arising out of the Merger helps to provide a better understanding of the operating performance of our business. Other income and expense items also include early extinguishment of debt and unrealized gains and losses, which may not ultimately be realized, such as gains or losses on derivative instruments and gains and losses on investments. In addition, by excluding non-cash income and expense items such as amortization of above-market and below-market leases intangibles, amortization of deferred financing costs, straight-line rent, vesting and conversion of the Class B Units and share-based compensation related to restricted shares and the 2018 OPP from AFFO, we believe we provide useful information regarding those income and expense items which have a direct impact on our ongoing operating performance. In calculating AFFO, we exclude certain expenses which under GAAP are characterized as operating expenses in determining operating net income (loss). All paid and accrued merger, acquisition and transaction related fees and certain other expenses negatively impact our operating performance during the period in which expenses are incurred or properties are acquired will also have negative effects on returns to investors but are not reflective of our on-going performance. Further, under GAAP, certain contemplated non-cash fair value and other non-cash adjustments are considered operating non-cash adjustments to net income (loss). In addition, as discussed above, we view gains and losses from fair value adjustments as items which are unrealized and may not ultimately be realized and not reflective of ongoing operations and are therefore typically adjusted for when assessing operating performance. Excluding income and expense items detailed above from our calculation of AFFO provides information consistent with management's analysis of our operating performance. Additionally, fair value adjustments, which are based on the impact of current market fluctuations and underlying assessments of general market conditions but can also result from operational factors such as rental and occupancy rates, may not be directly related or attributable to our current operating performance. By excluding such changes that may reflect anticipated and unrealized gains or losses, we believe AFFO provides useful supplemental information. By providing AFFO, we believe we are presenting useful information that can be used to better assess the sustainability of our ongoing operating performance without the impact of transactions or other items that are not related to the ongoing performance of our portfolio of properties. AFFO presented by us may not be comparable to AFFO reported by other REITs that define AFFO differently. Furthermore, we believe that in order to facilitate a clear understanding of our operating results, AFFO should be examined in conjunction with net income (loss) as presented in our consolidated financial statements. AFFO should not be considered as an alternative to net income (loss) as an indication of our performance or to cash flows as a measure of our liquidity or ability to pay dividends. Adjusted Earnings before Interest, Taxes, Depreciation and Amortization, Net Operating Income and Cash Net Operating Income. We believe that Adjusted EBITDA, which is defined as earnings before interest, taxes, depreciation and amortization adjusted for acquisition and transaction-related expenses, fees related to the Listing, other non-cash items such as the vesting and conversion of the Class B Units, expense related to our multi-year outperformance agreement with the Advisor and including our pro-rata share from unconsolidated joint ventures, is an appropriate measure of our ability to incur and service debt. Adjusted EBITDA should not be considered as an alternative to cash flows from operating activities, as a measure of our liquidity or as an alternative to net income as an indicator of our operating activities. Other REITs may calculate Adjusted EBITDA differently and our calculation should not be compared to that of other REITs. NOI is a non-GAAP financial measure used by us to evaluate the operating performance of our real estate. NOI is equal to total revenues, excluding contingent purchase price consideration, less property operating and maintenance expense. NOI excludes all other items of expense and income included in the financial statements in calculating net income (loss). We believe NOI provides useful and relevant information because it reflects only those income and expense items that are incurred at the property level and presents such items on an unleveraged basis. We use NOI to assess and compare property level performance and to make decisions concerning the operations of the properties. Further, we believe NOI is useful to investors as a performance measure because, when compared across periods, NOI reflects the impact on operations from trends in occupancy rates, rental rates, operating expenses and acquisition activity on an unleveraged basis, providing perspective not immediately apparent from net income (loss). NOI excludes certain items included in calculating net income (loss) in order to provide results that are more closely related to a property's results of operations. For example, interest expense is not necessarily linked to the operating performance of a real estate asset. In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort operating performance at the property level. NOI presented by us may not be comparable to NOI reported by other REITs that define NOI differently. We believe that in order to facilitate a clear understanding of our operating results, NOI should be examined in conjunction with net income (loss) as presented in our consolidated financial statements. NOI should not be considered as an alternative to net income (loss) as an indication of our performance or to cash flows as a measure of our liquidity or our ability to pay dividends. Cash NOI, is a non-GAAP financial measure that is intended to reflect the performance of our properties. We define Cash NOI as NOI excluding amortization of above/below market lease intangibles and straight-line adjustments that are included in GAAP lease revenues. We believe that Cash NOI is a helpful measure that both investors and management can use to evaluate the current financial performance of our properties and it allows for comparison of our operating performance between periods and to other REITs. Cash NOI should not be considered as an alternative to net income, as an indication of our financial performance, or to cash flows as a measure of liquidity or our ability to fund all needs. The method by which we calculate and present Cash NOI may not be directly comparable to the way other REITs present Cash NOI. SOURCE American Finance Trust, Inc. Related Links http://www.americanfinancetrust.com |
edtsum2891 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES, Dec. 4, 2020 /PRNewswire/ -- The States is the largest tech market globally, accounting for 33% of the total, or $6.1 trillion for 2021. Of the 20 biggest tech giants, over half of them are US-based. This includes Microsoft, Apple, Google, Intel, Oracle, Salesforce, and more. California's Silicon Valley is famously known for its tech hub. Los Angeles, the second-largest city in the US, is growing its tech market. As per the CBRE report, the market has created double the no. of tech jobs and ranks 26th in the country for tech jobs. LA has been forming a tech talent pool for years, which isn't something out of the ordinary. Out of a pool of IT solutions, mobile apps are what every business is seeking to implement for its expansion and development. There are 6300 tech companies already located in the city of LA. There is a massive demand for IT services in the upcoming tech hub of the US. Businesses worldwide are looking for a reputed and credible app development company, and for this, they can confirm their past work experience, team expertise, client reviews, and ratings. Hyperlink InfoSystem is a one-stop destination for offering the best app development solutions for all your technical requirements. Founded in 2011, Hyperlink InfoSystem is one of the leading app developersbased in India and has been expanding its operations ever since. The company currently has offices in the USA, UAE, UK, and Australia and has worked with more than 2300 clients worldwide, with most of them based in the USA. They have managed to develop over 3200 apps and 1600 websites with more than 400 other latest tech-based projects with years of experience. They provide services like web & app development, IoT solutions, Blockchain, Data Science, Salesforce, AR/VR apps, AI, ML, and more. The company even participates in tech events held in the States like MWC Los Angeles and CES every year & exhibit their services. Founder & CEO of Hyperlink InfoSystem, Harnil Oza, Says, "As a leading app development company, we aspire to grow bigger to cater to our clients' needs and help them grow as well. We understand the client's needs carefully before working on the project with the latest technologies." Hyperlink InfoSystem is one of the best app development companies for your business based in LA. You can connect with the team at [emailprotected] and discuss your requirements with one of the leading app development companies in the world. About Hyperlink InfoSystem: Hyperlink InfoSystemis an established and popular top web & mobile app development company based in USA, UK, UAE, France, Canada with its development center in India. The company's talented team of 250+ developers offers world-class services in the areas of Mobile app & Web Development, Blockchain Development, AR & VR App Development, Game App Development, Artificial Intelligence, Data Science, Salesforce & much more. Since 2011, the company has successfully built 3,200+ mobile apps for more than 2,300 clients around the world. Awarded As Top App Development Companies in Los Angeles in 2020; https://topappdevelopmentcompanies.com/us/directory/app-developers/los-angeles https://topsoftwarecompanies.co/united-states-of-america/app-development/agencies/los-angeles https://appdevelopmentcompanies.co/local-agencies/us/app-developers/los-angeles Contact Details: Hyperlink InfoSystemHarnil Oza+1-805-744-1224[emailprotected] New York Address: One World Trade Center285 Fulton Street suite 8500,New York, NY 10007,United States London Address: Level 30, The Leadenhall Building,122 Leadenhall Street,London EC3V 4AB SOURCE Hyperlink InfoSystem
Answer: | Hyperlink InfoSystem Becomes One Of The Most Popular App Development Companies In Los Angeles | LOS ANGELES, Dec. 4, 2020 /PRNewswire/ -- The States is the largest tech market globally, accounting for 33% of the total, or $6.1 trillion for 2021. Of the 20 biggest tech giants, over half of them are US-based. This includes Microsoft, Apple, Google, Intel, Oracle, Salesforce, and more. California's Silicon Valley is famously known for its tech hub. Los Angeles, the second-largest city in the US, is growing its tech market. As per the CBRE report, the market has created double the no. of tech jobs and ranks 26th in the country for tech jobs. LA has been forming a tech talent pool for years, which isn't something out of the ordinary. Out of a pool of IT solutions, mobile apps are what every business is seeking to implement for its expansion and development. There are 6300 tech companies already located in the city of LA. There is a massive demand for IT services in the upcoming tech hub of the US. Businesses worldwide are looking for a reputed and credible app development company, and for this, they can confirm their past work experience, team expertise, client reviews, and ratings. Hyperlink InfoSystem is a one-stop destination for offering the best app development solutions for all your technical requirements. Founded in 2011, Hyperlink InfoSystem is one of the leading app developersbased in India and has been expanding its operations ever since. The company currently has offices in the USA, UAE, UK, and Australia and has worked with more than 2300 clients worldwide, with most of them based in the USA. They have managed to develop over 3200 apps and 1600 websites with more than 400 other latest tech-based projects with years of experience. They provide services like web & app development, IoT solutions, Blockchain, Data Science, Salesforce, AR/VR apps, AI, ML, and more. The company even participates in tech events held in the States like MWC Los Angeles and CES every year & exhibit their services. Founder & CEO of Hyperlink InfoSystem, Harnil Oza, Says, "As a leading app development company, we aspire to grow bigger to cater to our clients' needs and help them grow as well. We understand the client's needs carefully before working on the project with the latest technologies." Hyperlink InfoSystem is one of the best app development companies for your business based in LA. You can connect with the team at [emailprotected] and discuss your requirements with one of the leading app development companies in the world. About Hyperlink InfoSystem: Hyperlink InfoSystemis an established and popular top web & mobile app development company based in USA, UK, UAE, France, Canada with its development center in India. The company's talented team of 250+ developers offers world-class services in the areas of Mobile app & Web Development, Blockchain Development, AR & VR App Development, Game App Development, Artificial Intelligence, Data Science, Salesforce & much more. Since 2011, the company has successfully built 3,200+ mobile apps for more than 2,300 clients around the world. Awarded As Top App Development Companies in Los Angeles in 2020; https://topappdevelopmentcompanies.com/us/directory/app-developers/los-angeles https://topsoftwarecompanies.co/united-states-of-america/app-development/agencies/los-angeles https://appdevelopmentcompanies.co/local-agencies/us/app-developers/los-angeles Contact Details: Hyperlink InfoSystemHarnil Oza+1-805-744-1224[emailprotected] New York Address: One World Trade Center285 Fulton Street suite 8500,New York, NY 10007,United States London Address: Level 30, The Leadenhall Building,122 Leadenhall Street,London EC3V 4AB SOURCE Hyperlink InfoSystem |
edtsum2892 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MINNEAPOLIS--(BUSINESS WIRE)--U.S. Bancorp (NYSE: USB) announced today that Chairman, President and Chief Executive Officer Andy Cecere along with Vice Chair and Chief Financial Officer Terry Dolan will present at the Barclays Global Financial Services Conference held virtually at 2 p.m. ET on Tuesday, September 15. A live webcast will be available on the day of the conference, at the Webcasts and Presentations section of the U.S. Bank Investor Relations website. About U.S. Bancorp U.S. Bancorp, with more than 70,000 employees and $547 billion in assets as of June 30, 2020, is the parent company of U.S. Bank National Association, the fifth-largest commercial bank in the United States. The Minneapolis-based bank blends its relationship teams, branches and ATM network with mobile and online tools that allow customers to bank how, when and where they prefer. U.S. Bank is committed to serving its millions of retail, business, wealth management, payment, commercial and corporate, and investment services customers across the country and around the world as a trusted financial partner, a commitment recognized by the Ethisphere Institute naming the bank one of the 2020 Worlds Most Ethical Companies. Visit U.S. Bank at www.usbank.com or follow on social media to stay up to date with company news.
Answer: | U.S. Bancorp to Speak at the Barclays Global Financial Services Conference | MINNEAPOLIS--(BUSINESS WIRE)--U.S. Bancorp (NYSE: USB) announced today that Chairman, President and Chief Executive Officer Andy Cecere along with Vice Chair and Chief Financial Officer Terry Dolan will present at the Barclays Global Financial Services Conference held virtually at 2 p.m. ET on Tuesday, September 15. A live webcast will be available on the day of the conference, at the Webcasts and Presentations section of the U.S. Bank Investor Relations website. About U.S. Bancorp U.S. Bancorp, with more than 70,000 employees and $547 billion in assets as of June 30, 2020, is the parent company of U.S. Bank National Association, the fifth-largest commercial bank in the United States. The Minneapolis-based bank blends its relationship teams, branches and ATM network with mobile and online tools that allow customers to bank how, when and where they prefer. U.S. Bank is committed to serving its millions of retail, business, wealth management, payment, commercial and corporate, and investment services customers across the country and around the world as a trusted financial partner, a commitment recognized by the Ethisphere Institute naming the bank one of the 2020 Worlds Most Ethical Companies. Visit U.S. Bank at www.usbank.com or follow on social media to stay up to date with company news. |
edtsum2893 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, April 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AMD, NIO, PFE, and WFC. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast. AAPL: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=AAPL&prnumber=041620217 AMD: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=AMD&prnumber=041620217 NIO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NIO&prnumber=041620217 PFE: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PFE&prnumber=041620217 WFC: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=WFC&prnumber=041620217 (Note: You may have to copy this link into your browser then press the [ENTER] key.) SOURCE InvestorsObserver Related Links http://www.investorsobserver.com
Answer: | Thinking about trading options or stock in Apple, Advanced Micro Devices, Nio, Pfizer, or Wells Fargo? | NEW YORK, April 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AMD, NIO, PFE, and WFC. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast. AAPL: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=AAPL&prnumber=041620217 AMD: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=AMD&prnumber=041620217 NIO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NIO&prnumber=041620217 PFE: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PFE&prnumber=041620217 WFC: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=WFC&prnumber=041620217 (Note: You may have to copy this link into your browser then press the [ENTER] key.) SOURCE InvestorsObserver Related Links http://www.investorsobserver.com |
edtsum2894 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHICAGO, April 7, 2020 /PRNewswire/ -- Global HR technology leader CareerBuilder today introduces a new tagline, We're Building For You, reaffirming its commitment to the job seekers and employers it has worked with for more than two decades. Recent labor market swings have put strain on job seekers and talent acquisition professionals around the globe, shedding light on the power of technology to improve and streamline every step of the job seeker experience as well as the talent acquisition and retention process. The company's new tagline serves as a brand promise to job seekers and employers alike that the solutions provided by CareerBuilder have been developed with their goals and success in mind. Continue Reading CareerBuilder: We're Building For You Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8701351-careerbuilder-were-building-for-you/ "The market changed suddenly from the lowest unemployment rate in more than a half century to the highest number of jobless claims ever recorded in just a matter of weeks," said Irina Novoselsky, CEO of CareerBuilder. "Given CareerBuilder's unique position in this dual-sided marketplace, as supply and demand shifts, we are able to provide valuable insights that help employers and job seekers react and adapt quickly. In response to the COVID-19 pandemic, our team mobilized swiftly to begin providing real time data on the labor market, create a dedicated job resources center and work with clients to determine which solutions best support them in this environment. Our new tagline embodies our commitment to constantly evolve and build solutions that connect job seekers with meaningful employment and help employers find quality candidates to quickly fill positions and build a strong talent pipeline to be ready when the need arises." "User feedback, performance data and industry research drive the solutions we develop at CareerBuilder," commented Leigh-Margaret Stull, EVP of Marketing and Product Enablement at CareerBuilder. "This new tagline is our way of sharing that our end-users are always top of mind. Given the current employment landscape driven by the coronavirus pandemic, we have many clients working to quickly fill highly in-demand positions while others are faced with hard decisions.Many of our job seekers find themselves and their families in very challenging times. Now more than ever we want our clients and job seekers to know that we are here to support them and that we will get through this together."CareerBuilder's highly flexible multi-channel Talent Acquisition Suite offers unmatched tools in one unified recruiting experience with a rich marketplace of more than 20 million active job seekers built in. Supporting businesses from Hello To Hire, CareerBuilder offers clients a range of tools including virtual hiring events, branded social networks to increase internal engagement and encourage employee referrals, and optimized career micro-sites that automatically re-engage candidates, manage recruitment workflow, and get real-time reports on the performance of recruitment sources. Solving critical pain points for job seekers, CareerBuilder offers a mobile app, improved geo-based job search functionality, augmented reality and an award-winning AI Resume Builder. In response to the COVID-19 crisis, CareerBuilder quickly mobilized to create a dedicated resources center offering guidance to job seekers and employers. Anyone affected can text COVID to 51893 to access job support and see which companies are hiring now. Additionally, data and information is being shared on social media to provide real-time labor market insights using the hashtag #CareerBuilderCovidData.CareerBuilder's innovations are fueled by AI and machine-learning technologies providing unparalleled capabilities to match job seekers to opportunities and deliver candidates to employers.CareerBuilder is the largest provider of AI-powered hiring solutions serving the majority of the Fortune 500 across five specialized markets. About CareerBuilderCareerBuilderis a global technology company that provides end-to-end talent acquisition solutions to help employers find, hire and onboard great talent, and helps job seekers build new skills and progressive careers as the modern world of work changes. An industry disruptor for nearly 25 years, CareerBuilder is the only company that offers both software and services to cover every step of the HelloToHire process, enabling its customers to free up valuable resources across their HR tech supply chain to drive their business forward.CareerBuilder operates in the United States, Canada, Europe and Asia and is the largest provider of AI-powered hiring solutions servingthe majority ofthe Fortune 500 across five specialized markets. CareerBuilder is majority-owned by funds managed by affiliates of Apollo Global Management, Inc. and Ontario Teachers' Pension Plan Board. For more information, visitcareerbuilder.comfor a great candidate experience andhiring.careerbuilder.comto learn more about our solutions for employers.Media ContactSteph Rosenblum[emailprotected]646.843.1822SOURCE CareerBuilder Related Links http://www.careerbuilder.com
Answer: | CareerBuilder Introduces New Tagline "We're Building For You" Underscoring its Commitment to Employers and Job Seekers Top talent acquisition platform proves innovation and agility are paramount for companies and candidates navigating the labor market | CHICAGO, April 7, 2020 /PRNewswire/ -- Global HR technology leader CareerBuilder today introduces a new tagline, We're Building For You, reaffirming its commitment to the job seekers and employers it has worked with for more than two decades. Recent labor market swings have put strain on job seekers and talent acquisition professionals around the globe, shedding light on the power of technology to improve and streamline every step of the job seeker experience as well as the talent acquisition and retention process. The company's new tagline serves as a brand promise to job seekers and employers alike that the solutions provided by CareerBuilder have been developed with their goals and success in mind. Continue Reading CareerBuilder: We're Building For You Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8701351-careerbuilder-were-building-for-you/ "The market changed suddenly from the lowest unemployment rate in more than a half century to the highest number of jobless claims ever recorded in just a matter of weeks," said Irina Novoselsky, CEO of CareerBuilder. "Given CareerBuilder's unique position in this dual-sided marketplace, as supply and demand shifts, we are able to provide valuable insights that help employers and job seekers react and adapt quickly. In response to the COVID-19 pandemic, our team mobilized swiftly to begin providing real time data on the labor market, create a dedicated job resources center and work with clients to determine which solutions best support them in this environment. Our new tagline embodies our commitment to constantly evolve and build solutions that connect job seekers with meaningful employment and help employers find quality candidates to quickly fill positions and build a strong talent pipeline to be ready when the need arises." "User feedback, performance data and industry research drive the solutions we develop at CareerBuilder," commented Leigh-Margaret Stull, EVP of Marketing and Product Enablement at CareerBuilder. "This new tagline is our way of sharing that our end-users are always top of mind. Given the current employment landscape driven by the coronavirus pandemic, we have many clients working to quickly fill highly in-demand positions while others are faced with hard decisions.Many of our job seekers find themselves and their families in very challenging times. Now more than ever we want our clients and job seekers to know that we are here to support them and that we will get through this together."CareerBuilder's highly flexible multi-channel Talent Acquisition Suite offers unmatched tools in one unified recruiting experience with a rich marketplace of more than 20 million active job seekers built in. Supporting businesses from Hello To Hire, CareerBuilder offers clients a range of tools including virtual hiring events, branded social networks to increase internal engagement and encourage employee referrals, and optimized career micro-sites that automatically re-engage candidates, manage recruitment workflow, and get real-time reports on the performance of recruitment sources. Solving critical pain points for job seekers, CareerBuilder offers a mobile app, improved geo-based job search functionality, augmented reality and an award-winning AI Resume Builder. In response to the COVID-19 crisis, CareerBuilder quickly mobilized to create a dedicated resources center offering guidance to job seekers and employers. Anyone affected can text COVID to 51893 to access job support and see which companies are hiring now. Additionally, data and information is being shared on social media to provide real-time labor market insights using the hashtag #CareerBuilderCovidData.CareerBuilder's innovations are fueled by AI and machine-learning technologies providing unparalleled capabilities to match job seekers to opportunities and deliver candidates to employers.CareerBuilder is the largest provider of AI-powered hiring solutions serving the majority of the Fortune 500 across five specialized markets. About CareerBuilderCareerBuilderis a global technology company that provides end-to-end talent acquisition solutions to help employers find, hire and onboard great talent, and helps job seekers build new skills and progressive careers as the modern world of work changes. An industry disruptor for nearly 25 years, CareerBuilder is the only company that offers both software and services to cover every step of the HelloToHire process, enabling its customers to free up valuable resources across their HR tech supply chain to drive their business forward.CareerBuilder operates in the United States, Canada, Europe and Asia and is the largest provider of AI-powered hiring solutions servingthe majority ofthe Fortune 500 across five specialized markets. CareerBuilder is majority-owned by funds managed by affiliates of Apollo Global Management, Inc. and Ontario Teachers' Pension Plan Board. For more information, visitcareerbuilder.comfor a great candidate experience andhiring.careerbuilder.comto learn more about our solutions for employers.Media ContactSteph Rosenblum[emailprotected]646.843.1822SOURCE CareerBuilder Related Links http://www.careerbuilder.com |
edtsum2898 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, March 16, 2020 /PRNewswire/ -- The "U.S. Major Networks & Issuers Market Analysis, Performance & Trends - Quarterly Review (2015-2019) and Annual Historical & Forecast (2015-2025)" report has been added to ResearchAndMarkets.com's offering. The mixed performance bag of the U.S. payment card market in 2019 produced record-setting double-digit yields and highest pre-tax ROAs in more than 30 years. However, portfolio metrics reveal erratic American consumer behavior with spending and debt, amidst global economic uncertainty. The extended U.S. recovery has produced an erosion in credit quality, re-igniting a race to the bottom. Going forward, profitability in the U.S. payment card market will likely face significant pressure from recession losses, reduced purchase volume coupled with rising account acquisition and card enhancement costs.This report, divided into seven sections, examines the operating performance, critical metrics, market dynamics and growth potential of the U.S. payment card market, including credit cards, charge cards, debit cards and prepaid cards.The report carefully examines the historical performance patterns on a quarter-by-quarter basis for the past five years. Annual historical performance of the past five years is reviewed and coupled with a five year forecast. Performance data are presented individually and by peer group.The report primarily covers a wide range of peer group performance metrics for the four major U.S.-based payment card networks, four largest U.S. bank payment card portfolios, and the two hybrid network/issuers. Collectively this peer group represents over 60% of the total U.S. market in payment card outstandings and nearly 100% of the U.S. market based on purchase dollar volume.Additionally, the report identifies and details the current individual annual performance data (outstandings and purchase dollar volume) of the 50 largest U.S. issuers, representing over 70% of the U.S. payment card market. Historical and current quarterly performance data (revolving debt, delinquency, charge-offs and pricing) of the Top 100 banks, based on assets, representing more than 80% of the U.S. payment card market, is presented on a peer group level.Most importantly each of the 43 parts includes a commentary and analysis of other key performance discussion, if relevant, including marketing expenses, per account acquisition costs, marketing channels, voluntary attrition, involuntary attrition, average tickets, portfolio segmentation by credit score and product type, reward redemption rates, fee development, demographics, new products and services, mobile apps and emerging payment technology.Through a total of 344 exhibits and more than 5,000 data points the U.S. payment card market reveals the trend lines developing over the past five years and the basis for a reliable five-year forecast.The report closely examines the four major U.S. networks quarterly and annually operating performance in the U.S. market as it pertains to gross dollar volume, purchase dollar volume, open accounts, cards-in-force, and market share. The data are presented individually and as a peer group.Additionally, the two largest networks are reviewed, quarterly and annually, individually and combined, for gross dollar volume, purchase dollar volume, cash dollar volume, open accounts, cards-in-force, gross transactions, purchase transactions, cash transactions.The four largest U.S. credit card issuer portfolios are examined individually, and as a peer group, for the past five-year period, quarter-by-quarter, and annually. Critical portfolio metrics include early stage delinquency, late stage delinquency, charge-offs, loan-loss reserves, yield, marketshare, profit/loss, outstandings, gross volume, purchase volume, total open accounts, total active accounts, and cards-in-force.The portfolios of the four largest U.S. credit card issuers, combined with the two largest hybrid issuer/networks, are examined individually and presented as a peer group, quarterly and annually. Metrics include early stage delinquency, late stage delinquency, charge-offs, loan-loss reserves, yield, marketshare, profit/loss, outstandings, gross volume, purchase volume, total open accounts, total active accounts, and cards-in-force.Report Highlights U.S. payment networks will post purchase volumes below an 8% CAGR (Compound Annual Growth Rate) for the next four years U.S. card issuers will face average delinquency ratios climbing above 3% for the next three years U.S. top issuers will report eroding average yields of less than 12% for the next five years U.S. consumer Debt Service Ratio will trend upward by 40 bps over next two years Industry Insights The U.S. payment card industry has reached the point of saturation of credit card products, the maturation of debit card products and the accelerating penetration of prepaid cards will produce unprecedented challenges in the next five years. Card issuers are also facing a likely downward global economic cycle in the 2021 to 2023 period, dampening U.S. consumer spending and personal debt aversion.Regardless, opportunities abound in the U.S, marketplace with the integration of mobile apps and other financial technology (Fintech) to capture payment volume. Migrating current and future card products to less complex and lower cost rewards programs is inevitable. Snippet counter marketing of competitor weaknesses in basic card pricing in late payment, balance transfers, cash advances and foreign transactions will likely emerge.While risk management will be the key to the mitigation of card metrics during the next few years including credit lines, opportunities exist to market consumer friendly debt management through minimum payment waivers and short-term interest rate reductions.It is imperative for U.S. payment card issuers to thoroughly review the effectiveness of current marketing channels, stem the rising tide of account attrition rates pervasive among major portfolios. Internet marketing has become intrusive over the past five years, diminishing brand value via the aggressiveness of online marketing via third parties. With a focus on the four largest payments networks and the four largest issuers in the U.S. credit, charge, debit, and prepaid card business, collectively representing the gorilla and lion of market share, this report: Provides quarter-by-quarter data points from Q1 2015 through Q4 2019 of all basic and critical metrics of network and issuer operating performance Furnishes annual portfolio operating performance for 2015 through 2019 and appropriately weighted performance annual projections for 2020 through 2025. Presents over 300 exhibits and more than 5,000 data points to rmly establish individual and peer group momentum during a stable macro economy. Appraises through 43 commentary reports voluntary attrition, involuntary attrition, average tickets, portfolio segmentation by credit score and product type, reward redemption rates, etc. Evaluates portfolio segmentation by credit score and product type, reward redemption rates, fee development, demographics, new products and services, mobile apps and emerging payment technology. Assess more than 50 individual U.S. bank credit card programs, including loans outstanding and purchase value, including a peer group snapshot of the Top 100 U.S. banks operating within the credit card segment. Estimates the macro, micro trends and particularity of the U.S. payment card market and the likelihood of merger and acquisition activity through 2025. Key Topics Covered(7 Sections - 43 Parts - 344 Exhibits - 5,000+ Data Points - 400+ Pages) SECTION A: U.S. Network Peer GroupPart 01 - U.S.-Based Network Credit/Charge Card U.S. Gross Dollar VolumePart 02 - U.S.-Based Network U.S. Payment Card (Credit+Charge+Debit+Prepaid) Purchase Dollar VolumePart 03 - U.S.-Based Network U.S. Payment Card (Credit+Charge+Debit+Prepaid) Gross (Open) AccountsPart 04 - U.S.-Based Network U.S. Payment Card (Credit+Charge+Debit+Prepaid) Cards-in-ForcePart 05 - U.S.-Based Network U.S. Payment Card (Credit+Charge+Debit+Prepaid) Marketshare/Gross Dollar Volume SECTION B: U.S. Issuer Peer GroupPart 06 - Four Largest U.S. Credit/Charge Card Issuers U.S. Gross Dollar VolumePart 07 - Four Largest U.S. Credit/Charge Card Issuers U.S. Purchase Dollar VolumePart 08 - Four Largest U.S. Credit/Charge Card Issuers U.S. End-of-Period OutstandingsPart 09 - Four Largest U.S. Credit/Charge Card Issuers U.S. Gross (Open) AccountsPart 10 - Four Largest U.S. Credit/Charge Card Issuers U.S. Active (Sales) AccountsPart 11 - Four Largest U.S. Credit/Charge Card Issuers U.S. Cards-in-ForcePart 12 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card 30+ Day DelinquencyPart 13 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card 90+ Day DelinquencyPart 14 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card Charge-OffsPart 15 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card Portfolio YieldPart 16 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card Marketshare/ Purchase Dollar VolumePart 17 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card Profit/Loss SECTION C: U.S. Visa + Mastercard Peer GroupPart 18 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Gross Dollar Volume ($US)Part 19 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Purchase Dollar Volume ($US)Part 20 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Cash Dollar Volume ($US)Part 21 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Gross (Open) Accounts [2015-2019]Part 22 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Cards-in-Force [2015-2019]Part 23 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Gross Transactions [2015-2019]Part 24 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Purchase Transactions [2015-2019]Part 25 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Cash Transactions [2015-2019] SECTION D: U.S. Issuer + Network Peer GroupPart 26 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Gross Dollar VolumePart 27 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Purchase Dollar VolumePart 28 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. End-of-Period OutstandingsPart 29 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Gross (Open) AccountsPart 30 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Active (Sales) AccountsPart 31 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Cards-in-ForcePart 32 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. 30+ Day DelinquencyPart 33 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. 90+ Day DelinquencyPart 34 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Charge-OffsPart 35 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Portfolio YieldPart 36 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Marketshare/Purchase Dollar VolumePart 37 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card Largest U.S. Profit/Loss SECTION E: U.S. Top 50 IssuersPart 38 - U.S. Top 50 Issuers Credit/Charge Card SECTION F: U.S. Top 100 IssuersPart 39 - Top 100 Banks Quarterly U.S. Credit Card 30+ Day DelinquencyPart 40 - Top 100 Banks Quarterly U.S. Credit Card Charge-OffsPart 41 - Top 100 Banks U.S. Credit Card Monthly Interest Rates SECTION G: U.S. Consumer StatisticsPart 42 - U.S. Monthly Revolving Consumer CreditPart 43 - U.S. Quarterly Consumer Financial Obligations & Debt Service Ratio Companies Mentioned Alliance Data Systems America First Credit Union American Express BBVA BECU BMO Harris Bank Bank of America Bank of the West Barclays Bank Capital One Chase Citibank Discover JPM Chase Mastercard Visa For more information about this report visit https://www.researchandmarkets.com/r/3yqic5 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | U.S. Major Networks & Issuers Industry, 2015-2025 - The Extended U.S. Recovery has Produced an Erosion in Credit Quality, Re-Igniting a Race to the Bottom | DUBLIN, March 16, 2020 /PRNewswire/ -- The "U.S. Major Networks & Issuers Market Analysis, Performance & Trends - Quarterly Review (2015-2019) and Annual Historical & Forecast (2015-2025)" report has been added to ResearchAndMarkets.com's offering. The mixed performance bag of the U.S. payment card market in 2019 produced record-setting double-digit yields and highest pre-tax ROAs in more than 30 years. However, portfolio metrics reveal erratic American consumer behavior with spending and debt, amidst global economic uncertainty. The extended U.S. recovery has produced an erosion in credit quality, re-igniting a race to the bottom. Going forward, profitability in the U.S. payment card market will likely face significant pressure from recession losses, reduced purchase volume coupled with rising account acquisition and card enhancement costs.This report, divided into seven sections, examines the operating performance, critical metrics, market dynamics and growth potential of the U.S. payment card market, including credit cards, charge cards, debit cards and prepaid cards.The report carefully examines the historical performance patterns on a quarter-by-quarter basis for the past five years. Annual historical performance of the past five years is reviewed and coupled with a five year forecast. Performance data are presented individually and by peer group.The report primarily covers a wide range of peer group performance metrics for the four major U.S.-based payment card networks, four largest U.S. bank payment card portfolios, and the two hybrid network/issuers. Collectively this peer group represents over 60% of the total U.S. market in payment card outstandings and nearly 100% of the U.S. market based on purchase dollar volume.Additionally, the report identifies and details the current individual annual performance data (outstandings and purchase dollar volume) of the 50 largest U.S. issuers, representing over 70% of the U.S. payment card market. Historical and current quarterly performance data (revolving debt, delinquency, charge-offs and pricing) of the Top 100 banks, based on assets, representing more than 80% of the U.S. payment card market, is presented on a peer group level.Most importantly each of the 43 parts includes a commentary and analysis of other key performance discussion, if relevant, including marketing expenses, per account acquisition costs, marketing channels, voluntary attrition, involuntary attrition, average tickets, portfolio segmentation by credit score and product type, reward redemption rates, fee development, demographics, new products and services, mobile apps and emerging payment technology.Through a total of 344 exhibits and more than 5,000 data points the U.S. payment card market reveals the trend lines developing over the past five years and the basis for a reliable five-year forecast.The report closely examines the four major U.S. networks quarterly and annually operating performance in the U.S. market as it pertains to gross dollar volume, purchase dollar volume, open accounts, cards-in-force, and market share. The data are presented individually and as a peer group.Additionally, the two largest networks are reviewed, quarterly and annually, individually and combined, for gross dollar volume, purchase dollar volume, cash dollar volume, open accounts, cards-in-force, gross transactions, purchase transactions, cash transactions.The four largest U.S. credit card issuer portfolios are examined individually, and as a peer group, for the past five-year period, quarter-by-quarter, and annually. Critical portfolio metrics include early stage delinquency, late stage delinquency, charge-offs, loan-loss reserves, yield, marketshare, profit/loss, outstandings, gross volume, purchase volume, total open accounts, total active accounts, and cards-in-force.The portfolios of the four largest U.S. credit card issuers, combined with the two largest hybrid issuer/networks, are examined individually and presented as a peer group, quarterly and annually. Metrics include early stage delinquency, late stage delinquency, charge-offs, loan-loss reserves, yield, marketshare, profit/loss, outstandings, gross volume, purchase volume, total open accounts, total active accounts, and cards-in-force.Report Highlights U.S. payment networks will post purchase volumes below an 8% CAGR (Compound Annual Growth Rate) for the next four years U.S. card issuers will face average delinquency ratios climbing above 3% for the next three years U.S. top issuers will report eroding average yields of less than 12% for the next five years U.S. consumer Debt Service Ratio will trend upward by 40 bps over next two years Industry Insights The U.S. payment card industry has reached the point of saturation of credit card products, the maturation of debit card products and the accelerating penetration of prepaid cards will produce unprecedented challenges in the next five years. Card issuers are also facing a likely downward global economic cycle in the 2021 to 2023 period, dampening U.S. consumer spending and personal debt aversion.Regardless, opportunities abound in the U.S, marketplace with the integration of mobile apps and other financial technology (Fintech) to capture payment volume. Migrating current and future card products to less complex and lower cost rewards programs is inevitable. Snippet counter marketing of competitor weaknesses in basic card pricing in late payment, balance transfers, cash advances and foreign transactions will likely emerge.While risk management will be the key to the mitigation of card metrics during the next few years including credit lines, opportunities exist to market consumer friendly debt management through minimum payment waivers and short-term interest rate reductions.It is imperative for U.S. payment card issuers to thoroughly review the effectiveness of current marketing channels, stem the rising tide of account attrition rates pervasive among major portfolios. Internet marketing has become intrusive over the past five years, diminishing brand value via the aggressiveness of online marketing via third parties. With a focus on the four largest payments networks and the four largest issuers in the U.S. credit, charge, debit, and prepaid card business, collectively representing the gorilla and lion of market share, this report: Provides quarter-by-quarter data points from Q1 2015 through Q4 2019 of all basic and critical metrics of network and issuer operating performance Furnishes annual portfolio operating performance for 2015 through 2019 and appropriately weighted performance annual projections for 2020 through 2025. Presents over 300 exhibits and more than 5,000 data points to rmly establish individual and peer group momentum during a stable macro economy. Appraises through 43 commentary reports voluntary attrition, involuntary attrition, average tickets, portfolio segmentation by credit score and product type, reward redemption rates, etc. Evaluates portfolio segmentation by credit score and product type, reward redemption rates, fee development, demographics, new products and services, mobile apps and emerging payment technology. Assess more than 50 individual U.S. bank credit card programs, including loans outstanding and purchase value, including a peer group snapshot of the Top 100 U.S. banks operating within the credit card segment. Estimates the macro, micro trends and particularity of the U.S. payment card market and the likelihood of merger and acquisition activity through 2025. Key Topics Covered(7 Sections - 43 Parts - 344 Exhibits - 5,000+ Data Points - 400+ Pages) SECTION A: U.S. Network Peer GroupPart 01 - U.S.-Based Network Credit/Charge Card U.S. Gross Dollar VolumePart 02 - U.S.-Based Network U.S. Payment Card (Credit+Charge+Debit+Prepaid) Purchase Dollar VolumePart 03 - U.S.-Based Network U.S. Payment Card (Credit+Charge+Debit+Prepaid) Gross (Open) AccountsPart 04 - U.S.-Based Network U.S. Payment Card (Credit+Charge+Debit+Prepaid) Cards-in-ForcePart 05 - U.S.-Based Network U.S. Payment Card (Credit+Charge+Debit+Prepaid) Marketshare/Gross Dollar Volume SECTION B: U.S. Issuer Peer GroupPart 06 - Four Largest U.S. Credit/Charge Card Issuers U.S. Gross Dollar VolumePart 07 - Four Largest U.S. Credit/Charge Card Issuers U.S. Purchase Dollar VolumePart 08 - Four Largest U.S. Credit/Charge Card Issuers U.S. End-of-Period OutstandingsPart 09 - Four Largest U.S. Credit/Charge Card Issuers U.S. Gross (Open) AccountsPart 10 - Four Largest U.S. Credit/Charge Card Issuers U.S. Active (Sales) AccountsPart 11 - Four Largest U.S. Credit/Charge Card Issuers U.S. Cards-in-ForcePart 12 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card 30+ Day DelinquencyPart 13 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card 90+ Day DelinquencyPart 14 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card Charge-OffsPart 15 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card Portfolio YieldPart 16 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card Marketshare/ Purchase Dollar VolumePart 17 - Four Largest U.S. Credit/Charge Card Issuers U.S. Card Profit/Loss SECTION C: U.S. Visa + Mastercard Peer GroupPart 18 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Gross Dollar Volume ($US)Part 19 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Purchase Dollar Volume ($US)Part 20 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Cash Dollar Volume ($US)Part 21 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Gross (Open) Accounts [2015-2019]Part 22 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Cards-in-Force [2015-2019]Part 23 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Gross Transactions [2015-2019]Part 24 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Purchase Transactions [2015-2019]Part 25 - Visa + Mastercard U.S. Payment Card (credit+charge+debit+prepaid) Cash Transactions [2015-2019] SECTION D: U.S. Issuer + Network Peer GroupPart 26 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Gross Dollar VolumePart 27 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Purchase Dollar VolumePart 28 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. End-of-Period OutstandingsPart 29 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Gross (Open) AccountsPart 30 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Active (Sales) AccountsPart 31 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Cards-in-ForcePart 32 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. 30+ Day DelinquencyPart 33 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. 90+ Day DelinquencyPart 34 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Charge-OffsPart 35 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Portfolio YieldPart 36 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card U.S. Marketshare/Purchase Dollar VolumePart 37 - Four Largest Issuers + Two Network/Issuers U.S. Credit/Charge Card Largest U.S. Profit/Loss SECTION E: U.S. Top 50 IssuersPart 38 - U.S. Top 50 Issuers Credit/Charge Card SECTION F: U.S. Top 100 IssuersPart 39 - Top 100 Banks Quarterly U.S. Credit Card 30+ Day DelinquencyPart 40 - Top 100 Banks Quarterly U.S. Credit Card Charge-OffsPart 41 - Top 100 Banks U.S. Credit Card Monthly Interest Rates SECTION G: U.S. Consumer StatisticsPart 42 - U.S. Monthly Revolving Consumer CreditPart 43 - U.S. Quarterly Consumer Financial Obligations & Debt Service Ratio Companies Mentioned Alliance Data Systems America First Credit Union American Express BBVA BECU BMO Harris Bank Bank of America Bank of the West Barclays Bank Capital One Chase Citibank Discover JPM Chase Mastercard Visa For more information about this report visit https://www.researchandmarkets.com/r/3yqic5 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum2904 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SOMERSET, N.J.--(BUSINESS WIRE)--SHI International, one of the worlds largest IT solutions providers, today announced the launch of its new SHI Mobile solution. SHI Mobile is a multi-carrier LTE data solution, designed to provide the fastest, most reliable LTE data connections for employees working from home, on the road, at customer sitesany location with a poor Wi-Fi connection. SHI Mobile offers an unlimited LTE data plan that harnesses the power of more than 600 U.S. and international carriers to provide the widest and strongest cellular data coverage. With a single SIM or eSIM, devices automatically connect to the highest-quality signal that will provide the fastest and most reliable data transfer. This makes SHI Mobile perfect for organizations with a hybrid workforce, where employees might be competing for available internet bandwidth while working from home, operating remotely where no secure broadband is available, or even for medics and warehouse staff who often operate beyond the range of quality Wi-Fi connections. Hospital frontline workers are using SHI Mobile to connect with caregivers who visit senior homes where there is no Wi-Fi connection at all. A major sporting franchise also uses SHI Mobile, in conjunction with a leading mobile health app, to screen and protect players, coaches, and support staff at stadiums across the U.S. It no longer matters where your staff work. You need them to be connected at all times and for that connectivity to be both fast and reliable, said Bill Wyckoff, Vice President of Hardware and Advanced Solutions at SHI. SHI Mobile is a solution that enables quick and easy internet connectivity, but also offers enhanced security without the risks of public Wi-Fi. SHI Mobile helps organizations streamline their carrier relationships and contracts for data plans as well as leverage SHIs immense buying power for LTE-enabled devices from all major manufacturers. SHI Mobile is part of SHIs growing portfolio of connectivity solutions, which also include mobile devices, voice and voice/data plans with most large U.S. carriers, and hosted desktop solutions. ABOUT SHI Founded in 1989, SHI International Corp. is an $11 billion global provider of technology products and services. Driven by the industrys most experienced and stable sales force and backed by software volume licensing experts, hardware procurement specialists, and certified IT services professionals, SHI delivers custom IT solutions to Corporate, Enterprise, Public Sector, and Academic customers. With over 5,000 employees worldwide, SHI is the largest Minority and Woman Owned Business Enterprise (MWBE) in the U.S. For more information, visit https://www.SHI.com. Press Resources: SHI Corporate Website: http://www.SHI.com SHI Blog: http://blog.SHI.com SHI Twitter Handle: @SHI_Intl
Answer: | SHI Connects Remote and Mobile Workforces with New SHI Mobile Solution Frontline healthcare workers and major sporting franchise already using SHI Mobile, which supports a wide variety of use cases and environments | SOMERSET, N.J.--(BUSINESS WIRE)--SHI International, one of the worlds largest IT solutions providers, today announced the launch of its new SHI Mobile solution. SHI Mobile is a multi-carrier LTE data solution, designed to provide the fastest, most reliable LTE data connections for employees working from home, on the road, at customer sitesany location with a poor Wi-Fi connection. SHI Mobile offers an unlimited LTE data plan that harnesses the power of more than 600 U.S. and international carriers to provide the widest and strongest cellular data coverage. With a single SIM or eSIM, devices automatically connect to the highest-quality signal that will provide the fastest and most reliable data transfer. This makes SHI Mobile perfect for organizations with a hybrid workforce, where employees might be competing for available internet bandwidth while working from home, operating remotely where no secure broadband is available, or even for medics and warehouse staff who often operate beyond the range of quality Wi-Fi connections. Hospital frontline workers are using SHI Mobile to connect with caregivers who visit senior homes where there is no Wi-Fi connection at all. A major sporting franchise also uses SHI Mobile, in conjunction with a leading mobile health app, to screen and protect players, coaches, and support staff at stadiums across the U.S. It no longer matters where your staff work. You need them to be connected at all times and for that connectivity to be both fast and reliable, said Bill Wyckoff, Vice President of Hardware and Advanced Solutions at SHI. SHI Mobile is a solution that enables quick and easy internet connectivity, but also offers enhanced security without the risks of public Wi-Fi. SHI Mobile helps organizations streamline their carrier relationships and contracts for data plans as well as leverage SHIs immense buying power for LTE-enabled devices from all major manufacturers. SHI Mobile is part of SHIs growing portfolio of connectivity solutions, which also include mobile devices, voice and voice/data plans with most large U.S. carriers, and hosted desktop solutions. ABOUT SHI Founded in 1989, SHI International Corp. is an $11 billion global provider of technology products and services. Driven by the industrys most experienced and stable sales force and backed by software volume licensing experts, hardware procurement specialists, and certified IT services professionals, SHI delivers custom IT solutions to Corporate, Enterprise, Public Sector, and Academic customers. With over 5,000 employees worldwide, SHI is the largest Minority and Woman Owned Business Enterprise (MWBE) in the U.S. For more information, visit https://www.SHI.com. Press Resources: SHI Corporate Website: http://www.SHI.com SHI Blog: http://blog.SHI.com SHI Twitter Handle: @SHI_Intl |
edtsum2907 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Optical Communication and Networking - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 8th edition of this report. The 188-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Optical Communication and Networking Market to Reach US$24.9 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Optical Communication and Networking estimated at US$15.7 Billion in the year 2020, is projected to reach a revised size of US$24.9 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027. Fiber, one of the segments analyzed in the report, is projected to grow at a 8.6% CAGR to reach US$4.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Transceiver segment is readjusted to a revised 9.4% CAGR for the next 7-year period. This segment currently accounts for a 11.7% share of the global Optical Communication and Networking market. The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 6.3% CAGR for the Period of 2020-2027 The Optical Communication and Networking market in the U.S. is estimated at US$4.6 Billion in the year 2020. The country currently accounts for a 29.56% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$4.3 Billion in the year 2027 trailing a CAGR of 6.3% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 5.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR while Rest of European market (as defined in the study) will reach US$4.3 Billion by the year 2027. Amplifier Segment Corners a 14.4% Share in 2020 In the global Amplifier segment, USA, Canada, Japan, China and Europe will drive the 7.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.8 Billion in the year 2020 will reach a projected size of US$3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.8 Billion by the year 2027. Competitors identified in this market include, among others: Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITION For more information about this report visit https://www.researchandmarkets.com/r/uxqups
Answer: | Insights on the Optical Communication and Networking Global Market to 2027 - Featuring Adtran, Arista and Broadcom Among Others - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Optical Communication and Networking - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 8th edition of this report. The 188-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Optical Communication and Networking Market to Reach US$24.9 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Optical Communication and Networking estimated at US$15.7 Billion in the year 2020, is projected to reach a revised size of US$24.9 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027. Fiber, one of the segments analyzed in the report, is projected to grow at a 8.6% CAGR to reach US$4.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Transceiver segment is readjusted to a revised 9.4% CAGR for the next 7-year period. This segment currently accounts for a 11.7% share of the global Optical Communication and Networking market. The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 6.3% CAGR for the Period of 2020-2027 The Optical Communication and Networking market in the U.S. is estimated at US$4.6 Billion in the year 2020. The country currently accounts for a 29.56% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$4.3 Billion in the year 2027 trailing a CAGR of 6.3% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 5.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR while Rest of European market (as defined in the study) will reach US$4.3 Billion by the year 2027. Amplifier Segment Corners a 14.4% Share in 2020 In the global Amplifier segment, USA, Canada, Japan, China and Europe will drive the 7.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.8 Billion in the year 2020 will reach a projected size of US$3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.8 Billion by the year 2027. Competitors identified in this market include, among others: Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITION For more information about this report visit https://www.researchandmarkets.com/r/uxqups |
edtsum2909 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DALLAS--(BUSINESS WIRE)--FireMon, the leading network security policy management company that brings visibility, control, agility and automation to enterprise cloud and hybrid network infrastructure, today announced an integration with Zscaler Internet Access (ZIA) to simplify enterprise adoption of Secure Access Service Edge (SASE) architectures. As enterprises move to the cloud, they are adopting hybrid network security architectures that incorporate cloud-first technologies like SASE to improve flexibility, performance, and agility. Using FireMon Security Manager, joint customers visualize and manage Zscaler Advanced Cloud Firewall policies in ZIA alongside traditional firewalls and other network security policy enforcement points. This simplifies migration and ensures continuous visibility, control, and compliance across hybrid network environments. Leveraging the APIs from Zscaler and FireMon, FireMon applies real-time policy analysis to ensure effective enforcement and network segmentation is in place. Joint customers can visualize configuration, policy, and rule usage statistics across all network security enforcement points through a single pane of glass. This centralized management approach allows customers to validate policies against regulatory or corporate standards, analyze access across the network, and monitor for change to pinpoint risks quickly. Together, FireMon and Zscaler improves a customer's security posture and simplifies governance and compliance with automated reporting, eliminating the need to swivel on multiple consoles. "Through our partnership with Zscaler, our customers can move faster towards zero-trust, cloud-centric network and security architectures," said Satin H. Mirchandani, President and CEO of FireMon. "Our partnership gives them a unified view to manage policy which reduces complexity and improves security agility and responsiveness." "Thousands of Zscaler customers use the Zero Trust Exchange to secure digital transformation by securely connecting applications, users and devices from anywhere," said Amit Raikar, Vice President of Business Development at Zscaler. "Customers have thousands of existing security policies to migrate or continue to enforce across a hybrid network. The FireMon integration with ZIA lets them visualize, normalize, and manage these policies across their entire network, within a single platform." FireMon is the first agile network security policy management (NSPM) platform, allowing customers to orchestrate security and compliance policy across cloud, on-prem, and hybrid networks through a single interface. Through its unique headless API, enterprises and technology partners can integrate and leverage any function available in the platform without modifying their own workflows. For more information on Zscaler and FireMon's work together, click here. To see FireMon present at Zscaler's Zenith Live, register here. About FireMon FireMon is the only agile network security policy platform for firewalls and cloud security groups providing the fastest way to streamline network security policy management, which is one of the biggest impediments to IT and enterprise agility. Since creating the first-ever network security policy management solution, FireMon has delivered command and control over complex network security infrastructures for more than 1,700 customers located in nearly 70 countries around the world. For more information, visit www.firemon.com. FireMon is on social media: LinkedIn, YouTube, and Facebook.
Answer: | FireMon Integration with Zscaler Internet Access Streamlines Enterprise Moves to Cloud-Centric Security Architectures Customers Can Migrate More Easily, Ensure Continuous Visibility and Control Across Heterogeneous Hybrid Networks | DALLAS--(BUSINESS WIRE)--FireMon, the leading network security policy management company that brings visibility, control, agility and automation to enterprise cloud and hybrid network infrastructure, today announced an integration with Zscaler Internet Access (ZIA) to simplify enterprise adoption of Secure Access Service Edge (SASE) architectures. As enterprises move to the cloud, they are adopting hybrid network security architectures that incorporate cloud-first technologies like SASE to improve flexibility, performance, and agility. Using FireMon Security Manager, joint customers visualize and manage Zscaler Advanced Cloud Firewall policies in ZIA alongside traditional firewalls and other network security policy enforcement points. This simplifies migration and ensures continuous visibility, control, and compliance across hybrid network environments. Leveraging the APIs from Zscaler and FireMon, FireMon applies real-time policy analysis to ensure effective enforcement and network segmentation is in place. Joint customers can visualize configuration, policy, and rule usage statistics across all network security enforcement points through a single pane of glass. This centralized management approach allows customers to validate policies against regulatory or corporate standards, analyze access across the network, and monitor for change to pinpoint risks quickly. Together, FireMon and Zscaler improves a customer's security posture and simplifies governance and compliance with automated reporting, eliminating the need to swivel on multiple consoles. "Through our partnership with Zscaler, our customers can move faster towards zero-trust, cloud-centric network and security architectures," said Satin H. Mirchandani, President and CEO of FireMon. "Our partnership gives them a unified view to manage policy which reduces complexity and improves security agility and responsiveness." "Thousands of Zscaler customers use the Zero Trust Exchange to secure digital transformation by securely connecting applications, users and devices from anywhere," said Amit Raikar, Vice President of Business Development at Zscaler. "Customers have thousands of existing security policies to migrate or continue to enforce across a hybrid network. The FireMon integration with ZIA lets them visualize, normalize, and manage these policies across their entire network, within a single platform." FireMon is the first agile network security policy management (NSPM) platform, allowing customers to orchestrate security and compliance policy across cloud, on-prem, and hybrid networks through a single interface. Through its unique headless API, enterprises and technology partners can integrate and leverage any function available in the platform without modifying their own workflows. For more information on Zscaler and FireMon's work together, click here. To see FireMon present at Zscaler's Zenith Live, register here. About FireMon FireMon is the only agile network security policy platform for firewalls and cloud security groups providing the fastest way to streamline network security policy management, which is one of the biggest impediments to IT and enterprise agility. Since creating the first-ever network security policy management solution, FireMon has delivered command and control over complex network security infrastructures for more than 1,700 customers located in nearly 70 countries around the world. For more information, visit www.firemon.com. FireMon is on social media: LinkedIn, YouTube, and Facebook. |
edtsum2913 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: RANCHO CUCAMONGA, Calif., April 20, 2020 /PRNewswire/ -- Local seniors will have grocery and hygiene products delivered to their senior living apartments for the next three weeks, thanks to a collaboration from San Bernardino County, Unidos Por La Musica (UPLM), and Inland Empire Health Plan (IEHP).Participating California senior living apartments include: Bloomington Grove & Lilian Court Senior Apartment Homes in Bloomington, The Magnolia at 9th Senior Apartments in San Bernardino, and Jeffrey Court Senior Living Apartments in Highland. Continue Reading IEHPs Eva Aparicio and Kevinn Porras gather boxes of hygiene products for distribution to local senior living apartments. "Our goal is to care for those most vulnerable right now," said IEHP Director of Community Health Gabriel Uribe. "With these partnerships and collaborations, local seniors keep food on the table and have products they need to remain comfortable and healthy." Starting on April 16 with UPLM's Bags of Hope Program and data from San Bernardino County, 415 bags of groceries are being delivered each week to seniors across three senior living apartments. In addition, IEHP will be contributing hygiene products to distribute along with food items. Products include shampoo, toothbrushes, toothpaste, lotion, mouthwash, a limited number of toilet paper, and sanitary supplies."For us, it's always about doing the right thing," said IEHP Senior Director of Care Integration Jeanna Kendrick. "With like-minded partners, we're able to do that by offering support to our most vulnerable populations." About IEHPIEHP, Inland Empire Health Plan, is a top 10 largest Medicaid health plan and the largest not-for-profit Medicare-Medicaid plan in the country. With a network of more than 6,400 Providers and more than 2,000 employees, IEHP serves more than 1.2 million residents in Riverside and San Bernardino counties who are enrolled in Medicaid or Cal MediConnect Plan (Medicare-Medicaid Plan). Through a dynamic partnership with Providers and Community, award-winning service and innovative products, IEHP is fully committed to advocating for our Members and providing them with quality, accessible and wellness-based health care services. For more information, visit www.iehp.org.SOURCE Inland Empire Health Plan (IEHP) Related Links http://www.iehp.org
Answer: | Local Seniors Receive Three Weeks of Food and Supply Deliveries | RANCHO CUCAMONGA, Calif., April 20, 2020 /PRNewswire/ -- Local seniors will have grocery and hygiene products delivered to their senior living apartments for the next three weeks, thanks to a collaboration from San Bernardino County, Unidos Por La Musica (UPLM), and Inland Empire Health Plan (IEHP).Participating California senior living apartments include: Bloomington Grove & Lilian Court Senior Apartment Homes in Bloomington, The Magnolia at 9th Senior Apartments in San Bernardino, and Jeffrey Court Senior Living Apartments in Highland. Continue Reading IEHPs Eva Aparicio and Kevinn Porras gather boxes of hygiene products for distribution to local senior living apartments. "Our goal is to care for those most vulnerable right now," said IEHP Director of Community Health Gabriel Uribe. "With these partnerships and collaborations, local seniors keep food on the table and have products they need to remain comfortable and healthy." Starting on April 16 with UPLM's Bags of Hope Program and data from San Bernardino County, 415 bags of groceries are being delivered each week to seniors across three senior living apartments. In addition, IEHP will be contributing hygiene products to distribute along with food items. Products include shampoo, toothbrushes, toothpaste, lotion, mouthwash, a limited number of toilet paper, and sanitary supplies."For us, it's always about doing the right thing," said IEHP Senior Director of Care Integration Jeanna Kendrick. "With like-minded partners, we're able to do that by offering support to our most vulnerable populations." About IEHPIEHP, Inland Empire Health Plan, is a top 10 largest Medicaid health plan and the largest not-for-profit Medicare-Medicaid plan in the country. With a network of more than 6,400 Providers and more than 2,000 employees, IEHP serves more than 1.2 million residents in Riverside and San Bernardino counties who are enrolled in Medicaid or Cal MediConnect Plan (Medicare-Medicaid Plan). Through a dynamic partnership with Providers and Community, award-winning service and innovative products, IEHP is fully committed to advocating for our Members and providing them with quality, accessible and wellness-based health care services. For more information, visit www.iehp.org.SOURCE Inland Empire Health Plan (IEHP) Related Links http://www.iehp.org |
edtsum2917 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PITTSBURGH, Dec. 10, 2020 /PRNewswire/ -- "I have a small kitchen and I thought there could be an improved, multi-purpose cooking lid to help save space," said an inventor, from Medina, Ohio, "so I invented the FRIENDLY LID. My design eliminates the hassle and mess associated with using and storing traditional lids." The patent-pending invention provides an effective way to retain heat or release steam from a pot or pan. In doing so, it offers a versatile alternative to traditional cooking lids and it ensures that steam from the cooking pot returns to the pot and not on the stove. As a result, it increases convenience, organization and storage space in the kitchen, it reduces messes and it enables a cook to temporarily store cooking utensils or serve food. The invention features a practical design that is easy to use and store so it is ideal for households, restaurants, small kitchens and students. Additionally, it is producible in design variations including various colors. The original design was submitted to the Cleveland sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-FGC-159, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com
Answer: | InventHelp Inventor Develops Versatile Cooking Lid to Increase Convenience & Space (FGC-159) | PITTSBURGH, Dec. 10, 2020 /PRNewswire/ -- "I have a small kitchen and I thought there could be an improved, multi-purpose cooking lid to help save space," said an inventor, from Medina, Ohio, "so I invented the FRIENDLY LID. My design eliminates the hassle and mess associated with using and storing traditional lids." The patent-pending invention provides an effective way to retain heat or release steam from a pot or pan. In doing so, it offers a versatile alternative to traditional cooking lids and it ensures that steam from the cooking pot returns to the pot and not on the stove. As a result, it increases convenience, organization and storage space in the kitchen, it reduces messes and it enables a cook to temporarily store cooking utensils or serve food. The invention features a practical design that is easy to use and store so it is ideal for households, restaurants, small kitchens and students. Additionally, it is producible in design variations including various colors. The original design was submitted to the Cleveland sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-FGC-159, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com |
edtsum2920 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BETHESDA, Md.--(BUSINESS WIRE)--Rotunda Capital Partners (Rotunda), a lower-middle market private equity firm focused on distribution, logistics, and industrial and business services, was recently named by Inc. Magazine as one of the top 50 founder-friendly PE firms in the United States. The list recognizes private equity firms that treat entrepreneurs as partners and have a successful track record of helping their businesses thrive. To compile the Top 50 list, Inc. went straight to the source: entrepreneurs who have sold to private equity. Founders gave input on their experiences working with private equity firms and shared information on how their companies have performed during these partnerships. Rotunda helps founder and family-owned businesses with functional expertise, industry experience, and strategic capital to drive transformational growth: Through multiple strategy sessions, Rotunda helped refine Munchs value proposition, which, in turn, gave us the confidence that we could replicate our unique service offering while expanding outside our traditional geographic area. As a result, we expanded from one metropolitan area to over seven states in just four years, while still preserving our family culture, said Bob Munch of Munchs Supply. Rotunda is committed to long-term value creation by investing in the infrastructure of each portfolio company: We chose Rotunda because of their commitment to long-term growth, not simply short-term results, said Gary Embretson, who founded Trinity3 Technology. Rotunda pushed us to invest in ourselves by adding to the management team, implementing technology improvements and adding service enhancements, while staying true to the MacQueen Way. These infrastructure investments allowed us to expand rapidly in the first year of our growth journey through both acquisitions and organic growth, said Dan Gage, CEO of MacQueen Equipment. We are honored to be recognized by Inc. as one of the most founder-friendly private equity firms, and thank all of our portfolio company partners we have worked with over the years, as well as the Rotunda team who promote a culture of partnership, integrity, transparency and excellence, said John Fruehwirth, managing partner at Rotunda Capital Partners. To see the full Inc. Magazine list, click here Introduced in 2019, the 50 Founder-Friendly Private Equity Firms list quickly established itself as one of Inc.s most resourceful franchises. It has become a go-to guide for entrepreneurs who want to grow their companies while retaining an ownership stake. The November 2020 issue of Inc. Magazine is available online now at https://www.inc.com/magazine as well as on newsstands. About Inc. The worlds most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community they need to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com. About Rotunda Capital Partners Rotunda Capital Partners is a private equity firm that invests equity capital in established, lower middle market companies. Rotunda Capital partners with management to build data-driven growth platforms within its targeted sectors, including value added distribution, asset light logistics, industrial/business services and specialty finance/insurance services. Founded in 2009, the firm has a long history of helping management teams achieve their goals for growth. The Rotunda Capital team actively provides guidance and draws on deep industry and financial relationships to contribute to the successful execution of Rotundas companies strategic plans. For more, visit www.rotundacapital.com. Disclaimer: This award information, as reported in the November, 2020 issue of Inc. Magazine, is being provided for informational purposes and should not be considered an endorsement of Rotunda, indicative of any persons experience with Rotunda or indicative of Rotundas future performance. Rankings were based on the founder-friendliness of the private equity firms analyzed as determined by metrics specified by Inc. Magazine in its report. Rotunda has no affiliation with Inc. Magazine.
Answer: | Rotunda Capital Partners Named in Inc.s 2020 Private Equity 50 List Annual roundup of founder-friendly private equity firms that treat entrepreneurs as partners | BETHESDA, Md.--(BUSINESS WIRE)--Rotunda Capital Partners (Rotunda), a lower-middle market private equity firm focused on distribution, logistics, and industrial and business services, was recently named by Inc. Magazine as one of the top 50 founder-friendly PE firms in the United States. The list recognizes private equity firms that treat entrepreneurs as partners and have a successful track record of helping their businesses thrive. To compile the Top 50 list, Inc. went straight to the source: entrepreneurs who have sold to private equity. Founders gave input on their experiences working with private equity firms and shared information on how their companies have performed during these partnerships. Rotunda helps founder and family-owned businesses with functional expertise, industry experience, and strategic capital to drive transformational growth: Through multiple strategy sessions, Rotunda helped refine Munchs value proposition, which, in turn, gave us the confidence that we could replicate our unique service offering while expanding outside our traditional geographic area. As a result, we expanded from one metropolitan area to over seven states in just four years, while still preserving our family culture, said Bob Munch of Munchs Supply. Rotunda is committed to long-term value creation by investing in the infrastructure of each portfolio company: We chose Rotunda because of their commitment to long-term growth, not simply short-term results, said Gary Embretson, who founded Trinity3 Technology. Rotunda pushed us to invest in ourselves by adding to the management team, implementing technology improvements and adding service enhancements, while staying true to the MacQueen Way. These infrastructure investments allowed us to expand rapidly in the first year of our growth journey through both acquisitions and organic growth, said Dan Gage, CEO of MacQueen Equipment. We are honored to be recognized by Inc. as one of the most founder-friendly private equity firms, and thank all of our portfolio company partners we have worked with over the years, as well as the Rotunda team who promote a culture of partnership, integrity, transparency and excellence, said John Fruehwirth, managing partner at Rotunda Capital Partners. To see the full Inc. Magazine list, click here Introduced in 2019, the 50 Founder-Friendly Private Equity Firms list quickly established itself as one of Inc.s most resourceful franchises. It has become a go-to guide for entrepreneurs who want to grow their companies while retaining an ownership stake. The November 2020 issue of Inc. Magazine is available online now at https://www.inc.com/magazine as well as on newsstands. About Inc. The worlds most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community they need to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com. About Rotunda Capital Partners Rotunda Capital Partners is a private equity firm that invests equity capital in established, lower middle market companies. Rotunda Capital partners with management to build data-driven growth platforms within its targeted sectors, including value added distribution, asset light logistics, industrial/business services and specialty finance/insurance services. Founded in 2009, the firm has a long history of helping management teams achieve their goals for growth. The Rotunda Capital team actively provides guidance and draws on deep industry and financial relationships to contribute to the successful execution of Rotundas companies strategic plans. For more, visit www.rotundacapital.com. Disclaimer: This award information, as reported in the November, 2020 issue of Inc. Magazine, is being provided for informational purposes and should not be considered an endorsement of Rotunda, indicative of any persons experience with Rotunda or indicative of Rotundas future performance. Rankings were based on the founder-friendliness of the private equity firms analyzed as determined by metrics specified by Inc. Magazine in its report. Rotunda has no affiliation with Inc. Magazine. |
edtsum2922 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, July 7, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212)682-3025(888) 593-4771[emailprotected] Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN)in connection with the proposed stock-for-stock merger of the company with privately-held Ocuphire Pharma, Inc. ("Ocuphire"). Under the terms of the acquisition agreement, REXN will be issued contingent value rights ("CVR") representing the right to receive (i) 90% of payments received by the combined company pursuant to its licensing agreements with BioSense Global LLC and Zhejiang HaiChang Biotechnology Co., Ltd. during the 15-year period after the closing of the merger; and (ii) 75% of the proceeds received by the combined company from the monetization of REXN existing intellectual property during the 10-year period after the merger's close. Upon consummation of the proposed merger, Ocuphire will own at least 85.7% of the newly-combined company, with REXN stockholders owning the remaining 14.3%. If you own REXN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/rexahn-pharmaceuticals-inc/ Delmarva Bancshares, Inc. (OTC: DLMV) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Delmarva Bancshares, Inc. (OTC: DLMV)in connection with the proposed acquisition of the company by BV Financial Inc. Under the terms of the agreement, DLMV shareholders will be entitled to receive $8.90 in cash for each share of DLMV common stock that they own. If you own DLMV shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/delmarva-bancshares-inc/ SOURCE WeissLaw LLP Related Links http://weisslawllp.com
Answer: | SHAREHOLDER ALERT: WeissLaw LLP Reminds REXN and DLMV Shareholders About Its Ongoing Investigations | NEW YORK, July 7, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212)682-3025(888) 593-4771[emailprotected] Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN)in connection with the proposed stock-for-stock merger of the company with privately-held Ocuphire Pharma, Inc. ("Ocuphire"). Under the terms of the acquisition agreement, REXN will be issued contingent value rights ("CVR") representing the right to receive (i) 90% of payments received by the combined company pursuant to its licensing agreements with BioSense Global LLC and Zhejiang HaiChang Biotechnology Co., Ltd. during the 15-year period after the closing of the merger; and (ii) 75% of the proceeds received by the combined company from the monetization of REXN existing intellectual property during the 10-year period after the merger's close. Upon consummation of the proposed merger, Ocuphire will own at least 85.7% of the newly-combined company, with REXN stockholders owning the remaining 14.3%. If you own REXN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/rexahn-pharmaceuticals-inc/ Delmarva Bancshares, Inc. (OTC: DLMV) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Delmarva Bancshares, Inc. (OTC: DLMV)in connection with the proposed acquisition of the company by BV Financial Inc. Under the terms of the agreement, DLMV shareholders will be entitled to receive $8.90 in cash for each share of DLMV common stock that they own. If you own DLMV shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/delmarva-bancshares-inc/ SOURCE WeissLaw LLP Related Links http://weisslawllp.com |
edtsum2927 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ST. PETERSBURG, Fla., Jan. 28, 2021 /PRNewswire/ -- Following the CDC announcement requiring all US citizens receive a negative Covid-19 test prior to reentry, initial reports show US travelers are still showing a willingness to travel internationally, taking additional steps to prepare rather than canceling travel altogether. Travel insurance aggregator, Squaremouth, compared data immediately following the CDC announcement on January 12th, 2020, with data from the two weeks prior, revealing the following takeaways: Travelers are insuring and spending more on cancellation coverage for international trips Travelers are insuring about $1,000 more per trip There has been a 42% spike in Cancel For Any Reason policy purchases Travelers are spending 31% more on insurance With a price tag 40% higher than a standard cancellation policy, the Cancel For Any Reason benefit allows travelers to cancel their trip for a reason not otherwise covered by their policy and receive a partial refund. Squaremouth says the reason for the upgrade is clear: with constant changes to travel requirements, including negative Covid tests and quarantine restrictions, travelers want the ability to opt-out of their trip, no questions asked. Minimal impact on destinations More than 70% of bookings post-announcement are still for international destinations "We expected to see an immediate shift to domestic travel and a drop in international bookings, due to the added complication of coordinating a Covid test abroad, but that hasn't been the case," says Squaremouth CMO, Megan Moncrief. Travelers are booking farther out US travelers are insuring their international trips 24% sooner than previously in the pandemic Throughout the coronavirus pandemic, Squaremouth saw a trend of last-minute bookings overtake far-planned out trips, attributing this to a general uncertainty around travel, changing quarantine requirements, and a newfound remote work flexibility. Now, Squaremouth reports travelers with an increasing thirst for travel are simply preparing more. Methodology: Squaremouth.com hosts the largest number of travel insurance providers and policies that offer coverage related to the Covid-19 pandemic. This data in this report is based on travel insurance policies purchased through Squaremouth.com, comparing sales trends in the immediate two week period following the CDC's announcement of a negative Covid test requirement for reentry to the two week period prior to the announcement. Squaremouth compared data from thousands of policies in identifying these trends. ABOUT SQUAREMOUTHSquaremouth compares travel insurance policies from every major travel insurance provider in the United States. Using Squaremouth's comparison engine and third-party customer reviews, travelers can research and compare travel insurance policies side-by-side. More information can be found at www.squaremouth.com. SOURCE Squaremouth Related Links http://www.squaremouth.com
Answer: | US Travelers Still Planning International Trips, Despite CDC Requirement | ST. PETERSBURG, Fla., Jan. 28, 2021 /PRNewswire/ -- Following the CDC announcement requiring all US citizens receive a negative Covid-19 test prior to reentry, initial reports show US travelers are still showing a willingness to travel internationally, taking additional steps to prepare rather than canceling travel altogether. Travel insurance aggregator, Squaremouth, compared data immediately following the CDC announcement on January 12th, 2020, with data from the two weeks prior, revealing the following takeaways: Travelers are insuring and spending more on cancellation coverage for international trips Travelers are insuring about $1,000 more per trip There has been a 42% spike in Cancel For Any Reason policy purchases Travelers are spending 31% more on insurance With a price tag 40% higher than a standard cancellation policy, the Cancel For Any Reason benefit allows travelers to cancel their trip for a reason not otherwise covered by their policy and receive a partial refund. Squaremouth says the reason for the upgrade is clear: with constant changes to travel requirements, including negative Covid tests and quarantine restrictions, travelers want the ability to opt-out of their trip, no questions asked. Minimal impact on destinations More than 70% of bookings post-announcement are still for international destinations "We expected to see an immediate shift to domestic travel and a drop in international bookings, due to the added complication of coordinating a Covid test abroad, but that hasn't been the case," says Squaremouth CMO, Megan Moncrief. Travelers are booking farther out US travelers are insuring their international trips 24% sooner than previously in the pandemic Throughout the coronavirus pandemic, Squaremouth saw a trend of last-minute bookings overtake far-planned out trips, attributing this to a general uncertainty around travel, changing quarantine requirements, and a newfound remote work flexibility. Now, Squaremouth reports travelers with an increasing thirst for travel are simply preparing more. Methodology: Squaremouth.com hosts the largest number of travel insurance providers and policies that offer coverage related to the Covid-19 pandemic. This data in this report is based on travel insurance policies purchased through Squaremouth.com, comparing sales trends in the immediate two week period following the CDC's announcement of a negative Covid test requirement for reentry to the two week period prior to the announcement. Squaremouth compared data from thousands of policies in identifying these trends. ABOUT SQUAREMOUTHSquaremouth compares travel insurance policies from every major travel insurance provider in the United States. Using Squaremouth's comparison engine and third-party customer reviews, travelers can research and compare travel insurance policies side-by-side. More information can be found at www.squaremouth.com. SOURCE Squaremouth Related Links http://www.squaremouth.com |
edtsum2928 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--New Senior Investment Group Inc. (New Senior or the Company) (NYSE: SNR) announced today that management will participate in the Capital One Securities Inaugural REIT Conference. The conference is scheduled for January 11 - 12, 2021. The Company also announced that management will participate in the Stifel 2021 Seniors Housing and Healthcare Real Estate Conference. The conference is scheduled for January 19, 2021. ABOUT NEW SENIOR New Senior Investment Group Inc. (NYSE: SNR) is a publicly-traded real estate investment trust with a diversified portfolio of senior housing properties located across the United States. New Senior is one of the largest owners of senior housing properties, with 103 properties across 36 states. More information about New Senior can be found at www.newseniorinv.com.
Answer: | New Senior to Participate in the Capital One Securities Inaugural REIT Conference and the Stifel 2021 Seniors Housing & Healthcare Real Estate Conference | NEW YORK--(BUSINESS WIRE)--New Senior Investment Group Inc. (New Senior or the Company) (NYSE: SNR) announced today that management will participate in the Capital One Securities Inaugural REIT Conference. The conference is scheduled for January 11 - 12, 2021. The Company also announced that management will participate in the Stifel 2021 Seniors Housing and Healthcare Real Estate Conference. The conference is scheduled for January 19, 2021. ABOUT NEW SENIOR New Senior Investment Group Inc. (NYSE: SNR) is a publicly-traded real estate investment trust with a diversified portfolio of senior housing properties located across the United States. New Senior is one of the largest owners of senior housing properties, with 103 properties across 36 states. More information about New Senior can be found at www.newseniorinv.com. |
edtsum2929 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2020 results after the financial markets close on Wednesday, February 24, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2020 financial and operating results. Conference Call/Webcast Details: Date: February 24, 2021 Time: 4:30 pm Eastern Time (1:30 pm Pacific Time) Toll Free Dial-In Number: (855) 427-4396 International Dial-In Number: (484) 756-4261 Conference ID: 7178576 Webcast Link: https://edge.media-server.com/mmc/p/272ym8kz An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Cares Investor Center website located at http://investor.tandemdiabetes.com in the Events & Presentations section. About Tandem Diabetes Care, Inc. Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandems flagship product, the t:slim X2 insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring, and optional automated insulin delivery technology. Tandem is based in San Diego, California. Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM. Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes. Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes. Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.
Answer: | Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021 | SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2020 results after the financial markets close on Wednesday, February 24, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2020 financial and operating results. Conference Call/Webcast Details: Date: February 24, 2021 Time: 4:30 pm Eastern Time (1:30 pm Pacific Time) Toll Free Dial-In Number: (855) 427-4396 International Dial-In Number: (484) 756-4261 Conference ID: 7178576 Webcast Link: https://edge.media-server.com/mmc/p/272ym8kz An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Cares Investor Center website located at http://investor.tandemdiabetes.com in the Events & Presentations section. About Tandem Diabetes Care, Inc. Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandems flagship product, the t:slim X2 insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring, and optional automated insulin delivery technology. Tandem is based in San Diego, California. Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM. Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes. Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes. Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc. |
edtsum2930 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE: IQV) announced today that it will collaborate with Corium, Inc a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies to support the launch of AZSTARYS, which was approved by the U.S. FDA on March 2, 2021. AZSTARYS is the first and only product containing a dexmethylphenidate (d-MPH) oral prodrug for the treatment of attention deficit hyperactivity disorder (ADHD) symptoms in patients aged six years and older. This is an exciting milestone for Corium as we prepare to bring AZSTARYS to market and provide patients with ADHD and their clinicians a new option for rapid and extended symptom control, said Perry J. Sternberg, President and CEO of Corium. To successfully do this, we need a partner with the expertise, resources, and technology to help us efficiently engage with clinicians and connect the right patients to this treatment. We are thrilled to be partnering with IQVIA to support and execute our commercialization strategy for AZSTARYS. Under the agreement, IQVIA will deploy a tailored combination of technology, analytics, and field services to enable coordinated, effective engagements with healthcare professionals who treat ADHD. IQVIAs team of sales reps and medical liaisons will complement Coriums deep internal ADHD and commercialization expertise and customer-facing leadership. Corium will also be supported by IQVIAs Orchestrated Customer Engagement (OCE) SaaS-based platform, which connects sales, marketing, and medical with AI-enabled recommendations through an intuitive and efficient user experience. This is an excellent example of how IQVIAs depth of expertise and breadth of offerings can support companies that are launching for the first time and need to maximize every engagement, said Susan Kitlas, a vice president of sales dedicated to pre-commercial clients. Leveraging IQVIA Connected Intelligence, Corium will be able to tap into the data, technology, analytics, and other resources they need to commercialize with speed, agility, and scale. We look forward to supporting Corium and bringing this valuable medicine to market for patients and families managing ADHD. About IQVIA IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence delivers powerful insights with speed and agility enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 72,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIAs insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
Answer: | IQVIAs Orchestrated Customer Engagement (OCE) Solution Chosen to Support the Commercial Launch of Novel ADHD Drug | RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE: IQV) announced today that it will collaborate with Corium, Inc a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies to support the launch of AZSTARYS, which was approved by the U.S. FDA on March 2, 2021. AZSTARYS is the first and only product containing a dexmethylphenidate (d-MPH) oral prodrug for the treatment of attention deficit hyperactivity disorder (ADHD) symptoms in patients aged six years and older. This is an exciting milestone for Corium as we prepare to bring AZSTARYS to market and provide patients with ADHD and their clinicians a new option for rapid and extended symptom control, said Perry J. Sternberg, President and CEO of Corium. To successfully do this, we need a partner with the expertise, resources, and technology to help us efficiently engage with clinicians and connect the right patients to this treatment. We are thrilled to be partnering with IQVIA to support and execute our commercialization strategy for AZSTARYS. Under the agreement, IQVIA will deploy a tailored combination of technology, analytics, and field services to enable coordinated, effective engagements with healthcare professionals who treat ADHD. IQVIAs team of sales reps and medical liaisons will complement Coriums deep internal ADHD and commercialization expertise and customer-facing leadership. Corium will also be supported by IQVIAs Orchestrated Customer Engagement (OCE) SaaS-based platform, which connects sales, marketing, and medical with AI-enabled recommendations through an intuitive and efficient user experience. This is an excellent example of how IQVIAs depth of expertise and breadth of offerings can support companies that are launching for the first time and need to maximize every engagement, said Susan Kitlas, a vice president of sales dedicated to pre-commercial clients. Leveraging IQVIA Connected Intelligence, Corium will be able to tap into the data, technology, analytics, and other resources they need to commercialize with speed, agility, and scale. We look forward to supporting Corium and bringing this valuable medicine to market for patients and families managing ADHD. About IQVIA IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence delivers powerful insights with speed and agility enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 72,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIAs insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com. |
edtsum2932 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--iHeartMedia, the No. 1 commercial podcast publisher globally according to Podtrac, and Charlamagne Tha God, one of the most influential and authoritative voices in media, announced today a historic joint venture partnership to launch The Black Effect Podcast Network. The Black Effect Podcast Network is positioned to become the worlds largest podcast publisher dedicated to Black listeners, bringing together the most influential and trusted voices in black culture for stimulating conversations around social justice, pop culture, sports, mental health, news, comedy and more. The multi-genre venture will feature a luminous roster of marquee talent and culture-shifting voices committed to enlightening, educating and entertaining audiences curated by Charlamagne himself. The programming will provide a bridge to understanding information and interaction rooted in diverse perspectives. Blackness has an immediate, culture shifting effect on everything, said Charlamagne. Blackness controls the cool. Blackness is the culture, but Black Voices are not monolithic. The only way to appreciate the diversity of thought and experiences in Black culture is to build a platform for those voices to be heard. Unapologetically Black experiences, unapologetically Black thought, unapologetically Black ideas. Black, Black, Blackity Black, Black, Black, Black. Everything Black. Black Everything. The vision for The Black Effect is to amplify, elevate, and empower emerging and established talent. Our goal is to shift the narrative from Black creators signing transactional deals, to instead forming legacy partnerships that build generational wealth while allowing each creative to have an equitable stake in their future. As a long-time partner of iHeart, its an honor to make history with them. The Black Effect Podcast Network creatives will include comedian/actress Jess Hilarious, Social Justice Activist Tamika Mallory, American attorney and TV Host Eboni K. Williams and many more. The Black Effect Podcast Network has also partnered with other widely successful podcasts like All The Smoke, Drink Champs and The 85 South Show, and will debut with 18 podcasts this fall on iHeartRadio and everywhere podcasts are available. Additionally, Charlamagnes wildly popular, co-anchored, nationally syndicated radio show, The Breakfast Club, will bring its replay podcast to The Black Effect Podcast Network as its flagship show, effective immediately. With over 4.5 million weekly listeners, The Breakfast Club has become the most sought after media destination for A-list talent and influential thought leaders. As our countrys number one audio company and podcaster, we have both the responsibility and the opportunity to give new voices a massive audience platform for creativity and innovationand for important ideas that need to be heard, said Bob Pittman, Chairman and CEO of iHeartMedia. Charlamagne Tha God is an unparalleled multi-platform creator whose impact extends across radio, digital, social, TV, events and podcasts. He is uniquely qualified to bring The Black Effect Podcast Network to life, and we are lucky and honored to be his chosen partner and to continue our successful partnership of over a decade in this exciting and fast-growing arena. The Black Effect Podcast Network will also produce exciting limited series podcasts in conjunction with various high wattage creators and talent, musical artists, actors, actresses, sports and literary superstars to support their upcoming films, music releases and related projects. All shows on The Black Effect Podcast Network will be distributed through the iHeartPodcast Network which is home to more than 750 original podcasts. With over 225 million downloads each month, iHeartRadio is the leading podcast publisher according to Podtrac, with a substantial lead over the next largest commercial podcaster. iHeartPodcasts span every category from business, sports, spirituality and technology to entertainment, family, comedy and true crime and everything in between making iHeartRadio the largest publisher of podcast content in the world. iHeartPodcasts are distributed on all major podcast platforms, including the iHeartRadio app. PepsiCo Beverages, in collaboration with its agency partner OMD, has signed on as an inaugural partner of The Black Effect Podcast Network with others to be announced. We knew we wanted to support this groundbreaking partnership as soon as Charlamagne and iHeart shared their vision for the network. This opportunity connects our brands to consumers through the newer trusted medium of podcasting, and more importantly, supports the overall PepsiCo strategic initiative to invest in Black communities and support diverse voices, said Katie Haniffy, PepsiCo Beverages Head of Media. Weve had the pleasure of collaborating with Charlamagne in the past and look forward to our continued partnership with him and iHeartMedia on this incredibly exciting venture. The Black Effect Podcast Network launch lineup will include: Drink Champs with N.O.R.E and DJ EFN All The Smoke with Matt Barnes The 85 South Show with Karlous Miller, DC Young Fly and Clayton English Whoreible Decisions with Mandii B and Weezy Dropping Gems with Devi Brown Holding Court with Eboni K. Williams Carefully Reckless with Jess Hilarious Street Politicians with Tamika Mallory and Mysonne Hot Happy Mess with Zuri Hall Untitled with Bonang Matheba Hello Somebody with Senator Nina Turner P.O.D. with Ashley and Tammy Straight Shot No Chaser with Tezlyn Figaro Laugh and Learn with Flame Monroe (executive produced by Tiffany Haddish) Checking In with Michelle Williams Cut To It with Steven Smith Sr. No Ceilings with Glasses Malone Gangster Chronicles with MC EIHT, Reggie Wright Jr. and James McDonald Fans can go to iHeart.com/apps to download and listen on all their favorite devices including smart speakers, digital auto dashes, tablets, wearables, smartphones, virtual assistants, televisions, gaming consoles and more. About iHeartMedia iHeartMedia (NASDAQ: IHRT) is the number one audio company in the United States, reaching nine out of 10 Americans every month and with its quarter of a billion monthly listeners, has a greater reach than any other media company in the U.S. The companys leadership position in audio extends across multiple platforms, including more than 850 live broadcast stations in over 160 markets nationwide; through its iHeartRadio digital service available across more than 250 platforms and 2,000 devices; through its influencers; social; branded iconic live music events; other digital products and newsletters; and podcasts as the #1 commercial podcast publisher. iHeartMedia also leads the audio industry in analytics, targeting and attribution for its marketing partners with its SmartAudio product, using data from its massive consumer base. Visit iHeartMedia.com for more company information. About Charlamagne Tha God Charlamagne Tha God is one of the most potent, influential, and authoritative voices in media today. He is the widely coveted, outspoken, thought-provoking co-host of the hottest nationally-syndicated radio show in the U.S., The Breakfast Club, heard by over 4.5 million listeners each week. Charlamagnes production company, CTHAGOD World Productions, discovers and advocates for original content and emerging talent who resonate with popular culture long before they are recognized mainstream. A cultural architect and executive producer, Charlamagne is the co-host of the popular podcast, Brilliant Idiots,. He is a New York Times bestselling author of the book, Black Privilege and global bestseller Shook One, which propelled him to become one of the worlds leading voices in the mental health discussion. Charlamagne will be inducted into the Radio Hall of Fame in October. About The Black Effect Podcast Network The Black Effect Podcast Network is a transformative network founded by renowned cultural architect, executive producer, bestselling author, and media mogul Charlamagne Tha God. In an historic joint venture with the worlds number one commercial podcast publisher, iHeartMedia, Charlamagne and iHeartMedia created the groundbreaking first-ever Black Effect Podcast Network, celebrating the most important Black culture-shapers on the planetin education, politics, entertainment, sports and pop culture. The Black Effect Podcast Network gives rise to emerging and established content creators and storytellers whose perspective and creative vision have been marginalized and overlooked while serving an audience that has been underserved. The Black Effect Podcast Network helps its partners define their place in culture through influence, ideas, and experiences that engage, inspire, inform and empower.
Answer: | iHeartMedia, Americas Leading Podcast Publisher, and Radio Hall-of-Famer Charlamagne Tha God Launch The Black Effect Podcast Network A historic first-of-its-kind joint venture partnership developed to amplify Black voices, celebrate Black creators and invest in the Black community, with culturally relevant content across a variety of genres | NEW YORK--(BUSINESS WIRE)--iHeartMedia, the No. 1 commercial podcast publisher globally according to Podtrac, and Charlamagne Tha God, one of the most influential and authoritative voices in media, announced today a historic joint venture partnership to launch The Black Effect Podcast Network. The Black Effect Podcast Network is positioned to become the worlds largest podcast publisher dedicated to Black listeners, bringing together the most influential and trusted voices in black culture for stimulating conversations around social justice, pop culture, sports, mental health, news, comedy and more. The multi-genre venture will feature a luminous roster of marquee talent and culture-shifting voices committed to enlightening, educating and entertaining audiences curated by Charlamagne himself. The programming will provide a bridge to understanding information and interaction rooted in diverse perspectives. Blackness has an immediate, culture shifting effect on everything, said Charlamagne. Blackness controls the cool. Blackness is the culture, but Black Voices are not monolithic. The only way to appreciate the diversity of thought and experiences in Black culture is to build a platform for those voices to be heard. Unapologetically Black experiences, unapologetically Black thought, unapologetically Black ideas. Black, Black, Blackity Black, Black, Black, Black. Everything Black. Black Everything. The vision for The Black Effect is to amplify, elevate, and empower emerging and established talent. Our goal is to shift the narrative from Black creators signing transactional deals, to instead forming legacy partnerships that build generational wealth while allowing each creative to have an equitable stake in their future. As a long-time partner of iHeart, its an honor to make history with them. The Black Effect Podcast Network creatives will include comedian/actress Jess Hilarious, Social Justice Activist Tamika Mallory, American attorney and TV Host Eboni K. Williams and many more. The Black Effect Podcast Network has also partnered with other widely successful podcasts like All The Smoke, Drink Champs and The 85 South Show, and will debut with 18 podcasts this fall on iHeartRadio and everywhere podcasts are available. Additionally, Charlamagnes wildly popular, co-anchored, nationally syndicated radio show, The Breakfast Club, will bring its replay podcast to The Black Effect Podcast Network as its flagship show, effective immediately. With over 4.5 million weekly listeners, The Breakfast Club has become the most sought after media destination for A-list talent and influential thought leaders. As our countrys number one audio company and podcaster, we have both the responsibility and the opportunity to give new voices a massive audience platform for creativity and innovationand for important ideas that need to be heard, said Bob Pittman, Chairman and CEO of iHeartMedia. Charlamagne Tha God is an unparalleled multi-platform creator whose impact extends across radio, digital, social, TV, events and podcasts. He is uniquely qualified to bring The Black Effect Podcast Network to life, and we are lucky and honored to be his chosen partner and to continue our successful partnership of over a decade in this exciting and fast-growing arena. The Black Effect Podcast Network will also produce exciting limited series podcasts in conjunction with various high wattage creators and talent, musical artists, actors, actresses, sports and literary superstars to support their upcoming films, music releases and related projects. All shows on The Black Effect Podcast Network will be distributed through the iHeartPodcast Network which is home to more than 750 original podcasts. With over 225 million downloads each month, iHeartRadio is the leading podcast publisher according to Podtrac, with a substantial lead over the next largest commercial podcaster. iHeartPodcasts span every category from business, sports, spirituality and technology to entertainment, family, comedy and true crime and everything in between making iHeartRadio the largest publisher of podcast content in the world. iHeartPodcasts are distributed on all major podcast platforms, including the iHeartRadio app. PepsiCo Beverages, in collaboration with its agency partner OMD, has signed on as an inaugural partner of The Black Effect Podcast Network with others to be announced. We knew we wanted to support this groundbreaking partnership as soon as Charlamagne and iHeart shared their vision for the network. This opportunity connects our brands to consumers through the newer trusted medium of podcasting, and more importantly, supports the overall PepsiCo strategic initiative to invest in Black communities and support diverse voices, said Katie Haniffy, PepsiCo Beverages Head of Media. Weve had the pleasure of collaborating with Charlamagne in the past and look forward to our continued partnership with him and iHeartMedia on this incredibly exciting venture. The Black Effect Podcast Network launch lineup will include: Drink Champs with N.O.R.E and DJ EFN All The Smoke with Matt Barnes The 85 South Show with Karlous Miller, DC Young Fly and Clayton English Whoreible Decisions with Mandii B and Weezy Dropping Gems with Devi Brown Holding Court with Eboni K. Williams Carefully Reckless with Jess Hilarious Street Politicians with Tamika Mallory and Mysonne Hot Happy Mess with Zuri Hall Untitled with Bonang Matheba Hello Somebody with Senator Nina Turner P.O.D. with Ashley and Tammy Straight Shot No Chaser with Tezlyn Figaro Laugh and Learn with Flame Monroe (executive produced by Tiffany Haddish) Checking In with Michelle Williams Cut To It with Steven Smith Sr. No Ceilings with Glasses Malone Gangster Chronicles with MC EIHT, Reggie Wright Jr. and James McDonald Fans can go to iHeart.com/apps to download and listen on all their favorite devices including smart speakers, digital auto dashes, tablets, wearables, smartphones, virtual assistants, televisions, gaming consoles and more. About iHeartMedia iHeartMedia (NASDAQ: IHRT) is the number one audio company in the United States, reaching nine out of 10 Americans every month and with its quarter of a billion monthly listeners, has a greater reach than any other media company in the U.S. The companys leadership position in audio extends across multiple platforms, including more than 850 live broadcast stations in over 160 markets nationwide; through its iHeartRadio digital service available across more than 250 platforms and 2,000 devices; through its influencers; social; branded iconic live music events; other digital products and newsletters; and podcasts as the #1 commercial podcast publisher. iHeartMedia also leads the audio industry in analytics, targeting and attribution for its marketing partners with its SmartAudio product, using data from its massive consumer base. Visit iHeartMedia.com for more company information. About Charlamagne Tha God Charlamagne Tha God is one of the most potent, influential, and authoritative voices in media today. He is the widely coveted, outspoken, thought-provoking co-host of the hottest nationally-syndicated radio show in the U.S., The Breakfast Club, heard by over 4.5 million listeners each week. Charlamagnes production company, CTHAGOD World Productions, discovers and advocates for original content and emerging talent who resonate with popular culture long before they are recognized mainstream. A cultural architect and executive producer, Charlamagne is the co-host of the popular podcast, Brilliant Idiots,. He is a New York Times bestselling author of the book, Black Privilege and global bestseller Shook One, which propelled him to become one of the worlds leading voices in the mental health discussion. Charlamagne will be inducted into the Radio Hall of Fame in October. About The Black Effect Podcast Network The Black Effect Podcast Network is a transformative network founded by renowned cultural architect, executive producer, bestselling author, and media mogul Charlamagne Tha God. In an historic joint venture with the worlds number one commercial podcast publisher, iHeartMedia, Charlamagne and iHeartMedia created the groundbreaking first-ever Black Effect Podcast Network, celebrating the most important Black culture-shapers on the planetin education, politics, entertainment, sports and pop culture. The Black Effect Podcast Network gives rise to emerging and established content creators and storytellers whose perspective and creative vision have been marginalized and overlooked while serving an audience that has been underserved. The Black Effect Podcast Network helps its partners define their place in culture through influence, ideas, and experiences that engage, inspire, inform and empower. |
edtsum2933 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SELBYVILLE, Del., Nov. 8, 2020 /PRNewswire/ -- According to the latest report "Animal Model Market Animal Type (Mice, Rats, Fish, Birds, Cattles, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), Applications (Research & Development, Production and Quality Control, Academics, Preclinical Applications), Use (Human and Veterinary), End-use (Companies, Organisations, Academic and Research Institutes, Contract Research Organizations (CRO)), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026", by Global Market Insights, Inc., the market valuation of animal modelwill cross $25.2 billion by 2026. Continue Reading Some of the major animal model market players include Charles River, Envigo, genOway, Harbour BioMed, Janvier Labs, Horizon Discovery Group plc, The Jackson Laboratory and Taconic Biosciences Inc. Emergence of CRISPR as a powerful tool in biomedical research in developed countries will significantly boost the market growth. The technique of CRISPR is easy to perform and time saving as compared toconventional techniques. CRISPR is a breakthrough technology that has enabled rapid and cost-effective production of animal models. The CRISPR-Cas9 technology allows the production of mutant mouse models that were not possible to create earlier using conventional methods. Knock-in and knockout mouse models have been created using this technique for drug safety tests. Thus, the demand for animal models has significantly augmented driven by the increase in the use of theCRISPR technique. The demand for animal models by a greater number of research institutions and well-established industry players in developed countries has uplifted owing to their affordability of tools and resources pertaining to CRISPR technology. Requesta sample of this research report @ https://www.gminsights.com/request-sample/detail/4435 The growing number of pharmaceutical research and development activities in developing regions will fuel animal model market revenue. The prevalence of chronic cardiovascular diseases such as hypertension and atherosclerosis in developing countries has led to an increased demand for the development of therapeutic drugs. In order to meet the demand for drugs by healthcare professionals and patients, pharmaceutical companies in developing countries are focusing on R&D activities for the production of novel drugs. Pharmaceutical companies also focus on production of animal models for rare diseases such as cardiomyopathy and osteoarthritis in collaboration with several other organizations. These factors have led to increase in the demand and adoption of animal models.The pig model segment in the animal model market valued at over USD 615 million in 2019 impelled by the high similarity of physiology and immune system of the pigs to the humans. The porcine immune system resembles human immune system for more than 80% of the analyzed parameters. The upper and lower respiratory tracts of the pig are similar to that of the humans. Therefore, pigs are reliable and appropriate animal models for intranasal vaccine formulations for humans. Pig models are also utilized for development of Bordetella pertussis vaccines and testing of human Norovirus vaccine. Pigs as an animal models are cost-effective and therefore, they are increasingly preferred by researchers.Animal model market for CRISPR technology segment exceeded USD 4.6 billion in 2019 led by the advantages such as cost-effectiveness and rapid generation of new mouse models. This technique has been used in generation knock-in and knockout mice required for research of neurodegenerative diseases such as Huntington disease and amyotrophic lateral sclerosis (ALS). CRISPR-Cas9 technology has produced rat models being used in development of effective therapeutic approaches.The preclinical application in the animal model market will showcase growth of around 8.5% till 2026. Growing prevalence of several disorders in humans is leading to increased demand for novel therapeutic drugs that require preclinical evaluation. The preclinical processes of drug development along with small molecules and biologics requires extensive use of animal models. The demand for development of animal models in preclinical applications is increasing due to the rising need for therapeutic drugs. The use of humanized mouse models for preclinical translational research of in vivo human immune system has witnessed significant progress in the recent years.The animal model market for human use segment is estimated to attain a CAGR of 7.6% through 2026. Animal modelsare increasingly being used in the study of human diseases propelled by the anatomical and physiological similarities to the humans. This factor enables the researchers to understand the pathogenesis and characteristics of diseases as well as the human physiology. The rising prevalence of viral diseases has augmented the demand of animal models for clinical trials of vaccines and drugs.Contract research organizations (CRO) end-use segment in the animal model market accounted for USD 1,111 million in 2019. The CROs are preferred for customized research by the pharmaceutical companies as these companies outsource their research activities to contract research organizations in order to reduce the production cost and time. Thus, the adoption of animal models by CROs is increasing at a moderate pace. CROs offer services supporting the process of veterinary drug discovery in veterinary pharmaceutical companies such as clinical trials and toxicology studies.The South Korea animal model market size is poised to expand at more than 10.7% CAGR during 2020 to 2026 on account of rising cosmetic surgeries and several other therapies being adopted by the people. Thus, the need to test the safety and efficacy of cosmetic drugs has led to increase in adoption and demand for animal models by the research institutions in the country. The increasing investment in the healthcare sector is also driving the demand for animal models. Growing focus towards medical research in the country will further boost the demand for animal models.Some of the major players operational in the animal model market are Charles River, Envigo, genOway, Harbour BioMed, Janvier Labs, Horizon Discovery Group plc, The Jackson Laboratory and Taconic Biosciences Inc. among others. These companies have implemented several strategic initiatives such as acquisitions and product launches to maintain competitive edge in the market.Request customization of this research report @ https://www.gminsights.com/roc/4435Table of Contents (ToC) of the report:Chapter 3Animal Model Market Insights3.1 Industry segmentation3.2 Industry landscape, 2015 - 20263.3 Industry impact factors3.3.1 Growth drivers3.3.2 Industry pitfalls & challenges3.4 Growth potential analysis3.5 COVID-19 impact analysis3.6 Regulatory landscape3.7 Pricing analysis3.8 Porter's analysis3.9 Competitive landscape, 20193.9.1 Competitive matrix analysis3.10 PESTEL analysisBrowse Complete Table of Contents (ToC) @ https://www.gminsights.com/toc/detail/animal-model-marketAbout Global Market Insights, Inc.Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.Contact Us:Arun HegdeCorporate Sales, USAGlobal Market Insights, Inc.Phone:1-302-846-7766Toll Free:1-888-689-0688Email:[emailprotected]Related Imagesanimal-model-market-growth.png Animal Model Market Growth Predicted at 7.5% Through 2026: GMI Some of the major animal model market players include Charles River, Envigo, genOway, Harbour BioMed, Janvier Labs, Horizon Discovery Group plc, The Jackson Laboratory and Taconic Biosciences Inc. Related LinksAnimal Healthcare Market Animal Diagnostics Market SOURCE Global Market Insights, Inc.
Answer: | Animal Model Market Revenue to Cross USD 25 Bn by 2026: Global Market Insights, Inc. The South Korea animal model market revenue is estimated to attain a CAGR of more than 10.7% during 2020 to 2026 owing to rising cosmetic surgeries and several other therapies being adopted by the people. | SELBYVILLE, Del., Nov. 8, 2020 /PRNewswire/ -- According to the latest report "Animal Model Market Animal Type (Mice, Rats, Fish, Birds, Cattles, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), Applications (Research & Development, Production and Quality Control, Academics, Preclinical Applications), Use (Human and Veterinary), End-use (Companies, Organisations, Academic and Research Institutes, Contract Research Organizations (CRO)), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026", by Global Market Insights, Inc., the market valuation of animal modelwill cross $25.2 billion by 2026. Continue Reading Some of the major animal model market players include Charles River, Envigo, genOway, Harbour BioMed, Janvier Labs, Horizon Discovery Group plc, The Jackson Laboratory and Taconic Biosciences Inc. Emergence of CRISPR as a powerful tool in biomedical research in developed countries will significantly boost the market growth. The technique of CRISPR is easy to perform and time saving as compared toconventional techniques. CRISPR is a breakthrough technology that has enabled rapid and cost-effective production of animal models. The CRISPR-Cas9 technology allows the production of mutant mouse models that were not possible to create earlier using conventional methods. Knock-in and knockout mouse models have been created using this technique for drug safety tests. Thus, the demand for animal models has significantly augmented driven by the increase in the use of theCRISPR technique. The demand for animal models by a greater number of research institutions and well-established industry players in developed countries has uplifted owing to their affordability of tools and resources pertaining to CRISPR technology. Requesta sample of this research report @ https://www.gminsights.com/request-sample/detail/4435 The growing number of pharmaceutical research and development activities in developing regions will fuel animal model market revenue. The prevalence of chronic cardiovascular diseases such as hypertension and atherosclerosis in developing countries has led to an increased demand for the development of therapeutic drugs. In order to meet the demand for drugs by healthcare professionals and patients, pharmaceutical companies in developing countries are focusing on R&D activities for the production of novel drugs. Pharmaceutical companies also focus on production of animal models for rare diseases such as cardiomyopathy and osteoarthritis in collaboration with several other organizations. These factors have led to increase in the demand and adoption of animal models.The pig model segment in the animal model market valued at over USD 615 million in 2019 impelled by the high similarity of physiology and immune system of the pigs to the humans. The porcine immune system resembles human immune system for more than 80% of the analyzed parameters. The upper and lower respiratory tracts of the pig are similar to that of the humans. Therefore, pigs are reliable and appropriate animal models for intranasal vaccine formulations for humans. Pig models are also utilized for development of Bordetella pertussis vaccines and testing of human Norovirus vaccine. Pigs as an animal models are cost-effective and therefore, they are increasingly preferred by researchers.Animal model market for CRISPR technology segment exceeded USD 4.6 billion in 2019 led by the advantages such as cost-effectiveness and rapid generation of new mouse models. This technique has been used in generation knock-in and knockout mice required for research of neurodegenerative diseases such as Huntington disease and amyotrophic lateral sclerosis (ALS). CRISPR-Cas9 technology has produced rat models being used in development of effective therapeutic approaches.The preclinical application in the animal model market will showcase growth of around 8.5% till 2026. Growing prevalence of several disorders in humans is leading to increased demand for novel therapeutic drugs that require preclinical evaluation. The preclinical processes of drug development along with small molecules and biologics requires extensive use of animal models. The demand for development of animal models in preclinical applications is increasing due to the rising need for therapeutic drugs. The use of humanized mouse models for preclinical translational research of in vivo human immune system has witnessed significant progress in the recent years.The animal model market for human use segment is estimated to attain a CAGR of 7.6% through 2026. Animal modelsare increasingly being used in the study of human diseases propelled by the anatomical and physiological similarities to the humans. This factor enables the researchers to understand the pathogenesis and characteristics of diseases as well as the human physiology. The rising prevalence of viral diseases has augmented the demand of animal models for clinical trials of vaccines and drugs.Contract research organizations (CRO) end-use segment in the animal model market accounted for USD 1,111 million in 2019. The CROs are preferred for customized research by the pharmaceutical companies as these companies outsource their research activities to contract research organizations in order to reduce the production cost and time. Thus, the adoption of animal models by CROs is increasing at a moderate pace. CROs offer services supporting the process of veterinary drug discovery in veterinary pharmaceutical companies such as clinical trials and toxicology studies.The South Korea animal model market size is poised to expand at more than 10.7% CAGR during 2020 to 2026 on account of rising cosmetic surgeries and several other therapies being adopted by the people. Thus, the need to test the safety and efficacy of cosmetic drugs has led to increase in adoption and demand for animal models by the research institutions in the country. The increasing investment in the healthcare sector is also driving the demand for animal models. Growing focus towards medical research in the country will further boost the demand for animal models.Some of the major players operational in the animal model market are Charles River, Envigo, genOway, Harbour BioMed, Janvier Labs, Horizon Discovery Group plc, The Jackson Laboratory and Taconic Biosciences Inc. among others. These companies have implemented several strategic initiatives such as acquisitions and product launches to maintain competitive edge in the market.Request customization of this research report @ https://www.gminsights.com/roc/4435Table of Contents (ToC) of the report:Chapter 3Animal Model Market Insights3.1 Industry segmentation3.2 Industry landscape, 2015 - 20263.3 Industry impact factors3.3.1 Growth drivers3.3.2 Industry pitfalls & challenges3.4 Growth potential analysis3.5 COVID-19 impact analysis3.6 Regulatory landscape3.7 Pricing analysis3.8 Porter's analysis3.9 Competitive landscape, 20193.9.1 Competitive matrix analysis3.10 PESTEL analysisBrowse Complete Table of Contents (ToC) @ https://www.gminsights.com/toc/detail/animal-model-marketAbout Global Market Insights, Inc.Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.Contact Us:Arun HegdeCorporate Sales, USAGlobal Market Insights, Inc.Phone:1-302-846-7766Toll Free:1-888-689-0688Email:[emailprotected]Related Imagesanimal-model-market-growth.png Animal Model Market Growth Predicted at 7.5% Through 2026: GMI Some of the major animal model market players include Charles River, Envigo, genOway, Harbour BioMed, Janvier Labs, Horizon Discovery Group plc, The Jackson Laboratory and Taconic Biosciences Inc. Related LinksAnimal Healthcare Market Animal Diagnostics Market SOURCE Global Market Insights, Inc. |
edtsum2935 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, April 5, 2021 /PRNewswire/ --MZ, a global leader in investor relations and corporate communications, has partnered with the NEO Exchange, a Canadian stock exchange, to provide its investor relations and technology solutions to NEO's corporate issuers through its Trusted Service Provider Program. Launched in 2015, the NEO Exchange has earned a reputation as Canada's innovative and disruptive tier-one stock exchange, bringing much-needed competition to the Canadian capital markets landscape. The Trusted Service Provider program recommends service providers who are committed to meeting the needs of capital raising companies. NEO Trusted Service Providers are leading experts in their fields and across all verticals including, legal, accounting, audit, communications, transfer agency, finance, governance, IR, PR and marketing support. In addition to MZ's comprehensive investor relations and outreach service offerings, MZ will provide NEO issuers preferential rates and exclusive technology packages. At launch, MZ isoffering to design and implement a company's new website in 7 days, as well as hosting of an IR website, completely freeofcharge, for an entire year. For more information on this offer, please contact [emailprotected]. "We are privileged to enroll in NEO's partner program and to begin extending our unique one-stop-shop model of high-value services and technologies to over 120 unique listings on the NEO Exchange," said Greg Falesnik, Chief Executive Officer of MZ North America. "NEO consistently represents close to 15% of all volume traded in Canadian-listed securities, and is backed by some of the most reputable financial organizations in Canada who recognized a need for innovation and disruption in the industry." "As a trusted partner, we can add significant value to the growing number of corporate issuers that turn to NEO for next-generation capital raising and liquidity solutions. NEO clients will now have access to some of the most robust outreach, consulting, and IR technology solutions on the market, such as ESG reporting and custom website capabilities. We look forward to a long and successful partnership with NEO, while providing issuers a suite of consulting and technology services tailored to their corporate lifecycles," concluded Falesnik. Erik Sloane, Chief Revenue Officer at NEO, added, "MZ is a robust addition to our corporate issuer toolkit as the world's largest independently owned investor relations and corporate communications firm. Several of our clients are already using MZ, and we have been consistently impressed by their attention to detail, strategic approach to investor relations, and masterful execution. We are confident in recommending their services and look forward to continuing to work together with the MZ team to help our corporate issuers thrive. MZ Group joins a carefully vetted collection of leading experts, across all verticals, who are committed to meeting the needs of growth companies and are aligned with NEO's vision, values, and commitment to providing exceptional client service." NEO Exchange Digital Market Open Event In conjunction with the new partnership, MZ will participate in a Digital Market Open Event for the NEO Exchange on Monday, April 5 2021, at 9:20 a.m. Eastern Time. The event will include welcome remarks from Erik Sloane, NEO, and remarks and a presentation from Greg Falesnik, CEO of MZ. Register for the event here. MZ Group's Comprehensive Service Offerings: Investor Relations and Outreach Full-service investor relations services and introduction capabilities, with a database of over 140,000 investors worldwide. Financial Media Awareness Targeted campaigns to business and financial media, as well as branded newsletter contributors. Social Media Services Account creation & optimization, custom graphics, posting and management, advertising campaigns and detailed monthly reporting. ESG Consulting & Software Education, auditing, reporting and strategic implementation of environmental, social, and governance (ESG) metrics leveraging MZ's proprietary software, ESGiQ. Market Surveillance & Intelligence Stock surveillance on a micro and macro level with real time ownership monitoring. Website Design & Hosting Corporate and investor relations websites designed to bring a better experience using benchmark practices based on the latest technology and trends. Conference Calls & Webcasting Enhance your audience engagement with top-tier call and webcasting services. Investor Relations CRM Manage information on key stakeholders and access investment fund profiles to enhance your targeting efforts. Board Portals Nasdaq Boardvantage Board Portal. A paperless boardroom for effective corporate engagement that improves workflow and organization for the board of directors. Press Release Distribution Services Unlimited news release distribution via our newswire partners, using the world's largest distribution networks. Regulatory Filings Edgar & XBRL filing capabilities to meet SEC and other regulatory requirements. To learn more about MZ Group, please visit www.mzgroup.com or contact Greg Falesnik at [emailprotected]. For more information on NEO's Trusted Service Provider Program, click here. About MZ Group MZ North America is the US division of MZ Group, a global leader in investor relations and corporate communications. MZ North America was founded in 1996 and provides full scale Investor Relations to both private and public companies across all industries. MZ North America has a global footprint with offices located in New York, Chicago, San Diego, Aliso Viejo, Austin, Minneapolis, Taipei and So Paulo. For more information, please visit www.mzgroup.us. Contact: Greg Falesnik, Chief Executive Officer MZ North America Direct: 949-385-6449 [emailprotected] SOURCE MZ
Answer: | MZ Partners with the NEO Exchange as a Trusted Service Provider MZ Offering NEO Clients Preferred Rates and Free Design and Hosting of Investor Relations Websites for A Full Year | NEW YORK, April 5, 2021 /PRNewswire/ --MZ, a global leader in investor relations and corporate communications, has partnered with the NEO Exchange, a Canadian stock exchange, to provide its investor relations and technology solutions to NEO's corporate issuers through its Trusted Service Provider Program. Launched in 2015, the NEO Exchange has earned a reputation as Canada's innovative and disruptive tier-one stock exchange, bringing much-needed competition to the Canadian capital markets landscape. The Trusted Service Provider program recommends service providers who are committed to meeting the needs of capital raising companies. NEO Trusted Service Providers are leading experts in their fields and across all verticals including, legal, accounting, audit, communications, transfer agency, finance, governance, IR, PR and marketing support. In addition to MZ's comprehensive investor relations and outreach service offerings, MZ will provide NEO issuers preferential rates and exclusive technology packages. At launch, MZ isoffering to design and implement a company's new website in 7 days, as well as hosting of an IR website, completely freeofcharge, for an entire year. For more information on this offer, please contact [emailprotected]. "We are privileged to enroll in NEO's partner program and to begin extending our unique one-stop-shop model of high-value services and technologies to over 120 unique listings on the NEO Exchange," said Greg Falesnik, Chief Executive Officer of MZ North America. "NEO consistently represents close to 15% of all volume traded in Canadian-listed securities, and is backed by some of the most reputable financial organizations in Canada who recognized a need for innovation and disruption in the industry." "As a trusted partner, we can add significant value to the growing number of corporate issuers that turn to NEO for next-generation capital raising and liquidity solutions. NEO clients will now have access to some of the most robust outreach, consulting, and IR technology solutions on the market, such as ESG reporting and custom website capabilities. We look forward to a long and successful partnership with NEO, while providing issuers a suite of consulting and technology services tailored to their corporate lifecycles," concluded Falesnik. Erik Sloane, Chief Revenue Officer at NEO, added, "MZ is a robust addition to our corporate issuer toolkit as the world's largest independently owned investor relations and corporate communications firm. Several of our clients are already using MZ, and we have been consistently impressed by their attention to detail, strategic approach to investor relations, and masterful execution. We are confident in recommending their services and look forward to continuing to work together with the MZ team to help our corporate issuers thrive. MZ Group joins a carefully vetted collection of leading experts, across all verticals, who are committed to meeting the needs of growth companies and are aligned with NEO's vision, values, and commitment to providing exceptional client service." NEO Exchange Digital Market Open Event In conjunction with the new partnership, MZ will participate in a Digital Market Open Event for the NEO Exchange on Monday, April 5 2021, at 9:20 a.m. Eastern Time. The event will include welcome remarks from Erik Sloane, NEO, and remarks and a presentation from Greg Falesnik, CEO of MZ. Register for the event here. MZ Group's Comprehensive Service Offerings: Investor Relations and Outreach Full-service investor relations services and introduction capabilities, with a database of over 140,000 investors worldwide. Financial Media Awareness Targeted campaigns to business and financial media, as well as branded newsletter contributors. Social Media Services Account creation & optimization, custom graphics, posting and management, advertising campaigns and detailed monthly reporting. ESG Consulting & Software Education, auditing, reporting and strategic implementation of environmental, social, and governance (ESG) metrics leveraging MZ's proprietary software, ESGiQ. Market Surveillance & Intelligence Stock surveillance on a micro and macro level with real time ownership monitoring. Website Design & Hosting Corporate and investor relations websites designed to bring a better experience using benchmark practices based on the latest technology and trends. Conference Calls & Webcasting Enhance your audience engagement with top-tier call and webcasting services. Investor Relations CRM Manage information on key stakeholders and access investment fund profiles to enhance your targeting efforts. Board Portals Nasdaq Boardvantage Board Portal. A paperless boardroom for effective corporate engagement that improves workflow and organization for the board of directors. Press Release Distribution Services Unlimited news release distribution via our newswire partners, using the world's largest distribution networks. Regulatory Filings Edgar & XBRL filing capabilities to meet SEC and other regulatory requirements. To learn more about MZ Group, please visit www.mzgroup.com or contact Greg Falesnik at [emailprotected]. For more information on NEO's Trusted Service Provider Program, click here. About MZ Group MZ North America is the US division of MZ Group, a global leader in investor relations and corporate communications. MZ North America was founded in 1996 and provides full scale Investor Relations to both private and public companies across all industries. MZ North America has a global footprint with offices located in New York, Chicago, San Diego, Aliso Viejo, Austin, Minneapolis, Taipei and So Paulo. For more information, please visit www.mzgroup.us. Contact: Greg Falesnik, Chief Executive Officer MZ North America Direct: 949-385-6449 [emailprotected] SOURCE MZ |
edtsum2937 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ALTADENA, Calif., April 1, 2021 /PRNewswire/ --Blue Marble Health, along with program partners in Long Beach, New York City, and Alpena, announced a self-assessment plan as a part of a return to independence. As the rate of new COVID vaccinations rises, communities are beginning to discuss the process of opening up. Residents are starting to think about expanding their independence and returning to their pre-COVID-19 routines. Whether it entails walking around the block or walking around the grocery store, are you ready for a new normal?How is your physical strength?Balance?Do you have the endurance you need to keep your independence and return to regular activities as you know them?How can you safely find out and, if necessary, get assistance in regaining your strength and balance to regain your independence? The partnership offers digitized self-assessments that will help older adults determine their readiness to stay independent and return to normal routines.The assessment battery considers strength, balance, endurance, diet, eyesight, mental health, and medication to calculate a fall risk score.Those who score in the "Typical for the Age and Gender," are likely ready to go about their day as before.Scores in the"Higher Fall Risk" suggest you will benefit from a consult with a physical therapist to help get you ready to interact with your friends and family safely.The program partners can help you target the areas you wish to improve so that you can safely and confidently return to your typical routine. Do you know someone who would be interested in learning about their independence and fall risk?Have them complete the digital assessment battery.There is no fee associated with taking the assessment(s).Fees associated with Physical Therapy are typically covered by healthcare insurance.Group exercise programs may have a nominal fee to cover the instructor's time. Ask your partner for details.Participation requires an Internet-enabled device such as a smartphone, tablet, computer, and an accessible email account. Follow the link (https://bluemarblehealthco.com/download/) and use the download codeHealthy to take the assessment. Program Partners Long Beach CA - Pools of Hope - poolsofhope.com Alpena MI - Alpena Senior Center - alpenaseniors.com If you would like your organization to host a Return to Independence event, please contact Chris Ashford at Blue Marble Health 626.296.6227, or email [emailprotected]. About Blue Marble HealthThe Blue Marble Health (www.BlueMarbleHealthCo.com) Assessment, Intervention, Monitoring and Analytics Platform supports onsite and home-based Telehealth and Care Management for COPD, and other chronic conditions. SOURCE Blue Marble Health Related Links https://www.bluemarblehealthco.com
Answer: | Get Ready to Return to Life Post COVID-19 Self-Assessment as part of the Return to Independence | ALTADENA, Calif., April 1, 2021 /PRNewswire/ --Blue Marble Health, along with program partners in Long Beach, New York City, and Alpena, announced a self-assessment plan as a part of a return to independence. As the rate of new COVID vaccinations rises, communities are beginning to discuss the process of opening up. Residents are starting to think about expanding their independence and returning to their pre-COVID-19 routines. Whether it entails walking around the block or walking around the grocery store, are you ready for a new normal?How is your physical strength?Balance?Do you have the endurance you need to keep your independence and return to regular activities as you know them?How can you safely find out and, if necessary, get assistance in regaining your strength and balance to regain your independence? The partnership offers digitized self-assessments that will help older adults determine their readiness to stay independent and return to normal routines.The assessment battery considers strength, balance, endurance, diet, eyesight, mental health, and medication to calculate a fall risk score.Those who score in the "Typical for the Age and Gender," are likely ready to go about their day as before.Scores in the"Higher Fall Risk" suggest you will benefit from a consult with a physical therapist to help get you ready to interact with your friends and family safely.The program partners can help you target the areas you wish to improve so that you can safely and confidently return to your typical routine. Do you know someone who would be interested in learning about their independence and fall risk?Have them complete the digital assessment battery.There is no fee associated with taking the assessment(s).Fees associated with Physical Therapy are typically covered by healthcare insurance.Group exercise programs may have a nominal fee to cover the instructor's time. Ask your partner for details.Participation requires an Internet-enabled device such as a smartphone, tablet, computer, and an accessible email account. Follow the link (https://bluemarblehealthco.com/download/) and use the download codeHealthy to take the assessment. Program Partners Long Beach CA - Pools of Hope - poolsofhope.com Alpena MI - Alpena Senior Center - alpenaseniors.com If you would like your organization to host a Return to Independence event, please contact Chris Ashford at Blue Marble Health 626.296.6227, or email [emailprotected]. About Blue Marble HealthThe Blue Marble Health (www.BlueMarbleHealthCo.com) Assessment, Intervention, Monitoring and Analytics Platform supports onsite and home-based Telehealth and Care Management for COPD, and other chronic conditions. SOURCE Blue Marble Health Related Links https://www.bluemarblehealthco.com |
edtsum2939 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CLEVELAND, Aug. 10, 2020 /PRNewswire/ -- CHAMPS Group Purchasing (GPO), in collaboration with four Cleveland-area agencies and organizations, is pleased to announce today its "Give Back With CHAMPS GPO" campaign in support of Northeast Ohio nonprofits. As part of the initiative, CHAMPS GPO will give a percentage of proceeds to a participating Greater Cleveland nonprofit organization with every purchase made by new CHAMPS GPO members. Participating CHAMPS GPO members have a choice of four organizations to direct their proceeds to, which include: Big Brothers Big Sisters of Greater Cleveland, a nonprofit driven by its mission to provide children facing adversity with strong and enduring, professionally supported 1-to-1 relationships that change their lives for the better; Cleveland Can't Wait, a Northeast Ohio nonprofit focused on revitalizing Cleveland through civic tech and entrepreneurship; Esperanza Inc., a nonprofit aimed at improving the academic achievement of Hispanic individuals in Greater Cleveland; and Providence House, Ohio's first and one of the nation's longest-operating crises nurseries which protects at-risk children and supports families through crisis. "The COVID-19 pandemic has hit everyone hard," said CHAMPS Group Purchasing Vice President Tracy Wise. "Despite that, it's important to recognize we're all in this together. By leveraging the connections our organization has to more than 2,200 discounted supplier agreements across the United States, including suppliers in our own backyard, I'm confident CHAMPS GPO and our new members will be able to make positive change within the Northeast Ohio community by supporting these Greater Cleveland nonprofit organizations." To get involved in the "Give Back With CHAMPS GPO" campaign, organizations can contact CHAMPS GPO to start their free CHAMPS GPO membership. Stay connected with the campaign by using and following the hashtag #GiveBackCleveland on Facebook, LinkedIn and Twitter. About CHAMPS GPO: CHAMPS Group Purchasing leverages the purchasing power of 14,000+ member locations across the United States. CHAMPS' members gain access to significant savings in product categories including medical / surgical supplies, foodservice, IT, wireless, office supplies and facility maintenance. Together with its national GPO partner Premier, CHAMPS supports healthcare and non-healthcare member supply chain initiatives through their expertise in contract management, aggregation savings, supply chain technology, spend analytics and customized service. For more, visit champsgpo.com. PRESS CONTACT: For more information, please contact CHAMPS GPO Vice President, Tracy Wise About The Center for Health Affairs The Center for Health Affairs: With a rich history as the nation's first regional hospital association, The Center for Health Affairs has served as the collective voice of Northeast Ohio hospitals for more than 100 years. The Center works collaboratively to increase the efficiency of healthcare delivery, providing insightful healthcare information to the public and undertaking initiatives aimed at improving the health of the community. The Center's business affiliates include CHAMPS Oncology, CHAMPS Group Purchasing and The Essentials Group. Press Contact: Lynn Eastep 2165010051 http://www.neohospitals.org SOURCE CHAMPS GPO Related Links http://champsgpo.com
Answer: | CHAMPS GPO Launches "Give Back" Campaign to Benefit Greater Cleveland Nonprofits | CLEVELAND, Aug. 10, 2020 /PRNewswire/ -- CHAMPS Group Purchasing (GPO), in collaboration with four Cleveland-area agencies and organizations, is pleased to announce today its "Give Back With CHAMPS GPO" campaign in support of Northeast Ohio nonprofits. As part of the initiative, CHAMPS GPO will give a percentage of proceeds to a participating Greater Cleveland nonprofit organization with every purchase made by new CHAMPS GPO members. Participating CHAMPS GPO members have a choice of four organizations to direct their proceeds to, which include: Big Brothers Big Sisters of Greater Cleveland, a nonprofit driven by its mission to provide children facing adversity with strong and enduring, professionally supported 1-to-1 relationships that change their lives for the better; Cleveland Can't Wait, a Northeast Ohio nonprofit focused on revitalizing Cleveland through civic tech and entrepreneurship; Esperanza Inc., a nonprofit aimed at improving the academic achievement of Hispanic individuals in Greater Cleveland; and Providence House, Ohio's first and one of the nation's longest-operating crises nurseries which protects at-risk children and supports families through crisis. "The COVID-19 pandemic has hit everyone hard," said CHAMPS Group Purchasing Vice President Tracy Wise. "Despite that, it's important to recognize we're all in this together. By leveraging the connections our organization has to more than 2,200 discounted supplier agreements across the United States, including suppliers in our own backyard, I'm confident CHAMPS GPO and our new members will be able to make positive change within the Northeast Ohio community by supporting these Greater Cleveland nonprofit organizations." To get involved in the "Give Back With CHAMPS GPO" campaign, organizations can contact CHAMPS GPO to start their free CHAMPS GPO membership. Stay connected with the campaign by using and following the hashtag #GiveBackCleveland on Facebook, LinkedIn and Twitter. About CHAMPS GPO: CHAMPS Group Purchasing leverages the purchasing power of 14,000+ member locations across the United States. CHAMPS' members gain access to significant savings in product categories including medical / surgical supplies, foodservice, IT, wireless, office supplies and facility maintenance. Together with its national GPO partner Premier, CHAMPS supports healthcare and non-healthcare member supply chain initiatives through their expertise in contract management, aggregation savings, supply chain technology, spend analytics and customized service. For more, visit champsgpo.com. PRESS CONTACT: For more information, please contact CHAMPS GPO Vice President, Tracy Wise About The Center for Health Affairs The Center for Health Affairs: With a rich history as the nation's first regional hospital association, The Center for Health Affairs has served as the collective voice of Northeast Ohio hospitals for more than 100 years. The Center works collaboratively to increase the efficiency of healthcare delivery, providing insightful healthcare information to the public and undertaking initiatives aimed at improving the health of the community. The Center's business affiliates include CHAMPS Oncology, CHAMPS Group Purchasing and The Essentials Group. Press Contact: Lynn Eastep 2165010051 http://www.neohospitals.org SOURCE CHAMPS GPO Related Links http://champsgpo.com |
edtsum2942 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, June 9, 2020 /PRNewswire/ -- Amid the COVID-19 crisis and the looming economic recession, the Vascular Access Devices market worldwide will grow by a projected US$2.1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 5.9%. Central Vascular Access Devices, one of the segments analyzed and sized in this study, is forecast to grow at over 6.6% and reach a market size of US$2.8 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Central Vascular Access Devices market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions. Read the full report: https://www.reportlinker.com/p05900487/?utm_source=PRN As part of the new emerging geographic scenario, the United States is forecast to readjust to a 4.7% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$64.4 Million to the region's size over the next 7 to 8 years. In addition, over US$62.4 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Central Vascular Access Devices segment will reach a market size of US$120.4 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Vascular Access Devices market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 9.9% over the next couple of years and add approximately US$570.8 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Vascular Access Devices market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. Competitors identified in this market include, among others, B. Braun Melsungen AG; Baxter International Inc.; Becton, Dickinson and Company; Fresenius Medical Care AG & Co. KgaA; Medtronic PLC; Nipro Medical Corporation; Siemens Healthineers; Smiths Medical; Teleflex Inc.; Terumo CorporationRead the full report: https://www.reportlinker.com/p05900487/?utm_source=PRN I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Vascular Access Device Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: Vascular Access Devices Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 2: Vascular Access Devices Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 Table 3: Vascular Access Devices Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Central Vascular Access Devices (Type) World Market by Region/Country in US$ Million: 2020 to 2027 Table 5: Central Vascular Access Devices (Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 Table 6: Central Vascular Access Devices (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Peripheral Vascular Access Devices (Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 Table 8: Peripheral Vascular Access Devices (Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 Table 9: Peripheral Vascular Access Devices (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 Table 10: Accessories (Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 Table 11: Accessories (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019 Table 12: Accessories (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 Table 13: Drug Administration (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027 Table 14: Drug Administration (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 Table 15: Drug Administration (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 Table 16: Fluid & Nutrition Administration (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 Table 17: Fluid & Nutrition Administration (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 Table 18: Fluid & Nutrition Administration (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 Table 19: Blood Transfusion (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 Table 20: Blood Transfusion (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 Table 21: Blood Transfusion (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 Table 22: Diagnostics & Testing (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 Table 23: Diagnostics & Testing (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 Table 24: Diagnostics & Testing (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Vascular Access Device Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 25: United States Vascular Access Devices Market Estimates and Projections in US$ Million by Type: 2020 to 2027 Table 26: Vascular Access Devices Market in the United States by Type: A Historic Review in US$ Million for 2012-2019 Table 27: United States Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 28: United States Vascular Access Devices Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 29: Vascular Access Devices Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019 Table 30: Vascular Access Devices Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 CANADA Table 31: Canadian Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 Table 32: Canadian Vascular Access Devices Historic Market Review by Type in US$ Million: 2012-2019 Table 33: Vascular Access Devices Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 Table 34: Canadian Vascular Access Devices Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 35: Vascular Access Devices Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 36: Canadian Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 JAPAN Table 37: Japanese Market for Vascular Access Devices: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 Table 38: Vascular Access Devices Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 Table 39: Japanese Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 40: Japanese Demand Estimates and Forecasts for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 41: Japanese Vascular Access Devices Market in US$ Million by Application: 2012-2019 Table 42: Vascular Access Devices Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 CHINA Table 43: Chinese Vascular Access Devices Market Growth Prospects in US$ Million by Type for the Period 2020-2027 Table 44: Vascular Access Devices Historic Market Analysis in China in US$ Million by Type: 2012-2019 Table 45: Chinese Vascular Access Devices Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 46: Chinese Demand for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 47: Vascular Access Devices Market Review in China in US$ Million by Application: 2012-2019 Table 48: Chinese Vascular Access Devices Market Share Breakdown by Application: 2012 VS 2020 VS 2027 EUROPE Market Facts & Figures European Vascular Access Device Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 49: European Vascular Access Devices Market Demand Scenario in US$ Million by Region/Country: 2020-2027 Table 50: Vascular Access Devices Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 Table 51: European Vascular Access Devices Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 52: European Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020-2027 Table 53: Vascular Access Devices Market in Europe in US$ Million by Type: A Historic Review for the Period 2012-2019 Table 54: European Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 55: European Vascular Access Devices Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 56: Vascular Access Devices Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 57: European Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 FRANCE Table 58: Vascular Access Devices Market in France by Type: Estimates and Projections in US$ Million for the Period 2020-2027 Table 59: French Vascular Access Devices Historic Market Scenario in US$ Million by Type: 2012-2019 Table 60: French Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 61: Vascular Access Devices Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027 Table 62: French Vascular Access Devices Historic Market Review in US$ Million by Application: 2012-2019 Table 63: French Vascular Access Devices Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 GERMANY Table 64: Vascular Access Devices Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 65: German Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 66: German Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 67: Vascular Access Devices Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 68: German Vascular Access Devices Market in Retrospect in US$ Million by Application: 2012-2019 Table 69: Vascular Access Devices Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 ITALY Table 70: Italian Vascular Access Devices Market Growth Prospects in US$ Million by Type for the Period 2020-2027 Table 71: Vascular Access Devices Historic Market Analysis in Italy in US$ Million by Type: 2012-2019 Table 72: Italian Vascular Access Devices Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 73: Italian Demand for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 74: Vascular Access Devices Market Review in Italy in US$ Million by Application: 2012-2019 Table 75: Italian Vascular Access Devices Market Share Breakdown by Application: 2012 VS 2020 VS 2027 UNITED KINGDOM Table 76: United Kingdom Market for Vascular Access Devices: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 Table 77: Vascular Access Devices Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 Table 78: United Kingdom Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 79: United Kingdom Demand Estimates and Forecasts for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 80: United Kingdom Vascular Access Devices Market in US$ Million by Application: 2012-2019 Table 81: Vascular Access Devices Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 SPAIN Table 82: Spanish Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 Table 83: Spanish Vascular Access Devices Historic Market Review by Type in US$ Million: 2012-2019 Table 84: Vascular Access Devices Market in Spain: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 Table 85: Spanish Vascular Access Devices Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 86: Vascular Access Devices Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 87: Spanish Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 RUSSIA Table 88: Russian Vascular Access Devices Market Estimates and Projections in US$ Million by Type: 2020 to 2027 Table 89: Vascular Access Devices Market in Russia by Type: A Historic Review in US$ Million for 2012-2019 Table 90: Russian Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 91: Russian Vascular Access Devices Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 92: Vascular Access Devices Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019 Table 93: Vascular Access Devices Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027 REST OF EUROPE Table 94: Rest of Europe Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020-2027 Table 95: Vascular Access Devices Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2012-2019 Table 96: Rest of Europe Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 97: Rest of Europe Vascular Access Devices Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 98: Vascular Access Devices Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 99: Rest of Europe Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 100: Asia-Pacific Vascular Access Devices Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 101: Vascular Access Devices Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019 Table 102: Asia-Pacific Vascular Access Devices Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 Table 103: Vascular Access Devices Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2020-2027 Table 104: Asia-Pacific Vascular Access Devices Historic Market Scenario in US$ Million by Type: 2012-2019 Table 105: Asia-Pacific Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 106: Vascular Access Devices Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027 Table 107: Asia-Pacific Vascular Access Devices Historic Market Review in US$ Million by Application: 2012-2019 Table 108: Asia-Pacific Vascular Access Devices Market Share Analysis: A 17-Year Perspectiveby Application for 2012, 2020, and 2027 AUSTRALIA Table 109: Vascular Access Devices Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 110: Australian Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 111: Australian Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 112: Vascular Access Devices Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 113: Australian Vascular Access Devices Market in Retrospect in US$ Million by Application: 2012-2019 Table 114: Vascular Access Devices Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027 INDIA Table 115: Indian Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 Table 116: Indian Vascular Access Devices Historic Market Review by Type in US$ Million: 2012-2019 Table 117: Vascular Access Devices Market in India: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 Table 118: Indian Vascular Access Devices Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 119: Vascular Access Devices Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 120: Indian Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 SOUTH KOREA Table 121: Vascular Access Devices Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 122: South Korean Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 123: Vascular Access Devices Market Share Distribution in South Korea by Type: 2012 VS 2020 VS 2027 Table 124: Vascular Access Devices Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 Table 125: South Korean Vascular Access Devices Historic Market Analysis in US$ Million by Application: 2012-2019 Table 126: Vascular Access Devices Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027 REST OF ASIA-PACIFIC Table 127: Rest of Asia-Pacific Market for Vascular Access Devices: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 Table 128: Vascular Access Devices Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 Table 129: Rest of Asia-Pacific Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 130: Rest of Asia-Pacific Demand Estimates and Forecasts for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 131: Rest of Asia-Pacific Vascular Access Devices Market in US$ Million by Application: 2012-2019 Table 132: Vascular Access Devices Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027 LATIN AMERICA Table 133: Latin American Vascular Access Devices Market Trends by Region/Country in US$ Million: 2020-2027 Table 134: Vascular Access Devices Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019 Table 135: Latin American Vascular Access Devices Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 Table 136: Latin American Vascular Access Devices Market Growth Prospects in US$ Million by Type for the Period 2020-2027 Table 137: Vascular Access Devices Historic Market Analysis in Latin America in US$ Million by Type: 2012-2019 Table 138: Latin American Vascular Access Devices Marketby Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 139: Latin American Demand for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 140: Vascular Access Devices Market Review in Latin America in US$ Million by Application: 2012-2019 Table 141: Latin American Vascular Access Devices Market Share Breakdown by Application: 2012 VS 2020 VS 2027 ARGENTINA Table 142: Argentinean Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020-2027 Table 143: Vascular Access Devices Market in Argentina in US$ Million by Type: A Historic Review for the Period 2012-2019 Table 144: Argentinean Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 145: Argentinean Vascular Access Devices Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 146: Vascular Access Devices Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 147: Argentinean Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 BRAZIL Table 148: Vascular Access Devices Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2020-2027 Table 149: Brazilian Vascular Access Devices Historic Market Scenario in US$ Million by Type: 2012-2019 Table 150: Brazilian Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 151: Vascular Access Devices Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027 Table 152: Brazilian Vascular Access Devices Historic Market Review in US$ Million by Application: 2012-2019 Table 153: Brazilian Vascular Access Devices Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 MEXICO Table 154: Vascular Access Devices Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 155: Mexican Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 156: Mexican Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 157: Vascular Access Devices Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 158: Mexican Vascular Access Devices Market in Retrospect in US$ Million by Application: 2012-2019 Table 159: Vascular Access Devices Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027 REST OF LATIN AMERICA Table 160: Rest of Latin America Vascular Access Devices Market Estimates and Projections in US$ Million by Type: 2020 to 2027 Table 161: Vascular Access Devices Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2012-2019 Table 162: Rest of Latin America Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 163: Rest of Latin America Vascular Access Devices Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 164: Vascular Access Devices Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019 Table 165: Vascular Access Devices Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027 MIDDLE EAST Table 166: The Middle East Vascular Access Devices Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 167: Vascular Access Devices Market in the Middle East by Region/Country in US$ Million: 2012-2019 Table 168: The Middle East Vascular Access Devices Market Share Breakdown by Region/Country: 2012, 2020, and 2027 Table 169: The Middle East Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 Table 170: The Middle East Vascular Access Devices Historic Marketby Type in US$ Million: 2012-2019 Table 171: Vascular Access Devices Market in the Middle East: Percentage Share Breakdown of Salesby Type for 2012,2020, and 2027 Table 172: The Middle East Vascular Access Devices Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 173: Vascular Access Devices Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 174: The Middle East Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 IRAN Table 175: Iranian Market for Vascular Access Devices: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 Table 176: Vascular Access Devices Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 Table 177: Iranian Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 178: Iranian Demand Estimates and Forecasts for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 179: Iranian Vascular Access Devices Market in US$ Million by Application: 2012-2019 Table 180: Vascular Access Devices Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027 ISRAEL Table 181: Israeli Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020-2027 Table 182: Vascular Access Devices Market in Israel in US$ Million by Type: A Historic Review for the Period 2012-2019 Table 183: Israeli Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 184: Israeli Vascular Access Devices Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 185: Vascular Access Devices Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 186: Israeli Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 SAUDI ARABIA Table 187: Saudi Arabian Vascular Access Devices Market Growth Prospects in US$ Million by Type for the Period 2020-2027 Table 188: Vascular Access Devices Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2012-2019 Table 189: Saudi Arabian Vascular Access Devices Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 190: Saudi Arabian Demand for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 191: Vascular Access Devices Market Review in Saudi Arabia in US$ Million by Application: 2012-2019 Table 192: Saudi Arabian Vascular Access Devices Market Share Breakdown by Application: 2012 VS 2020 VS 2027 UNITED ARAB EMIRATES Table 193: Vascular Access Devices Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 194: United Arab Emirates Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 195: Vascular Access Devices Market Share Distribution in United Arab Emirates by Type: 2012 VS 2020 VS 2027 Table 196: Vascular Access Devices Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 Table 197: United Arab Emirates Vascular Access Devices Historic Market Analysis in US$ Million by Application: 2012-2019 Table 198: Vascular Access Devices Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027 REST OF MIDDLE EAST Table 199: Vascular Access Devices Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 200: Rest of Middle East Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 201: Rest of Middle East Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 202: Vascular Access Devices Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 203: Rest of Middle East Vascular Access Devices Market in Retrospect in US$ Million by Application: 2012-2019 Table 204: Vascular Access Devices Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027 AFRICA Table 205: African Vascular Access Devices Market Estimates and Projections in US$ Million by Type: 2020 to 2027 Table 206: Vascular Access Devices Market in Africa by Type: A Historic Review in US$ Million for 2012-2019 Table 207: African Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 208: African Vascular Access Devices Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 209: Vascular Access Devices Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019 Table 210: Vascular Access Devices Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027 IV. COMPETITION Total Companies Profiled: 44Read the full report: https://www.reportlinker.com/p05900487/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com
Answer: | Amid the COVID-19 crisis and the looming economic recession, the Vascular Access Devices market worldwide will grow by a projected US$2.1 Billion, during the analysis period | NEW YORK, June 9, 2020 /PRNewswire/ -- Amid the COVID-19 crisis and the looming economic recession, the Vascular Access Devices market worldwide will grow by a projected US$2.1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 5.9%. Central Vascular Access Devices, one of the segments analyzed and sized in this study, is forecast to grow at over 6.6% and reach a market size of US$2.8 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Central Vascular Access Devices market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions. Read the full report: https://www.reportlinker.com/p05900487/?utm_source=PRN As part of the new emerging geographic scenario, the United States is forecast to readjust to a 4.7% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$64.4 Million to the region's size over the next 7 to 8 years. In addition, over US$62.4 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Central Vascular Access Devices segment will reach a market size of US$120.4 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Vascular Access Devices market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 9.9% over the next couple of years and add approximately US$570.8 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Vascular Access Devices market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. Competitors identified in this market include, among others, B. Braun Melsungen AG; Baxter International Inc.; Becton, Dickinson and Company; Fresenius Medical Care AG & Co. KgaA; Medtronic PLC; Nipro Medical Corporation; Siemens Healthineers; Smiths Medical; Teleflex Inc.; Terumo CorporationRead the full report: https://www.reportlinker.com/p05900487/?utm_source=PRN I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Vascular Access Device Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: Vascular Access Devices Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 2: Vascular Access Devices Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 Table 3: Vascular Access Devices Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Central Vascular Access Devices (Type) World Market by Region/Country in US$ Million: 2020 to 2027 Table 5: Central Vascular Access Devices (Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 Table 6: Central Vascular Access Devices (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Peripheral Vascular Access Devices (Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 Table 8: Peripheral Vascular Access Devices (Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 Table 9: Peripheral Vascular Access Devices (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 Table 10: Accessories (Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 Table 11: Accessories (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019 Table 12: Accessories (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 Table 13: Drug Administration (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027 Table 14: Drug Administration (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 Table 15: Drug Administration (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 Table 16: Fluid & Nutrition Administration (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 Table 17: Fluid & Nutrition Administration (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 Table 18: Fluid & Nutrition Administration (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 Table 19: Blood Transfusion (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 Table 20: Blood Transfusion (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 Table 21: Blood Transfusion (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 Table 22: Diagnostics & Testing (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 Table 23: Diagnostics & Testing (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 Table 24: Diagnostics & Testing (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Vascular Access Device Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 25: United States Vascular Access Devices Market Estimates and Projections in US$ Million by Type: 2020 to 2027 Table 26: Vascular Access Devices Market in the United States by Type: A Historic Review in US$ Million for 2012-2019 Table 27: United States Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 28: United States Vascular Access Devices Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 29: Vascular Access Devices Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019 Table 30: Vascular Access Devices Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 CANADA Table 31: Canadian Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 Table 32: Canadian Vascular Access Devices Historic Market Review by Type in US$ Million: 2012-2019 Table 33: Vascular Access Devices Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 Table 34: Canadian Vascular Access Devices Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 35: Vascular Access Devices Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 36: Canadian Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 JAPAN Table 37: Japanese Market for Vascular Access Devices: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 Table 38: Vascular Access Devices Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 Table 39: Japanese Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 40: Japanese Demand Estimates and Forecasts for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 41: Japanese Vascular Access Devices Market in US$ Million by Application: 2012-2019 Table 42: Vascular Access Devices Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 CHINA Table 43: Chinese Vascular Access Devices Market Growth Prospects in US$ Million by Type for the Period 2020-2027 Table 44: Vascular Access Devices Historic Market Analysis in China in US$ Million by Type: 2012-2019 Table 45: Chinese Vascular Access Devices Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 46: Chinese Demand for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 47: Vascular Access Devices Market Review in China in US$ Million by Application: 2012-2019 Table 48: Chinese Vascular Access Devices Market Share Breakdown by Application: 2012 VS 2020 VS 2027 EUROPE Market Facts & Figures European Vascular Access Device Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 49: European Vascular Access Devices Market Demand Scenario in US$ Million by Region/Country: 2020-2027 Table 50: Vascular Access Devices Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 Table 51: European Vascular Access Devices Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 52: European Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020-2027 Table 53: Vascular Access Devices Market in Europe in US$ Million by Type: A Historic Review for the Period 2012-2019 Table 54: European Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 55: European Vascular Access Devices Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 56: Vascular Access Devices Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 57: European Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 FRANCE Table 58: Vascular Access Devices Market in France by Type: Estimates and Projections in US$ Million for the Period 2020-2027 Table 59: French Vascular Access Devices Historic Market Scenario in US$ Million by Type: 2012-2019 Table 60: French Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 61: Vascular Access Devices Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027 Table 62: French Vascular Access Devices Historic Market Review in US$ Million by Application: 2012-2019 Table 63: French Vascular Access Devices Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 GERMANY Table 64: Vascular Access Devices Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 65: German Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 66: German Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 67: Vascular Access Devices Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 68: German Vascular Access Devices Market in Retrospect in US$ Million by Application: 2012-2019 Table 69: Vascular Access Devices Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 ITALY Table 70: Italian Vascular Access Devices Market Growth Prospects in US$ Million by Type for the Period 2020-2027 Table 71: Vascular Access Devices Historic Market Analysis in Italy in US$ Million by Type: 2012-2019 Table 72: Italian Vascular Access Devices Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 73: Italian Demand for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 74: Vascular Access Devices Market Review in Italy in US$ Million by Application: 2012-2019 Table 75: Italian Vascular Access Devices Market Share Breakdown by Application: 2012 VS 2020 VS 2027 UNITED KINGDOM Table 76: United Kingdom Market for Vascular Access Devices: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 Table 77: Vascular Access Devices Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 Table 78: United Kingdom Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 79: United Kingdom Demand Estimates and Forecasts for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 80: United Kingdom Vascular Access Devices Market in US$ Million by Application: 2012-2019 Table 81: Vascular Access Devices Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 SPAIN Table 82: Spanish Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 Table 83: Spanish Vascular Access Devices Historic Market Review by Type in US$ Million: 2012-2019 Table 84: Vascular Access Devices Market in Spain: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 Table 85: Spanish Vascular Access Devices Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 86: Vascular Access Devices Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 87: Spanish Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 RUSSIA Table 88: Russian Vascular Access Devices Market Estimates and Projections in US$ Million by Type: 2020 to 2027 Table 89: Vascular Access Devices Market in Russia by Type: A Historic Review in US$ Million for 2012-2019 Table 90: Russian Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 91: Russian Vascular Access Devices Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 92: Vascular Access Devices Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019 Table 93: Vascular Access Devices Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027 REST OF EUROPE Table 94: Rest of Europe Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020-2027 Table 95: Vascular Access Devices Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2012-2019 Table 96: Rest of Europe Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 97: Rest of Europe Vascular Access Devices Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 98: Vascular Access Devices Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 99: Rest of Europe Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 100: Asia-Pacific Vascular Access Devices Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 101: Vascular Access Devices Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019 Table 102: Asia-Pacific Vascular Access Devices Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 Table 103: Vascular Access Devices Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2020-2027 Table 104: Asia-Pacific Vascular Access Devices Historic Market Scenario in US$ Million by Type: 2012-2019 Table 105: Asia-Pacific Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 106: Vascular Access Devices Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027 Table 107: Asia-Pacific Vascular Access Devices Historic Market Review in US$ Million by Application: 2012-2019 Table 108: Asia-Pacific Vascular Access Devices Market Share Analysis: A 17-Year Perspectiveby Application for 2012, 2020, and 2027 AUSTRALIA Table 109: Vascular Access Devices Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 110: Australian Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 111: Australian Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 112: Vascular Access Devices Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 113: Australian Vascular Access Devices Market in Retrospect in US$ Million by Application: 2012-2019 Table 114: Vascular Access Devices Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027 INDIA Table 115: Indian Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 Table 116: Indian Vascular Access Devices Historic Market Review by Type in US$ Million: 2012-2019 Table 117: Vascular Access Devices Market in India: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 Table 118: Indian Vascular Access Devices Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 119: Vascular Access Devices Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 120: Indian Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 SOUTH KOREA Table 121: Vascular Access Devices Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 122: South Korean Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 123: Vascular Access Devices Market Share Distribution in South Korea by Type: 2012 VS 2020 VS 2027 Table 124: Vascular Access Devices Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 Table 125: South Korean Vascular Access Devices Historic Market Analysis in US$ Million by Application: 2012-2019 Table 126: Vascular Access Devices Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027 REST OF ASIA-PACIFIC Table 127: Rest of Asia-Pacific Market for Vascular Access Devices: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 Table 128: Vascular Access Devices Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 Table 129: Rest of Asia-Pacific Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 130: Rest of Asia-Pacific Demand Estimates and Forecasts for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 131: Rest of Asia-Pacific Vascular Access Devices Market in US$ Million by Application: 2012-2019 Table 132: Vascular Access Devices Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027 LATIN AMERICA Table 133: Latin American Vascular Access Devices Market Trends by Region/Country in US$ Million: 2020-2027 Table 134: Vascular Access Devices Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019 Table 135: Latin American Vascular Access Devices Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 Table 136: Latin American Vascular Access Devices Market Growth Prospects in US$ Million by Type for the Period 2020-2027 Table 137: Vascular Access Devices Historic Market Analysis in Latin America in US$ Million by Type: 2012-2019 Table 138: Latin American Vascular Access Devices Marketby Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 139: Latin American Demand for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 140: Vascular Access Devices Market Review in Latin America in US$ Million by Application: 2012-2019 Table 141: Latin American Vascular Access Devices Market Share Breakdown by Application: 2012 VS 2020 VS 2027 ARGENTINA Table 142: Argentinean Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020-2027 Table 143: Vascular Access Devices Market in Argentina in US$ Million by Type: A Historic Review for the Period 2012-2019 Table 144: Argentinean Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 145: Argentinean Vascular Access Devices Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 146: Vascular Access Devices Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 147: Argentinean Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 BRAZIL Table 148: Vascular Access Devices Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2020-2027 Table 149: Brazilian Vascular Access Devices Historic Market Scenario in US$ Million by Type: 2012-2019 Table 150: Brazilian Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 151: Vascular Access Devices Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027 Table 152: Brazilian Vascular Access Devices Historic Market Review in US$ Million by Application: 2012-2019 Table 153: Brazilian Vascular Access Devices Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 MEXICO Table 154: Vascular Access Devices Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 155: Mexican Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 156: Mexican Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 157: Vascular Access Devices Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 158: Mexican Vascular Access Devices Market in Retrospect in US$ Million by Application: 2012-2019 Table 159: Vascular Access Devices Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027 REST OF LATIN AMERICA Table 160: Rest of Latin America Vascular Access Devices Market Estimates and Projections in US$ Million by Type: 2020 to 2027 Table 161: Vascular Access Devices Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2012-2019 Table 162: Rest of Latin America Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 163: Rest of Latin America Vascular Access Devices Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 164: Vascular Access Devices Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019 Table 165: Vascular Access Devices Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027 MIDDLE EAST Table 166: The Middle East Vascular Access Devices Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 167: Vascular Access Devices Market in the Middle East by Region/Country in US$ Million: 2012-2019 Table 168: The Middle East Vascular Access Devices Market Share Breakdown by Region/Country: 2012, 2020, and 2027 Table 169: The Middle East Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 Table 170: The Middle East Vascular Access Devices Historic Marketby Type in US$ Million: 2012-2019 Table 171: Vascular Access Devices Market in the Middle East: Percentage Share Breakdown of Salesby Type for 2012,2020, and 2027 Table 172: The Middle East Vascular Access Devices Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 173: Vascular Access Devices Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 174: The Middle East Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 IRAN Table 175: Iranian Market for Vascular Access Devices: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 Table 176: Vascular Access Devices Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 Table 177: Iranian Vascular Access Devices Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 178: Iranian Demand Estimates and Forecasts for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 179: Iranian Vascular Access Devices Market in US$ Million by Application: 2012-2019 Table 180: Vascular Access Devices Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027 ISRAEL Table 181: Israeli Vascular Access Devices Market Estimates and Forecasts in US$ Million by Type: 2020-2027 Table 182: Vascular Access Devices Market in Israel in US$ Million by Type: A Historic Review for the Period 2012-2019 Table 183: Israeli Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 184: Israeli Vascular Access Devices Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 185: Vascular Access Devices Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 186: Israeli Vascular Access Devices Market Share Analysis by Application: 2012 VS 2020 VS 2027 SAUDI ARABIA Table 187: Saudi Arabian Vascular Access Devices Market Growth Prospects in US$ Million by Type for the Period 2020-2027 Table 188: Vascular Access Devices Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2012-2019 Table 189: Saudi Arabian Vascular Access Devices Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 190: Saudi Arabian Demand for Vascular Access Devices in US$ Million by Application: 2020 to 2027 Table 191: Vascular Access Devices Market Review in Saudi Arabia in US$ Million by Application: 2012-2019 Table 192: Saudi Arabian Vascular Access Devices Market Share Breakdown by Application: 2012 VS 2020 VS 2027 UNITED ARAB EMIRATES Table 193: Vascular Access Devices Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 194: United Arab Emirates Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 195: Vascular Access Devices Market Share Distribution in United Arab Emirates by Type: 2012 VS 2020 VS 2027 Table 196: Vascular Access Devices Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 Table 197: United Arab Emirates Vascular Access Devices Historic Market Analysis in US$ Million by Application: 2012-2019 Table 198: Vascular Access Devices Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027 REST OF MIDDLE EAST Table 199: Vascular Access Devices Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 Table 200: Rest of Middle East Vascular Access Devices Historic Market Analysis in US$ Million by Type: 2012-2019 Table 201: Rest of Middle East Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 202: Vascular Access Devices Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 203: Rest of Middle East Vascular Access Devices Market in Retrospect in US$ Million by Application: 2012-2019 Table 204: Vascular Access Devices Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027 AFRICA Table 205: African Vascular Access Devices Market Estimates and Projections in US$ Million by Type: 2020 to 2027 Table 206: Vascular Access Devices Market in Africa by Type: A Historic Review in US$ Million for 2012-2019 Table 207: African Vascular Access Devices Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 208: African Vascular Access Devices Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 209: Vascular Access Devices Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019 Table 210: Vascular Access Devices Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027 IV. COMPETITION Total Companies Profiled: 44Read the full report: https://www.reportlinker.com/p05900487/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com |
edtsum2947 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WASHINGTON, Jan. 7, 2021 /PRNewswire/ --ATI Advisory, a research and advisory services firm working to transform the delivery of healthcare and aging services for older adults, and LeadingAge LTSS Center @UMass Boston released new analysis that shows significant benefit value contained in private long-term care insurance policies in force today. With support from the Anthem Public Policy Institute, ATI Advisory and LeadingAge LTSS Center @UMass Boston analyzed data on private long-term care insurance (LTCi) policyholders who purchased policies between 1995 and 2005 to understand national and state-level in force policy value, buyer demographics, and the likelihood of buyers' Medicaid eligibility in absence of their LTCi policy. "We estimate that among individuals who bought policies between 1995 and 2005, nearly $800B in benefit value is available to pay for LTSS expenses. To put this in context, in 2016, the Medicaid program spent just over $100B annually on LTSS for older adults and individuals with physical disabilities," said lead researcher Marc Cohen. These findings point to an important opportunity for state policymakers to adopt policy and regulatory approaches to support the retention of benefit value in current policies. Doing so would help to protect states' and individuals' financial resources. "Like so many things, COVID-19 heightens the need for intense focus on addressing our regulatory system's ability to ensure that policyholders retain as much private long-term care insurance benefit value as possible. As this study shows, there's too much money on the table to let it slip and too much at stake both for individuals and the largest public payer of care Medicaid," said Anne Tumlinson, CEO of ATI Advisory. See the full analysis and recommendations for states to protect individuals and public resources: https://atiadvisory.com/significant-financial-benefits-locked-in-ltci-policies-in-force-today/. About ATI Advisory ATI Advisory is a research and advisory services firm working to transform the delivery of healthcare and aging services for older adults. By providing insight and strategy backed by original research, ATI helps organizations lead and deliver change in senior healthcare and long-term services and supports systems. For more information, visit www.atiadvisory.com. About LeadingAge LTSS Center @UMass Boston The LeadingAge LTSS Center @UMass Boston is a research Center that translates research into policy and practice to improve quality of care and quality of life for older vulnerable adults. For more information, visit https://www.ltsscenter.org/. SOURCE ATI Advisory Related Links https://atiadvisory.com
Answer: | New Analysis Finds Significant Financial Benefits Locked in Long-Term Care Insurance Policies Sold Fifteen to Twenty-Five Years Ago | WASHINGTON, Jan. 7, 2021 /PRNewswire/ --ATI Advisory, a research and advisory services firm working to transform the delivery of healthcare and aging services for older adults, and LeadingAge LTSS Center @UMass Boston released new analysis that shows significant benefit value contained in private long-term care insurance policies in force today. With support from the Anthem Public Policy Institute, ATI Advisory and LeadingAge LTSS Center @UMass Boston analyzed data on private long-term care insurance (LTCi) policyholders who purchased policies between 1995 and 2005 to understand national and state-level in force policy value, buyer demographics, and the likelihood of buyers' Medicaid eligibility in absence of their LTCi policy. "We estimate that among individuals who bought policies between 1995 and 2005, nearly $800B in benefit value is available to pay for LTSS expenses. To put this in context, in 2016, the Medicaid program spent just over $100B annually on LTSS for older adults and individuals with physical disabilities," said lead researcher Marc Cohen. These findings point to an important opportunity for state policymakers to adopt policy and regulatory approaches to support the retention of benefit value in current policies. Doing so would help to protect states' and individuals' financial resources. "Like so many things, COVID-19 heightens the need for intense focus on addressing our regulatory system's ability to ensure that policyholders retain as much private long-term care insurance benefit value as possible. As this study shows, there's too much money on the table to let it slip and too much at stake both for individuals and the largest public payer of care Medicaid," said Anne Tumlinson, CEO of ATI Advisory. See the full analysis and recommendations for states to protect individuals and public resources: https://atiadvisory.com/significant-financial-benefits-locked-in-ltci-policies-in-force-today/. About ATI Advisory ATI Advisory is a research and advisory services firm working to transform the delivery of healthcare and aging services for older adults. By providing insight and strategy backed by original research, ATI helps organizations lead and deliver change in senior healthcare and long-term services and supports systems. For more information, visit www.atiadvisory.com. About LeadingAge LTSS Center @UMass Boston The LeadingAge LTSS Center @UMass Boston is a research Center that translates research into policy and practice to improve quality of care and quality of life for older vulnerable adults. For more information, visit https://www.ltsscenter.org/. SOURCE ATI Advisory Related Links https://atiadvisory.com |
edtsum2953 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NASSAU, Bahamas, June 19, 2020 /PRNewswire/ --The Bahamas Ministry of Tourism & Aviation is preparing for Phase 2 of the Tourism Readiness and Recovery Plan, which will begin on Wednesday, July 1 and allow for the resumption of international travel to The Bahamas, with the exception of visitors from China, Iran, Italy and France. Policies and Procedures for all travellers visiting The Bahamas beginning July 1 are as follows. Plans continue to evolve in response to COVID-19 trends, and so additional guidance will be communicated as details are available. Due to the recent increase of COVID-19 cases in the U.S., and in an abundance of caution for the health and safety of both travellers and residents, all incoming visitors must present a COVID-19 RT-PCR Negative (Swab) Test upon arrival. Results must be no more than ten (10) days old. Select individuals will be exempt from testing, which includes children under the age of two, private pilots who do not deplane, and Bahamian citizens, residents and homeowners returning from English speaking CARICOM countries. All travellers will be required to complete an electronic Health Visa. Additional information is forthcoming. No quarantine will be required upon arrival, however, travellers who show symptoms of COVID-19 may be transferred to an area away from other passengers for further testing and evaluation. All inter-island travellers must complete an electronic Domestic Travel form at travel.gov.bs prior to departure and for any inter-island travel within The Bahamas. An automated response will be provided upon completion. All travellers must have their confirmation on hand upon arrival to their destination. This is a crucial step for contact tracing purposes. At airports and seaports, healthcare personnel will conduct temperature screenings for all incoming visitors. Travellers will be required to wear a face mask in any situation where it is necessary to enforce physical distancing guidelines, such as when entering and transiting air and sea terminals, while navigating security and customs screenings, and at baggage claim. As part of Phase 2, hotels and vacation rentals, including Airbnb and HomeAway will open to guests. Domestic and International airlines are permitted to resume service, and many are beginning to announce plans for their return to The Bahamas: Delta Airlines will be resuming its twice daily Atlanta to Nassau service July 2 United Airlines announced its daily Houston to Nassau service will resume July 6 and the Saturday-only Denver to Nassau service will resume July 11. American Airlines will resume flights to Nassau and Exuma on July 7. Air Canada is scheduled to resume flights from Toronto to Nassau on July 3, 2020 Additional airlift resumptions are expected to be announced in the coming weeks. Travellers should check with airlines directly for details on recommencement of service and any protocols for travel. This July 1 tourism re-entry builds on and supports existing government rules and regulations, which already allows for the resumption of travel for international boaters, yachters and those traveling on private aviation as well as inter-island domestic travel for Bahamian citizens and residents. Once on island, travellers should expect to follow The Bahamas' "Healthy Traveler Campaign" that encourages both visitors and residents to continue practicing social distancing measures, regularly wash hands or use hand sanitizers, and pack appropriate PPE such as face masks, just as they would their swimsuits and sunscreen. A Certification Agency has been established - representing a collaboration between the Ministry of Tourism, Ministry of Health, and other regulatory agencies - to enforce a Clean & Pristine certification program across the islands. All tourism related, customer-facing entities in The Bahamas must verify they have in place and are adhering to the Government approved health and safety guidelines to receive Clean & Pristine certification. Adequate signage outlining policies will be clearly displayed at all locations helping to guide staff and visitors. Travellers are encouraged to visit direct business websites prior to booking or traveling to ensure they are aware and comfortable with the policies they will need to abide by. Additional details about on-island protocols can be found at www.bahamas.com/travelupdates. Reopening of borders will continue to be monitored and guided by The Bahamas government and health officials. Reopening dates are subject to change based on COVID-19 trends, if there is a deterioration in improvement or if government and health organizations deem these phases unsafe for residents or visitors. The Bahamas Ministry of Tourism & Aviation believes it is an absolute baseline requirement for consumers to have a comfort level that The Bahamas is a safe and healthy destination to visit, and the ultimate goal is for that to remain the case. For more information, or to view the Tourism Readiness and Recovery Plan, please visit: www.bahamas.com/travelupdates. All COVID-19 inquiries should be directed to the Ministry of Health. For questions or concerns, please call the COVID-19 hotline: 242-376-9350 (8 a.m. 8 p.m. EDT) / 242-376-9387 (8 p.m. 8 a.m. EDT). PRESS INQUIRIESAnita Johnson-PattyBahamas Ministry of Tourism & Aviation[emailprotected] Weber ShandwickPublic Relations[emailprotected] SOURCE Bahamas Ministry of Tourism & Aviation Related Links http://www.bahamas.com/travelupdates
Answer: | Bahamas Ministry of Tourism & Aviation Prepares For Phase 2 Reopening July 1 All Islands Of The Bahamas Will Reopen to International Travel; Visitors Must Present Negative COVID-19 Test and Complete an Electronic Health Visa to be Granted Entry | NASSAU, Bahamas, June 19, 2020 /PRNewswire/ --The Bahamas Ministry of Tourism & Aviation is preparing for Phase 2 of the Tourism Readiness and Recovery Plan, which will begin on Wednesday, July 1 and allow for the resumption of international travel to The Bahamas, with the exception of visitors from China, Iran, Italy and France. Policies and Procedures for all travellers visiting The Bahamas beginning July 1 are as follows. Plans continue to evolve in response to COVID-19 trends, and so additional guidance will be communicated as details are available. Due to the recent increase of COVID-19 cases in the U.S., and in an abundance of caution for the health and safety of both travellers and residents, all incoming visitors must present a COVID-19 RT-PCR Negative (Swab) Test upon arrival. Results must be no more than ten (10) days old. Select individuals will be exempt from testing, which includes children under the age of two, private pilots who do not deplane, and Bahamian citizens, residents and homeowners returning from English speaking CARICOM countries. All travellers will be required to complete an electronic Health Visa. Additional information is forthcoming. No quarantine will be required upon arrival, however, travellers who show symptoms of COVID-19 may be transferred to an area away from other passengers for further testing and evaluation. All inter-island travellers must complete an electronic Domestic Travel form at travel.gov.bs prior to departure and for any inter-island travel within The Bahamas. An automated response will be provided upon completion. All travellers must have their confirmation on hand upon arrival to their destination. This is a crucial step for contact tracing purposes. At airports and seaports, healthcare personnel will conduct temperature screenings for all incoming visitors. Travellers will be required to wear a face mask in any situation where it is necessary to enforce physical distancing guidelines, such as when entering and transiting air and sea terminals, while navigating security and customs screenings, and at baggage claim. As part of Phase 2, hotels and vacation rentals, including Airbnb and HomeAway will open to guests. Domestic and International airlines are permitted to resume service, and many are beginning to announce plans for their return to The Bahamas: Delta Airlines will be resuming its twice daily Atlanta to Nassau service July 2 United Airlines announced its daily Houston to Nassau service will resume July 6 and the Saturday-only Denver to Nassau service will resume July 11. American Airlines will resume flights to Nassau and Exuma on July 7. Air Canada is scheduled to resume flights from Toronto to Nassau on July 3, 2020 Additional airlift resumptions are expected to be announced in the coming weeks. Travellers should check with airlines directly for details on recommencement of service and any protocols for travel. This July 1 tourism re-entry builds on and supports existing government rules and regulations, which already allows for the resumption of travel for international boaters, yachters and those traveling on private aviation as well as inter-island domestic travel for Bahamian citizens and residents. Once on island, travellers should expect to follow The Bahamas' "Healthy Traveler Campaign" that encourages both visitors and residents to continue practicing social distancing measures, regularly wash hands or use hand sanitizers, and pack appropriate PPE such as face masks, just as they would their swimsuits and sunscreen. A Certification Agency has been established - representing a collaboration between the Ministry of Tourism, Ministry of Health, and other regulatory agencies - to enforce a Clean & Pristine certification program across the islands. All tourism related, customer-facing entities in The Bahamas must verify they have in place and are adhering to the Government approved health and safety guidelines to receive Clean & Pristine certification. Adequate signage outlining policies will be clearly displayed at all locations helping to guide staff and visitors. Travellers are encouraged to visit direct business websites prior to booking or traveling to ensure they are aware and comfortable with the policies they will need to abide by. Additional details about on-island protocols can be found at www.bahamas.com/travelupdates. Reopening of borders will continue to be monitored and guided by The Bahamas government and health officials. Reopening dates are subject to change based on COVID-19 trends, if there is a deterioration in improvement or if government and health organizations deem these phases unsafe for residents or visitors. The Bahamas Ministry of Tourism & Aviation believes it is an absolute baseline requirement for consumers to have a comfort level that The Bahamas is a safe and healthy destination to visit, and the ultimate goal is for that to remain the case. For more information, or to view the Tourism Readiness and Recovery Plan, please visit: www.bahamas.com/travelupdates. All COVID-19 inquiries should be directed to the Ministry of Health. For questions or concerns, please call the COVID-19 hotline: 242-376-9350 (8 a.m. 8 p.m. EDT) / 242-376-9387 (8 p.m. 8 a.m. EDT). PRESS INQUIRIESAnita Johnson-PattyBahamas Ministry of Tourism & Aviation[emailprotected] Weber ShandwickPublic Relations[emailprotected] SOURCE Bahamas Ministry of Tourism & Aviation Related Links http://www.bahamas.com/travelupdates |
edtsum2955 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: KOHLER, Wis., April 29, 2021 /PRNewswire/ --With demand for reliable power escalating throughout the U.S. as a result of homeowners' dependence on it and an increasing rate of severe weather events, Kohler Power announces a significant capital expansion of home standby generator assembly at its manufacturing site in Hattiesburg, Mississippi. The company has had a presence in Hattiesburg since 1998, where it produces air-cooled engines for a variety of applications, including KOHLER home standby generators. Kohler Power Announces Significant Plant Expansion of Home Standby Generator Products at Existing Mississippi Site "This expansion allows us to get closer to our customers and responding with quicker delivery," said Kyle Brandemuhl, general manager residential and power products at Kohler, adding that a high concentration of Kohler's home generator business are customers in the southeast and gulf coast. "Over these last couple years, we have seen demand for residential products skyrocket due to a number of factors, including a record hurricane season in 2020, the Texas winter storms, increasing wild fires in the western U.S., along with the pandemic sending a high number of people home for work and school. An increasing number of consumers are speaking with their wallets prolonged power outages are no longer acceptable due to severe weather events and an aging power grid." "With this expansion, we will more than triple our current capacity for residential standby generators and take further advantage of our world-class engine manufacturing facility that we more than doubled in the last two years. We are committed to supporting our valued dealer network and delighting the end customers that we serve," said Brian Melka, group president Kohler Power. With the company having already ramped up production in the current manufacturing sites in Saukville and Mosel, Wisconsin, Kohler expects Hattiesburg to come online in the third quarter to better match the spiking demand and reduce lead times with innovative power solutions. "Hurricane season starts June 1, and is a stark reminder that our lives are significantly disrupted when power is lost; it is that essential," said Brandemuhl. "An automatic home standby generator is your best defense against a power outage to help ensure safety and peace of mind." To learn more, visit KohlerGenerators.com.Plant expansion underway in Wisconsin to increase industrial generator capacityIn early March, Kohler Power initiated a 155,000 square-foot expansion to its existing manufacturing facility in Mosel, Wisconsin. The project will include a state-of-the-art production and testing space of large generators above 2,000 kilowatts and increased warehousing, as well as a world-class customer experience center. The plant expansion supports Kohler's continued growth in key strategic markets, including data centers, health care and other mission critical segments. This is the second major expansion in the last eight years at this site, following a decade of sustained growth, and addresses future capacity requirements to provide a safer, more efficient, and seamless flow of integrated power system assembly, testing and enclosing all under one roof."This capital investment helps us achieve operational excellence in product development, manufacturing capabilities, and supply chain efficiency to ensure we are positioned to meet increasing demand and surpass our customers' expectations," said Melka. "The data center segment is a key pillar of our long-term growth strategy, as well as developing cleaner energy solutions with generators that lead the industry in power density and fuel economy, and contribute to a lower environmental impact."About Kohler Power GroupA global force in power solutions since 1920, KOHLER manufactures complete power systems, including engines, generators (portable, marine, residential, commercial and industrial), automatic transfer switches, switchgear, monitoring controls, and accessories for emergency, prime power and energy-management applications all around the world. The business is committed to reliable, leading edge power-generation products, as well as comprehensive after-sale support. VisitKohlerPower.com.About Kohler Co.Founded in 1873 and headquartered in Kohler, Wisconsin, Kohler Co. is one of America's oldest and largest privately held companies comprised of more than 35,000 associates. With more than 50 manufacturing locations worldwide, Kohler is a global leader in the design, innovation and manufacture of kitchen and bath products; engines and power systems; luxury cabinetry, tile and lighting; and owner/operator of two, five-star hospitality and golf resort destinations in Kohler, Wisconsin, and St. Andrews, Scotland, as well as Lodge Kohler in Green Bay, Wisconsin. Kohler's Whistling Straits golf course will host the Ryder Cup in 2021. The company also develops solutions to address pressing issues, such as clean water and sanitation, for underserved communities around the world to enhance the quality of life for current and future generations. For more details, please visit KohlerCompany.com CONTACT: Todd Weber Vicki Hafenstein [emailprotected] [emailprotected] 920-457-4441, ext. 72707 920-457-4441, ext. 70519 SOURCE Kohler Co. Related Links http://www.kohler.com
Answer: | Kohler Power Announces Significant Plant Expansion of Home Standby Generator Products at Existing Mississippi Site Capital investment to meet escalating consumer demand for residential power solutions comes on heels of Kohler's industrial generator plant expansion at Mosel, Wisconsin site | KOHLER, Wis., April 29, 2021 /PRNewswire/ --With demand for reliable power escalating throughout the U.S. as a result of homeowners' dependence on it and an increasing rate of severe weather events, Kohler Power announces a significant capital expansion of home standby generator assembly at its manufacturing site in Hattiesburg, Mississippi. The company has had a presence in Hattiesburg since 1998, where it produces air-cooled engines for a variety of applications, including KOHLER home standby generators. Kohler Power Announces Significant Plant Expansion of Home Standby Generator Products at Existing Mississippi Site "This expansion allows us to get closer to our customers and responding with quicker delivery," said Kyle Brandemuhl, general manager residential and power products at Kohler, adding that a high concentration of Kohler's home generator business are customers in the southeast and gulf coast. "Over these last couple years, we have seen demand for residential products skyrocket due to a number of factors, including a record hurricane season in 2020, the Texas winter storms, increasing wild fires in the western U.S., along with the pandemic sending a high number of people home for work and school. An increasing number of consumers are speaking with their wallets prolonged power outages are no longer acceptable due to severe weather events and an aging power grid." "With this expansion, we will more than triple our current capacity for residential standby generators and take further advantage of our world-class engine manufacturing facility that we more than doubled in the last two years. We are committed to supporting our valued dealer network and delighting the end customers that we serve," said Brian Melka, group president Kohler Power. With the company having already ramped up production in the current manufacturing sites in Saukville and Mosel, Wisconsin, Kohler expects Hattiesburg to come online in the third quarter to better match the spiking demand and reduce lead times with innovative power solutions. "Hurricane season starts June 1, and is a stark reminder that our lives are significantly disrupted when power is lost; it is that essential," said Brandemuhl. "An automatic home standby generator is your best defense against a power outage to help ensure safety and peace of mind." To learn more, visit KohlerGenerators.com.Plant expansion underway in Wisconsin to increase industrial generator capacityIn early March, Kohler Power initiated a 155,000 square-foot expansion to its existing manufacturing facility in Mosel, Wisconsin. The project will include a state-of-the-art production and testing space of large generators above 2,000 kilowatts and increased warehousing, as well as a world-class customer experience center. The plant expansion supports Kohler's continued growth in key strategic markets, including data centers, health care and other mission critical segments. This is the second major expansion in the last eight years at this site, following a decade of sustained growth, and addresses future capacity requirements to provide a safer, more efficient, and seamless flow of integrated power system assembly, testing and enclosing all under one roof."This capital investment helps us achieve operational excellence in product development, manufacturing capabilities, and supply chain efficiency to ensure we are positioned to meet increasing demand and surpass our customers' expectations," said Melka. "The data center segment is a key pillar of our long-term growth strategy, as well as developing cleaner energy solutions with generators that lead the industry in power density and fuel economy, and contribute to a lower environmental impact."About Kohler Power GroupA global force in power solutions since 1920, KOHLER manufactures complete power systems, including engines, generators (portable, marine, residential, commercial and industrial), automatic transfer switches, switchgear, monitoring controls, and accessories for emergency, prime power and energy-management applications all around the world. The business is committed to reliable, leading edge power-generation products, as well as comprehensive after-sale support. VisitKohlerPower.com.About Kohler Co.Founded in 1873 and headquartered in Kohler, Wisconsin, Kohler Co. is one of America's oldest and largest privately held companies comprised of more than 35,000 associates. With more than 50 manufacturing locations worldwide, Kohler is a global leader in the design, innovation and manufacture of kitchen and bath products; engines and power systems; luxury cabinetry, tile and lighting; and owner/operator of two, five-star hospitality and golf resort destinations in Kohler, Wisconsin, and St. Andrews, Scotland, as well as Lodge Kohler in Green Bay, Wisconsin. Kohler's Whistling Straits golf course will host the Ryder Cup in 2021. The company also develops solutions to address pressing issues, such as clean water and sanitation, for underserved communities around the world to enhance the quality of life for current and future generations. For more details, please visit KohlerCompany.com CONTACT: Todd Weber Vicki Hafenstein [emailprotected] [emailprotected] 920-457-4441, ext. 72707 920-457-4441, ext. 70519 SOURCE Kohler Co. Related Links http://www.kohler.com |
edtsum2960 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, July 20, 2020 /PRNewswire/ --KPS Capital Partners, LP ("KPS") announced today that, through a newly formed affiliate, it has entered into an asset purchase agreement with Briggs & Stratton Corporation (NYSE: BGG) and certain of its wholly-owned subsidiaries (collectively, "Briggs & Stratton" or the "Company")under which KPS willacquire substantially all of the assets of Briggs & Stratton, including equity of foreign subsidiaries, for approximately $550 million. Briggs & Stratton has filed a motion with the United States Bankruptcy Court for the Eastern District of Missouri seeking the designation of KPS as the stalking horse bidder in a sale motion as part of the Company's filing of voluntary petitions under Chapter 11 of the Bankruptcy Code today. Briggs & Stratton expects to sell its assets through a court-supervised sale process under Section 363 of the Bankruptcy Code. KPS, through an affiliate, has also agreed to invest $265 million in a FILO tranche of Briggs & Stratton's Debtor in Possession ("DIP") financing to support the Company's operations. Upon the entry of a final order approving the DIP facility, KPS will have the right to "credit bid" its $265 million participation in the DIP financing in connection with the proposed acquisition of Briggs & Stratton. Following court approval, the DIP facility will ensure that Briggs & Stratton has sufficient liquidity to continue normal operationsand continue to meet its financial obligations during the Chapter 11 process, including the timely payment of employee wages and benefits, continued servicing of customer orders and shipments, and other obligations. KPS also announced that it has entered into an agreement in principle with the United Steelworkers of America (the "USW") with respect to a new collective bargaining agreement ("CBA") for Briggs & Stratton hourly employees represented by the union at the Company's manufacturing facilities in Wisconsin. The new CBA, an exclusive agreement between KPS and the USW, will become effective upon completion of the acquisition. Further, Wells Fargo has agreed to continue to provide floorplan financing to support Briggs & Stratton's customers under KPS' ownership, and a syndicate of banks including Wells Fargo, Bank of America, BMO Harris Bank and PNC Business Credit has committed to provide exit financing to Briggs & Stratton. The financings are subject to completion of the acquisition and customary closing conditions. Michael Psaros, Co-Founder and Co-Managing Partner of KPS, said, "We are very excited to acquire Briggs & Stratton, a legendary brand in American manufacturing and the leading company in its industry. Briggs & Stratton enjoys a leading market position, scale, a global manufacturing footprint, world-class design and engineering capabilities, and a portfolio of industry-leading products sold under iconic brand names. We intend to capitalize on the Company's many attractive growth opportunities and to support its already substantial investment in research and development, technology and new product development. KPS intends to grow the new Briggs & Stratton aggressively through strategic acquisitions. "KPS is committed to the expeditious acquisition of Briggs & Stratton to provide certainty of outcome and confidence in the new Company's future for all of its stakeholders, including customers, employees and suppliers. The Company and its stakeholders will benefit from KPS' demonstrated commitment to manufacturing excellence, continuous improvement, global network, access to capital and significant financial resources. The new Briggs & Stratton will be conservatively capitalized and not encumbered by its predecessor's significant liabilities. "We thank the United Steelworkers of America for its support of our acquisition of the Company. "We have expended an enormous amount of effort, resources and capital on this process to date.We are confident that all of the conditions necessary to create a new thriving going concern enterprise are in place," Mr. Psaros concluded. Kirkland & Ellis LLP is acting as legal counsel to KPS with respect to the transaction. About Briggs & Stratton CorporationBriggs & Stratton Corporation(NYSE: BGG), headquartered inMilwaukee, Wisconsin, is focused on providing power to get work done and make people's lives better. Briggs & Strattonis the world's largest producer of gasoline engines for outdoor power equipment, and is a leading designer, manufacturer and marketer of power generation, pressure washer, lawn and garden, turf care and job site products through its Briggs & Stratton, Simplicity, Snapper, Ferris, Vanguard, Allmand,Billy Goat, Murray, BrancoandVictabrands. Briggs & Strattonproducts are designed, manufactured, marketed and serviced in over 100 countries on six continents. For additional information, please visit www.basco.com and www.briggsandstratton.com. About KPS Capital PartnersKPS, through its affiliated management entities, is the manager of the KPS Special Situations Funds, a family of investment funds with over $11.4 billion of assets under management (as of March 31, 2020). For over two decades, the Partners of KPS have worked exclusively to realize significant capital appreciation by making controlling equity investments in manufacturing and industrial companies across a diverse array of industries, including basic materials, branded consumer, healthcare and luxury products, automotive parts, capital equipment and general manufacturing. KPS creates value for its investors by working constructively with talented management teams to make businesses better, and generates investment returns by structurally improving the strategic position, competitiveness and profitability of its portfolio companies, rather than primarily relying on financial leverage. The KPS Funds' portfolio companies have aggregate annual revenues of approximately $8.4 billion, operate 150 manufacturing facilities in 26 countries, and have approximately 23,000 employees, directly and through joint ventures worldwide. The KPS investment strategy and portfolio companies are described in detail at www.kpsfund.com. SOURCE KPS Capital Partners, LP Related Links kpsfund.com
Answer: | KPS Capital Partners Agrees To Acquire Substantially All Of The Assets Of Briggs & Stratton Corporation, Including Equity Of Foreign Subsidiaries English Nederlands Deutsch Franais Brazil - Portugus Latin America - espaol | NEW YORK, July 20, 2020 /PRNewswire/ --KPS Capital Partners, LP ("KPS") announced today that, through a newly formed affiliate, it has entered into an asset purchase agreement with Briggs & Stratton Corporation (NYSE: BGG) and certain of its wholly-owned subsidiaries (collectively, "Briggs & Stratton" or the "Company")under which KPS willacquire substantially all of the assets of Briggs & Stratton, including equity of foreign subsidiaries, for approximately $550 million. Briggs & Stratton has filed a motion with the United States Bankruptcy Court for the Eastern District of Missouri seeking the designation of KPS as the stalking horse bidder in a sale motion as part of the Company's filing of voluntary petitions under Chapter 11 of the Bankruptcy Code today. Briggs & Stratton expects to sell its assets through a court-supervised sale process under Section 363 of the Bankruptcy Code. KPS, through an affiliate, has also agreed to invest $265 million in a FILO tranche of Briggs & Stratton's Debtor in Possession ("DIP") financing to support the Company's operations. Upon the entry of a final order approving the DIP facility, KPS will have the right to "credit bid" its $265 million participation in the DIP financing in connection with the proposed acquisition of Briggs & Stratton. Following court approval, the DIP facility will ensure that Briggs & Stratton has sufficient liquidity to continue normal operationsand continue to meet its financial obligations during the Chapter 11 process, including the timely payment of employee wages and benefits, continued servicing of customer orders and shipments, and other obligations. KPS also announced that it has entered into an agreement in principle with the United Steelworkers of America (the "USW") with respect to a new collective bargaining agreement ("CBA") for Briggs & Stratton hourly employees represented by the union at the Company's manufacturing facilities in Wisconsin. The new CBA, an exclusive agreement between KPS and the USW, will become effective upon completion of the acquisition. Further, Wells Fargo has agreed to continue to provide floorplan financing to support Briggs & Stratton's customers under KPS' ownership, and a syndicate of banks including Wells Fargo, Bank of America, BMO Harris Bank and PNC Business Credit has committed to provide exit financing to Briggs & Stratton. The financings are subject to completion of the acquisition and customary closing conditions. Michael Psaros, Co-Founder and Co-Managing Partner of KPS, said, "We are very excited to acquire Briggs & Stratton, a legendary brand in American manufacturing and the leading company in its industry. Briggs & Stratton enjoys a leading market position, scale, a global manufacturing footprint, world-class design and engineering capabilities, and a portfolio of industry-leading products sold under iconic brand names. We intend to capitalize on the Company's many attractive growth opportunities and to support its already substantial investment in research and development, technology and new product development. KPS intends to grow the new Briggs & Stratton aggressively through strategic acquisitions. "KPS is committed to the expeditious acquisition of Briggs & Stratton to provide certainty of outcome and confidence in the new Company's future for all of its stakeholders, including customers, employees and suppliers. The Company and its stakeholders will benefit from KPS' demonstrated commitment to manufacturing excellence, continuous improvement, global network, access to capital and significant financial resources. The new Briggs & Stratton will be conservatively capitalized and not encumbered by its predecessor's significant liabilities. "We thank the United Steelworkers of America for its support of our acquisition of the Company. "We have expended an enormous amount of effort, resources and capital on this process to date.We are confident that all of the conditions necessary to create a new thriving going concern enterprise are in place," Mr. Psaros concluded. Kirkland & Ellis LLP is acting as legal counsel to KPS with respect to the transaction. About Briggs & Stratton CorporationBriggs & Stratton Corporation(NYSE: BGG), headquartered inMilwaukee, Wisconsin, is focused on providing power to get work done and make people's lives better. Briggs & Strattonis the world's largest producer of gasoline engines for outdoor power equipment, and is a leading designer, manufacturer and marketer of power generation, pressure washer, lawn and garden, turf care and job site products through its Briggs & Stratton, Simplicity, Snapper, Ferris, Vanguard, Allmand,Billy Goat, Murray, BrancoandVictabrands. Briggs & Strattonproducts are designed, manufactured, marketed and serviced in over 100 countries on six continents. For additional information, please visit www.basco.com and www.briggsandstratton.com. About KPS Capital PartnersKPS, through its affiliated management entities, is the manager of the KPS Special Situations Funds, a family of investment funds with over $11.4 billion of assets under management (as of March 31, 2020). For over two decades, the Partners of KPS have worked exclusively to realize significant capital appreciation by making controlling equity investments in manufacturing and industrial companies across a diverse array of industries, including basic materials, branded consumer, healthcare and luxury products, automotive parts, capital equipment and general manufacturing. KPS creates value for its investors by working constructively with talented management teams to make businesses better, and generates investment returns by structurally improving the strategic position, competitiveness and profitability of its portfolio companies, rather than primarily relying on financial leverage. The KPS Funds' portfolio companies have aggregate annual revenues of approximately $8.4 billion, operate 150 manufacturing facilities in 26 countries, and have approximately 23,000 employees, directly and through joint ventures worldwide. The KPS investment strategy and portfolio companies are described in detail at www.kpsfund.com. SOURCE KPS Capital Partners, LP Related Links kpsfund.com |
edtsum2980 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WOONSOCKET, R.I., April 21, 2021 /PRNewswire/ --CVS Health (NYSE: CVS) today announced that MinuteClinic, the medical clinic inside CVS Pharmacy, is now offering Video Visits for patients in the state of Alaska. The service is available in 48 states and Washington, DC. People in Alaska can now seek care for non-emergency, routine health care through MinuteClinic Video Visits, a telehealth offering. Video Visits are available 24 hours a day, seven days a week, and can be accessed via a mobile device or computer. Video Visits are also an effective screening option for people that may have COVID-19, enabling patients to talk with a health care provider and have a basic screening to determine their risk for COVID-19, without having to leave home. MinuteClinic is the medical clinic located inside select CVS Pharmacy locations in 34 states and Washington, D.C. While there are currently no physical MinuteClinic locations in Alaska, MinuteClinic Video Visits provides state residents with convenient access to high quality care. "As the COVID-19 pandemic continues in communities across the country, our MinuteClinic Video Visits are a convenient, affordable way for people to receive care for a variety of routine health care needs without having to leave home," said Sharon Vitti, President, MinuteClinic. "The expansion of this service into Alaska enables us to introduce local residents to MinuteClinic with an on-demand telehealth option that provides the same evidence-based and high-quality care that people can expect when visiting a MinuteClinic in person." Working collaboratively with Teladoc, the global leader in virtual care, and utilizing Teladoc's technology platform, video visits can be used to provide care for patients ages two years and older who are seeking treatment for a minor illness, minor injury, or a skin condition. Each patient will be matched to a board-certified health care provider licensed in their state, who will review the completed questionnaire with the patient's medical history and proceed with the video-enabled visit. During a MinuteClinic Video Visit, the provider will assess the patient's condition and determine the appropriate course of treatment following evidence-based clinical care guidelines. For patients who require a prescription as part of their treatment plan, the provider will submit the prescription to the patient's preferred pharmacy. If it is determined the patient should be seen in person for follow-up care or testing, the provider will recommend that the patient visit a health care provider in their community, such as their primary care provider. MinuteClinic Video Visits are an affordable option for people who do not have health insurance, with visits costing $59. Video Visits are also covered by most Aetna insurance plans. Patients can initiate a MinuteClinic Video Visit on MinuteClinic.com or from the CVS Pharmacy app. About CVS Health CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com. Contact: Mary Gattuso [emailprotected] SOURCE CVS Health Related Links https://www.cvshealth.com
Answer: | MinuteClinic Video Visit Telehealth Offering Now Available in Alaska | WOONSOCKET, R.I., April 21, 2021 /PRNewswire/ --CVS Health (NYSE: CVS) today announced that MinuteClinic, the medical clinic inside CVS Pharmacy, is now offering Video Visits for patients in the state of Alaska. The service is available in 48 states and Washington, DC. People in Alaska can now seek care for non-emergency, routine health care through MinuteClinic Video Visits, a telehealth offering. Video Visits are available 24 hours a day, seven days a week, and can be accessed via a mobile device or computer. Video Visits are also an effective screening option for people that may have COVID-19, enabling patients to talk with a health care provider and have a basic screening to determine their risk for COVID-19, without having to leave home. MinuteClinic is the medical clinic located inside select CVS Pharmacy locations in 34 states and Washington, D.C. While there are currently no physical MinuteClinic locations in Alaska, MinuteClinic Video Visits provides state residents with convenient access to high quality care. "As the COVID-19 pandemic continues in communities across the country, our MinuteClinic Video Visits are a convenient, affordable way for people to receive care for a variety of routine health care needs without having to leave home," said Sharon Vitti, President, MinuteClinic. "The expansion of this service into Alaska enables us to introduce local residents to MinuteClinic with an on-demand telehealth option that provides the same evidence-based and high-quality care that people can expect when visiting a MinuteClinic in person." Working collaboratively with Teladoc, the global leader in virtual care, and utilizing Teladoc's technology platform, video visits can be used to provide care for patients ages two years and older who are seeking treatment for a minor illness, minor injury, or a skin condition. Each patient will be matched to a board-certified health care provider licensed in their state, who will review the completed questionnaire with the patient's medical history and proceed with the video-enabled visit. During a MinuteClinic Video Visit, the provider will assess the patient's condition and determine the appropriate course of treatment following evidence-based clinical care guidelines. For patients who require a prescription as part of their treatment plan, the provider will submit the prescription to the patient's preferred pharmacy. If it is determined the patient should be seen in person for follow-up care or testing, the provider will recommend that the patient visit a health care provider in their community, such as their primary care provider. MinuteClinic Video Visits are an affordable option for people who do not have health insurance, with visits costing $59. Video Visits are also covered by most Aetna insurance plans. Patients can initiate a MinuteClinic Video Visit on MinuteClinic.com or from the CVS Pharmacy app. About CVS Health CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com. Contact: Mary Gattuso [emailprotected] SOURCE CVS Health Related Links https://www.cvshealth.com |
edtsum2982 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BANGALORE, India, June 29, 2020 /PRNewswire/ -- In 2018, the global Private LTE market size was 2420 Million USD and it is expected to reach 4240 Million USD by the end of 2025, with a CAGR of 8.4% during 2019-2025. Private LTE is a standards-based LTE network scaled down to fit the needs of entities. Private LTE networks are based on wide-area mobility technologies and can easily be adapted for deployment in private organizations. Organizations that use a private LTE network can control their networking environment, which allows them to modify and optimize the networking technology to meet their needs. This report focuses on the global Private LTE status, future forecast, growth opportunity, key market and key players. Inquire For Sample (COVID-19 impact is covered): https://reports.valuates.com/request/sample/QYRE-Auto-667/Global_Private_LTE TRENDS INFLUENCING PRIVATE LTE MARKET SIZE Private LTE market size is expected to witness an increase in growth due to rapid adoption of IoT-based devices which are compatible with wireless networks. Private LTE systems offer smooth mobility and inter-cell hand-off, a key feature required by industrial IoT applications. Furthermore, the usage of IoT in smart building and cities will further drive the deployment of IoT modules, augmenting the growth of private LTE market size. Other factors that can contribute to the growth of convergence of Private LTE and 5G, and the need for unique and defined network qualities. Increasing demand for safe private networks with low latency and high operating efficiency at a reduced cost is expected to accelerate the deployment of private LTE networks through multiple end-use companies. However, interoperability issues between various network platforms is a prominent industry challenge. The growing need for stable private networks with high operational reliability and low latency levels at a reduced cost is likely to accelerate the deployment of private LTE networks through multiple end-use companies. Without sacrificing network security, private LTE networks allow companies to securely expand their networks to mobile devices & clouds for their employees The growing use of private LTE networks by public safety agencies is expected to increase the private LTE market size. These networks allow them to increase awareness of situations, reduce response times and obtain more accurate information. To effectively respond to emergency situations, the public safety agencies as well as the Emergency Service Provider Organizations (ESPOs) are deploying private LTE networks to deliver secure mission-critical voice, video, and data. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-667/global-private-lte PRIVATE LTE MARKET SHARE ANALYSIS Based on Application, the Transportation segment is expected to hold a significant Private LTE market share during the forecast period. Private LTE solutions provide service for various transport applications, including real-time surveillance, signaling data transfer, remote maintenance & control, vehicle internet, and vehicle information system. Based in Type, the FDD segment is expected to hold the largest Private LTE market share. Based on Region, due to the rising adoption of IoT platforms in various sectors like retail, manufacturing, and transportation in the Asia pacific region, the Private LTE market is expected to see a significant growth during the forecast period. IoT's exponential growth has sparked competition for private IoT networks. This has also allowed businesses to enhance resilience and security in their networks. Moreover, multiple spectrum and regulatory requirements adopted by regional governments are increasing the adoption of Private LTE networks. North America is expected to hold the largest private LTE market share in 2018 and is expected to dominate during the forecast period as well. Increased LTE adoption to meet demand for low-latency networks within mission-critical communication and industrial IoT applications are the main factors contributing to the region's market development. PRIVATE LTE MARKET SEGMENTATION Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America. Inquire For Regional Reports: https://reports.valuates.com/request/regional/QYRE-Auto-667/Global_Private_LTE The key players covered in this study Nokia Ericsson Huawei NEC Verizon Cisco Samsung Comba Arris International Netnumber General Dynamics Mavenir Future Technologies Redline Communications Pdvwireless Quortus Ambra Solutions Zinwave Star Solutions Druid Software Cradlepoint, Inc. Lemko Others. Market segment by Type, the product can be split into FDD TDD. Market segment by Application, split into Public Safety and Defense Oil & Gas Utilities Mining Transportation Others. Buy Now for Single User: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-667&lic=single-user Buy Now for Enterprise License: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-667&lic=enterprise-user SIMILAR REPORTS: Private LTE Network Market Report This report focuses on the global Private LTE Network status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Private LTE Network development in the United States, Europe and China. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-12W2275/global-private-lte-network 4G LTE Market Report 4G LTE Market 's main growth driver includes rising technological developments in the telecommunications industry, growing demand for high-speed mobile networks, and increasing smart device production among others. This report focuses on 4G LTE volume and value at global level, regional level and company level. From a global perspective, this report represents overall 4G LTE market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-31M2095/global-4g-lte LTE and 5G Broadcast Market Report In 2019, the global LTE and 5G Broadcast market size was USD 386.6 Million and it is expected to reach USD 609.1 Million by the end of 2026, with a CAGR of 6.6% during 2021-2026. The primary factors driving market growth are increased need for higher data-rates and higher spectral efficiency. The demand is further influenced by the introduction of LTE in public sectors such as public health, as well as in defense and security. During emergencies, these applications need high-speed communication; therefore, LTE is the best-suited network to fuel this need. Furthermore, the growing need of minimizing network capacity congestion is pushing the growth of the LTE and 5G broadcast market. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-0O1410/global-lte-and-5g-broadcast LTE Base Station System Market Report LTE base station system market size was valued at USD 21,824 Million in 2016, and is projected to reach USD 71,977 Million by 2023, growing at a CAGR of 18.6%. The rapid growth of the urban population with an increase in telecom user base necessitated the introduction of a base station network for long-term evolution (LTE) to meet the rise in need of high-speed broadband services. In addition , the rise in companies' adoption of mobile media for promotional and sales activities has provided scope for the LTE base station system market. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-3N253/lte-base-station-system Voice Over LTE (VoLTE) Market Report Voice over Long Term Evolution (VoLTE) market is expected to garner USD 34.8 Billion by 2022, registering a CAGR of 50.1% during the forecast period 2016 - 2022. The growing popularity of VoLTE services of video conferencing and file sharing have increased the rate of adoption of VoLTE in enterprises.The telecommunication sector currently demands for efficient voice call services with faster call setup time and improved spectral efficiency. The deployment of VoLTE services suffices these demands of the sector efficiently. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-1O63/voice-over-lte-volte Public Safety LTE Market Report View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-11X1844/global-public-safety-lte ABOUT US: Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs. Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs. To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources CONTACT US: Valuates Reports[emailprotected]For U.S. Toll-Free Call: 1-(315)-215-3225For IST Call: +91-8040957137WhatsApp : +91-9945648335Website: https://reports.valuates.comTwitter - https://twitter.com/valuatesreportsLinkedin - https://in.linkedin.com/company/valuatesreportsFacebook - https://www.facebook.com/valuatesreports SOURCE Valuates Reports
Answer: | Private LTE Market Size is Expected To Reach USD 4240 Million By 2025 - Valuates Reports English English | BANGALORE, India, June 29, 2020 /PRNewswire/ -- In 2018, the global Private LTE market size was 2420 Million USD and it is expected to reach 4240 Million USD by the end of 2025, with a CAGR of 8.4% during 2019-2025. Private LTE is a standards-based LTE network scaled down to fit the needs of entities. Private LTE networks are based on wide-area mobility technologies and can easily be adapted for deployment in private organizations. Organizations that use a private LTE network can control their networking environment, which allows them to modify and optimize the networking technology to meet their needs. This report focuses on the global Private LTE status, future forecast, growth opportunity, key market and key players. Inquire For Sample (COVID-19 impact is covered): https://reports.valuates.com/request/sample/QYRE-Auto-667/Global_Private_LTE TRENDS INFLUENCING PRIVATE LTE MARKET SIZE Private LTE market size is expected to witness an increase in growth due to rapid adoption of IoT-based devices which are compatible with wireless networks. Private LTE systems offer smooth mobility and inter-cell hand-off, a key feature required by industrial IoT applications. Furthermore, the usage of IoT in smart building and cities will further drive the deployment of IoT modules, augmenting the growth of private LTE market size. Other factors that can contribute to the growth of convergence of Private LTE and 5G, and the need for unique and defined network qualities. Increasing demand for safe private networks with low latency and high operating efficiency at a reduced cost is expected to accelerate the deployment of private LTE networks through multiple end-use companies. However, interoperability issues between various network platforms is a prominent industry challenge. The growing need for stable private networks with high operational reliability and low latency levels at a reduced cost is likely to accelerate the deployment of private LTE networks through multiple end-use companies. Without sacrificing network security, private LTE networks allow companies to securely expand their networks to mobile devices & clouds for their employees The growing use of private LTE networks by public safety agencies is expected to increase the private LTE market size. These networks allow them to increase awareness of situations, reduce response times and obtain more accurate information. To effectively respond to emergency situations, the public safety agencies as well as the Emergency Service Provider Organizations (ESPOs) are deploying private LTE networks to deliver secure mission-critical voice, video, and data. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-667/global-private-lte PRIVATE LTE MARKET SHARE ANALYSIS Based on Application, the Transportation segment is expected to hold a significant Private LTE market share during the forecast period. Private LTE solutions provide service for various transport applications, including real-time surveillance, signaling data transfer, remote maintenance & control, vehicle internet, and vehicle information system. Based in Type, the FDD segment is expected to hold the largest Private LTE market share. Based on Region, due to the rising adoption of IoT platforms in various sectors like retail, manufacturing, and transportation in the Asia pacific region, the Private LTE market is expected to see a significant growth during the forecast period. IoT's exponential growth has sparked competition for private IoT networks. This has also allowed businesses to enhance resilience and security in their networks. Moreover, multiple spectrum and regulatory requirements adopted by regional governments are increasing the adoption of Private LTE networks. North America is expected to hold the largest private LTE market share in 2018 and is expected to dominate during the forecast period as well. Increased LTE adoption to meet demand for low-latency networks within mission-critical communication and industrial IoT applications are the main factors contributing to the region's market development. PRIVATE LTE MARKET SEGMENTATION Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America. Inquire For Regional Reports: https://reports.valuates.com/request/regional/QYRE-Auto-667/Global_Private_LTE The key players covered in this study Nokia Ericsson Huawei NEC Verizon Cisco Samsung Comba Arris International Netnumber General Dynamics Mavenir Future Technologies Redline Communications Pdvwireless Quortus Ambra Solutions Zinwave Star Solutions Druid Software Cradlepoint, Inc. Lemko Others. Market segment by Type, the product can be split into FDD TDD. Market segment by Application, split into Public Safety and Defense Oil & Gas Utilities Mining Transportation Others. Buy Now for Single User: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-667&lic=single-user Buy Now for Enterprise License: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-667&lic=enterprise-user SIMILAR REPORTS: Private LTE Network Market Report This report focuses on the global Private LTE Network status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Private LTE Network development in the United States, Europe and China. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-12W2275/global-private-lte-network 4G LTE Market Report 4G LTE Market 's main growth driver includes rising technological developments in the telecommunications industry, growing demand for high-speed mobile networks, and increasing smart device production among others. This report focuses on 4G LTE volume and value at global level, regional level and company level. From a global perspective, this report represents overall 4G LTE market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-31M2095/global-4g-lte LTE and 5G Broadcast Market Report In 2019, the global LTE and 5G Broadcast market size was USD 386.6 Million and it is expected to reach USD 609.1 Million by the end of 2026, with a CAGR of 6.6% during 2021-2026. The primary factors driving market growth are increased need for higher data-rates and higher spectral efficiency. The demand is further influenced by the introduction of LTE in public sectors such as public health, as well as in defense and security. During emergencies, these applications need high-speed communication; therefore, LTE is the best-suited network to fuel this need. Furthermore, the growing need of minimizing network capacity congestion is pushing the growth of the LTE and 5G broadcast market. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-0O1410/global-lte-and-5g-broadcast LTE Base Station System Market Report LTE base station system market size was valued at USD 21,824 Million in 2016, and is projected to reach USD 71,977 Million by 2023, growing at a CAGR of 18.6%. The rapid growth of the urban population with an increase in telecom user base necessitated the introduction of a base station network for long-term evolution (LTE) to meet the rise in need of high-speed broadband services. In addition , the rise in companies' adoption of mobile media for promotional and sales activities has provided scope for the LTE base station system market. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-3N253/lte-base-station-system Voice Over LTE (VoLTE) Market Report Voice over Long Term Evolution (VoLTE) market is expected to garner USD 34.8 Billion by 2022, registering a CAGR of 50.1% during the forecast period 2016 - 2022. The growing popularity of VoLTE services of video conferencing and file sharing have increased the rate of adoption of VoLTE in enterprises.The telecommunication sector currently demands for efficient voice call services with faster call setup time and improved spectral efficiency. The deployment of VoLTE services suffices these demands of the sector efficiently. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-1O63/voice-over-lte-volte Public Safety LTE Market Report View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-11X1844/global-public-safety-lte ABOUT US: Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs. Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs. To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources CONTACT US: Valuates Reports[emailprotected]For U.S. Toll-Free Call: 1-(315)-215-3225For IST Call: +91-8040957137WhatsApp : +91-9945648335Website: https://reports.valuates.comTwitter - https://twitter.com/valuatesreportsLinkedin - https://in.linkedin.com/company/valuatesreportsFacebook - https://www.facebook.com/valuatesreports SOURCE Valuates Reports |
edtsum2986 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HOUSTON, Aug. 6, 2020 /PRNewswire/ --Blue Sprig Pediatrics, Inc. ("BlueSprig") announces that it has acquired the assets of the Carmel, CA based Aptitude Habilitation Services ("Aptitude"). Aptitude is a multi-state clinic and home-based provider of Applied Behavior Analysis (ABA) therapy services treating children with Autism Spectrum Disorder (ASD). Terms of the transaction were not disclosed. "We are proud to partner with the team at Aptitude and excited about the opportunity to expand into Colorado, North Carolina, Tennessee, Hawaii, and Virginia as a result," said Keith Jones, President and CEO of BlueSprig. "This partnership also adds density in some areas we are already serving which allows us to bring more in the way of high-quality services, advocacy, and awareness to those communities." "We are excited to join with BlueSprig in our shared vision and values as service providers," said Margarett Gabrielson, CEO of Aptitude. "In partnership, we have the ability to reach families in ways we previously could have only imagined. This is the perfect way to honor the dream and mission of our founder and my late husband, Jeffrey Gabrielson." The Centers for Disease Control and Prevention ("CDC") now estimates that one in 54 children in the U.S. are diagnosed with ASD by the age of eight. ABA therapy is recognized as the gold standard of care for children with ASD. Jones added, "BlueSprig's mission is to change the world for children with autism and we are excited to have Aptitude join us on our mission. Together, we look forward to increasing access and fulfilling the unmet need for high-quality behavior analysis treatment across the United States." About Blue Sprig Pediatrics, Inc.BlueSprig, founded in 2017, is a clinic and home-based provider of Applied Behavior Analysis ("ABA") therapy services to children with Autism Spectrum Disorder ("ASD"). BlueSprig is on a mission to change the world for children with autism and is committed to providing compassionate, individualized, and evidence-based behavior analysis treatment. Headquartered in Houston, TX, BlueSprig is the largest autism services provider in Texas and the southeast with locations in Arizona, Arkansas, Florida, Georgia, Illinois, Kentucky, Missouri, Ohio, Oklahoma, Oregon, South Carolina, and Washington. For additional information about BlueSprig or to receive updates, visit www.bluesprigautism.com About Aptitude Habilitation ServicesAptitude Habilitations Services was founded in 2009 and provides Applied Behavior Analysis ("ABA") treatment services to children diagnosed with Autism Spectrum Disorder ("ASD"). The company serves the autism community with clinic and home-based services as well as community and school-based services in 11 states. For additional information about Aptitude, visit www.aptitudeservices.com Contacts:Blue Sprig Pediatrics, Inc.Laurie MarinoHead of Marketing and PR[emailprotected] SOURCE Blue Sprig Pediatrics, Inc. Related Links https://www.bluesprigautism.com
Answer: | Blue Sprig Pediatrics Announces Acquisition Of Aptitude Habilitation Services Acquisition of Aptitude Habilitation Services expands BlueSprig footprint to four new states | HOUSTON, Aug. 6, 2020 /PRNewswire/ --Blue Sprig Pediatrics, Inc. ("BlueSprig") announces that it has acquired the assets of the Carmel, CA based Aptitude Habilitation Services ("Aptitude"). Aptitude is a multi-state clinic and home-based provider of Applied Behavior Analysis (ABA) therapy services treating children with Autism Spectrum Disorder (ASD). Terms of the transaction were not disclosed. "We are proud to partner with the team at Aptitude and excited about the opportunity to expand into Colorado, North Carolina, Tennessee, Hawaii, and Virginia as a result," said Keith Jones, President and CEO of BlueSprig. "This partnership also adds density in some areas we are already serving which allows us to bring more in the way of high-quality services, advocacy, and awareness to those communities." "We are excited to join with BlueSprig in our shared vision and values as service providers," said Margarett Gabrielson, CEO of Aptitude. "In partnership, we have the ability to reach families in ways we previously could have only imagined. This is the perfect way to honor the dream and mission of our founder and my late husband, Jeffrey Gabrielson." The Centers for Disease Control and Prevention ("CDC") now estimates that one in 54 children in the U.S. are diagnosed with ASD by the age of eight. ABA therapy is recognized as the gold standard of care for children with ASD. Jones added, "BlueSprig's mission is to change the world for children with autism and we are excited to have Aptitude join us on our mission. Together, we look forward to increasing access and fulfilling the unmet need for high-quality behavior analysis treatment across the United States." About Blue Sprig Pediatrics, Inc.BlueSprig, founded in 2017, is a clinic and home-based provider of Applied Behavior Analysis ("ABA") therapy services to children with Autism Spectrum Disorder ("ASD"). BlueSprig is on a mission to change the world for children with autism and is committed to providing compassionate, individualized, and evidence-based behavior analysis treatment. Headquartered in Houston, TX, BlueSprig is the largest autism services provider in Texas and the southeast with locations in Arizona, Arkansas, Florida, Georgia, Illinois, Kentucky, Missouri, Ohio, Oklahoma, Oregon, South Carolina, and Washington. For additional information about BlueSprig or to receive updates, visit www.bluesprigautism.com About Aptitude Habilitation ServicesAptitude Habilitations Services was founded in 2009 and provides Applied Behavior Analysis ("ABA") treatment services to children diagnosed with Autism Spectrum Disorder ("ASD"). The company serves the autism community with clinic and home-based services as well as community and school-based services in 11 states. For additional information about Aptitude, visit www.aptitudeservices.com Contacts:Blue Sprig Pediatrics, Inc.Laurie MarinoHead of Marketing and PR[emailprotected] SOURCE Blue Sprig Pediatrics, Inc. Related Links https://www.bluesprigautism.com |
edtsum2991 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LAKE FOREST, Ill.--(BUSINESS WIRE)--Packaging Corporation of America (NYSE: PKG) will hold a conference call on Thursday, January 28, 2021 at 9:30 a.m. Eastern Time to discuss fourth quarter and full year 2020 results. Fourth quarter and full year earnings results will be released after the market closes on Wednesday, January 27, 2021. To access the conference call, please dial (855) 730-0288 (U.S. and Canada) or (832) 412-2295 (International) by 9:15 a.m. (Eastern Time). The conference call leader will be Mark Kowlzan, and the conference ID is 3857029. A replay of the call will also be available from 12:00 p.m. (Eastern Time) on January 28, 2021 until 11:59 p.m. (Eastern Time) on February 11, 2021. To access the recording, please dial (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (International). The passcode is 3857029. This call will also be webcast and accessible at PCAs website at www.packagingcorp.com. PCA is the third largest producer of containerboard products and the third largest producer of uncoated freesheet paper in North America. PCA operates eight paper mills and 92 corrugated products plants and related facilities.
Answer: | Packaging Corporation of America Schedules Conference Call to Discuss Fourth Quarter and Full Year 2020 Operating Results | LAKE FOREST, Ill.--(BUSINESS WIRE)--Packaging Corporation of America (NYSE: PKG) will hold a conference call on Thursday, January 28, 2021 at 9:30 a.m. Eastern Time to discuss fourth quarter and full year 2020 results. Fourth quarter and full year earnings results will be released after the market closes on Wednesday, January 27, 2021. To access the conference call, please dial (855) 730-0288 (U.S. and Canada) or (832) 412-2295 (International) by 9:15 a.m. (Eastern Time). The conference call leader will be Mark Kowlzan, and the conference ID is 3857029. A replay of the call will also be available from 12:00 p.m. (Eastern Time) on January 28, 2021 until 11:59 p.m. (Eastern Time) on February 11, 2021. To access the recording, please dial (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (International). The passcode is 3857029. This call will also be webcast and accessible at PCAs website at www.packagingcorp.com. PCA is the third largest producer of containerboard products and the third largest producer of uncoated freesheet paper in North America. PCA operates eight paper mills and 92 corrugated products plants and related facilities. |
edtsum3002 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, July 29, 2020 /PRNewswire/ -- The "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. Rising government funding and increase in the number of genomic projects, especially in the area of rare diseases, and a growing application horizon are all expected to drive the growth of the genome editing/genome engineering market.Market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases & cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.Based on technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies. CRISPR accounted for the largest share of the genome editing/genome engineering market in 2019. The large share of this segment can be attributed to the ease of use associated with the CRISPR technology and its ability to multiplex.By end-user, the genome editing/genome engineering market is segmented into pharmaceutical companies, biotechnology companies, and academic & government research institutes. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. This is due to the increasing prevalence of infectious diseases and cancer, which is driving research in the pharma sector for drug development.The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, the rising number of genomic projects, and the presence of a genetically diverse population have supported the region's high growth rate. Key Topics Covered: 1 Introduction2 Research Methodology3 Executive Summary4 Premium Insights5 Market Overview5.1 Introduction5.2 Market Dynamics: Drivers, Opportunities, and Challenges5.3 Value Chain Analysis5.4 Impact of Covid-19 Outbreak on the Genome Editing/Genome Engineering Market6 Genome Editing/Genome Engineering Market, by Technology6.1 Introduction6.2 CRISPR6.3 Talen6.4 ZFN6.5 Antisense6.6 Other Technologies7 Genome Editing/Genome Engineering Market, by Application7.1 Introduction7.2 Cell Line Engineering7.3 Genetic Engineering7.4 Diagnostic Applications7.5 Drug Discovery & Development7.6 Other Applications8 Genome Editing/Genome Engineering Market, by Product & Service8.1 Introduction8.2 Reagents & Consumables8.3 Software & Systems8.4 Services9 Genome Editing/Genome Engineering Market, by End-user9.1 Introduction9.2 Pharmaceutical Companies9.3 Biotechnology Companies10 Genome Editing/Genome Engineering Market, by Region11 Competitive Landscape11.1 Introduction11.2 Market Ranking Analysis11.3 Market Evaluation Framework11.4 Competitive Leadership Mapping11.4.1 Visionary Leaders11.4.2 Dynamic Differentiators11.4.3 Innovators11.4.4 Emerging Companies11.5 Competitive Scenario11.5.1 Key Product Launches11.5.2 Key Partnerships & Collaborations11.5.3 Key Acquisitions12 Company ProfilesBusiness Overview, Products and Services Offered, Recent Developments, the Author's View12.1 Thermo Fisher Scientific12.2 Merck12.3 Horizon Discovery12.4 Genscript12.5 Sangamo Therapeutics12.6 Lonza12.7 Editas Medicine12.8 CRISPR Therapeutics12.9 Eurofins Scientific12.10 Precision Biosciences12.11 Oxford Genetics12.12 Intellia Therapeutics12.13 Synthego12.14 Vigene Biosciences12.15 Epigenie12.16 Integrated DNA Technologies12.17 New England Biolabs12.18 Origene Technologies12.19 Transposagen Biopharmaceuticals12.20 Creative Biogene For more information about this report visit https://www.researchandmarkets.com/r/f02b4l About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | Global Market Outlook for the Genome Editing/Genome Engineering Market to 2027 - CRISPR Accounted for Largest Market Share in 2019 | DUBLIN, July 29, 2020 /PRNewswire/ -- The "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. Rising government funding and increase in the number of genomic projects, especially in the area of rare diseases, and a growing application horizon are all expected to drive the growth of the genome editing/genome engineering market.Market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases & cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.Based on technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies. CRISPR accounted for the largest share of the genome editing/genome engineering market in 2019. The large share of this segment can be attributed to the ease of use associated with the CRISPR technology and its ability to multiplex.By end-user, the genome editing/genome engineering market is segmented into pharmaceutical companies, biotechnology companies, and academic & government research institutes. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. This is due to the increasing prevalence of infectious diseases and cancer, which is driving research in the pharma sector for drug development.The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, the rising number of genomic projects, and the presence of a genetically diverse population have supported the region's high growth rate. Key Topics Covered: 1 Introduction2 Research Methodology3 Executive Summary4 Premium Insights5 Market Overview5.1 Introduction5.2 Market Dynamics: Drivers, Opportunities, and Challenges5.3 Value Chain Analysis5.4 Impact of Covid-19 Outbreak on the Genome Editing/Genome Engineering Market6 Genome Editing/Genome Engineering Market, by Technology6.1 Introduction6.2 CRISPR6.3 Talen6.4 ZFN6.5 Antisense6.6 Other Technologies7 Genome Editing/Genome Engineering Market, by Application7.1 Introduction7.2 Cell Line Engineering7.3 Genetic Engineering7.4 Diagnostic Applications7.5 Drug Discovery & Development7.6 Other Applications8 Genome Editing/Genome Engineering Market, by Product & Service8.1 Introduction8.2 Reagents & Consumables8.3 Software & Systems8.4 Services9 Genome Editing/Genome Engineering Market, by End-user9.1 Introduction9.2 Pharmaceutical Companies9.3 Biotechnology Companies10 Genome Editing/Genome Engineering Market, by Region11 Competitive Landscape11.1 Introduction11.2 Market Ranking Analysis11.3 Market Evaluation Framework11.4 Competitive Leadership Mapping11.4.1 Visionary Leaders11.4.2 Dynamic Differentiators11.4.3 Innovators11.4.4 Emerging Companies11.5 Competitive Scenario11.5.1 Key Product Launches11.5.2 Key Partnerships & Collaborations11.5.3 Key Acquisitions12 Company ProfilesBusiness Overview, Products and Services Offered, Recent Developments, the Author's View12.1 Thermo Fisher Scientific12.2 Merck12.3 Horizon Discovery12.4 Genscript12.5 Sangamo Therapeutics12.6 Lonza12.7 Editas Medicine12.8 CRISPR Therapeutics12.9 Eurofins Scientific12.10 Precision Biosciences12.11 Oxford Genetics12.12 Intellia Therapeutics12.13 Synthego12.14 Vigene Biosciences12.15 Epigenie12.16 Integrated DNA Technologies12.17 New England Biolabs12.18 Origene Technologies12.19 Transposagen Biopharmaceuticals12.20 Creative Biogene For more information about this report visit https://www.researchandmarkets.com/r/f02b4l About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum3008 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Data Catalog Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering. The Data Catalog Market is expected to grow at a CAGR of 25.7% over the forecast period 2021 to 2026. A catalog is an information directory that gives information about the data sets, files, or databases. It describes where a data set is located and also some other information regarding the type of device on which the file is stored. Companies Mentioned Key Market Trends Solutions Segment is Expected to Hold a Larger Market Size North America to Dominate the Data Catalog Market Key Topics Covered: 1 INTRODUCTION 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET INSIGHTS 4.1 Market Overview 4.2 Industry Attractiveness Porter's Five Forces Analysis 5 MARKET DYNAMICS 5.1 Market Drivers 5.1.1 Surging Appropriation of Self-Service Analytics 5.1.2 Accelerated Data Proliferation 5.2 Market Restraints 5.2.1 Absence of Standardization in Enterprise Data Management 5.2.2 Data Security and Privacy Concerns 5.3 Industry Value Chain Analysis 5.4 Assessment of Impact of COVID-19 on the Industry 6 MARKET SEGMENTATION 6.1 By Component 6.1.1 Solutions 6.1.2 Services 6.2 By Deployment Mode 6.2.1 Cloud 6.2.2 On-Premises 6.3 By Industry Vertical 6.3.1 BFSI 6.3.2 Retail & E-commerce 6.3.3 Healthcare 6.3.4 Manufacturing 6.3.5 Other Industry Verticals 6.4 Geography 6.4.1 North America 6.4.2 Europe 6.4.3 Asia Pacific 6.4.4 Latin America 6.4.5 Middle East and Africa 7 COMPETITIVE LANDSCAPE 7.1 Company Profiles 8 INVESTMENT ANALYSIS 9 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/m2coxs
Answer: | Global Data Catalog Market (2021 to 2026) - Growth, Trends, COVID-19 Impact, and Forecasts - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Data Catalog Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering. The Data Catalog Market is expected to grow at a CAGR of 25.7% over the forecast period 2021 to 2026. A catalog is an information directory that gives information about the data sets, files, or databases. It describes where a data set is located and also some other information regarding the type of device on which the file is stored. Companies Mentioned Key Market Trends Solutions Segment is Expected to Hold a Larger Market Size North America to Dominate the Data Catalog Market Key Topics Covered: 1 INTRODUCTION 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET INSIGHTS 4.1 Market Overview 4.2 Industry Attractiveness Porter's Five Forces Analysis 5 MARKET DYNAMICS 5.1 Market Drivers 5.1.1 Surging Appropriation of Self-Service Analytics 5.1.2 Accelerated Data Proliferation 5.2 Market Restraints 5.2.1 Absence of Standardization in Enterprise Data Management 5.2.2 Data Security and Privacy Concerns 5.3 Industry Value Chain Analysis 5.4 Assessment of Impact of COVID-19 on the Industry 6 MARKET SEGMENTATION 6.1 By Component 6.1.1 Solutions 6.1.2 Services 6.2 By Deployment Mode 6.2.1 Cloud 6.2.2 On-Premises 6.3 By Industry Vertical 6.3.1 BFSI 6.3.2 Retail & E-commerce 6.3.3 Healthcare 6.3.4 Manufacturing 6.3.5 Other Industry Verticals 6.4 Geography 6.4.1 North America 6.4.2 Europe 6.4.3 Asia Pacific 6.4.4 Latin America 6.4.5 Middle East and Africa 7 COMPETITIVE LANDSCAPE 7.1 Company Profiles 8 INVESTMENT ANALYSIS 9 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/m2coxs |
edtsum3025 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DALLAS--(BUSINESS WIRE)--Naturally Slim (NS), a skills-based digital behavioral health company focused on mind-body weight management and diabetes prevention within the employer-sponsored space, today reveals its forward-thinking predictions on workplace wellness, benefits, and digital health in 2021 and beyond. As a leading weight management program for employers, trusts, and health plansNaturally Slim has the deep market background and extensive real-life case examples to share its unique and strategic predictions as we embark on the new year. Great expectations: how employers, vendors, and programs will be held even more accountable This year there will be a cycle of increased expectations and accountability. Employers will be more likely to choose employee benefits using employee inputincreasing the demand for programs that focus on overall well-being. Employers will also require vendors to deliver on ROI and employee engagementor require a money back guarantee. In 2020, 43% of employers surveyed offered solutions based on employee demand. I predict that this year will incorporate more employee-centric decision making and this number is going to increase to 50%, or even as high as 70%, by the end of 2021. Employers will be accountable when it comes to giving employees the benefits they need in order to retain top talent and increase employee engagement, productivity, and overall wellness. -Rob Butler, CEO As employers work to understand and incorporate new initiatives to lessen the impact of COVID-19 and social unrest, employees will be watching closely to see how they respond. The focus on mental health, stress and resilience will also be aggressive in 2021. Employers will not just hope that people will participate in their new initiatives, they will work diligently to create an environment that motivates and awards employees to engage in programs that will improve their health holistically. -Lauren Goerschler, Chief Marketing Officer In 2021, employers are going to require quick, immediate ROI from vendors or money back guarantees. They are going to demand repayment for programs that dont deliver on ROI or meaningful engagement levels. Employers are going to expect vendors to be more responsible for driving employee engagement and start sharing incentive costs for their employees to do so. -Doug Layman, Chief Revenue Officer Digital remains king: convenient, digital health resources will be key to reaching employees and avoiding burnout The continued reliance on virtual solutions shouldnt be a surprise, but still worth emphasizing. The overarching trend that will continue in 2021 is the rise in virtual and digital mental and physical health benefits that meet employees unique needsrequiring employer-offered tools that are easily accessible to a fully remote workforce. The key to this trend is the rising demand for tools that address whole body health in one solution. Employers need to be able to implement virtual and digital health solutions that provide convenience not additional hurdles. There will be increased emphasis on ease and helping employees understand the link between emotional and physical health. I expect sleep will also become a priority for many employers and employees alike moving forward. -Todd Whitthorne, Chief Inspiration Officer HR will focus on wellness, engagement, and skill development. Wellness now encompasses employees physical and mental health, which is why HR needs to offer holistic benefits addressing mind and body. Not only that, but employees who are suffering burnout need additional support to boost engagement to be productive at home. Lastly, were in a challenging financial market, meaning hiring may not be an option. Ramping up skill development and investing in training will help the company and its employees in the long run. -Emily Taylor, Chief Financial & Human Resources Officer Building resilience: employers will constantly evolve to reduce costs and promote employee growth Employers will need to focus on evolving while decreasing spend in 2021. These savings will be driven by a new emphasis on the health and wellbeing of their employees, from preventive health programs to innovative ways to redeploy financial resources. The status quo will not survive in 2021. Employers will either become stronger and become an example for others to follow or will constantly have trouble meeting objectives. Employers that were already hyper-sensitive to inclusion and improving the overall well-being of their employees will be positioned for growth and prosperity. The key is to always be proactive. As an employer, be in a constant state of evolution when it comes to providing a personalized benefits package focused on the whole health of employees and their families. -Doug Layman, Chief Revenue Officer Employers will redeploy financial resources previously dedicated to physical office space to focus on employee wellness, engagement, and training. This is in order to maximize employee stability, productivity, and focus, which will ultimately improve the bottom-line, boost retention and avoid costly insurance claims. - Emily Taylor, Chief Financial & Human Resources Officer If youre interested in learning more about the benefits or how to get your company involved with NS today, visit: https://www.naturallyslim.com/contact. About Naturally Slim (NS) NS is a digital behavior change program that focuses on improving the physical and mental health of employees and plan members across America. Although the name does not convey it, NS is much more than a weight loss program. With NS, participants learn the skills needed to sustain clinically meaningful weight loss, lower stress, sleep better, and move moreall without the hefty price tag of traditional health coach-centric programs. Simply put, NS is the single most cost-effective way for plan sponsors to reduce obesity-related disease and foster resilience in populations, helping employers and health plans do the most good for the most people. You can learn more at www.naturallyslim.com.
Answer: | Naturally Slim Predicts New 2021 Trends for Employee Benefits and the Digital Health Market Heading into the new year, Naturally Slim executives share perspectives on whats on the horizon for workplace wellness, benefits and digital health | DALLAS--(BUSINESS WIRE)--Naturally Slim (NS), a skills-based digital behavioral health company focused on mind-body weight management and diabetes prevention within the employer-sponsored space, today reveals its forward-thinking predictions on workplace wellness, benefits, and digital health in 2021 and beyond. As a leading weight management program for employers, trusts, and health plansNaturally Slim has the deep market background and extensive real-life case examples to share its unique and strategic predictions as we embark on the new year. Great expectations: how employers, vendors, and programs will be held even more accountable This year there will be a cycle of increased expectations and accountability. Employers will be more likely to choose employee benefits using employee inputincreasing the demand for programs that focus on overall well-being. Employers will also require vendors to deliver on ROI and employee engagementor require a money back guarantee. In 2020, 43% of employers surveyed offered solutions based on employee demand. I predict that this year will incorporate more employee-centric decision making and this number is going to increase to 50%, or even as high as 70%, by the end of 2021. Employers will be accountable when it comes to giving employees the benefits they need in order to retain top talent and increase employee engagement, productivity, and overall wellness. -Rob Butler, CEO As employers work to understand and incorporate new initiatives to lessen the impact of COVID-19 and social unrest, employees will be watching closely to see how they respond. The focus on mental health, stress and resilience will also be aggressive in 2021. Employers will not just hope that people will participate in their new initiatives, they will work diligently to create an environment that motivates and awards employees to engage in programs that will improve their health holistically. -Lauren Goerschler, Chief Marketing Officer In 2021, employers are going to require quick, immediate ROI from vendors or money back guarantees. They are going to demand repayment for programs that dont deliver on ROI or meaningful engagement levels. Employers are going to expect vendors to be more responsible for driving employee engagement and start sharing incentive costs for their employees to do so. -Doug Layman, Chief Revenue Officer Digital remains king: convenient, digital health resources will be key to reaching employees and avoiding burnout The continued reliance on virtual solutions shouldnt be a surprise, but still worth emphasizing. The overarching trend that will continue in 2021 is the rise in virtual and digital mental and physical health benefits that meet employees unique needsrequiring employer-offered tools that are easily accessible to a fully remote workforce. The key to this trend is the rising demand for tools that address whole body health in one solution. Employers need to be able to implement virtual and digital health solutions that provide convenience not additional hurdles. There will be increased emphasis on ease and helping employees understand the link between emotional and physical health. I expect sleep will also become a priority for many employers and employees alike moving forward. -Todd Whitthorne, Chief Inspiration Officer HR will focus on wellness, engagement, and skill development. Wellness now encompasses employees physical and mental health, which is why HR needs to offer holistic benefits addressing mind and body. Not only that, but employees who are suffering burnout need additional support to boost engagement to be productive at home. Lastly, were in a challenging financial market, meaning hiring may not be an option. Ramping up skill development and investing in training will help the company and its employees in the long run. -Emily Taylor, Chief Financial & Human Resources Officer Building resilience: employers will constantly evolve to reduce costs and promote employee growth Employers will need to focus on evolving while decreasing spend in 2021. These savings will be driven by a new emphasis on the health and wellbeing of their employees, from preventive health programs to innovative ways to redeploy financial resources. The status quo will not survive in 2021. Employers will either become stronger and become an example for others to follow or will constantly have trouble meeting objectives. Employers that were already hyper-sensitive to inclusion and improving the overall well-being of their employees will be positioned for growth and prosperity. The key is to always be proactive. As an employer, be in a constant state of evolution when it comes to providing a personalized benefits package focused on the whole health of employees and their families. -Doug Layman, Chief Revenue Officer Employers will redeploy financial resources previously dedicated to physical office space to focus on employee wellness, engagement, and training. This is in order to maximize employee stability, productivity, and focus, which will ultimately improve the bottom-line, boost retention and avoid costly insurance claims. - Emily Taylor, Chief Financial & Human Resources Officer If youre interested in learning more about the benefits or how to get your company involved with NS today, visit: https://www.naturallyslim.com/contact. About Naturally Slim (NS) NS is a digital behavior change program that focuses on improving the physical and mental health of employees and plan members across America. Although the name does not convey it, NS is much more than a weight loss program. With NS, participants learn the skills needed to sustain clinically meaningful weight loss, lower stress, sleep better, and move moreall without the hefty price tag of traditional health coach-centric programs. Simply put, NS is the single most cost-effective way for plan sponsors to reduce obesity-related disease and foster resilience in populations, helping employers and health plans do the most good for the most people. You can learn more at www.naturallyslim.com. |
edtsum3028 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Global Meetings, Incentives, Conventions, and Exhibitions (MICE) Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The MICE market is poised to grow by $ 38.45 bn during 2020-2024 progressing at a CAGR of 2% during the forecast period. The market is driven by the growing contribution toward GDP and employment and digitalization of travel payments. This study identifies the high impact of MICE on employees as one of the prime reasons driving the mice market growth during the next few years. The reports on mice market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The mice market analysis includes type segment and geographical landscapes. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mice market vendors that include ATPI Ltd., BCD Group, Capita Travel and Events, CWT Global BV, Flight Centre Travel Group Ltd., IBTM Events, Maritz Holdings Inc., Questex, The Freeman Co., and The Interpublic Group of Companies Inc.. Also, the mice market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Type Market Segmentation by Service Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix For more information about this report visit https://www.researchandmarkets.com/r/bmek1h
Answer: | Global Meetings, Incentives, Conventions, and Exhibitions (MICE) Markets 2020-2024 - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Global Meetings, Incentives, Conventions, and Exhibitions (MICE) Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The MICE market is poised to grow by $ 38.45 bn during 2020-2024 progressing at a CAGR of 2% during the forecast period. The market is driven by the growing contribution toward GDP and employment and digitalization of travel payments. This study identifies the high impact of MICE on employees as one of the prime reasons driving the mice market growth during the next few years. The reports on mice market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The mice market analysis includes type segment and geographical landscapes. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mice market vendors that include ATPI Ltd., BCD Group, Capita Travel and Events, CWT Global BV, Flight Centre Travel Group Ltd., IBTM Events, Maritz Holdings Inc., Questex, The Freeman Co., and The Interpublic Group of Companies Inc.. Also, the mice market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Type Market Segmentation by Service Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix For more information about this report visit https://www.researchandmarkets.com/r/bmek1h |
edtsum3030 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CINCINNATI, March 17, 2021 /PRNewswire/ --fraXtion, a new "Advice as a Service" platform provides SMBs with a cost-effective alternative to access advice from experienced functional experts with flexible subscription plans that grow with you. At fraXtion, we serve private and family-owned business owners and their functional leaderships teams across a wide range of industries. Access to our senior or associate functional experts is delivered via our online platform with subscription plans that provide flexible monthly hourly packages to one or more fraXtioners to maximize your time and investment. "We created fraXtion during the pandemic as we saw a gap in the market for SMBs to gain advice from experts without having to hire full time resources. The breadth and depth of expertise being made available on our platform is unprecedented and provides SMBs with an affordable alternative to augment their internal teams and knowledge." Michael Fillios, Co-Founder fraXtion is a unique business model in that it not only provides affordable advice to SMBs, but also creates a digital channel for advisors to grow their respective consulting practices. fraXtioners get paid for the time spent on servicing clients and can often turn into broader offline engagement opportunities that helps them grown their practice and build their brand. "To become a fraXtioner, you need to be a functional expert with 10+ years of experience in one or more areas including Cybersecurity, Finance, HR, IT, Marketing, Operations or Sales. You also need to be running your own professional services practice for SMBs. This enables us to attract and incent the quality of advisors to our digital platform." Mike Womack, Co-Founder Given our experience serving the SMB market and seeing these functional gaps firsthand at our clients, we felt compelled to create an alternative solution to address this need with our advice as a service platform. For more information, contact Michael Fillios at [emailprotected]or [emailprotected]or visit www.fraxtionsmb.comto learn more. SOURCE IT Ally Holdings
Answer: | fraXtion launches to provide affordable advice from experienced functional experts fraXtion launches to provide small and mid-sized business (SMBs) access to a network of functional experts across multiple disciplines and industries. Through our digital platform, subscribers can easily engage with our fraXtioners for advice and support on important topics such as Cybersecurity, Finance, Human Resources, Information Technology, Marketing, Operations and Sales. | CINCINNATI, March 17, 2021 /PRNewswire/ --fraXtion, a new "Advice as a Service" platform provides SMBs with a cost-effective alternative to access advice from experienced functional experts with flexible subscription plans that grow with you. At fraXtion, we serve private and family-owned business owners and their functional leaderships teams across a wide range of industries. Access to our senior or associate functional experts is delivered via our online platform with subscription plans that provide flexible monthly hourly packages to one or more fraXtioners to maximize your time and investment. "We created fraXtion during the pandemic as we saw a gap in the market for SMBs to gain advice from experts without having to hire full time resources. The breadth and depth of expertise being made available on our platform is unprecedented and provides SMBs with an affordable alternative to augment their internal teams and knowledge." Michael Fillios, Co-Founder fraXtion is a unique business model in that it not only provides affordable advice to SMBs, but also creates a digital channel for advisors to grow their respective consulting practices. fraXtioners get paid for the time spent on servicing clients and can often turn into broader offline engagement opportunities that helps them grown their practice and build their brand. "To become a fraXtioner, you need to be a functional expert with 10+ years of experience in one or more areas including Cybersecurity, Finance, HR, IT, Marketing, Operations or Sales. You also need to be running your own professional services practice for SMBs. This enables us to attract and incent the quality of advisors to our digital platform." Mike Womack, Co-Founder Given our experience serving the SMB market and seeing these functional gaps firsthand at our clients, we felt compelled to create an alternative solution to address this need with our advice as a service platform. For more information, contact Michael Fillios at [emailprotected]or [emailprotected]or visit www.fraxtionsmb.comto learn more. SOURCE IT Ally Holdings |
edtsum3037 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--Technavio has been monitoring the solar street lighting market and it is poised to grow by USD 3.77 billion during 2020-2024, progressing at a CAGR of almost 11% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Download Latest Free Sample Report 2020 - 2024 Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Frequently Asked Questions: Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Anhui Longvolt Energy Co., Ltd., BISOL Group, d.o.o. , Bridgelux Inc., Carmanah Technologies Corp., DragonsBreathSolar Ltd., EnGoPlanet Energy Solutions Inc., Exide Industries Ltd., Havells India Ltd., Signify NV, and Urja Global Ltd. are some of the major market participants. The decreasing cost of solar PV systems will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Solar Street Lighting Market 2020-2024: Segmentation Solar Street Lighting Market is segmented as below: To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR45611 Solar Street Lighting Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The solar street lighting market report covers the following areas: This study identifies the adoption of energy-efficient lighting technologies as one of the prime reasons driving the Solar Street Lighting Market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Solar Street Lighting Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Answer: | Solar Street Lighting Market 2020-2024, Anhui Longvolt Energy Co., Ltd. and BISOL Group Emergeas Key Contributors to Growth | Technavio | LONDON--(BUSINESS WIRE)--Technavio has been monitoring the solar street lighting market and it is poised to grow by USD 3.77 billion during 2020-2024, progressing at a CAGR of almost 11% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Download Latest Free Sample Report 2020 - 2024 Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Frequently Asked Questions: Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Anhui Longvolt Energy Co., Ltd., BISOL Group, d.o.o. , Bridgelux Inc., Carmanah Technologies Corp., DragonsBreathSolar Ltd., EnGoPlanet Energy Solutions Inc., Exide Industries Ltd., Havells India Ltd., Signify NV, and Urja Global Ltd. are some of the major market participants. The decreasing cost of solar PV systems will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Solar Street Lighting Market 2020-2024: Segmentation Solar Street Lighting Market is segmented as below: To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR45611 Solar Street Lighting Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The solar street lighting market report covers the following areas: This study identifies the adoption of energy-efficient lighting technologies as one of the prime reasons driving the Solar Street Lighting Market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Solar Street Lighting Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. |
edtsum3045 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "World - Chocolates Containing Alcohol - Market Analysis, Forecast, Size, Trends and Insights" report has been added to ResearchAndMarkets.com's offering. This report provides an in-depth analysis of the supply and demand for chocolates containing alcohol. It will help you to find actionable insights and make data-driven decisions for growing your business. This report contains the latest data on market trends and opportunities, consumption, production, imports, exports and price developments. The forecast reveals the market perspectives through to 2025. Countries coverage: Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries (United States, China, Japan, Germany, United Kingdom, France, Brazil, Italy, Russian Federation, India, Canada, Australia, Republic of Korea, Spain, Mexico, Indonesia, Netherlands, Turkey, Saudi Arabia, Switzerland, Sweden, Nigeria, Poland, Belgium, Argentina, Norway, Austria, Thailand, United Arab Emirates, Colombia, Denmark, South Africa, Malaysia, Israel, Singapore, Egypt, Philippines, Finland, Chile, Ireland, Pakistan, Greece, Portugal, Kazakhstan, Algeria, Czech Republic, Qatar, Peru, Romania, Vietnam) + the largest producing countries. This report is designed for manufacturers, distributors, importers, and wholesalers of chocolates containing alcohol, as well as for investors, consultants and advisors. In this report, you can find information that helps you to make informed decisions on the following issues: 1. How to diversify your business and benefit from new market opportunities 2. How to load your idle production capacity 3. How to boost your sales on overseas markets 4. How to increase your profit margins 5. How to make your supply chain more sustainable 6. How to reduce your production and supply chain costs 7. How to outsource production to other countries 8. How to prepare your business for global expansion While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data. Key Topics Covered: 1. Introduction 1.1 Report Description 1.2 Research Methodology And AI Platform 1.3 Data-Driven Decisions For Your Business 1.4 Glossary And Specific Terms 2. Executive Summary 2.1 Key Findings 2.2 Market Trends 3. Market Overview 3.1 Market Size 3.2 Consumption By Country 3.3 Market Forecast To 2025 4. Global Marketplace 4.1 Top Products To Diversify Your Business 4.2 Best-Selling Products Worldwide 4.3 Most Consumed Products Worldwide 4.4 Most Traded Products 4.5 Most Profitable Products For Export 5. Most Promising Supplying Countries 5.1 Top Countries To Source Your Product 5.2 Top Producing Countries 5.3 Top Exporting Countries 5.4 Low-Cost Exporting Countries 6. Most Promising Overseas Markets 6.1 Top Overseas Markets For Exporting Your Product 6.2 Top Consuming Markets 6.3 Unsaturated Markets 6.4 Top Importing Markets 6.5 Most Profitable Markets 7. Global Production 7.1 Production Volume And Value 7.2 Production By Country 8. Global Imports 8.1 Imports From 2007-2017 8.2 Imports By Country 8.3 Import Prices By Country 9. Global Exports 9.1 Exports From 2007-2017 9.2 Exports By Country 9.3 Export Prices By Country 10. Profiles Of Major Producers 11. Country Profiles For more information about this report visit https://www.researchandmarkets.com/r/6fdif7
Answer: | Global Alcohol Chocolates Market to 2025 - Analysis, Forecast, Size, Trends and Insights - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "World - Chocolates Containing Alcohol - Market Analysis, Forecast, Size, Trends and Insights" report has been added to ResearchAndMarkets.com's offering. This report provides an in-depth analysis of the supply and demand for chocolates containing alcohol. It will help you to find actionable insights and make data-driven decisions for growing your business. This report contains the latest data on market trends and opportunities, consumption, production, imports, exports and price developments. The forecast reveals the market perspectives through to 2025. Countries coverage: Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries (United States, China, Japan, Germany, United Kingdom, France, Brazil, Italy, Russian Federation, India, Canada, Australia, Republic of Korea, Spain, Mexico, Indonesia, Netherlands, Turkey, Saudi Arabia, Switzerland, Sweden, Nigeria, Poland, Belgium, Argentina, Norway, Austria, Thailand, United Arab Emirates, Colombia, Denmark, South Africa, Malaysia, Israel, Singapore, Egypt, Philippines, Finland, Chile, Ireland, Pakistan, Greece, Portugal, Kazakhstan, Algeria, Czech Republic, Qatar, Peru, Romania, Vietnam) + the largest producing countries. This report is designed for manufacturers, distributors, importers, and wholesalers of chocolates containing alcohol, as well as for investors, consultants and advisors. In this report, you can find information that helps you to make informed decisions on the following issues: 1. How to diversify your business and benefit from new market opportunities 2. How to load your idle production capacity 3. How to boost your sales on overseas markets 4. How to increase your profit margins 5. How to make your supply chain more sustainable 6. How to reduce your production and supply chain costs 7. How to outsource production to other countries 8. How to prepare your business for global expansion While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data. Key Topics Covered: 1. Introduction 1.1 Report Description 1.2 Research Methodology And AI Platform 1.3 Data-Driven Decisions For Your Business 1.4 Glossary And Specific Terms 2. Executive Summary 2.1 Key Findings 2.2 Market Trends 3. Market Overview 3.1 Market Size 3.2 Consumption By Country 3.3 Market Forecast To 2025 4. Global Marketplace 4.1 Top Products To Diversify Your Business 4.2 Best-Selling Products Worldwide 4.3 Most Consumed Products Worldwide 4.4 Most Traded Products 4.5 Most Profitable Products For Export 5. Most Promising Supplying Countries 5.1 Top Countries To Source Your Product 5.2 Top Producing Countries 5.3 Top Exporting Countries 5.4 Low-Cost Exporting Countries 6. Most Promising Overseas Markets 6.1 Top Overseas Markets For Exporting Your Product 6.2 Top Consuming Markets 6.3 Unsaturated Markets 6.4 Top Importing Markets 6.5 Most Profitable Markets 7. Global Production 7.1 Production Volume And Value 7.2 Production By Country 8. Global Imports 8.1 Imports From 2007-2017 8.2 Imports By Country 8.3 Import Prices By Country 9. Global Exports 9.1 Exports From 2007-2017 9.2 Exports By Country 9.3 Export Prices By Country 10. Profiles Of Major Producers 11. Country Profiles For more information about this report visit https://www.researchandmarkets.com/r/6fdif7 |
edtsum3049 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHICAGO, March 10, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this U.S. precision parts market report. The U.S. precision parts market is expected to grow at a CAGR of over 12% during the period 20202026. Key Highlights Offered in the Report: 1. With around 45% of the cost involved in the raw material procurement, the accessibility to the same and at lower prices decides the margins of vendors. 2. CNC machines witnessing widespread adoption and the requirement of skilled labor has increased thereby, impacting the overall labor dynamics in the U.S. precision parts market. 3. North America (mainly US) has the highest number of airports, which are currently undergoing infrastructure expansion and modernization, worth more than USD 120 billion. The requirement for heavy equipment is expected to be high post 2020. 4. The trade dispute between the US and China over the tariff imposed on certain goods is expected to impact the market in the short term. These disputes are expected to be resolved by the end of 2020 and provide impetus to the market after that. 5. The price trends of steel and iron ore expected to be volatile during the forecast period as the investments to expand capacities for steel production units are witnessing a delay. 6. The market is expected to see more traction in the automotive industry on account of autonomous vehicles, new mobility solutions, and electric vehicles. The slow phasing out of diesel cars in many countries and by automotive manufacturers is expected to provide more opportunities for the vendors. 7. The industry is characterized by a high degree competition. In the present scenarios where COVID-19 has dealt a strong blow to the industry, more aggressive joint ventures is expected to be a strong proposition to beat the market uncertainties and sustain for a longer time period. 8. The end-users are looking at procurement price renegotiation to overcome the high raw material cost. A realignment of the agreement is expected to save the end-users significantly if the order volumes are high. Hence, it is recommended for the vendors to look at cost reduction and efficient inventory and operational planning at their end. Key Offerings: Market Size & Forecast by Revenue | 20202026 Market Dynamics Leading trends, growth drivers, restraints, and investment opportunities Market Segmentation A detailed analysis by end-users and geography Competitive Landscape 7 key vendors and 23 other vendors Get your sample today! https://www.arizton.com/market-reports/united-states-precision-parts-market-research-analysis U.S. Precision Parts Market Segmentation Automotive, healthcare, electronic and semiconductors, aerospace, watching making, defense, marine & offshoring are the major end-users for precision components. U.S. auto manufacturers are increasing the focus on the development of electric and hybrid variants. The US healthcare industry took new strides in 2020. Several technical advances such as telehealth, online consulting, AI-based surgical planning are key driving factors expecting to propel the demand for precision components during the forecast period. The growing concern over quality in medical treatments and government initiatives in offering public health insurance significantly increases the spending toward the healthcare segment. The demand for US manufactured electronics and semiconductors has increased at a steady pace in recent years. Advances in digital technology, artificial intelligence (AI), and the expected adoption of the 5G network communication across the US are expected to influence electronics and semiconductors' growth. U.S. Precision Parts Market By End-user Automotive Light, Medium, & Heavy Commercial Vehicles Light Vehicles Two and Three Wheelers Healthcare Medical Imaging IVD Patient Monitoring Others Electronic and Semiconductors Semiconductors Electronic Aerospace Watchmaking Others Industrial Equipment Defense Heavy Equipment Marine and Offshoring Power Tools Electric Others U.S. Precision Parts Market Dynamics Precision parts manufacturing in the aerospace industry experiences high development in terms of its aftermarket services such as maintenance repair and overhaul (MRO) services and the manufacture and delivery of aerospace aftermarket spare parts. The aerospace aftermarket business provides various products and services for major turbine engine manufacturers, commercial airlines, and the military, such as aircraft engine component MRO services and other services. Activities in the aerospace aftermarket often require the manufacturing and delivery of spare parts for the aerospace aftermarket, under which some manufacturers have an exclusive right to supply specified aftermarket parts over the life of specific programs for aircraft engines. Such facilities also require precision components due to breakage and other supporting services. Key Drivers and Trends fueling Market Growth: Rising Prominence of EVs in US Application of Additive Manufacturing Across Industries Demand from Automotive and Other Industrial Machinery Demand in Healthcare Applications U.S. Precision Parts Market Geography The western region of the country includes states such as Colorado, Washington, Oregon, Utah, Nevada, California, Alaska, Hawaii, and others. The rapid growth in the rate of urbanization and the residential construction industry in most states was one of the key drivers for the rise in demand for precision parts. Growing investments and increasing sales volume of IT and consumer electronics manufacturing industries have significantly propelled the precision manufactured components market in Washington. In addition, Washington dominated the market in terms of sales volume of aircraft spares and investment in the aerospace industry. In 2020, the aerospace industry in the US was valued at approximately $95.4 billion, owing to the increasing public-private partnership in airlines and carrier flights. Furthermore, most precision parts manufacturers in Seattle and Tacoma are involved in manufacturing components for defense equipment and the aircraft manufacturing sector. Get your sample today! https://www.arizton.com/market-reports/united-states-precision-parts-market-research-analysis U.S. Precision Parts Market by Geography US North East West South Midwest Major Vendors Barnes Group Inc. NN, Inc. Martinrea International Linamar WM Berg Renishaw ARC Group Worldwide Other Prominent Vendors Petersen Precision E-Fab Inc. AccuRounds Lampin Corporation WSI Industries Inc. Precision Castparts Corp (PCC) Greystone Tessa Precision Products Hoppe Technologies Doncasters Consolidated Precision Products ZOLLERN Impro Hitchiner Fritz Winter KERN-LIEBERS BERGER Group IPE Group Paradigm Precision Anton Hring KG Pacific West America, Inc. Caldwell Beere Precision Products Explore our industrial machineryprofileto know more about the industry. Read some of the top-selling reports: Industrial Motors Market - Global Outlook and Forecast 2021-2026 Electric Drives Market - Global Outlook and Forecast 2021-2026 Machine Tools Market - Global Outlook and Forecast 2021-2026 Precision Parts Market - Global Outlook and Forecast 2020-2025 About Arizton: AriztonAdvisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services. We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. Mail: [emailprotected] Call: +1-312-235-2040 +1 302 469 0707 SOURCE Arizton Advisory & Intelligence
Answer: | U.S. Precision Parts Market Size to Reach Revenues of over USD 71 Billion by 2026 - Arizton | CHICAGO, March 10, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this U.S. precision parts market report. The U.S. precision parts market is expected to grow at a CAGR of over 12% during the period 20202026. Key Highlights Offered in the Report: 1. With around 45% of the cost involved in the raw material procurement, the accessibility to the same and at lower prices decides the margins of vendors. 2. CNC machines witnessing widespread adoption and the requirement of skilled labor has increased thereby, impacting the overall labor dynamics in the U.S. precision parts market. 3. North America (mainly US) has the highest number of airports, which are currently undergoing infrastructure expansion and modernization, worth more than USD 120 billion. The requirement for heavy equipment is expected to be high post 2020. 4. The trade dispute between the US and China over the tariff imposed on certain goods is expected to impact the market in the short term. These disputes are expected to be resolved by the end of 2020 and provide impetus to the market after that. 5. The price trends of steel and iron ore expected to be volatile during the forecast period as the investments to expand capacities for steel production units are witnessing a delay. 6. The market is expected to see more traction in the automotive industry on account of autonomous vehicles, new mobility solutions, and electric vehicles. The slow phasing out of diesel cars in many countries and by automotive manufacturers is expected to provide more opportunities for the vendors. 7. The industry is characterized by a high degree competition. In the present scenarios where COVID-19 has dealt a strong blow to the industry, more aggressive joint ventures is expected to be a strong proposition to beat the market uncertainties and sustain for a longer time period. 8. The end-users are looking at procurement price renegotiation to overcome the high raw material cost. A realignment of the agreement is expected to save the end-users significantly if the order volumes are high. Hence, it is recommended for the vendors to look at cost reduction and efficient inventory and operational planning at their end. Key Offerings: Market Size & Forecast by Revenue | 20202026 Market Dynamics Leading trends, growth drivers, restraints, and investment opportunities Market Segmentation A detailed analysis by end-users and geography Competitive Landscape 7 key vendors and 23 other vendors Get your sample today! https://www.arizton.com/market-reports/united-states-precision-parts-market-research-analysis U.S. Precision Parts Market Segmentation Automotive, healthcare, electronic and semiconductors, aerospace, watching making, defense, marine & offshoring are the major end-users for precision components. U.S. auto manufacturers are increasing the focus on the development of electric and hybrid variants. The US healthcare industry took new strides in 2020. Several technical advances such as telehealth, online consulting, AI-based surgical planning are key driving factors expecting to propel the demand for precision components during the forecast period. The growing concern over quality in medical treatments and government initiatives in offering public health insurance significantly increases the spending toward the healthcare segment. The demand for US manufactured electronics and semiconductors has increased at a steady pace in recent years. Advances in digital technology, artificial intelligence (AI), and the expected adoption of the 5G network communication across the US are expected to influence electronics and semiconductors' growth. U.S. Precision Parts Market By End-user Automotive Light, Medium, & Heavy Commercial Vehicles Light Vehicles Two and Three Wheelers Healthcare Medical Imaging IVD Patient Monitoring Others Electronic and Semiconductors Semiconductors Electronic Aerospace Watchmaking Others Industrial Equipment Defense Heavy Equipment Marine and Offshoring Power Tools Electric Others U.S. Precision Parts Market Dynamics Precision parts manufacturing in the aerospace industry experiences high development in terms of its aftermarket services such as maintenance repair and overhaul (MRO) services and the manufacture and delivery of aerospace aftermarket spare parts. The aerospace aftermarket business provides various products and services for major turbine engine manufacturers, commercial airlines, and the military, such as aircraft engine component MRO services and other services. Activities in the aerospace aftermarket often require the manufacturing and delivery of spare parts for the aerospace aftermarket, under which some manufacturers have an exclusive right to supply specified aftermarket parts over the life of specific programs for aircraft engines. Such facilities also require precision components due to breakage and other supporting services. Key Drivers and Trends fueling Market Growth: Rising Prominence of EVs in US Application of Additive Manufacturing Across Industries Demand from Automotive and Other Industrial Machinery Demand in Healthcare Applications U.S. Precision Parts Market Geography The western region of the country includes states such as Colorado, Washington, Oregon, Utah, Nevada, California, Alaska, Hawaii, and others. The rapid growth in the rate of urbanization and the residential construction industry in most states was one of the key drivers for the rise in demand for precision parts. Growing investments and increasing sales volume of IT and consumer electronics manufacturing industries have significantly propelled the precision manufactured components market in Washington. In addition, Washington dominated the market in terms of sales volume of aircraft spares and investment in the aerospace industry. In 2020, the aerospace industry in the US was valued at approximately $95.4 billion, owing to the increasing public-private partnership in airlines and carrier flights. Furthermore, most precision parts manufacturers in Seattle and Tacoma are involved in manufacturing components for defense equipment and the aircraft manufacturing sector. Get your sample today! https://www.arizton.com/market-reports/united-states-precision-parts-market-research-analysis U.S. Precision Parts Market by Geography US North East West South Midwest Major Vendors Barnes Group Inc. NN, Inc. Martinrea International Linamar WM Berg Renishaw ARC Group Worldwide Other Prominent Vendors Petersen Precision E-Fab Inc. AccuRounds Lampin Corporation WSI Industries Inc. Precision Castparts Corp (PCC) Greystone Tessa Precision Products Hoppe Technologies Doncasters Consolidated Precision Products ZOLLERN Impro Hitchiner Fritz Winter KERN-LIEBERS BERGER Group IPE Group Paradigm Precision Anton Hring KG Pacific West America, Inc. Caldwell Beere Precision Products Explore our industrial machineryprofileto know more about the industry. Read some of the top-selling reports: Industrial Motors Market - Global Outlook and Forecast 2021-2026 Electric Drives Market - Global Outlook and Forecast 2021-2026 Machine Tools Market - Global Outlook and Forecast 2021-2026 Precision Parts Market - Global Outlook and Forecast 2020-2025 About Arizton: AriztonAdvisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services. We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. Mail: [emailprotected] Call: +1-312-235-2040 +1 302 469 0707 SOURCE Arizton Advisory & Intelligence |
edtsum3050 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, Feb. 8, 2021 /PRNewswire/ -- The "Telecom API Market by Technologies, Application and Service Types, Stakeholders, User Types, Deployment, and Platform as a Service Types 2021 - 2026" report has been added to ResearchAndMarkets.com's offering. Now in its ninth year of coverage, the publisher offers the most comprehensive research analyzing the telecom API market ecosystem including players, platforms, tools, solutions, and service offerings. This report provides an in-depth assessment of the global and regional telecom API market, including business models, value chain analysis, operator strategies and a quantitative assessment of the industry from 2021 to 2026. Furthermore, the report evaluates the current state of the market and outlook for the future including analysis and forecasts for the telecom API market, which is segmented in many ways. Report Findings: Global Telecom API related revenue will reach $674B by 2026 Global UCaaS revenue will reach $91B by 2026 with 48.0% CAGR Enterprise-hosted deployment is growing most rapidly through 2026 While the smallest in revenue overall, MEA is fastest-growing region at CAGR 40.2% Global Communication Service Providers (CSP) continue to see Telecom APIs as a means of leveraging their network and subscriber assets to generate revenues with high margins. However, the ecosystem remains one in which largely third-parties, such as OTT players, maintain the end-user relationship with app and service clients, while CSPs merely provide data as a service on a B2B basis. While this model may suffice for CSPs with respect to the consumer segment and SMBs, it is not sustainable for large corporate clients. CSPs are facing increasing pressure to provide a greater variety of high-quality enterprise communications and business collaboration solutions. Accordingly, the author sees this as an area ripe for leveraging Telecom APIs to offer value-added carrier offerings such as team collaboration, telepresence, and unified communications (UC) as part of a Telecom API enabled marketplace. This vision is beginning to come true. With the help of leading Telecom API and Communications-enabled app providers like Ribbon Communications, AT&T has recently launched an API Marketplace, which is something that the author has recommended since 2011. Offering a turn-key approach by leveraging solutions such as Ribbon's Kandy APIs and Wrappers, AT&T plans to facilitate enterprise customer ability to leverage telecom assets for embedded applications. Ribbon is also supporting KPN's Telecom API marketplace. Other leading telecom vendors such as Mavenir support the programmable telecom (Telecom APIs, platforms, and apps) ecosystem. The company recently announced its Mobile-Native Unified Communications and Collaboration as a Service (mUCaaS) solution. One of the key differentiators claimed by this solution is the ability for business-critical communications are prioritized by the mobile network using quality of service indicators that don't have to compete with other existing OTT UCaaS applications. For many larger Telecom API vendors, a substantial proportion of revenue continues to be generated from SIP Trunking in support of their client's VoIP, UC, and other IP-based communications apps and services. However, many smaller players are innovating in areas that have high growth potential such as analytics data, device information, edge computing, and number management for calls, data, and subscribers. The last category, in particular, is emerging as an important area for unwanted call management solutions including robocall management. Longer-term, we see CSPs leveraging Telecom APIs and related tools to support a variety of industry requirements in which carriers are amply positioned to leverage their market position. Those opportunities include Internet of Things (IoT) authentication, robotics, Artificial Intelligence (AI) platforms, Mobile Edge Computing (MEC), and support of Blockchain. Three areas that represent great opportunities for carriers to aggressively pursue solution development in the more near-term timeframe are AI, IoT, and Mobile Edge Computing. Report Benefits: Gain a better perspective of the State of the Market for Telecom APIs Identify challenges and opportunities across the entire API ecosystem Understand the role of Telecom APIs within the realm of Programmable Telecom Identify leading companies and solutions for Telecom API enabled apps and services Understand the market dynamics, players, and outlook for communication enabled apps Forecasts for every major Telecom API area including Categories, Solutions, Stakeholder Share, and more Forecasts for Telecom API support of Unwanted Call Management including Do Not Disturb and Call Screening Key Topics Covered: 1.0 Executive Summary 2.0 Introduction3.0 Telecom API Overview3.1 Role and Importance of Telecom APIs3.2 Business Drivers for CSPs to Leverage APIs3.2.1 Need for New Revenue Sources3.2.2 Need for Collaboration with Development Community3.2.3 B2B Services and Asymmetric Business Models3.2.4 Emerging Need for IoT Mediation3.3 Telecom API Categories3.3.1 Access Management3.3.2 Advertising and Marketing3.3.3 Billing of Non-Digital Goods3.3.4 Content Delivery3.3.5 Directory and Registry Management3.3.6 Enterprise Collaboration3.3.7 IVR/Voice Solutions3.3.8 Location Determination3.3.9 M2M and Internet of Things3.3.10 Messaging and other Non-Voice Communications3.3.10.1 Text Messaging3.3.10.2 Rich Communications Suite Enhanced Messaging (RCS-e)3.3.10.3 Multimedia Messaging3.3.11 Number Management3.3.12 Payments including Purchaser Present Verification3.3.13 Presence Detection3.3.14 Real-time Communications and WebRTC3.3.15 Subscriber Identity Management3.3.16 Subscriber Profile Management3.3.17 Quality of Service Management3.3.18 Unified Communications and UCaaS3.3.19 Unstructured Supplementary Service Data3.3.20 Unwanted Call Management and Robo Calls3.3.21 Voice/Speech3.4 Telecom API Business Models3.4.1 Three Business Model Types3.4.1.1 Model One3.4.1.2 Model Two3.4.1.3 Model Three3.5 Enterprise Market Segmentation3.5.1 Use Case Segmentation3.5.2 Workforce Management3.5.3 Fraud Prevention3.5.4 Call Centers3.6 Competitive Issues3.6.1 Reduced Total Cost of Ownership3.6.2 Open APIs3.6.3 Configurability and Customization3.7 Applications that use APIs3.8 Telecom API Revenue Potential3.8.1 Standalone API Revenue vs. API enabled Revenue3.8.2 Telecom API-enabled Mobile VAS Applications3.8.3 Carrier Focus on Telecom API's for the Enterprise3.9 Telecom API Usage by Industry Segment3.10 Telecom API Value Chain3.10.1 Telecom API Value Chain3.10.2 How the Value Chain Evolves3.10.3 API Transaction Value Split among Players3.11 API Transaction Cost by Type3.12 Volume of API Transactions 4.0 API Aggregation Marketplace4.1 Role of API Aggregators4.2 Total Cost of Operation with API Aggregators4.2.1 Start-up Costs4.2.2 Transaction Costs4.2.3 Ongoing Maintenance/Support4.2.4 Professional Services by Intermediaries4.3 Aggregator API Usage by Category4.3.1 API Aggregator Example: LocationSmart4.3.2 Aggregation: Intersection of Two Big Needs4.3.3 The Case for Other API Categories4.3.4 Moving Towards New Business Models 5.0 Telecom API Marketplace5.1 Data as a Service (DaaS)5.1.1 Carrier Structured and Unstructured Data5.1.2 Carrier Data Management in DaaS5.1.3 Data Federation in the DaaS Ecosystem5.2 API Marketplace Companies5.2.1 Kong (Mashape)5.2.2 Salesforce (Mulesoft)5.2.3 TeleStax5.3 Telecom API Ecosystem Vendors5.3.1 APIs part of Infrastructure and Services Portfolio5.3.1.1 Ericsson5.3.1.2 Huawei5.3.1.3 Nokia Networks5.3.1.4 Ribbon Communications5.3.2 API Capabilities acquired via Merger & Acquisitions5.3.2.1 Amdocs5.3.2.2 Aspect Software5.3.2.3 BICS5.3.2.4 CA Technologies5.3.2.5 Cisco5.3.2.6 Google5.3.2.7 Oracle5.3.2.8 Persistent Systems5.3.2.9 VoIP Innovations5.3.2.10 Vonage5.3.3 API Capabilities Independently Developed5.3.3.1 Apidaze (VoIP Innovations)5.3.3.2 Apifonica5.3.3.3 Bandwidth Communications Inc.5.3.3.4 CLX Communications5.3.3.5 Fortumo5.3.3.6 hSenid Mobile5.3.3.7 Hubtel5.3.3.8 MessageBird5.3.3.9 Syniverse5.3.3.10 Telnyx5.3.3.11 Tyntec5.3.3.12 Twilio5.3.3.13 Vidyo5.4 Telecom Application Development Market5.4.1 Communications-enabled App Marketplace ("CAM")5.4.1.1 Market Opportunities and Challenges5.4.1.2 Marketplace Facilitators5.4.2 Improving Existing Apps and Services Marketplace 6.0 Telecom API App Enablers6.1 Monetization of Communications-enabled Apps6.1.1 Direct API Revenue6.1.2 Data Monetization6.1.3 Cost Savings6.1.4 Higher Usage6.1.5 Churn Reduction6.2 Telecom App Development Issues6.2.1 Security6.2.2 Data Privacy6.2.3 Interoperability 7.0 Communication Service Provider Telecom API Strategies7.1 Carrier Market Strategy and Positioning7.1.1 API Investment Stabilization7.1.2 Carriers, APIs, and OTT7.1.3 Leveraging Subscriber Data and APIs7.1.4 Telecom API Standards7.1.4.1 GSMA7.1.4.2 TM Forum7.1.5 Telecom APIs and Enterprise7.2 Select Network Operator API Programs7.2.1 AT&T7.2.2 Verizon Wireless7.2.3 Vodafone7.2.4 France Telecom (Orange)7.2.5 Telefonica7.3 Carrier Focus on Internal Telecom API Usage7.3.1 The Case for Internal Usage7.3.2 Internal Telecom API Use Cases7.4 Carriers and OTT Service Providers7.4.1 Allowing OTT Providers to Manage Applications7.4.2 Carriers Lack the Innovative Skills to Capitalize on APIs Alone7.5 Carriers and Value-added Services7.5.1 Role and Importance of VAS7.5.2 The Case for Carrier Communication-enabled VAS7.5.3 Challenges and Opportunities for Carriers in VAS 8.0 API Enabled App Developer Strategies8.1 Telecom APIs as a Critical Developer Asset8.2 Judicious Choice of API Releases8.3 Working alongside Carrier Programs8.4 Developer Preferences: OTT Service Providers vs Carriers 9.0 Telecom API Vendor Strategies9.1 General Strategies9.1.1 Value Chain Enhancers and Development Facilitators9.1.2 Moving from Platforms to Cloud-based CPaaS9.2 Specific Strategies9.2.1 Reliance upon SIP Trunking9.2.2 Improving Existing Solutions9.2.3 Increased Focus on Enterprise Solutions9.2.4 Embracing Next Generation Use Cases 10.0 Global Markets for Telecom APIs10.1 Telecom API Market by Category10.2 Telecom API Market by Service Type10.3 Telecom API Market by User Type10.4 Telecom API Market by Network Technology10.5 Telecom API Market by Deployment10.6 Telecom APIs Market by Platform as a Service10.6.1 Telecom APIs Market by CPaaS10.6.2 Telecom APIs Market by UCaaS10.7 Telecom API Market by Module10.8 Telecom API Market by Stakeholders10.9 Telecom API Market by Region 11.0 North American Markets for Telecom APIs12.0 Latin American Markets for Telecom APIs 13.0 European Markets for Telecom APIs 14.0 APAC Markets for Telecom APIs 15.0 MEA Markets for Telecom APIs 16.0 Telecom API Success Stories16.1 Patronus16.2 RumbleUP16.3 Rently16.4 Phone.com16.5 VOIPo 17.0 Technology and Market Drivers for Future API Market Growth17.1 Service Oriented Architecture17.2 Software Defined Networks17.3 Virtualization17.4 Internet of Things17.5 Bringing it all Together for a Bright Telecom API Future17.6 IoT WANs and Telecom APIs18.0 Conclusions and Recommendation 19.0 Appendix For more information about this report visit https://www.researchandmarkets.com/r/nhbavj Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | Insights on the Telecom API Global Market to 2026 - Identify Challenges and Opportunities | DUBLIN, Feb. 8, 2021 /PRNewswire/ -- The "Telecom API Market by Technologies, Application and Service Types, Stakeholders, User Types, Deployment, and Platform as a Service Types 2021 - 2026" report has been added to ResearchAndMarkets.com's offering. Now in its ninth year of coverage, the publisher offers the most comprehensive research analyzing the telecom API market ecosystem including players, platforms, tools, solutions, and service offerings. This report provides an in-depth assessment of the global and regional telecom API market, including business models, value chain analysis, operator strategies and a quantitative assessment of the industry from 2021 to 2026. Furthermore, the report evaluates the current state of the market and outlook for the future including analysis and forecasts for the telecom API market, which is segmented in many ways. Report Findings: Global Telecom API related revenue will reach $674B by 2026 Global UCaaS revenue will reach $91B by 2026 with 48.0% CAGR Enterprise-hosted deployment is growing most rapidly through 2026 While the smallest in revenue overall, MEA is fastest-growing region at CAGR 40.2% Global Communication Service Providers (CSP) continue to see Telecom APIs as a means of leveraging their network and subscriber assets to generate revenues with high margins. However, the ecosystem remains one in which largely third-parties, such as OTT players, maintain the end-user relationship with app and service clients, while CSPs merely provide data as a service on a B2B basis. While this model may suffice for CSPs with respect to the consumer segment and SMBs, it is not sustainable for large corporate clients. CSPs are facing increasing pressure to provide a greater variety of high-quality enterprise communications and business collaboration solutions. Accordingly, the author sees this as an area ripe for leveraging Telecom APIs to offer value-added carrier offerings such as team collaboration, telepresence, and unified communications (UC) as part of a Telecom API enabled marketplace. This vision is beginning to come true. With the help of leading Telecom API and Communications-enabled app providers like Ribbon Communications, AT&T has recently launched an API Marketplace, which is something that the author has recommended since 2011. Offering a turn-key approach by leveraging solutions such as Ribbon's Kandy APIs and Wrappers, AT&T plans to facilitate enterprise customer ability to leverage telecom assets for embedded applications. Ribbon is also supporting KPN's Telecom API marketplace. Other leading telecom vendors such as Mavenir support the programmable telecom (Telecom APIs, platforms, and apps) ecosystem. The company recently announced its Mobile-Native Unified Communications and Collaboration as a Service (mUCaaS) solution. One of the key differentiators claimed by this solution is the ability for business-critical communications are prioritized by the mobile network using quality of service indicators that don't have to compete with other existing OTT UCaaS applications. For many larger Telecom API vendors, a substantial proportion of revenue continues to be generated from SIP Trunking in support of their client's VoIP, UC, and other IP-based communications apps and services. However, many smaller players are innovating in areas that have high growth potential such as analytics data, device information, edge computing, and number management for calls, data, and subscribers. The last category, in particular, is emerging as an important area for unwanted call management solutions including robocall management. Longer-term, we see CSPs leveraging Telecom APIs and related tools to support a variety of industry requirements in which carriers are amply positioned to leverage their market position. Those opportunities include Internet of Things (IoT) authentication, robotics, Artificial Intelligence (AI) platforms, Mobile Edge Computing (MEC), and support of Blockchain. Three areas that represent great opportunities for carriers to aggressively pursue solution development in the more near-term timeframe are AI, IoT, and Mobile Edge Computing. Report Benefits: Gain a better perspective of the State of the Market for Telecom APIs Identify challenges and opportunities across the entire API ecosystem Understand the role of Telecom APIs within the realm of Programmable Telecom Identify leading companies and solutions for Telecom API enabled apps and services Understand the market dynamics, players, and outlook for communication enabled apps Forecasts for every major Telecom API area including Categories, Solutions, Stakeholder Share, and more Forecasts for Telecom API support of Unwanted Call Management including Do Not Disturb and Call Screening Key Topics Covered: 1.0 Executive Summary 2.0 Introduction3.0 Telecom API Overview3.1 Role and Importance of Telecom APIs3.2 Business Drivers for CSPs to Leverage APIs3.2.1 Need for New Revenue Sources3.2.2 Need for Collaboration with Development Community3.2.3 B2B Services and Asymmetric Business Models3.2.4 Emerging Need for IoT Mediation3.3 Telecom API Categories3.3.1 Access Management3.3.2 Advertising and Marketing3.3.3 Billing of Non-Digital Goods3.3.4 Content Delivery3.3.5 Directory and Registry Management3.3.6 Enterprise Collaboration3.3.7 IVR/Voice Solutions3.3.8 Location Determination3.3.9 M2M and Internet of Things3.3.10 Messaging and other Non-Voice Communications3.3.10.1 Text Messaging3.3.10.2 Rich Communications Suite Enhanced Messaging (RCS-e)3.3.10.3 Multimedia Messaging3.3.11 Number Management3.3.12 Payments including Purchaser Present Verification3.3.13 Presence Detection3.3.14 Real-time Communications and WebRTC3.3.15 Subscriber Identity Management3.3.16 Subscriber Profile Management3.3.17 Quality of Service Management3.3.18 Unified Communications and UCaaS3.3.19 Unstructured Supplementary Service Data3.3.20 Unwanted Call Management and Robo Calls3.3.21 Voice/Speech3.4 Telecom API Business Models3.4.1 Three Business Model Types3.4.1.1 Model One3.4.1.2 Model Two3.4.1.3 Model Three3.5 Enterprise Market Segmentation3.5.1 Use Case Segmentation3.5.2 Workforce Management3.5.3 Fraud Prevention3.5.4 Call Centers3.6 Competitive Issues3.6.1 Reduced Total Cost of Ownership3.6.2 Open APIs3.6.3 Configurability and Customization3.7 Applications that use APIs3.8 Telecom API Revenue Potential3.8.1 Standalone API Revenue vs. API enabled Revenue3.8.2 Telecom API-enabled Mobile VAS Applications3.8.3 Carrier Focus on Telecom API's for the Enterprise3.9 Telecom API Usage by Industry Segment3.10 Telecom API Value Chain3.10.1 Telecom API Value Chain3.10.2 How the Value Chain Evolves3.10.3 API Transaction Value Split among Players3.11 API Transaction Cost by Type3.12 Volume of API Transactions 4.0 API Aggregation Marketplace4.1 Role of API Aggregators4.2 Total Cost of Operation with API Aggregators4.2.1 Start-up Costs4.2.2 Transaction Costs4.2.3 Ongoing Maintenance/Support4.2.4 Professional Services by Intermediaries4.3 Aggregator API Usage by Category4.3.1 API Aggregator Example: LocationSmart4.3.2 Aggregation: Intersection of Two Big Needs4.3.3 The Case for Other API Categories4.3.4 Moving Towards New Business Models 5.0 Telecom API Marketplace5.1 Data as a Service (DaaS)5.1.1 Carrier Structured and Unstructured Data5.1.2 Carrier Data Management in DaaS5.1.3 Data Federation in the DaaS Ecosystem5.2 API Marketplace Companies5.2.1 Kong (Mashape)5.2.2 Salesforce (Mulesoft)5.2.3 TeleStax5.3 Telecom API Ecosystem Vendors5.3.1 APIs part of Infrastructure and Services Portfolio5.3.1.1 Ericsson5.3.1.2 Huawei5.3.1.3 Nokia Networks5.3.1.4 Ribbon Communications5.3.2 API Capabilities acquired via Merger & Acquisitions5.3.2.1 Amdocs5.3.2.2 Aspect Software5.3.2.3 BICS5.3.2.4 CA Technologies5.3.2.5 Cisco5.3.2.6 Google5.3.2.7 Oracle5.3.2.8 Persistent Systems5.3.2.9 VoIP Innovations5.3.2.10 Vonage5.3.3 API Capabilities Independently Developed5.3.3.1 Apidaze (VoIP Innovations)5.3.3.2 Apifonica5.3.3.3 Bandwidth Communications Inc.5.3.3.4 CLX Communications5.3.3.5 Fortumo5.3.3.6 hSenid Mobile5.3.3.7 Hubtel5.3.3.8 MessageBird5.3.3.9 Syniverse5.3.3.10 Telnyx5.3.3.11 Tyntec5.3.3.12 Twilio5.3.3.13 Vidyo5.4 Telecom Application Development Market5.4.1 Communications-enabled App Marketplace ("CAM")5.4.1.1 Market Opportunities and Challenges5.4.1.2 Marketplace Facilitators5.4.2 Improving Existing Apps and Services Marketplace 6.0 Telecom API App Enablers6.1 Monetization of Communications-enabled Apps6.1.1 Direct API Revenue6.1.2 Data Monetization6.1.3 Cost Savings6.1.4 Higher Usage6.1.5 Churn Reduction6.2 Telecom App Development Issues6.2.1 Security6.2.2 Data Privacy6.2.3 Interoperability 7.0 Communication Service Provider Telecom API Strategies7.1 Carrier Market Strategy and Positioning7.1.1 API Investment Stabilization7.1.2 Carriers, APIs, and OTT7.1.3 Leveraging Subscriber Data and APIs7.1.4 Telecom API Standards7.1.4.1 GSMA7.1.4.2 TM Forum7.1.5 Telecom APIs and Enterprise7.2 Select Network Operator API Programs7.2.1 AT&T7.2.2 Verizon Wireless7.2.3 Vodafone7.2.4 France Telecom (Orange)7.2.5 Telefonica7.3 Carrier Focus on Internal Telecom API Usage7.3.1 The Case for Internal Usage7.3.2 Internal Telecom API Use Cases7.4 Carriers and OTT Service Providers7.4.1 Allowing OTT Providers to Manage Applications7.4.2 Carriers Lack the Innovative Skills to Capitalize on APIs Alone7.5 Carriers and Value-added Services7.5.1 Role and Importance of VAS7.5.2 The Case for Carrier Communication-enabled VAS7.5.3 Challenges and Opportunities for Carriers in VAS 8.0 API Enabled App Developer Strategies8.1 Telecom APIs as a Critical Developer Asset8.2 Judicious Choice of API Releases8.3 Working alongside Carrier Programs8.4 Developer Preferences: OTT Service Providers vs Carriers 9.0 Telecom API Vendor Strategies9.1 General Strategies9.1.1 Value Chain Enhancers and Development Facilitators9.1.2 Moving from Platforms to Cloud-based CPaaS9.2 Specific Strategies9.2.1 Reliance upon SIP Trunking9.2.2 Improving Existing Solutions9.2.3 Increased Focus on Enterprise Solutions9.2.4 Embracing Next Generation Use Cases 10.0 Global Markets for Telecom APIs10.1 Telecom API Market by Category10.2 Telecom API Market by Service Type10.3 Telecom API Market by User Type10.4 Telecom API Market by Network Technology10.5 Telecom API Market by Deployment10.6 Telecom APIs Market by Platform as a Service10.6.1 Telecom APIs Market by CPaaS10.6.2 Telecom APIs Market by UCaaS10.7 Telecom API Market by Module10.8 Telecom API Market by Stakeholders10.9 Telecom API Market by Region 11.0 North American Markets for Telecom APIs12.0 Latin American Markets for Telecom APIs 13.0 European Markets for Telecom APIs 14.0 APAC Markets for Telecom APIs 15.0 MEA Markets for Telecom APIs 16.0 Telecom API Success Stories16.1 Patronus16.2 RumbleUP16.3 Rently16.4 Phone.com16.5 VOIPo 17.0 Technology and Market Drivers for Future API Market Growth17.1 Service Oriented Architecture17.2 Software Defined Networks17.3 Virtualization17.4 Internet of Things17.5 Bringing it all Together for a Bright Telecom API Future17.6 IoT WANs and Telecom APIs18.0 Conclusions and Recommendation 19.0 Appendix For more information about this report visit https://www.researchandmarkets.com/r/nhbavj Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum3055 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OTTAWA, June 8, 2020 /PRNewswire/ - The Government of Canada remains committed to protecting the health and safety of Canadians and reducing the spread of COVID-19 in Canada. The Government recognizes however that the temporary border measures put in place to fight the spread of COVID-19, while necessary, have created challenges for some families. The Government has therefore been looking at ways to keep families together and support unity while respecting the need for continued vigilance and border measures at this time. The Canada Border Services Agency is announcing that as of June 8, 2020 23:59 EDT, foreign nationals who are immediate family members of Canadian citizens and permanent residents, and who do not have COVID-19 or exhibit any signs or symptoms of COVID-19, or who do not have reason to believe they have COVID-19, will be exempt from the prohibition on entry to Canada if entering to be with an immediate family member for a period of at least 15 days. Foreign nationals who are admitted into Canadapursuant to this exemption must quarantine for 14 days. An immediate family member refers to a person's: spouse or common-law partner; dependent child, as defined in section 2 of the Immigration and Refugee Protection Regulations, or a dependent child of the person's spouse or common-law partner; dependent child, as defined in section 2 of the Immigration and Refugee Protection Regulations, of a dependent child referred to in paragraph (b): parent or step-parent or the parent or step-parent of the person's spouse or common-law partner; guardian or tutor. All foreign nationals who have COVID-19 or exhibit any signs or symptoms of COVID-19 continue to remain prohibited from entering Canada. This change does not apply to immediate family members of temporary residents in Canada, such as those on a student or work visa. Quick Facts All persons entering Canada no matter their country of origin or mode of entry must isolate themselves for 14 days if they have symptoms of or confirmed COVID-19 or quarantine themselves for 14 days if they do not have symptoms of COVID-19. Asymptomatic foreign national immediate family members of Canadian citizens and permanent residents who intend to stay in Canada for 14 days or less may still enter Canada as long as their entry is not for a purpose that is discretionary and, if seeking entry from the United States, are able to comply with the requirement to quarantine based on their purpose of travel and intended length of stay. The temporary restriction on all discretionary/optional travel at the Canada-U.S. border put in place on March 21 at 12:01 a.m. EDT continues. This restriction is in place until at least June 21, 2020. Canadian citizens, permanent residents and Registered Indians under the Indian Act can continue to enter Canada by right, and are subject to COVID-19 entry screening measures. The immediate family member will need to confirm that they have a suitable place to quarantinefor 14 days where they will have access to basic necessities (such as food and medication) and not have contact with vulnerable people, such as adults aged 65 years or over and people with pre-existing medical conditions, unless the vulnerable person is a consenting adult or is the parent or minor in a parent-minor relationship. Travellers will be expected to make plans for where they will quarantine in advance of arriving to Canada. Travellers should consult the respective provincial/territorial websites to ensure that they are aware of the provincial/territorial entry, quarantine and public health requirements and can abide by those requirements. As of March 31, 2020, anyone arriving in Canada in any mode (air, land or marine) must provide their contact information to a border services officer when seeking entry. This information is collected on behalf of Public Health Agency of Canada to support their compliance and enforcement of the 14-day quarantine or isolation requirement outlined in Order in Council 2020-0260.Travellers are encouraged to download the mobile ArriveCAN App prior to arrival to reduce wait times and limit contact at the border. The App is available on the Apple App and Google Play stores. Associated Links COVID-19 - Travel restrictions, exemptions and advice ArriveCAN App Website: www.cbsa-asfc.gc.ca Twitter: @CanBorderFacebook: CanBorderInstagram: CanBorderYouTube: CanBorder SOURCE Canada Border Services Agency Related Links http://www.cbsa-asfc.gc.ca/
Answer: | Changes to travel restrictions for immediate family members of Canadian citizens and permanent residents | OTTAWA, June 8, 2020 /PRNewswire/ - The Government of Canada remains committed to protecting the health and safety of Canadians and reducing the spread of COVID-19 in Canada. The Government recognizes however that the temporary border measures put in place to fight the spread of COVID-19, while necessary, have created challenges for some families. The Government has therefore been looking at ways to keep families together and support unity while respecting the need for continued vigilance and border measures at this time. The Canada Border Services Agency is announcing that as of June 8, 2020 23:59 EDT, foreign nationals who are immediate family members of Canadian citizens and permanent residents, and who do not have COVID-19 or exhibit any signs or symptoms of COVID-19, or who do not have reason to believe they have COVID-19, will be exempt from the prohibition on entry to Canada if entering to be with an immediate family member for a period of at least 15 days. Foreign nationals who are admitted into Canadapursuant to this exemption must quarantine for 14 days. An immediate family member refers to a person's: spouse or common-law partner; dependent child, as defined in section 2 of the Immigration and Refugee Protection Regulations, or a dependent child of the person's spouse or common-law partner; dependent child, as defined in section 2 of the Immigration and Refugee Protection Regulations, of a dependent child referred to in paragraph (b): parent or step-parent or the parent or step-parent of the person's spouse or common-law partner; guardian or tutor. All foreign nationals who have COVID-19 or exhibit any signs or symptoms of COVID-19 continue to remain prohibited from entering Canada. This change does not apply to immediate family members of temporary residents in Canada, such as those on a student or work visa. Quick Facts All persons entering Canada no matter their country of origin or mode of entry must isolate themselves for 14 days if they have symptoms of or confirmed COVID-19 or quarantine themselves for 14 days if they do not have symptoms of COVID-19. Asymptomatic foreign national immediate family members of Canadian citizens and permanent residents who intend to stay in Canada for 14 days or less may still enter Canada as long as their entry is not for a purpose that is discretionary and, if seeking entry from the United States, are able to comply with the requirement to quarantine based on their purpose of travel and intended length of stay. The temporary restriction on all discretionary/optional travel at the Canada-U.S. border put in place on March 21 at 12:01 a.m. EDT continues. This restriction is in place until at least June 21, 2020. Canadian citizens, permanent residents and Registered Indians under the Indian Act can continue to enter Canada by right, and are subject to COVID-19 entry screening measures. The immediate family member will need to confirm that they have a suitable place to quarantinefor 14 days where they will have access to basic necessities (such as food and medication) and not have contact with vulnerable people, such as adults aged 65 years or over and people with pre-existing medical conditions, unless the vulnerable person is a consenting adult or is the parent or minor in a parent-minor relationship. Travellers will be expected to make plans for where they will quarantine in advance of arriving to Canada. Travellers should consult the respective provincial/territorial websites to ensure that they are aware of the provincial/territorial entry, quarantine and public health requirements and can abide by those requirements. As of March 31, 2020, anyone arriving in Canada in any mode (air, land or marine) must provide their contact information to a border services officer when seeking entry. This information is collected on behalf of Public Health Agency of Canada to support their compliance and enforcement of the 14-day quarantine or isolation requirement outlined in Order in Council 2020-0260.Travellers are encouraged to download the mobile ArriveCAN App prior to arrival to reduce wait times and limit contact at the border. The App is available on the Apple App and Google Play stores. Associated Links COVID-19 - Travel restrictions, exemptions and advice ArriveCAN App Website: www.cbsa-asfc.gc.ca Twitter: @CanBorderFacebook: CanBorderInstagram: CanBorderYouTube: CanBorder SOURCE Canada Border Services Agency Related Links http://www.cbsa-asfc.gc.ca/ |
edtsum3061 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO, May 19, 2020 /PRNewswire/ -- Talent Board, a non-profit organization focused on the elevation and promotion of a quality candidate experience, today announced Symphony Talent, a global leader in transforming brand experiences through talent marketing software and services, , has become a North American Platinum sponsor for this year's2020 Candidate Experience (CandE) Awards global benchmark research program. Continue Reading Symphony Talent Talent Board and the Candidate Experience Awards "We're excited to have Symphony Talent as a Platinum sponsor this year. Their strong combination of brand services and technology platform ensure that candidates, employees and employers engage in regular communication, a key differentiator of improving all talent experiences," said Kevin Grossman, Talent Board president and board member. "The annual Talent Board Benchmark Research Program helps employers around the world better understand that communication and feedback are vital to a better candidate experience and Symphony Talent is a big supporter of this mission." The annual Talent Board recruiting and candidate experience benchmarking and awards program offer employers in North America; Europe, the Middle East and Africa (EMEA); Asia-Pacific (APAC); and now for the first time Latin America, a risk-free and confidential opportunity to learn how their organization's candidate experience practices compare to those of their peers and obtain feedback from their candidates, while gaining insight into the latest tools and strategies for optimizing the recruiting process. The largest study of its kind, the Talent Board benchmark research program has evaluated responses from hundreds of global employers each year and nearly 1 million job seekers since 2011. To qualify, each company has to commit to a statistically significant candidate response, and the proportion of respondents not hired also had to exceed a set standard.Registration for the 2020 CandE program is now open."People make connections with brands and through experiences, not just jobs. The CandE research program provides employers with invaluable insights on their talent experience, directly from the talent navigating it," said Roopesh Nair, CEO of Symphony Talent. "We can't transform talent acquisition or empower recruiting teams without this type of candidate research." Additional information about the 2020 Talent Board Candidate Experience Awards Benchmark Research Program can be accessed at:https://www.thetalentboard.org/cande-awards/how-to-register/About Symphony TalentCombining industry-leading talent marketing software and services, Symphony Talent transforms the experiences between companies and talent. In 2019, they acquired SmashFly Technologies; the combined talent marketing platform unifies CRM, career site and programmatic advertising to help talent acquisition automate tasks for efficiency and empower teams for interaction. Symphony Talent fuels Fortune 1000 brands across the globe. To learn more, visit www.symphonytalent.coom and follow us on Twitter @SymphonyTalent_. About Talent BoardTalent Board and the Candidate Experience Awards, founded in 2011, is the first non-profit research organization focused on the elevation and promotion of a quality candidate experience with industry benchmarks that highlight accountability, fairness and business impact. The organization, Candidate Experience (CandE) Awards program and its sponsors are dedicated to recognizing the candidate experience offered by companies throughout the entire recruitment cycle and to forever changing the manner in which job candidates are treated. The CandE Awards also serve as a benchmarking program to raise awareness of the benefits of a positive candidate experience and highlight the processes, methodologies and technology that can enhance the recruiting experience as demonstrated by the winning organizations. More information can be accessed at https://www.thetalentboard.org. Media ContactKevin Grossman831-419-6810[emailprotected]SOURCE Talent Board Related Links https://www.thetalentboard.org
Answer: | Symphony Talent Supports the 2020 Candidate Experience Awards as a North American Platinum Sponsor Candidate Experience Awards Recognizes Organizations That Deliver Exceptional Candidate Experience | SAN FRANCISCO, May 19, 2020 /PRNewswire/ -- Talent Board, a non-profit organization focused on the elevation and promotion of a quality candidate experience, today announced Symphony Talent, a global leader in transforming brand experiences through talent marketing software and services, , has become a North American Platinum sponsor for this year's2020 Candidate Experience (CandE) Awards global benchmark research program. Continue Reading Symphony Talent Talent Board and the Candidate Experience Awards "We're excited to have Symphony Talent as a Platinum sponsor this year. Their strong combination of brand services and technology platform ensure that candidates, employees and employers engage in regular communication, a key differentiator of improving all talent experiences," said Kevin Grossman, Talent Board president and board member. "The annual Talent Board Benchmark Research Program helps employers around the world better understand that communication and feedback are vital to a better candidate experience and Symphony Talent is a big supporter of this mission." The annual Talent Board recruiting and candidate experience benchmarking and awards program offer employers in North America; Europe, the Middle East and Africa (EMEA); Asia-Pacific (APAC); and now for the first time Latin America, a risk-free and confidential opportunity to learn how their organization's candidate experience practices compare to those of their peers and obtain feedback from their candidates, while gaining insight into the latest tools and strategies for optimizing the recruiting process. The largest study of its kind, the Talent Board benchmark research program has evaluated responses from hundreds of global employers each year and nearly 1 million job seekers since 2011. To qualify, each company has to commit to a statistically significant candidate response, and the proportion of respondents not hired also had to exceed a set standard.Registration for the 2020 CandE program is now open."People make connections with brands and through experiences, not just jobs. The CandE research program provides employers with invaluable insights on their talent experience, directly from the talent navigating it," said Roopesh Nair, CEO of Symphony Talent. "We can't transform talent acquisition or empower recruiting teams without this type of candidate research." Additional information about the 2020 Talent Board Candidate Experience Awards Benchmark Research Program can be accessed at:https://www.thetalentboard.org/cande-awards/how-to-register/About Symphony TalentCombining industry-leading talent marketing software and services, Symphony Talent transforms the experiences between companies and talent. In 2019, they acquired SmashFly Technologies; the combined talent marketing platform unifies CRM, career site and programmatic advertising to help talent acquisition automate tasks for efficiency and empower teams for interaction. Symphony Talent fuels Fortune 1000 brands across the globe. To learn more, visit www.symphonytalent.coom and follow us on Twitter @SymphonyTalent_. About Talent BoardTalent Board and the Candidate Experience Awards, founded in 2011, is the first non-profit research organization focused on the elevation and promotion of a quality candidate experience with industry benchmarks that highlight accountability, fairness and business impact. The organization, Candidate Experience (CandE) Awards program and its sponsors are dedicated to recognizing the candidate experience offered by companies throughout the entire recruitment cycle and to forever changing the manner in which job candidates are treated. The CandE Awards also serve as a benchmarking program to raise awareness of the benefits of a positive candidate experience and highlight the processes, methodologies and technology that can enhance the recruiting experience as demonstrated by the winning organizations. More information can be accessed at https://www.thetalentboard.org. Media ContactKevin Grossman831-419-6810[emailprotected]SOURCE Talent Board Related Links https://www.thetalentboard.org |
edtsum3062 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WESTPORT, Conn., Jan. 5, 2021 /PRNewswire/ -- Newman's Own, Inc., the food and beverage company that was created by Paul Newman to give 100% of its profits to charity, announced the appointment of Michael Mardy to its board of directors. Mr. Mardy is an experienced C-level executive and board director who brings financial, food industry and retail expertise to help guide growth and performance. Mr. Mardy most recently served as Executive Vice President, Chief Financial Officer and Board Director of Tumi Holdings, Inc., a retailer of prestige luggage and travel accessories. Prior to that, he served as Executive Vice President and Chief Financial Officer of Keystone Foods LLC, a global food products manufacturer. Previously, he held senior-level financial positions with Nabisco, Inc., a leading U.S. cookie and cracker manufacturer. Currently, Mr. Mardy serves as a Board Director of top fashion retail brands Vince Holdings and LULUS Fashion Lounge. In the past, he served as a Board Director for several publicly traded companies, including True Leaf Brands, David's Tea, Green Mountain Coffee Roasters and Modus Link Global Solutions. He also previously served on the New York Stock Exchange Advisory Board. "We are delighted to have Mike join the Newman's Own, Inc. Board of Directors," said Ellen Marram, Board Chair. "His deep financial expertise and insights will greatly benefit our organization." Mr. Mardy's not for profit board work includes being a Board Director for the Eden Institute for Autism based in Princeton, New Jersey, as well as being on the Board of Trustees at Princeton Hospital. "I'm honored to step into my new role as a member of the Newman's Own, Inc. Board of Directors. I look forward to helping a brand of great tasting, high quality food products that in turn helps transform the lives of so many through its unique giving model," said Mr. Mardy. Mr. Mardy received his BA from Princeton University and his MBA from Rutgers University. He is a member of the American Institute of Certified Public Accountants and a member of the New Jersey Society of CPAs. About Newman's Own Newman's Own, Inc., founded by Paul Newman in 1982, offers great tasting, high quality food and beverage products for people and pets. Its product offerings include salad dressings, pasta sauces, frozen pizza, salsa, refrigerated drinks, cookies, and snacks as well as pet food and pet treats. Newman's Own Foundation continues Paul Newman's commitment to use 100% of the royalties and profits that it receives from the sale of its food products for charitable purposes. Over $560 million has been given to thousands of charities since 1982. For more information, visit NewmansOwn.com. SOURCE Newman's Own, Inc.
Answer: | Newman's Own, Inc. Appoints Michael Mardy to Board of Directors | WESTPORT, Conn., Jan. 5, 2021 /PRNewswire/ -- Newman's Own, Inc., the food and beverage company that was created by Paul Newman to give 100% of its profits to charity, announced the appointment of Michael Mardy to its board of directors. Mr. Mardy is an experienced C-level executive and board director who brings financial, food industry and retail expertise to help guide growth and performance. Mr. Mardy most recently served as Executive Vice President, Chief Financial Officer and Board Director of Tumi Holdings, Inc., a retailer of prestige luggage and travel accessories. Prior to that, he served as Executive Vice President and Chief Financial Officer of Keystone Foods LLC, a global food products manufacturer. Previously, he held senior-level financial positions with Nabisco, Inc., a leading U.S. cookie and cracker manufacturer. Currently, Mr. Mardy serves as a Board Director of top fashion retail brands Vince Holdings and LULUS Fashion Lounge. In the past, he served as a Board Director for several publicly traded companies, including True Leaf Brands, David's Tea, Green Mountain Coffee Roasters and Modus Link Global Solutions. He also previously served on the New York Stock Exchange Advisory Board. "We are delighted to have Mike join the Newman's Own, Inc. Board of Directors," said Ellen Marram, Board Chair. "His deep financial expertise and insights will greatly benefit our organization." Mr. Mardy's not for profit board work includes being a Board Director for the Eden Institute for Autism based in Princeton, New Jersey, as well as being on the Board of Trustees at Princeton Hospital. "I'm honored to step into my new role as a member of the Newman's Own, Inc. Board of Directors. I look forward to helping a brand of great tasting, high quality food products that in turn helps transform the lives of so many through its unique giving model," said Mr. Mardy. Mr. Mardy received his BA from Princeton University and his MBA from Rutgers University. He is a member of the American Institute of Certified Public Accountants and a member of the New Jersey Society of CPAs. About Newman's Own Newman's Own, Inc., founded by Paul Newman in 1982, offers great tasting, high quality food and beverage products for people and pets. Its product offerings include salad dressings, pasta sauces, frozen pizza, salsa, refrigerated drinks, cookies, and snacks as well as pet food and pet treats. Newman's Own Foundation continues Paul Newman's commitment to use 100% of the royalties and profits that it receives from the sale of its food products for charitable purposes. Over $560 million has been given to thousands of charities since 1982. For more information, visit NewmansOwn.com. SOURCE Newman's Own, Inc. |
edtsum3068 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LAKEWOOD, Colo., Oct. 22, 2020 /PRNewswire/ --Natural Grocers, the nation's largest family-operated natural and organic grocery retailer, announces its special Post-Election Promo running from November 5 to November 7, 2020. When shopping during the three-day sale, members of {N}power, Natural Grocers' free loyalty program, will receive a free chocolate bar and deals from around the store. Additionally, Natural Grocers is hosting a prize giveaway which includes one company-wide grand prize, and one in-store prize winner at every store. Continue Reading {N}power is free to join and offers exclusive discounts, digital coupons, rewards benefits, and other members-only features. Customers can sign up for {N}power here or by texting1 organic to 41411. Natural Grocers announces its special Post-Election Promo running from November 5 to November 7, 2020. Tweet this Post-Election Giveaways {N}power members are eligible for one free chocolate bar2during the three days and can choose their favorite flavor (while supplies last) from these popular brands: Alter Eco, Natural Grocers Brand, Chocolove, Endangered Species, or Theo Chocolate. Prize giveaways are open to all customers who can enter by filling out the sweepstakes form at their local store. A drawing among all entries will determine the winners of the following prizes3: Grand Prize: One winner, company-wide will be selected to win a $500 Natural Grocers gift card, an Oster Roaster, and a Natural Grocers cutting boardjust in time for Thanksgiving. One Prize Each Per Store: One winner per store will be selected to wina NOW diffuser and essential oil or a $25 Natural Grocers gift card. 3-Day, Post-Election Deals {N}power Members Only{N}power members will save on customer favorites of pasture-based and humanely raised bacon and bacon alternatives (Sale price $3.99; Always Affordable price: $4.15 - $7.19) and Natural Grocers Brand Organic Snack Packs (Sale Price $0.99; Always Affordable price: $1.49), which are available in 11 varieties including Organic Pistachios, Organic Whole Almonds, Organic Margaret's Mix, and Organic Pumpkin Seeds. The sale also features 20% off select self-care essentials from the Supplement and Body Care departments for de-stressing and relaxation, such as all diffusers and essential oils, Bach Rescue Remedy Spray (20ml), Pacha Soap Co. bath bombs and brews, body scrubs, and mineral soaks, Garden of Life myKind Organics Ashwagandha (60 tab), Solaray Magnesium Glycinate (120 veg), WishGarden Deep Stress Pump (2oz), and more. Check out Natural Grocers' Post-Election Promo details here.While shopping the Post-Election Promo, customers can pre-order their Thanksgiving turkey or sign up for the Turkey Call List. Earlier this month, Natural Grocers debuted its parody video titled, "Let's Talk Turkey,"an engaging, playful, and educational short video which highlights the unique benefits of each type of Mary's Free-Range Turkey and why they are a better choice than conventionally raised varieties. For a list of Natural Grocers stores, visit naturalgrocers.com/store-directoryAbout Natural Grocers by Vitamin CottageNatural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is an expanding specialty retailer of natural and organic groceries, body care products and dietary supplements. The products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial colors, flavors, preservatives or sweeteners, or partially hydrogenated or hydrogenated oils. The Company sells only USDA certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers' flexible smaller-store format allows it to offer affordable prices in a shopper-friendly retail environment. The Company also provides extensive free science-based nutrition education programs to help customers make informed health and nutrition choices. The Company, founded in 1955, has 159 stores in 20 states.Follow Natural Grocers on social media viaFacebook,InstagramandTwitter. #NaturalGrocers1 Messageand data rates may apply. See naturalgrocers.com/privacy for our Privacy Policy and naturalgrocers.com/terms for the {N}Power terms of use.2 Limit 1 per {N}power number. Valid November 5 7, 2020 at participating Natural Grocers stores while supplies last: no rainchecks.3 No purchase necessary. A purchase will not increase your chance of winning. For Official Rules and complete details, visit: www.naturalgrocers.com/sweepstakes. Sponsor: Vitamin cottage Natural Food Markets, Inc.SOURCE Natural Grocers by Vitamin Cottage, Inc. Related Links www.NaturalGrocers.com
Answer: | Natural Grocers Introduces Special Post-Election Promo Sale From November 5-7 Customers can enjoy sales, prize giveaways and a free chocolate bar at their local store | LAKEWOOD, Colo., Oct. 22, 2020 /PRNewswire/ --Natural Grocers, the nation's largest family-operated natural and organic grocery retailer, announces its special Post-Election Promo running from November 5 to November 7, 2020. When shopping during the three-day sale, members of {N}power, Natural Grocers' free loyalty program, will receive a free chocolate bar and deals from around the store. Additionally, Natural Grocers is hosting a prize giveaway which includes one company-wide grand prize, and one in-store prize winner at every store. Continue Reading {N}power is free to join and offers exclusive discounts, digital coupons, rewards benefits, and other members-only features. Customers can sign up for {N}power here or by texting1 organic to 41411. Natural Grocers announces its special Post-Election Promo running from November 5 to November 7, 2020. Tweet this Post-Election Giveaways {N}power members are eligible for one free chocolate bar2during the three days and can choose their favorite flavor (while supplies last) from these popular brands: Alter Eco, Natural Grocers Brand, Chocolove, Endangered Species, or Theo Chocolate. Prize giveaways are open to all customers who can enter by filling out the sweepstakes form at their local store. A drawing among all entries will determine the winners of the following prizes3: Grand Prize: One winner, company-wide will be selected to win a $500 Natural Grocers gift card, an Oster Roaster, and a Natural Grocers cutting boardjust in time for Thanksgiving. One Prize Each Per Store: One winner per store will be selected to wina NOW diffuser and essential oil or a $25 Natural Grocers gift card. 3-Day, Post-Election Deals {N}power Members Only{N}power members will save on customer favorites of pasture-based and humanely raised bacon and bacon alternatives (Sale price $3.99; Always Affordable price: $4.15 - $7.19) and Natural Grocers Brand Organic Snack Packs (Sale Price $0.99; Always Affordable price: $1.49), which are available in 11 varieties including Organic Pistachios, Organic Whole Almonds, Organic Margaret's Mix, and Organic Pumpkin Seeds. The sale also features 20% off select self-care essentials from the Supplement and Body Care departments for de-stressing and relaxation, such as all diffusers and essential oils, Bach Rescue Remedy Spray (20ml), Pacha Soap Co. bath bombs and brews, body scrubs, and mineral soaks, Garden of Life myKind Organics Ashwagandha (60 tab), Solaray Magnesium Glycinate (120 veg), WishGarden Deep Stress Pump (2oz), and more. Check out Natural Grocers' Post-Election Promo details here.While shopping the Post-Election Promo, customers can pre-order their Thanksgiving turkey or sign up for the Turkey Call List. Earlier this month, Natural Grocers debuted its parody video titled, "Let's Talk Turkey,"an engaging, playful, and educational short video which highlights the unique benefits of each type of Mary's Free-Range Turkey and why they are a better choice than conventionally raised varieties. For a list of Natural Grocers stores, visit naturalgrocers.com/store-directoryAbout Natural Grocers by Vitamin CottageNatural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is an expanding specialty retailer of natural and organic groceries, body care products and dietary supplements. The products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial colors, flavors, preservatives or sweeteners, or partially hydrogenated or hydrogenated oils. The Company sells only USDA certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers' flexible smaller-store format allows it to offer affordable prices in a shopper-friendly retail environment. The Company also provides extensive free science-based nutrition education programs to help customers make informed health and nutrition choices. The Company, founded in 1955, has 159 stores in 20 states.Follow Natural Grocers on social media viaFacebook,InstagramandTwitter. #NaturalGrocers1 Messageand data rates may apply. See naturalgrocers.com/privacy for our Privacy Policy and naturalgrocers.com/terms for the {N}Power terms of use.2 Limit 1 per {N}power number. Valid November 5 7, 2020 at participating Natural Grocers stores while supplies last: no rainchecks.3 No purchase necessary. A purchase will not increase your chance of winning. For Official Rules and complete details, visit: www.naturalgrocers.com/sweepstakes. Sponsor: Vitamin cottage Natural Food Markets, Inc.SOURCE Natural Grocers by Vitamin Cottage, Inc. Related Links www.NaturalGrocers.com |
edtsum3078 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases with significant unmet needs, today announced that management will participate in the following virtual healthcare investor conferences: A live webcast of the presentation will be available on the Investors & Media section of Millendos website at http://investors.millendo.com. A replay of the webcast will be archived on Millendos website for 30 days following the presentation. About Millendo Therapeutics, Inc. Millendo Therapeutics is a biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need. The company is currently advancing MLE-301 for the treatment of vasomotor symptoms associated with menopause. For more information, please visit https://millendo.com/.
Answer: | Millendo Therapeutics to Participate in September Investor Conferences | ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases with significant unmet needs, today announced that management will participate in the following virtual healthcare investor conferences: A live webcast of the presentation will be available on the Investors & Media section of Millendos website at http://investors.millendo.com. A replay of the webcast will be archived on Millendos website for 30 days following the presentation. About Millendo Therapeutics, Inc. Millendo Therapeutics is a biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need. The company is currently advancing MLE-301 for the treatment of vasomotor symptoms associated with menopause. For more information, please visit https://millendo.com/. |
edtsum3082 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MILWAUKEE, Dec. 21, 2020 /PRNewswire/ -- Ademi LLP is investigating QEP Resources (NYSE:QEP)for possible breaches of fiduciary duty and other violations of the law in its transaction with Diamondback. Click here to learn how to join the action: http://ademilaw.com/case/qep-resources-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. Ademi LLP allegesQEP Resources' financial outlook is improving and yet QEP Resources shareholders will receive only 0.05 shares of Diamondback common stock for each share of QEP Resources common stock, representing an implied value to each QEP Resources stockholder of $2.29 per share based on the closing price of Diamondback common stock on December 18, 2020. The merger agreement unreasonably limits competing bids for QEP Resourcesby prohibiting solicitation of further bids, and imposing a termination penalty if QEP Resourcesaccepts a superior bid. QEP Resourcesinsiders will receive millions of dollars as part of change of control arrangements. We are investigating the conduct of QEP Resources' board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for QEP Resources. If you own QEP Resourcescommon stock and wish to obtain additional information, please contact Guri Ademi either at [emailprotected]or toll-free: 866-264-3995, or http://ademilaw.com/case/qep-resources-inc. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts Ademi LLPGuri AdemiToll Free: (866) 264-3995Fax: (414) 482-8001 SOURCE Ademi LLP Related Links http://www.ademilaw.com
Answer: | Shareholder Alert: Ademi LLP Investigates whether QEP Resources, Inc. has obtained a Fair Price in its transaction with Diamondback Energy, Inc. | MILWAUKEE, Dec. 21, 2020 /PRNewswire/ -- Ademi LLP is investigating QEP Resources (NYSE:QEP)for possible breaches of fiduciary duty and other violations of the law in its transaction with Diamondback. Click here to learn how to join the action: http://ademilaw.com/case/qep-resources-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. Ademi LLP allegesQEP Resources' financial outlook is improving and yet QEP Resources shareholders will receive only 0.05 shares of Diamondback common stock for each share of QEP Resources common stock, representing an implied value to each QEP Resources stockholder of $2.29 per share based on the closing price of Diamondback common stock on December 18, 2020. The merger agreement unreasonably limits competing bids for QEP Resourcesby prohibiting solicitation of further bids, and imposing a termination penalty if QEP Resourcesaccepts a superior bid. QEP Resourcesinsiders will receive millions of dollars as part of change of control arrangements. We are investigating the conduct of QEP Resources' board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for QEP Resources. If you own QEP Resourcescommon stock and wish to obtain additional information, please contact Guri Ademi either at [emailprotected]or toll-free: 866-264-3995, or http://ademilaw.com/case/qep-resources-inc. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts Ademi LLPGuri AdemiToll Free: (866) 264-3995Fax: (414) 482-8001 SOURCE Ademi LLP Related Links http://www.ademilaw.com |
edtsum3096 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: EXTON, Pa.--(BUSINESS WIRE)--Lungpacer Medical, Inc. today announced results from the RESCUE 2 multicenter, randomized, controlled trial presented at the European Respiratory Society (ERS) 2020 Virtual International Congress. The RESCUE 2 trial compared Lungpacer therapy plus Standard of Care (SoC) vs. SoC alone in patients who are receiving prolonged invasive mechanical ventilation (MV). RESCUE 2 demonstrated that Lungpacer therapy improves diaphragm strength by an average of 246% compared to SoC alone, as measured by improvement in Maximal Inspiratory Pressure (MIP).1 Improvement in MIP has been shown to correlate with weaning success in MV patients2,3 and is associated with lower mortality.2,4 The Lungpacer therapy group also showed a strong positive trend in proportion of MV patients weaned and reduction in average MV duration, as compared to SoC.1 While MV is a life-saving therapy, unfortunately, it comes with unwanted side effects. Ventilators use positive pressure to push air into the lungs, leaving the diaphragm unused and causing it to weaken quickly. The Lungpacer System is designed to stimulate the diaphragm during MV and strengthen the weakened muscle, so that the patient can be weaned off MV and resume natural breathing. The Lungpacer System is in the midst of clinical studies in the U.S. and Europe and has been authorized for emergency use by the FDA for patients on invasive mechanical ventilation who are at high risk of weaning failure during the COVID-19 pandemic. There are currently no FDA approved products to assist patients in weaning from mechanical ventilation. Typically to remove a patient from invasive mechanical ventilation, we have relied on spontaneous breathing trials or experience to see if the patient is ready to wean. These trials involve removing the patient from the ventilator and closely observing the patients success at breathing independently. The results of the RESCUE 2 study showed that the Lungpacer System improved MIP, an indicator of diaphragm strengthening, and also showed a positive trend for weaning success. Lungpacer therapy may, therefore, offer our ventilated patients a better chance at breathing independently again, noted Dr. Martin Dres, Respiratory and Critical Care Department, APHP, Sorbonne University. The RESCUE 2 patient population had already been on invasive MV for an average of 25.2 days, making them at high-risk for MV weaning failure and Ventilator-Induced Diaphragm Dysfunction (VIDD). The MIP improvement results, combined with reduction in average MV days, suggests that Lungpacer therapy may offer hospital ICUs another option for improving outcomes for MV patients, said Doug Evans, CEO of Lungpacer Medical, Inc. Our therapy may also allow hospitals to free up precious ICU beds and resources, enabling them to better serve their patient population, particularly during the coronavirus pandemic. The Lungpacer System is designed to fit into the routine care of mechanically ventilated patients. The System uses a catheter (LIVE Catheter), similar to the central venous catheters placed in most ventilated patients. This catheter can deliver both fluid and medications as well as stimulate the phrenic nerve to contract the diaphragm, exercising the muscle. The RESCUE 2 results also help to validate the design of the RESCUE 3 pivotal clinical trial, currently underway at multiple sites in Europe and the United States. RESCUE 3 is designed to determine statistically significant weaning success in patients treated with Lungpacer therapy plus SoC vs. SoC alone in patients who are receiving prolonged invasive mechanical ventilation. About Mechanical Ventilation and the COVID-19 Pandemic According to the World Health Organization (WHO), severe COVID-19 patients commonly suffer from severe pneumonia, sepsis and Acute Respiratory Distress Syndrome (ARDS); these patients may require 15 to 20 days of mechanical ventilation during their treatment.4 The WHO guideline for management of these patients to preserve lung function includes methods to reduce complications related to mechanical ventilation such as reducing the time on MV and decreasing the incidence of ventilator-associated pneumonia. About the Lungpacer System The Lungpacer System is a novel, first-in-class, temporary transvenous diaphragm neurostimulation system, FDA-designated as a breakthrough device, with FDA Emergency Use Authorization (EUA) during the COVID-19 pandemic. The Lungpacer System operates using the following main components: Lungpacer IntraVenous Electrode - LIVE Catheter, Lungpacer Control Unit, and Intermediate Cable. The LIVE Catheter is a minimally invasive, central venous catheter used to deliver fluids and medications and to activate the diaphragm muscle via transvenous phrenic-nerve stimulation. The Lungpacer Control Unit is a mobile, portable unit that is used with the LIVE Catheter and Intermediate Cable to provide temporary transvenous diaphragmatic neurostimulation. About the Emergency Use Authorization On April 14, 2020 the FDA authorized the emergency use of the Lungpacer Diaphragm Pacing Therapy System for patients on invasive mechanical ventilators at high risk of weaning failure, including COVID-19 patients requiring ventilation and patients being mechanically ventilated for other high-risk conditions including post-cardiac and post-thoracic surgical procedures and medical ICU patients requiring prolonged ventilation.6 Based on pre-clinical and clinical experience, FDA has concluded that the Lungpacer System may be effective at treating patients during COVID-19 by helping wean them off ventilators in healthcare settings, thereby reducing their risks of prolonged MV and increasing the availability of ventilators during the COVID-19 pandemic. The scope of the Emergency Use Authorization is limited to the use of the Lungpacer System for emergency use to assist in weaning patients determined by their healthcare provider to be at high risk of weaning failure off of ventilators in healthcare settings during the COVID-19 pandemic, for a maximum treatment duration of 30 days. For more information on the Lungpacer System, please visit: www.lungpacer.com EMERGENCY USE INDICATION: The Lungpacer DPTS has been authorized for emergency use in healthcare settings for treatment of patients on invasive mechanical ventilation who are at high risk of weaning failure, including COVID-19 patients, during the COVID-19 pandemic. The Lungpacer DPTS may improve inspiratory muscle strength and weaning success in patients ages 18 years or older who have failed to wean from mechanical ventilation. IMPORTANT SAFETY AND EFFECTIVENESS INFORMATION: There are no FDA approved, licensed, or cleared device treatments to assist in weaning patients off of ventilators. Based on bench testing and reported clinical experience, FDA has concluded that the Lungpacer DPTS may be effective at treating patients during COVID-19 by helping wean patients off ventilators in healthcare settings, thereby reducing their risks of prolonged mechanical ventilation and increasing the availability of ventilators during the COVID-19 pandemic. Lungpacer DPTS treatment is for a maximum of 30 days. Device-related serious adverse events reported in clinical trials were single events of pneumothorax and mucus plug liberation. The LIVE Catheter component of the Lungpacer system has not been evaluated for safety when used with cardiac pacemakers or defibrillators and should be removed prior to Magnetic Resonance (MR) imaging. Do not place the LIVE catheter into or allow it to remain in the right atrium or right ventricle. Emergency Use Instructions for Use, Fact Sheet for Healthcare Providers, and Fact Sheet for Patients are available at: http://lungpacer.com/emergency-use-authorization/ The Lungpacer DPTS is available under an Emergency Use Authorization for the duration of the COVID-19 pandemic. For more information visit https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations. EMERGENCY USE AUTHORIZATION INFORMATION: This Diaphragmatic Pacing Stimulator has not been FDA cleared or approved. This Diaphragmatic Pacing Stimulator has been authorized by FDA under an Emergency Use Authorization (EUA). This Diaphragmatic Pacing Stimulator is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of Diaphragmatic Pacing Stimulator Systems under section 564(b)(1) of the Act, 21 U.S.C. 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Lungpacer, Weaning Solution, Lungpacer DPT System, Lungpacer DPT, LIVE Catheter are registered trademarks of Lungpacer Medical. Copyright 2020. All rights reserved. MKT-0000, RevA 082020
Answer: | Improvements in Multiple Respiratory Measures Reported in Multicenter, Randomized Controlled Trial Using the Lungpacer System Novel Diaphragm Stimulation Therapy Helps to Wean Patients at High Risk of Weaning Failure from Prolonged Invasive Mechanical Ventilation | EXTON, Pa.--(BUSINESS WIRE)--Lungpacer Medical, Inc. today announced results from the RESCUE 2 multicenter, randomized, controlled trial presented at the European Respiratory Society (ERS) 2020 Virtual International Congress. The RESCUE 2 trial compared Lungpacer therapy plus Standard of Care (SoC) vs. SoC alone in patients who are receiving prolonged invasive mechanical ventilation (MV). RESCUE 2 demonstrated that Lungpacer therapy improves diaphragm strength by an average of 246% compared to SoC alone, as measured by improvement in Maximal Inspiratory Pressure (MIP).1 Improvement in MIP has been shown to correlate with weaning success in MV patients2,3 and is associated with lower mortality.2,4 The Lungpacer therapy group also showed a strong positive trend in proportion of MV patients weaned and reduction in average MV duration, as compared to SoC.1 While MV is a life-saving therapy, unfortunately, it comes with unwanted side effects. Ventilators use positive pressure to push air into the lungs, leaving the diaphragm unused and causing it to weaken quickly. The Lungpacer System is designed to stimulate the diaphragm during MV and strengthen the weakened muscle, so that the patient can be weaned off MV and resume natural breathing. The Lungpacer System is in the midst of clinical studies in the U.S. and Europe and has been authorized for emergency use by the FDA for patients on invasive mechanical ventilation who are at high risk of weaning failure during the COVID-19 pandemic. There are currently no FDA approved products to assist patients in weaning from mechanical ventilation. Typically to remove a patient from invasive mechanical ventilation, we have relied on spontaneous breathing trials or experience to see if the patient is ready to wean. These trials involve removing the patient from the ventilator and closely observing the patients success at breathing independently. The results of the RESCUE 2 study showed that the Lungpacer System improved MIP, an indicator of diaphragm strengthening, and also showed a positive trend for weaning success. Lungpacer therapy may, therefore, offer our ventilated patients a better chance at breathing independently again, noted Dr. Martin Dres, Respiratory and Critical Care Department, APHP, Sorbonne University. The RESCUE 2 patient population had already been on invasive MV for an average of 25.2 days, making them at high-risk for MV weaning failure and Ventilator-Induced Diaphragm Dysfunction (VIDD). The MIP improvement results, combined with reduction in average MV days, suggests that Lungpacer therapy may offer hospital ICUs another option for improving outcomes for MV patients, said Doug Evans, CEO of Lungpacer Medical, Inc. Our therapy may also allow hospitals to free up precious ICU beds and resources, enabling them to better serve their patient population, particularly during the coronavirus pandemic. The Lungpacer System is designed to fit into the routine care of mechanically ventilated patients. The System uses a catheter (LIVE Catheter), similar to the central venous catheters placed in most ventilated patients. This catheter can deliver both fluid and medications as well as stimulate the phrenic nerve to contract the diaphragm, exercising the muscle. The RESCUE 2 results also help to validate the design of the RESCUE 3 pivotal clinical trial, currently underway at multiple sites in Europe and the United States. RESCUE 3 is designed to determine statistically significant weaning success in patients treated with Lungpacer therapy plus SoC vs. SoC alone in patients who are receiving prolonged invasive mechanical ventilation. About Mechanical Ventilation and the COVID-19 Pandemic According to the World Health Organization (WHO), severe COVID-19 patients commonly suffer from severe pneumonia, sepsis and Acute Respiratory Distress Syndrome (ARDS); these patients may require 15 to 20 days of mechanical ventilation during their treatment.4 The WHO guideline for management of these patients to preserve lung function includes methods to reduce complications related to mechanical ventilation such as reducing the time on MV and decreasing the incidence of ventilator-associated pneumonia. About the Lungpacer System The Lungpacer System is a novel, first-in-class, temporary transvenous diaphragm neurostimulation system, FDA-designated as a breakthrough device, with FDA Emergency Use Authorization (EUA) during the COVID-19 pandemic. The Lungpacer System operates using the following main components: Lungpacer IntraVenous Electrode - LIVE Catheter, Lungpacer Control Unit, and Intermediate Cable. The LIVE Catheter is a minimally invasive, central venous catheter used to deliver fluids and medications and to activate the diaphragm muscle via transvenous phrenic-nerve stimulation. The Lungpacer Control Unit is a mobile, portable unit that is used with the LIVE Catheter and Intermediate Cable to provide temporary transvenous diaphragmatic neurostimulation. About the Emergency Use Authorization On April 14, 2020 the FDA authorized the emergency use of the Lungpacer Diaphragm Pacing Therapy System for patients on invasive mechanical ventilators at high risk of weaning failure, including COVID-19 patients requiring ventilation and patients being mechanically ventilated for other high-risk conditions including post-cardiac and post-thoracic surgical procedures and medical ICU patients requiring prolonged ventilation.6 Based on pre-clinical and clinical experience, FDA has concluded that the Lungpacer System may be effective at treating patients during COVID-19 by helping wean them off ventilators in healthcare settings, thereby reducing their risks of prolonged MV and increasing the availability of ventilators during the COVID-19 pandemic. The scope of the Emergency Use Authorization is limited to the use of the Lungpacer System for emergency use to assist in weaning patients determined by their healthcare provider to be at high risk of weaning failure off of ventilators in healthcare settings during the COVID-19 pandemic, for a maximum treatment duration of 30 days. For more information on the Lungpacer System, please visit: www.lungpacer.com EMERGENCY USE INDICATION: The Lungpacer DPTS has been authorized for emergency use in healthcare settings for treatment of patients on invasive mechanical ventilation who are at high risk of weaning failure, including COVID-19 patients, during the COVID-19 pandemic. The Lungpacer DPTS may improve inspiratory muscle strength and weaning success in patients ages 18 years or older who have failed to wean from mechanical ventilation. IMPORTANT SAFETY AND EFFECTIVENESS INFORMATION: There are no FDA approved, licensed, or cleared device treatments to assist in weaning patients off of ventilators. Based on bench testing and reported clinical experience, FDA has concluded that the Lungpacer DPTS may be effective at treating patients during COVID-19 by helping wean patients off ventilators in healthcare settings, thereby reducing their risks of prolonged mechanical ventilation and increasing the availability of ventilators during the COVID-19 pandemic. Lungpacer DPTS treatment is for a maximum of 30 days. Device-related serious adverse events reported in clinical trials were single events of pneumothorax and mucus plug liberation. The LIVE Catheter component of the Lungpacer system has not been evaluated for safety when used with cardiac pacemakers or defibrillators and should be removed prior to Magnetic Resonance (MR) imaging. Do not place the LIVE catheter into or allow it to remain in the right atrium or right ventricle. Emergency Use Instructions for Use, Fact Sheet for Healthcare Providers, and Fact Sheet for Patients are available at: http://lungpacer.com/emergency-use-authorization/ The Lungpacer DPTS is available under an Emergency Use Authorization for the duration of the COVID-19 pandemic. For more information visit https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations. EMERGENCY USE AUTHORIZATION INFORMATION: This Diaphragmatic Pacing Stimulator has not been FDA cleared or approved. This Diaphragmatic Pacing Stimulator has been authorized by FDA under an Emergency Use Authorization (EUA). This Diaphragmatic Pacing Stimulator is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of Diaphragmatic Pacing Stimulator Systems under section 564(b)(1) of the Act, 21 U.S.C. 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Lungpacer, Weaning Solution, Lungpacer DPT System, Lungpacer DPT, LIVE Catheter are registered trademarks of Lungpacer Medical. Copyright 2020. All rights reserved. MKT-0000, RevA 082020 |
edtsum3103 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WASHINGTON, June 23, 2020 /PRNewswire/ -- TheAmerican Medical Association, American Pharmacists Association, and American Society of Health-System PharmacistsappreciatestheFood and Drug Administration's (FDA's)continuing efforts to review and advise the nation on the safe andeffective use ofhydroxychloroquine,chloroquine,and other medicationsto prevent and treatcoronavirus.We recognize the body of evidence for addressing the COVID-19 global pandemic is evolving rapidly, requiring vigilant yet timely decision making. We emphasize thatthe FDA's recentannouncement to cancel theemergency use authorizations forhydroxychloroquineand chloroquinefor certain hospitalized patients with COVID-19does not apply toother evidence-based usesof these medicationsforconditionssuch asrheumatoid arthritis and lupus.Our organizationscontinue to advocatefor medication-use policies that ensure patients who need hydroxychloroquine and chloroquine do not face unintended barriers to evidence-based care. We encourage patients and healthcare providers to consult theFDA's Frequently Asked Questions on the Revocation of the EUA for Hydroxychloroquine and Chloroquine Phosphate, andCOVID-19 related information and resources available from our three organizations. AMA COVID-19 Resource Center for PhysiciansAPhA COVID-19 Resource CenterASHP COVID-19 Resource Center About the AMAThe American Medical Association is the powerful ally and unifying voice for America's physicians, the patients they serve, and the promise of a healthier nation. The AMA attacks the dysfunction in health care by removing obstacles and burdens that interfere with patient care. It reimagines medical education, training, and lifelong learning for the digital age to help physicians grow at every stage of their careers, and it improves the health of the nation by confronting the increasing chronic disease burden. For more information, visit ama-assn.org. About the APhAThe American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, is a 501 (c)(6) organization, representing 60,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession. APhA is dedicated to helping all pharmacists improve medication use and advance patient care and is the first and largest association of pharmacists in the United States. For more information, please visit www.pharmacist.com. About the ASHPASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization's nearly 55,000 members include pharmacists, student pharmacists, and pharmacy technicians. For more than 75 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists advance healthcare, visit ASHP's website, ashp.org, or its consumer website, SafeMedication.com. SOURCE American Pharmacists Association Related Links http://www.pharmacist.com
Answer: | Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on new FDA action to Remove Emergency Use Authorization of Medications to Treat COVID-19 | WASHINGTON, June 23, 2020 /PRNewswire/ -- TheAmerican Medical Association, American Pharmacists Association, and American Society of Health-System PharmacistsappreciatestheFood and Drug Administration's (FDA's)continuing efforts to review and advise the nation on the safe andeffective use ofhydroxychloroquine,chloroquine,and other medicationsto prevent and treatcoronavirus.We recognize the body of evidence for addressing the COVID-19 global pandemic is evolving rapidly, requiring vigilant yet timely decision making. We emphasize thatthe FDA's recentannouncement to cancel theemergency use authorizations forhydroxychloroquineand chloroquinefor certain hospitalized patients with COVID-19does not apply toother evidence-based usesof these medicationsforconditionssuch asrheumatoid arthritis and lupus.Our organizationscontinue to advocatefor medication-use policies that ensure patients who need hydroxychloroquine and chloroquine do not face unintended barriers to evidence-based care. We encourage patients and healthcare providers to consult theFDA's Frequently Asked Questions on the Revocation of the EUA for Hydroxychloroquine and Chloroquine Phosphate, andCOVID-19 related information and resources available from our three organizations. AMA COVID-19 Resource Center for PhysiciansAPhA COVID-19 Resource CenterASHP COVID-19 Resource Center About the AMAThe American Medical Association is the powerful ally and unifying voice for America's physicians, the patients they serve, and the promise of a healthier nation. The AMA attacks the dysfunction in health care by removing obstacles and burdens that interfere with patient care. It reimagines medical education, training, and lifelong learning for the digital age to help physicians grow at every stage of their careers, and it improves the health of the nation by confronting the increasing chronic disease burden. For more information, visit ama-assn.org. About the APhAThe American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, is a 501 (c)(6) organization, representing 60,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession. APhA is dedicated to helping all pharmacists improve medication use and advance patient care and is the first and largest association of pharmacists in the United States. For more information, please visit www.pharmacist.com. About the ASHPASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization's nearly 55,000 members include pharmacists, student pharmacists, and pharmacy technicians. For more than 75 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists advance healthcare, visit ASHP's website, ashp.org, or its consumer website, SafeMedication.com. SOURCE American Pharmacists Association Related Links http://www.pharmacist.com |
edtsum3109 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO--(BUSINESS WIRE)--Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced that it intends to offer, subject to market conditions and other factors, $750 million aggregate principal amount of convertible senior notes due 2026 (the notes) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act). Zynga also intends to grant the initial purchasers of the notes a 13-day option to purchase up to an additional $112.5 million aggregate principal amount of the notes. The notes will be senior unsecured obligations of Zynga and will accrue interest payable semiannually in arrears. The notes will be convertible into cash, shares of Zyngas Class A common stock (common stock) or a combination of cash and shares of Zyngas common stock, at Zyngas election. The interest rate, initial conversion rate and other terms of the notes will be determined at the time of pricing of the offering. Zynga intends to use a portion of the net proceeds from the offering to pay the cost of the capped call transactions described below. Zynga intends to use the remainder of the net proceeds for working capital and other general corporate purposes, which may include potential acquisitions, capital expenditures, the repayment of debt, and future transactions. However, it has not designated any specific uses and has no current agreements with respect to any material acquisition or strategic transaction. In connection with the pricing of the notes, Zynga expects to enter into capped call transactions with respect to the notes with one or more of the initial purchasers of the notes and/or their respective affiliates and/or other financial institutions (the option counterparties). The capped call transactions are expected generally to reduce potential dilution to Zyngas common stock upon any conversion of the notes and/or offset any cash payments Zynga is required to make in excess of the principal amount of converted notes, with such reduction and/or offset subject to a cap. If the initial purchasers of the notes exercise their option to purchase additional notes, Zynga expects to enter into additional capped call transactions with the option counterparties. Zynga expects that, in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates may enter into various derivative transactions with respect to Zyngas common stock and/or purchase shares of Zyngas common stock concurrently with or shortly after the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Zyngas common stock or the notes at that time. In addition, Zynga expects that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Zyngas common stock and/or purchasing or selling Zyngas common stock or other securities of Zynga in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so on each exercise date for the capped call transactions, which are expected to occur on each trading day during the 25 trading day period beginning on the 26th scheduled trading date prior to the maturity date of the notes, or following any termination of any portion of the capped call transactions in connection with any repurchase, redemption or early conversion of the notes). This activity could also cause a decrease or prevent an increase in the market price of Zyngas common stock or the notes, and to the extent the activity occurs during any observation period related to a conversion of such notes, this could affect the value of the consideration that a noteholder will receive upon conversion of such notes. Neither the notes, nor any shares of Zyngas common stock potentially issuable upon conversion of such notes, have been, nor will be, registered under the Securities Act or any state securities laws and, unless so registered, such securities may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws. This press release is neither an offer to sell nor a solicitation of an offer to buy any securities, nor shall it constitute an offer, solicitation or sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
Answer: | Zynga Inc. Announces Proposed Private Offering of $750 Million of Convertible Senior Notes | SAN FRANCISCO--(BUSINESS WIRE)--Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced that it intends to offer, subject to market conditions and other factors, $750 million aggregate principal amount of convertible senior notes due 2026 (the notes) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act). Zynga also intends to grant the initial purchasers of the notes a 13-day option to purchase up to an additional $112.5 million aggregate principal amount of the notes. The notes will be senior unsecured obligations of Zynga and will accrue interest payable semiannually in arrears. The notes will be convertible into cash, shares of Zyngas Class A common stock (common stock) or a combination of cash and shares of Zyngas common stock, at Zyngas election. The interest rate, initial conversion rate and other terms of the notes will be determined at the time of pricing of the offering. Zynga intends to use a portion of the net proceeds from the offering to pay the cost of the capped call transactions described below. Zynga intends to use the remainder of the net proceeds for working capital and other general corporate purposes, which may include potential acquisitions, capital expenditures, the repayment of debt, and future transactions. However, it has not designated any specific uses and has no current agreements with respect to any material acquisition or strategic transaction. In connection with the pricing of the notes, Zynga expects to enter into capped call transactions with respect to the notes with one or more of the initial purchasers of the notes and/or their respective affiliates and/or other financial institutions (the option counterparties). The capped call transactions are expected generally to reduce potential dilution to Zyngas common stock upon any conversion of the notes and/or offset any cash payments Zynga is required to make in excess of the principal amount of converted notes, with such reduction and/or offset subject to a cap. If the initial purchasers of the notes exercise their option to purchase additional notes, Zynga expects to enter into additional capped call transactions with the option counterparties. Zynga expects that, in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates may enter into various derivative transactions with respect to Zyngas common stock and/or purchase shares of Zyngas common stock concurrently with or shortly after the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Zyngas common stock or the notes at that time. In addition, Zynga expects that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Zyngas common stock and/or purchasing or selling Zyngas common stock or other securities of Zynga in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so on each exercise date for the capped call transactions, which are expected to occur on each trading day during the 25 trading day period beginning on the 26th scheduled trading date prior to the maturity date of the notes, or following any termination of any portion of the capped call transactions in connection with any repurchase, redemption or early conversion of the notes). This activity could also cause a decrease or prevent an increase in the market price of Zyngas common stock or the notes, and to the extent the activity occurs during any observation period related to a conversion of such notes, this could affect the value of the consideration that a noteholder will receive upon conversion of such notes. Neither the notes, nor any shares of Zyngas common stock potentially issuable upon conversion of such notes, have been, nor will be, registered under the Securities Act or any state securities laws and, unless so registered, such securities may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws. This press release is neither an offer to sell nor a solicitation of an offer to buy any securities, nor shall it constitute an offer, solicitation or sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. |
edtsum3119 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MILWAUKEE, Dec. 1, 2020 /PRNewswire/ --The costly treatment associated with childhood cancer can lead to long-term financial challenges, including questions of how to afford higher education. Northwestern Mutual is committed to helping children and families affected by this disease achieve their college dreams. The company, through its Foundation, today announced the 2020 Childhood Cancer Survivor and Sibling Scholarship program recipients and opened its application process for the 2021 program. "Families impacted by childhood cancer are facing even greater financial and emotional challenges due to the COVID-19 pandemic," said Eric Christophersen, president, Northwestern Mutual Foundation. "We believe these factors shouldn't stand in the way of college dreams. Now, more than ever, Northwestern Mutual is proud to support students who have overcome childhood cancer challenges as they pursue higher education." The scholarship program was developed to alleviate the financial strain on families that often results from expensive cancer treatments by helping to fund school tuition and fees. Forty-three students, the largest cohort to date, have each been awarded a $5,000 renewable scholarship (for a total of $10,000) through this year's program. Each recipient has been affected by childhood cancer, either as a survivor or sibling. The complete list of 2020 Childhood Cancer Survivor and Sibling Scholarship recipients is included below. 2020 Survivor Scholarship Recipients Name/State School Abigail Davis; Indiana Lipscomb University Abigail Pribisova; New Mexico University of New Mexico Adam Gregg; Washington University of Oregon Andrew Felsted; Utah Brigham Young University Idaho Ava Mortier; California Barnard College Danica Nolton; Iowa Luther College Daniel Krekoska; Connecticut Providence College David Kotter; Utah Brigham Young University Elizabeth Kuhlmann; Wisconsin University of Wisconsin Milwaukee Griffin Rost; California Utah Valley University Hailey Combs; Kentucky University of Kentucky Harry Heiberger; Massachusetts Massachusetts Institute of Technology Jocelyn Shipman; Nebraska University of Nebraska at Kearney Johnny Kirkpatrick; Kentucky University of Kentucky Kaitlin Gartrell; Oregon Pepperdine University Kate Pierson; Utah Brigham Young University Idaho Kimberly Peacock; Montana University of Montana Maeve Smart; New York Northeastern University Michelle Dong; Ohio Cornell University Raquel Baskin; Pennsylvania Penn State University Rhea Jansen; Washington Gonzaga University Samantha Smith; Ohio Cleveland State University Sana Moezzi; California University of San Diego Thomas Horst; Idaho Grand Canyon University Wacim Benyoucef; Colorado University of Colorado Boulder 2020 Sibling Scholarship Recipients Annie Voss; Wisconsin St. Catherine University Audrey Sylvester; Illinois University of Minnesota Twin Cities Conrad Gregg; Washington University of Oregon Ethan Salmeron; California Loyola Marymount University Hannah Bhar; Arizona Northland Pioneer College Hannah Shell; New York Harvard University Joshua Amato; Ohio Shawnee State University Kaelynn Chandler; Idaho Brigham Young University Idaho Kristen Caldwell; Maine George Washington University Lauren Witt; Kentucky University of Kentucky Levi Hancock; Ohio Brigham Young University Madeline Kling; Colorado Colorado State University Maria Gregg; Washington Santa Clara University Nick Shininger; Wisconsin University of Wisconsin Whitewater Preston Gunter; Wyoming Bridgerland Applied Technology College Sarah McKenna; Washington Pepperdine University Shaddi Abdala; Florida Embry-Riddle Aeronautical University Trent Kingsbury; South Dakota University of South Dakota Applications forthe 2021scholarshipprogramareopen nowthroughFeb.1, 2021. SelectionresultsareexpectedbyMay2021. Tolearn more and apply, visit: https://learnmore.scholarsapply.org/nmsurvivors/ https://learnmore.scholarsapply.org/nmsibling/ To date, Northwestern Mutual has supported 113 scholars and contributed more than $900,000 through its Childhood Cancer Scholarship Program. The program is administered through Scholarship America, an organization dedicated to developing scholarship solutions for student success. This year, Northwestern Mutual donated $300,000 to support the rapidly changing needs of families battling childhood cancer. Funding assisted families with essential grocery and travel expenses, in addition to bringing virtual childhood cancer camps to kids nationwide. Since 2012, Northwestern Mutual's Childhood Cancer Program has focused on advancing childhood cancer research, providing family and patient support and serving as a resource to families managing the long-term effects of cancer treatment. With the support of Northwestern Mutual employees and financial advisors nationwide, the company has contributed more than $30 million and funded over 400,000 hours of research through the program. About Northwestern Mutual FoundationThe mission of the Northwestern Mutual Foundation is to improve the lives of children and families in need. The Foundation has given more than $386 million since its inception in 1992 and is designed to create lasting impact in the communities where the company's employees and financial representatives live and work. We accomplish this by combining financial support, volunteerism, thought leadership and convening community partners to deliver the best outcomes. Our efforts are focused nationally on curing childhood cancer, and locally on education, neighborhoods and making our hometown of Milwaukee a great destination. Visit Northwestern Mutual Foundationto learn more. About Northwestern MutualNorthwestern Mutualhas been helping people and businesses achieve financial security for more than 160 years. Through a holistic planning approach, Northwestern Mutual combines the expertise of its financial professionals with a personalized digital experience and industry-leading products to help its clients plan for what's most important. With $290.3 billion in total assets, $29.9 billion in revenues, and $1.9 trillion worth of life insurance protection in force, Northwestern Mutual delivers financial security to more than 4.6 million people with life, disability income and long-term care insurance, annuities, and brokerage and advisory services. The company manages more than $161 billion of investments owned by its clients and held or managed through its wealth management and investment services businesses. Northwestern Mutual ranks 102 on the 2020 FORTUNE 500 and is recognized by FORTUNE as one of the "World's Most Admired" life insurance companies in 2020. Northwestern Mutual is the marketing name for The Northwestern Mutual Life Insurance Company (NM)(life and disability insurance, annuities, and life insurance with long-term care benefits) and its subsidiaries in Milwaukee, WI. Subsidiaries include Northwestern Mutual Investment Services, LLC (investment brokerage services), broker-dealer, registered investment adviser, member FINRA and SIPC; the Northwestern Mutual Wealth Management Company (investment advisory and trust services), a federal savings bank; and Northwestern Long Term Care Insurance Company. SOURCE Northwestern Mutual
Answer: | Northwestern Mutual Dedicates More Than $400,000 to Childhood Cancer Survivors and Siblings Through Annual Scholarship Program Company awards scholarships for largest cohort to date, opens applications for 2021 | MILWAUKEE, Dec. 1, 2020 /PRNewswire/ --The costly treatment associated with childhood cancer can lead to long-term financial challenges, including questions of how to afford higher education. Northwestern Mutual is committed to helping children and families affected by this disease achieve their college dreams. The company, through its Foundation, today announced the 2020 Childhood Cancer Survivor and Sibling Scholarship program recipients and opened its application process for the 2021 program. "Families impacted by childhood cancer are facing even greater financial and emotional challenges due to the COVID-19 pandemic," said Eric Christophersen, president, Northwestern Mutual Foundation. "We believe these factors shouldn't stand in the way of college dreams. Now, more than ever, Northwestern Mutual is proud to support students who have overcome childhood cancer challenges as they pursue higher education." The scholarship program was developed to alleviate the financial strain on families that often results from expensive cancer treatments by helping to fund school tuition and fees. Forty-three students, the largest cohort to date, have each been awarded a $5,000 renewable scholarship (for a total of $10,000) through this year's program. Each recipient has been affected by childhood cancer, either as a survivor or sibling. The complete list of 2020 Childhood Cancer Survivor and Sibling Scholarship recipients is included below. 2020 Survivor Scholarship Recipients Name/State School Abigail Davis; Indiana Lipscomb University Abigail Pribisova; New Mexico University of New Mexico Adam Gregg; Washington University of Oregon Andrew Felsted; Utah Brigham Young University Idaho Ava Mortier; California Barnard College Danica Nolton; Iowa Luther College Daniel Krekoska; Connecticut Providence College David Kotter; Utah Brigham Young University Elizabeth Kuhlmann; Wisconsin University of Wisconsin Milwaukee Griffin Rost; California Utah Valley University Hailey Combs; Kentucky University of Kentucky Harry Heiberger; Massachusetts Massachusetts Institute of Technology Jocelyn Shipman; Nebraska University of Nebraska at Kearney Johnny Kirkpatrick; Kentucky University of Kentucky Kaitlin Gartrell; Oregon Pepperdine University Kate Pierson; Utah Brigham Young University Idaho Kimberly Peacock; Montana University of Montana Maeve Smart; New York Northeastern University Michelle Dong; Ohio Cornell University Raquel Baskin; Pennsylvania Penn State University Rhea Jansen; Washington Gonzaga University Samantha Smith; Ohio Cleveland State University Sana Moezzi; California University of San Diego Thomas Horst; Idaho Grand Canyon University Wacim Benyoucef; Colorado University of Colorado Boulder 2020 Sibling Scholarship Recipients Annie Voss; Wisconsin St. Catherine University Audrey Sylvester; Illinois University of Minnesota Twin Cities Conrad Gregg; Washington University of Oregon Ethan Salmeron; California Loyola Marymount University Hannah Bhar; Arizona Northland Pioneer College Hannah Shell; New York Harvard University Joshua Amato; Ohio Shawnee State University Kaelynn Chandler; Idaho Brigham Young University Idaho Kristen Caldwell; Maine George Washington University Lauren Witt; Kentucky University of Kentucky Levi Hancock; Ohio Brigham Young University Madeline Kling; Colorado Colorado State University Maria Gregg; Washington Santa Clara University Nick Shininger; Wisconsin University of Wisconsin Whitewater Preston Gunter; Wyoming Bridgerland Applied Technology College Sarah McKenna; Washington Pepperdine University Shaddi Abdala; Florida Embry-Riddle Aeronautical University Trent Kingsbury; South Dakota University of South Dakota Applications forthe 2021scholarshipprogramareopen nowthroughFeb.1, 2021. SelectionresultsareexpectedbyMay2021. Tolearn more and apply, visit: https://learnmore.scholarsapply.org/nmsurvivors/ https://learnmore.scholarsapply.org/nmsibling/ To date, Northwestern Mutual has supported 113 scholars and contributed more than $900,000 through its Childhood Cancer Scholarship Program. The program is administered through Scholarship America, an organization dedicated to developing scholarship solutions for student success. This year, Northwestern Mutual donated $300,000 to support the rapidly changing needs of families battling childhood cancer. Funding assisted families with essential grocery and travel expenses, in addition to bringing virtual childhood cancer camps to kids nationwide. Since 2012, Northwestern Mutual's Childhood Cancer Program has focused on advancing childhood cancer research, providing family and patient support and serving as a resource to families managing the long-term effects of cancer treatment. With the support of Northwestern Mutual employees and financial advisors nationwide, the company has contributed more than $30 million and funded over 400,000 hours of research through the program. About Northwestern Mutual FoundationThe mission of the Northwestern Mutual Foundation is to improve the lives of children and families in need. The Foundation has given more than $386 million since its inception in 1992 and is designed to create lasting impact in the communities where the company's employees and financial representatives live and work. We accomplish this by combining financial support, volunteerism, thought leadership and convening community partners to deliver the best outcomes. Our efforts are focused nationally on curing childhood cancer, and locally on education, neighborhoods and making our hometown of Milwaukee a great destination. Visit Northwestern Mutual Foundationto learn more. About Northwestern MutualNorthwestern Mutualhas been helping people and businesses achieve financial security for more than 160 years. Through a holistic planning approach, Northwestern Mutual combines the expertise of its financial professionals with a personalized digital experience and industry-leading products to help its clients plan for what's most important. With $290.3 billion in total assets, $29.9 billion in revenues, and $1.9 trillion worth of life insurance protection in force, Northwestern Mutual delivers financial security to more than 4.6 million people with life, disability income and long-term care insurance, annuities, and brokerage and advisory services. The company manages more than $161 billion of investments owned by its clients and held or managed through its wealth management and investment services businesses. Northwestern Mutual ranks 102 on the 2020 FORTUNE 500 and is recognized by FORTUNE as one of the "World's Most Admired" life insurance companies in 2020. Northwestern Mutual is the marketing name for The Northwestern Mutual Life Insurance Company (NM)(life and disability insurance, annuities, and life insurance with long-term care benefits) and its subsidiaries in Milwaukee, WI. Subsidiaries include Northwestern Mutual Investment Services, LLC (investment brokerage services), broker-dealer, registered investment adviser, member FINRA and SIPC; the Northwestern Mutual Wealth Management Company (investment advisory and trust services), a federal savings bank; and Northwestern Long Term Care Insurance Company. SOURCE Northwestern Mutual |
edtsum3131 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the common stock of Wrap Technologies, Inc (Wrap or the Company) (NASDAQ: WRTC) between July 31, 2020, and September 23, 2020 (the Class Period). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934. If you purchased Wrap securities, and/or would like to discuss your legal rights and options please visit Wrap Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]. The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations and prospects. Specifically, Defendants misrepresented and/or failed to disclose to investors that:(1) the Company had concealed the results of the LAPD BolaWrap pilot program, which demonstrated that the BolaWrap was ineffective, expensive, and sparingly used in the field; and (2) as a result, Defendants public statements were materially false and/or misleading at all relevant times. On September 23, 2020, White Diamond Research published a report entitled Wrap Technologies: Disastrous LAPD BolaWrap Pilot Program Results, No Evidence These Have Been Communicated To Investors alleging, among other things, that the Companys trial pilot program with the LAPD was a disaster, and that the Company had not disclosed the results to investors. On this news, securities of Wrap fell $2.07 per share, or 25.43% to close at $6.07 per share on September 23, 2020. If you wish to serve as lead plaintiff, you must move the Court no later than November 23, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesnt require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member. If you purchased Wrap securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/wraptechnologiesinc-wrtc-shareholder-class-action-lawsuit-stock-fraud-314/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]. Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journals Plaintiffs Hot List thirteen times and listed in The Legal 500 for ten consecutive years. ATTORNEY ADVERTISING. 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Answer: | WRTC INVESTOR ALERT: Bernstein Liebhard Announces that a Securities Class Action Lawsuit has been Filed Against Wrap Technologies Inc. | NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the common stock of Wrap Technologies, Inc (Wrap or the Company) (NASDAQ: WRTC) between July 31, 2020, and September 23, 2020 (the Class Period). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934. If you purchased Wrap securities, and/or would like to discuss your legal rights and options please visit Wrap Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]. The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations and prospects. Specifically, Defendants misrepresented and/or failed to disclose to investors that:(1) the Company had concealed the results of the LAPD BolaWrap pilot program, which demonstrated that the BolaWrap was ineffective, expensive, and sparingly used in the field; and (2) as a result, Defendants public statements were materially false and/or misleading at all relevant times. On September 23, 2020, White Diamond Research published a report entitled Wrap Technologies: Disastrous LAPD BolaWrap Pilot Program Results, No Evidence These Have Been Communicated To Investors alleging, among other things, that the Companys trial pilot program with the LAPD was a disaster, and that the Company had not disclosed the results to investors. On this news, securities of Wrap fell $2.07 per share, or 25.43% to close at $6.07 per share on September 23, 2020. If you wish to serve as lead plaintiff, you must move the Court no later than November 23, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesnt require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member. If you purchased Wrap securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/wraptechnologiesinc-wrtc-shareholder-class-action-lawsuit-stock-fraud-314/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]. Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journals Plaintiffs Hot List thirteen times and listed in The Legal 500 for ten consecutive years. ATTORNEY ADVERTISING. 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter. |
edtsum3132 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SILVER SPRING, Md., Nov. 17, 2020 /PRNewswire/ -- Did you know November is National Diabetes Month? The U.S. Food and Drug Administration (FDA) reminds people with diabetes (and those preparing food for them) about the importance of safe food handling in preventing foodborne illness.Learn how to safely choose and prepare foods for people with diabetes in this free booklet:Food Safety for Older Adults and People with Cancer, Diabetes, HIV/AIDS, Organ Transplants, and Autoimmune Diseases. (PRNewsfoto/U.S. FDA) Practicing food safety is important for everyone, but especially for people living with diabetes. They are more likely to get sick from bacteria that cause foodborne illness (often called "food poisoning"), and are more likely to be sicker for longer, be hospitalized, or even die. This increased risk is why food choices and safe food handling are so important in managing this chronic disease. Make Wise Food ChoicesSome foods are riskier for people with diabetes because they are more likely to contain harmful bacteria or viruses. In general, these foods fall into two categories: Uncooked fresh fruits and vegetables. Some animal products, such as unpasteurized (raw) milk; soft cheeses made with raw milk; raw or undercooked eggs, meat, poultry, fish and shellfish; luncheon meats; improperly reheated hot dogs; and salads containing animal products such as seafood, ham, or chicken that are prepared outside the home. Follow the Four Steps to Food SafetyAnyone who is diabetic or who prepares food for people with diabetes should also carefully follow these steps: CLEAN: Wash hands and surfaces often. Bacteria can be spread throughout the kitchen and get onto hands, cutting boards, utensils, counter tops, and food. SEPARATE: Keep raw meat, poultry, eggs, and seafood and their juices away from ready-to-eat foods. COOK to the right temperatures. Use a food thermometer to make sure meat, poultry, seafood, and egg products are cooked to a safe minimum internal temperature to destroy any harmful bacteria. (See Safe Minimal Internal Temperatures charts.) Follow cooking instructions on packaged foods such as frozen vegetables. CHILL foods promptly. Cold temperatures slow the growth of harmful bacteria. Use an appliance thermometer to be sure the refrigerator temperature is 40 degrees F or below and the freezer temperature is 0 degrees F or below. Know the SymptomsDangerous foodborne bacteria will usually cause illness within 1 to 3 days. However, sickness can also happen within 20 minutes or up to 6 weeks later. Symptoms of foodborne illness include: vomiting, diarrhea, abdominal pain, and flu-like symptoms (such as fever, headache, and body ache).Take ActionIf you think you or a family member has a foodborne illness, contact your healthcare provider immediately. Also, report the suspected foodborne illness to FDA in either of these ways: Contact the Consumer Complaint Coordinator in your area. Locate a coordinator here: http://www.fda.gov/Safety/ReportaProblem/ConsumerComplaintCoordinators Contact MedWatch, FDA's Safety Information and Adverse Event Reporting Program: By Phone: 1-800-FDA-1088 Online: File a voluntary report at http://www.fda.gov/medwatch Contact: Media: 1-301-796-4540 Consumers: 1-888-SAFEFOOD (toll free)SOURCE U.S. Food and Drug Administration
Answer: | Food Safety Can Be Crucial for People With Diabetes France - Franais USA - espaol Espaa - espaol Deutschland - Deutsch | SILVER SPRING, Md., Nov. 17, 2020 /PRNewswire/ -- Did you know November is National Diabetes Month? The U.S. Food and Drug Administration (FDA) reminds people with diabetes (and those preparing food for them) about the importance of safe food handling in preventing foodborne illness.Learn how to safely choose and prepare foods for people with diabetes in this free booklet:Food Safety for Older Adults and People with Cancer, Diabetes, HIV/AIDS, Organ Transplants, and Autoimmune Diseases. (PRNewsfoto/U.S. FDA) Practicing food safety is important for everyone, but especially for people living with diabetes. They are more likely to get sick from bacteria that cause foodborne illness (often called "food poisoning"), and are more likely to be sicker for longer, be hospitalized, or even die. This increased risk is why food choices and safe food handling are so important in managing this chronic disease. Make Wise Food ChoicesSome foods are riskier for people with diabetes because they are more likely to contain harmful bacteria or viruses. In general, these foods fall into two categories: Uncooked fresh fruits and vegetables. Some animal products, such as unpasteurized (raw) milk; soft cheeses made with raw milk; raw or undercooked eggs, meat, poultry, fish and shellfish; luncheon meats; improperly reheated hot dogs; and salads containing animal products such as seafood, ham, or chicken that are prepared outside the home. Follow the Four Steps to Food SafetyAnyone who is diabetic or who prepares food for people with diabetes should also carefully follow these steps: CLEAN: Wash hands and surfaces often. Bacteria can be spread throughout the kitchen and get onto hands, cutting boards, utensils, counter tops, and food. SEPARATE: Keep raw meat, poultry, eggs, and seafood and their juices away from ready-to-eat foods. COOK to the right temperatures. Use a food thermometer to make sure meat, poultry, seafood, and egg products are cooked to a safe minimum internal temperature to destroy any harmful bacteria. (See Safe Minimal Internal Temperatures charts.) Follow cooking instructions on packaged foods such as frozen vegetables. CHILL foods promptly. Cold temperatures slow the growth of harmful bacteria. Use an appliance thermometer to be sure the refrigerator temperature is 40 degrees F or below and the freezer temperature is 0 degrees F or below. Know the SymptomsDangerous foodborne bacteria will usually cause illness within 1 to 3 days. However, sickness can also happen within 20 minutes or up to 6 weeks later. Symptoms of foodborne illness include: vomiting, diarrhea, abdominal pain, and flu-like symptoms (such as fever, headache, and body ache).Take ActionIf you think you or a family member has a foodborne illness, contact your healthcare provider immediately. Also, report the suspected foodborne illness to FDA in either of these ways: Contact the Consumer Complaint Coordinator in your area. Locate a coordinator here: http://www.fda.gov/Safety/ReportaProblem/ConsumerComplaintCoordinators Contact MedWatch, FDA's Safety Information and Adverse Event Reporting Program: By Phone: 1-800-FDA-1088 Online: File a voluntary report at http://www.fda.gov/medwatch Contact: Media: 1-301-796-4540 Consumers: 1-888-SAFEFOOD (toll free)SOURCE U.S. Food and Drug Administration |
edtsum3134 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--The new Soft Tissue Repair Market Research from Technavio indicates Positive and Superior growth in the short term as the business impact of COVID-19 spreads. "One of the primary growth drivers for this market is the rising incidence of accidental injuries, says a senior analyst for Healthcare at Technavio. As the markets recover Technavio expects the soft tissue repair market size to grow by USD 10.44 million during the period 2020-2024." Get detailed insights on COVID-19 pandemic Crisis and Recovery analysis of soft tissue repair market. Download free report sample Soft Tissue Repair Segment Highlights for 2020 Regional Analysis Click here to learn about report detailed analysis and insights on how you can leverage them to grow your business. Notes: Register for a free trial today to access 17,000+ market research reports using Technavio's SUBSCRIPTION platform About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Coverage Regions Covered Worldwide Topics Covered COVID-19, Soft Tissue Repair, Tissue Repair, Soft Tissue Fixation Devices and Accessories, Cell Therapy, and Tissue Scaffold
Answer: | New Soft Tissue Repair Market Research Highlights Recovery Path for Businesses from COVID-19 based on Cell Therapy and Tissue scaffold Products | Technavio | LONDON--(BUSINESS WIRE)--The new Soft Tissue Repair Market Research from Technavio indicates Positive and Superior growth in the short term as the business impact of COVID-19 spreads. "One of the primary growth drivers for this market is the rising incidence of accidental injuries, says a senior analyst for Healthcare at Technavio. As the markets recover Technavio expects the soft tissue repair market size to grow by USD 10.44 million during the period 2020-2024." Get detailed insights on COVID-19 pandemic Crisis and Recovery analysis of soft tissue repair market. Download free report sample Soft Tissue Repair Segment Highlights for 2020 Regional Analysis Click here to learn about report detailed analysis and insights on how you can leverage them to grow your business. Notes: Register for a free trial today to access 17,000+ market research reports using Technavio's SUBSCRIPTION platform About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Coverage Regions Covered Worldwide Topics Covered COVID-19, Soft Tissue Repair, Tissue Repair, Soft Tissue Fixation Devices and Accessories, Cell Therapy, and Tissue Scaffold |
edtsum3141 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--Moodys affiliate Four Twenty Seven today released a report analyzing the future exposure of the global population, the economy, and agriculture to a range of climate hazards, exploring both global trends and findings by country. Leveraging new analytics developed by Four Twenty Seven, the report assesses exposure to floods, heat stress, hurricanes and typhoons, rising sea levels, wildfires, and water stress and is based on the only known global dataset matching physical climate risk exposure to population location, GDP Purchasing Power Parity (PPP), and agricultural areas within countries. This novel dataset provides a detailed view of the exposure of key human and economic assets around the world. Understanding exposure is critical for investors and credit institutions to price climate risk, but also to help direct finance flows towards adaptation and resilience where theyre most needed, says Emilie Mazzacurati, Global Head of Moodys Climate Solutions in Moodys ESG Solutions Group, and Four Twenty Sevens Founder & CEO. The findings of Measuring What Matters: A New Approach to Assessing Sovereign Climate Risk have significant implications for human health, food security and economic productivity. Key findings include: A full copy of the report can be found here. The full sovereign dataset is available from Moodys ESG Solutions on request. ABOUT MOODYS ESG SOLUTIONS Moodys ESG Solutions Group is a business unit of Moodys Corporation serving the growing global demand for ESG and climate insights. It houses Four Twenty Seven, a leading publisher and provider of data, market intelligence and analysis related to physical climate and environmental risks. The group leverages Moodys data and expertise across ESG, climate risk, and sustainable finance, and aligns with Moody's Investors Service (MIS) and Moody's Analytics (MA) to deliver a comprehensive, integrated suite of ESG and climate risk solutions including ESG scores, analytics, Sustainability Ratings and Sustainable Finance Reviewer/certifier services. For more information visit Moodys ESG & Climate Risk hub.
Answer: | Measuring What Matters: A New Approach to Assessing Sovereign Climate Risk 41% of the global population and 57% of the economy could be exposed to flooding by 2040 and over a third of todays agricultural land will be under high water stress | LONDON--(BUSINESS WIRE)--Moodys affiliate Four Twenty Seven today released a report analyzing the future exposure of the global population, the economy, and agriculture to a range of climate hazards, exploring both global trends and findings by country. Leveraging new analytics developed by Four Twenty Seven, the report assesses exposure to floods, heat stress, hurricanes and typhoons, rising sea levels, wildfires, and water stress and is based on the only known global dataset matching physical climate risk exposure to population location, GDP Purchasing Power Parity (PPP), and agricultural areas within countries. This novel dataset provides a detailed view of the exposure of key human and economic assets around the world. Understanding exposure is critical for investors and credit institutions to price climate risk, but also to help direct finance flows towards adaptation and resilience where theyre most needed, says Emilie Mazzacurati, Global Head of Moodys Climate Solutions in Moodys ESG Solutions Group, and Four Twenty Sevens Founder & CEO. The findings of Measuring What Matters: A New Approach to Assessing Sovereign Climate Risk have significant implications for human health, food security and economic productivity. Key findings include: A full copy of the report can be found here. The full sovereign dataset is available from Moodys ESG Solutions on request. ABOUT MOODYS ESG SOLUTIONS Moodys ESG Solutions Group is a business unit of Moodys Corporation serving the growing global demand for ESG and climate insights. It houses Four Twenty Seven, a leading publisher and provider of data, market intelligence and analysis related to physical climate and environmental risks. The group leverages Moodys data and expertise across ESG, climate risk, and sustainable finance, and aligns with Moody's Investors Service (MIS) and Moody's Analytics (MA) to deliver a comprehensive, integrated suite of ESG and climate risk solutions including ESG scores, analytics, Sustainability Ratings and Sustainable Finance Reviewer/certifier services. For more information visit Moodys ESG & Climate Risk hub. |
edtsum3147 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, June 17, 2020 /PRNewswire/ --Pareteum Corporation (Nasdaq: TEUM), a global cloud communications platform company, announced today that it has been selected by Liberty Global, a multinational telecommunications company, to build a pan-European Voicemail platform. Leveraging the Pareteum Experience Cloud Voicemail solution, Liberty Global's new platform will be available to its entire European customer base. Liberty Global is one of the world's leading converged video, broadband, and communication companies, with headquarters in London, Amsterdam, and Denver. They have operations in several European countries under the consumer brands Virgin Media, Telenet, and UPC. The Pareteum Experience Cloud Voicemail solution is a multi-tenant,API-drivenvoicemail offering that supports over 100 features, settings, and options, enabling rich customer experiences. The partnership provides Liberty Global with one pan-European, geo-redundant voicemail platform capable of serving millions of customers across Europe and supporting the continent's many languages and time zones. Additionally, the Pareteum Experience Cloud Voicemail solution has been integrated with IMS, enabling both fixed and mobile customers to use the same voicemail environment. The solution is based on the Pareteum Experience Cloud architecture. This means that other Pareteum offerings, such as Interactive VoiceResponse (IVR) and Missed Call Alert,can be easily deployed to further expand Liberty Global's new platform in the future. "The flexibility, scalability, and cost effectiveness of our Voicemail solution offers many advantages to telecom operators around the world," said Bart Weijermars, Pareteum's interim CEO. "I see the delivery of our Voicemail solution as the next step in our long-standing relationship with Liberty Global." On April 23, 2020, Liberty Global migrated the first users to the platform. About Pareteum CorporationPareteum is an experienced provider of Communications Platform as a Service solutions. Pareteum empowers enterprises, communications service providers, early stage innovators, developers, IoT, and telecommunications infrastructure providers with the freedom and control to create, deliver and scale innovative communications experiences. The Pareteum platformconnects people and devices around the world using the secure, ubiquitous, and highly scalable solution to deliver data, voice, video, SMS/text messaging, media, and content enablement. For more information please visit: www.pareteum.com. Forward Looking StatementsCertain statements contained in this press release constitute "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company's plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. We discuss many of these risks, uncertainties and assumptions in Item 1A under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2018, as updated by our other filings with the SEC. Because such statements involve risks and uncertainties, the actual results and performance of the Company may differ materially from the results expressed or implied by such forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. Additional information concerning certain risks and uncertainties that could cause actual results to differ materially from those projected or suggested in the Company's filings with the Securities and Exchange Commission, copies of which are available from the SEC or may be obtained upon request from the Company. Media Inquiries[emailprotected] Pareteum Investor Relations Contacts:Investor Relations +1 (646) 975-0400[emailprotected] SOURCE Pareteum Corporation Related Links http://www.pareteum.com
Answer: | Liberty Global to Leverage the Pareteum Experience Cloud in New Pan-European Voicemail Platform | NEW YORK, June 17, 2020 /PRNewswire/ --Pareteum Corporation (Nasdaq: TEUM), a global cloud communications platform company, announced today that it has been selected by Liberty Global, a multinational telecommunications company, to build a pan-European Voicemail platform. Leveraging the Pareteum Experience Cloud Voicemail solution, Liberty Global's new platform will be available to its entire European customer base. Liberty Global is one of the world's leading converged video, broadband, and communication companies, with headquarters in London, Amsterdam, and Denver. They have operations in several European countries under the consumer brands Virgin Media, Telenet, and UPC. The Pareteum Experience Cloud Voicemail solution is a multi-tenant,API-drivenvoicemail offering that supports over 100 features, settings, and options, enabling rich customer experiences. The partnership provides Liberty Global with one pan-European, geo-redundant voicemail platform capable of serving millions of customers across Europe and supporting the continent's many languages and time zones. Additionally, the Pareteum Experience Cloud Voicemail solution has been integrated with IMS, enabling both fixed and mobile customers to use the same voicemail environment. The solution is based on the Pareteum Experience Cloud architecture. This means that other Pareteum offerings, such as Interactive VoiceResponse (IVR) and Missed Call Alert,can be easily deployed to further expand Liberty Global's new platform in the future. "The flexibility, scalability, and cost effectiveness of our Voicemail solution offers many advantages to telecom operators around the world," said Bart Weijermars, Pareteum's interim CEO. "I see the delivery of our Voicemail solution as the next step in our long-standing relationship with Liberty Global." On April 23, 2020, Liberty Global migrated the first users to the platform. About Pareteum CorporationPareteum is an experienced provider of Communications Platform as a Service solutions. Pareteum empowers enterprises, communications service providers, early stage innovators, developers, IoT, and telecommunications infrastructure providers with the freedom and control to create, deliver and scale innovative communications experiences. The Pareteum platformconnects people and devices around the world using the secure, ubiquitous, and highly scalable solution to deliver data, voice, video, SMS/text messaging, media, and content enablement. For more information please visit: www.pareteum.com. Forward Looking StatementsCertain statements contained in this press release constitute "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company's plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. We discuss many of these risks, uncertainties and assumptions in Item 1A under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2018, as updated by our other filings with the SEC. Because such statements involve risks and uncertainties, the actual results and performance of the Company may differ materially from the results expressed or implied by such forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. Additional information concerning certain risks and uncertainties that could cause actual results to differ materially from those projected or suggested in the Company's filings with the Securities and Exchange Commission, copies of which are available from the SEC or may be obtained upon request from the Company. Media Inquiries[emailprotected] Pareteum Investor Relations Contacts:Investor Relations +1 (646) 975-0400[emailprotected] SOURCE Pareteum Corporation Related Links http://www.pareteum.com |
edtsum3148 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: GREENFIELD, Ind.--(BUSINESS WIRE)--Based on recent misleading media coverage, a U.S. House of Representatives subcommittee chair made a request to Elanco Animal Health, Incorporated (NYSE: ELAN) to temporarily remove Seresto collars from the market. Elanco reiterates that it stands behind the safety data of Seresto generated for its registration and monitored via post-marketing surveillance. All data and scientific evaluation used during the product registration process and through Elancos robust pharmacovigilance review supports the products safety profile and efficacy. Therefore, no market action, such as a recall, is warranted, nor has it been suggested by any regulatory agency. Elanco continues to stand behind the safety profile for Seresto. The product remains available to consumers across the U.S. and around the world for protection of pets from fleas and ticks, which can negatively impact their quality of life and may act as vectors of dangerous disease. Since its initial U.S. Environmental Protection Agency (EPA) registration in 2012, more than 25 million Seresto collars have protected dogs and cats in the U.S. from fleas and ticks. In that time period, the incident report rate for all adverse events related to Seresto in the U.S. has been below 0.3%. Furthermore, the significant majority of these incidents relate to non-serious effects, such as dermatologic application site issues. As a globally distributed product, Serestos safety data was rigorously reviewed over the course of its development prior to registration by more than 80 regulatory authorities around the world, including the U.S. EPA. Importantly, as regulated by the EPA, Seresto remains available on the market. Elanco is cooperating with the Subcommittees request and looks forward to explaining how the media reports on this topic have been widely refuted by toxicologists and veterinarians. Elanco believes that any further reporting on these matters should be based on the relevant science and facts. There is no medical or scientific basis to initiate a recall of Seresto collars and we are disappointed this is causing confusion and unfounded fear for pet owners trying to protect their pets from fleas and ticks, said Dr. Tony Rumschlag, senior director for Technical Consultants at Elanco. The recent media reports were based on raw data and cannot be used to draw conclusions on what may have actually caused the issues. It is critically important to understand that a report is not an indication of cause...if a dog were to be wearing a collar and experienced any sort of health issue, the collar would be mentioned in the resulting report as required, even if the collar was very obviously not the source of the issue. In most cases, further investigation and assessment are required to determine cause, often a veterinary exam, laboratory diagnostics, or necropsy, as appropriate. Data are continuously monitored for signals or trends. Thorough investigation of available data has shown no established link between exposure to the active ingredients in Seresto and pet deaths. Taking drastic action such as a recall results in unjustified worry and confusion that may increase pet exposure to disease carrying parasites like fleas and ticks." Elanco takes the safety of its products seriously and has policies to ensure that concerns related to their use are investigated and addressed as appropriate. As with all its products, Elanco will continue to take actions to achieve the highest levels of safety and efficacy. About Elanco Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose ESG/Sustainability framework all to advance the health of animals, people and the planet. Learn more at www.elanco.com.
Answer: | Elanco Stands Behind Seresto and its Safety Profile Chairman of U.S. House of Representatives subcommittee asks for action based on misleading media reports Elanco stands behind the safety profile associated with Seresto, remains available to consumers | GREENFIELD, Ind.--(BUSINESS WIRE)--Based on recent misleading media coverage, a U.S. House of Representatives subcommittee chair made a request to Elanco Animal Health, Incorporated (NYSE: ELAN) to temporarily remove Seresto collars from the market. Elanco reiterates that it stands behind the safety data of Seresto generated for its registration and monitored via post-marketing surveillance. All data and scientific evaluation used during the product registration process and through Elancos robust pharmacovigilance review supports the products safety profile and efficacy. Therefore, no market action, such as a recall, is warranted, nor has it been suggested by any regulatory agency. Elanco continues to stand behind the safety profile for Seresto. The product remains available to consumers across the U.S. and around the world for protection of pets from fleas and ticks, which can negatively impact their quality of life and may act as vectors of dangerous disease. Since its initial U.S. Environmental Protection Agency (EPA) registration in 2012, more than 25 million Seresto collars have protected dogs and cats in the U.S. from fleas and ticks. In that time period, the incident report rate for all adverse events related to Seresto in the U.S. has been below 0.3%. Furthermore, the significant majority of these incidents relate to non-serious effects, such as dermatologic application site issues. As a globally distributed product, Serestos safety data was rigorously reviewed over the course of its development prior to registration by more than 80 regulatory authorities around the world, including the U.S. EPA. Importantly, as regulated by the EPA, Seresto remains available on the market. Elanco is cooperating with the Subcommittees request and looks forward to explaining how the media reports on this topic have been widely refuted by toxicologists and veterinarians. Elanco believes that any further reporting on these matters should be based on the relevant science and facts. There is no medical or scientific basis to initiate a recall of Seresto collars and we are disappointed this is causing confusion and unfounded fear for pet owners trying to protect their pets from fleas and ticks, said Dr. Tony Rumschlag, senior director for Technical Consultants at Elanco. The recent media reports were based on raw data and cannot be used to draw conclusions on what may have actually caused the issues. It is critically important to understand that a report is not an indication of cause...if a dog were to be wearing a collar and experienced any sort of health issue, the collar would be mentioned in the resulting report as required, even if the collar was very obviously not the source of the issue. In most cases, further investigation and assessment are required to determine cause, often a veterinary exam, laboratory diagnostics, or necropsy, as appropriate. Data are continuously monitored for signals or trends. Thorough investigation of available data has shown no established link between exposure to the active ingredients in Seresto and pet deaths. Taking drastic action such as a recall results in unjustified worry and confusion that may increase pet exposure to disease carrying parasites like fleas and ticks." Elanco takes the safety of its products seriously and has policies to ensure that concerns related to their use are investigated and addressed as appropriate. As with all its products, Elanco will continue to take actions to achieve the highest levels of safety and efficacy. About Elanco Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose ESG/Sustainability framework all to advance the health of animals, people and the planet. Learn more at www.elanco.com. |
edtsum3159 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--The global legal cocaine market size is expected to grow by 1.27 thousand oz as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. Moreover, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 3%. Request Free Sample Report on COVID-19 Impacts Read the 120-page report with TOC on "Legal Cocaine Market Analysis Report by Application (Surgical and Recreational) and Geography (Europe, North America, APAC, and ROW), and the Segment Forecasts, 2020-2024". https://www.technavio.com/report/legal-cocaine-market-industry-analysis The market is driven by the growing demand for pharmaceutical-grade cocaine. In addition, the rising number of countries decriminalizing and legalizing cocaine is anticipated to boost the growth of the legal cocaine market. Cocaine is frequently used as a topical anesthetic during outpatient procedures. Cocaine is used by healthcare professionals to temporarily numb the lining of the mouth, nose, and throat before certain medical procedures like biopsy, stitches, and wound cleaning. Cocaine also causes blood vessels to narrow, which helps in decreasing bleeding and swelling from the procedure. The legal cocaine used during medical procedures is available in the form of a topical cocaine hydrochloride solution, which comes in three different concentrations of 1%, 4%, and 10%. Cocaine is ranked among the strongest anesthetics and vasoconstrictors, which makes it an ideal option for use during sinus surgery as well as nasal procedures where bleeding and pain may pose as major challenges. Therefore, the growing demand for pharmaceutical-grade cocaine is expected to drive the growth of the legal cocaine market significantly during the forecast period. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Major Five Legal Cocaine Companies: Bio-Techne Corp. Bio-Techne Corp. has business operations under various segments such as protein sciences, and diagnostics and genomics. The company offers cocaine hydrochloride which is an inhibitor of monoamine transporters. Lannett Co. Inc. Lannett Co. Inc. is involved in the production and distribution of generic pharmaceutical products. The company offers Cocaine Hydrochloride Nasal Solution, a branded local anesthetic product, which is FDA approved. Mallinckrodt Plc Mallinckrodt Plc operates its business through various segments such as specialty brands and specialty generic. The company offers cocaine hydrochloride USP CII. Merck & Co. Inc. Merck & Co. Inc. has business operations under segments such as pharmaceuticals and animal health. The company offers cocaine for medicinal applications such as local anesthetic. Stepan Co. Stepan Co. operates its business through three segments: surfactants, polymers and specialty products. The company supplies cocaine to pharmaceutical companies for use in medicine. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Legal Cocaine Application Outlook (Revenue, thousand oz, 2020-2024) Legal Cocaine Regional Outlook (Revenue, thousand oz, 2020-2024) Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Answer: | Analysis on Impact of COVID-19 - Global Legal Cocaine Market 2020-2024 | Evolving Opportunities with Bio-Techne Corp. and Lannett Co. Inc. | Technavio | LONDON--(BUSINESS WIRE)--The global legal cocaine market size is expected to grow by 1.27 thousand oz as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. Moreover, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 3%. Request Free Sample Report on COVID-19 Impacts Read the 120-page report with TOC on "Legal Cocaine Market Analysis Report by Application (Surgical and Recreational) and Geography (Europe, North America, APAC, and ROW), and the Segment Forecasts, 2020-2024". https://www.technavio.com/report/legal-cocaine-market-industry-analysis The market is driven by the growing demand for pharmaceutical-grade cocaine. In addition, the rising number of countries decriminalizing and legalizing cocaine is anticipated to boost the growth of the legal cocaine market. Cocaine is frequently used as a topical anesthetic during outpatient procedures. Cocaine is used by healthcare professionals to temporarily numb the lining of the mouth, nose, and throat before certain medical procedures like biopsy, stitches, and wound cleaning. Cocaine also causes blood vessels to narrow, which helps in decreasing bleeding and swelling from the procedure. The legal cocaine used during medical procedures is available in the form of a topical cocaine hydrochloride solution, which comes in three different concentrations of 1%, 4%, and 10%. Cocaine is ranked among the strongest anesthetics and vasoconstrictors, which makes it an ideal option for use during sinus surgery as well as nasal procedures where bleeding and pain may pose as major challenges. Therefore, the growing demand for pharmaceutical-grade cocaine is expected to drive the growth of the legal cocaine market significantly during the forecast period. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Major Five Legal Cocaine Companies: Bio-Techne Corp. Bio-Techne Corp. has business operations under various segments such as protein sciences, and diagnostics and genomics. The company offers cocaine hydrochloride which is an inhibitor of monoamine transporters. Lannett Co. Inc. Lannett Co. Inc. is involved in the production and distribution of generic pharmaceutical products. The company offers Cocaine Hydrochloride Nasal Solution, a branded local anesthetic product, which is FDA approved. Mallinckrodt Plc Mallinckrodt Plc operates its business through various segments such as specialty brands and specialty generic. The company offers cocaine hydrochloride USP CII. Merck & Co. Inc. Merck & Co. Inc. has business operations under segments such as pharmaceuticals and animal health. The company offers cocaine for medicinal applications such as local anesthetic. Stepan Co. Stepan Co. operates its business through three segments: surfactants, polymers and specialty products. The company supplies cocaine to pharmaceutical companies for use in medicine. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Legal Cocaine Application Outlook (Revenue, thousand oz, 2020-2024) Legal Cocaine Regional Outlook (Revenue, thousand oz, 2020-2024) Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. |
edtsum3174 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OLD BRIDGE, N.J., June 9, 2020 The Bridge Women's Center announced the opening of its Mobile Pregnancy Center on 5/18/20. The Bridge Women's Mobile Pregnancy Center provides free, confidential and compassionate support and resources to pregnant women and women who may be pregnant. All services are provided at no cost as the center operates on donations from those who share their vision and mission. Providing services such as ultrasounds, pregnancy tests, maternity support and post-abortion counseling - Hannah as the Bridge Women's Mobile Pregnancy Center is named, will meet women facing unplanned pregnancies right where they are. While the center is mobile and will be traveling throughout New Jersey, due to Covid-19 the center will be heading out 2-3 days a week to abortion clinics, other key areas and will also be stationed at 127 White Oak Lane in Old Bridge where they are accepting walk-ins and appointments. "Despite Covid-19 and the adjustments that have been made due to this pandemic, we are still proceeding, still making an impact and have a vision for the future. We want women facing unexpected pregnancies to know that we are here, we will meet them where they are and are ready to serve them," stated Bridge Women's Center Executive Director, Debbie Biskey. While the Mobile Pregnancy Center is staffed with medical professionals, the work of the Bridge Women's Center does not end at ultrasounds and pregnancy tests. The Bridge Women's Center introduces women with unplanned pregnancies to various resources including counseling, programs, abortion healing and recovery, childbirth preparation classes, lactation consultations, and support during pregnancy and after the child is born. Bridge Women's Center's Executive Director, Debbie Biskey said, "Opening our Mobile Pregnancy Center has been a vision of ours for many years. We are so grateful to our supporters and are excited to serve women, men and families through pregnancy and after. We are here for life." The Bridge Women's Center is currently accepting appointments. To make an appointment call 732-588-0999 or email [emailprotected] To find out more about Bridge Women's Center visithttps://www.bridgewomenscenter.com/or email [emailprotected]. Debbie BiskeyExecutive Director, Bridge Women's Center[emailprotected]Bridgewomenscenter.com 732-588-0999 SOURCE Bridge Women's Center Related Links https://www.bridgewomenscenter.com/
Answer: | Bridge Women's Center Opens Mobile Pregnancy Center Mobile Pregnancy Center Provides Free Resources to Women Who Are Pregnant or May Be Pregnant | OLD BRIDGE, N.J., June 9, 2020 The Bridge Women's Center announced the opening of its Mobile Pregnancy Center on 5/18/20. The Bridge Women's Mobile Pregnancy Center provides free, confidential and compassionate support and resources to pregnant women and women who may be pregnant. All services are provided at no cost as the center operates on donations from those who share their vision and mission. Providing services such as ultrasounds, pregnancy tests, maternity support and post-abortion counseling - Hannah as the Bridge Women's Mobile Pregnancy Center is named, will meet women facing unplanned pregnancies right where they are. While the center is mobile and will be traveling throughout New Jersey, due to Covid-19 the center will be heading out 2-3 days a week to abortion clinics, other key areas and will also be stationed at 127 White Oak Lane in Old Bridge where they are accepting walk-ins and appointments. "Despite Covid-19 and the adjustments that have been made due to this pandemic, we are still proceeding, still making an impact and have a vision for the future. We want women facing unexpected pregnancies to know that we are here, we will meet them where they are and are ready to serve them," stated Bridge Women's Center Executive Director, Debbie Biskey. While the Mobile Pregnancy Center is staffed with medical professionals, the work of the Bridge Women's Center does not end at ultrasounds and pregnancy tests. The Bridge Women's Center introduces women with unplanned pregnancies to various resources including counseling, programs, abortion healing and recovery, childbirth preparation classes, lactation consultations, and support during pregnancy and after the child is born. Bridge Women's Center's Executive Director, Debbie Biskey said, "Opening our Mobile Pregnancy Center has been a vision of ours for many years. We are so grateful to our supporters and are excited to serve women, men and families through pregnancy and after. We are here for life." The Bridge Women's Center is currently accepting appointments. To make an appointment call 732-588-0999 or email [emailprotected] To find out more about Bridge Women's Center visithttps://www.bridgewomenscenter.com/or email [emailprotected]. Debbie BiskeyExecutive Director, Bridge Women's Center[emailprotected]Bridgewomenscenter.com 732-588-0999 SOURCE Bridge Women's Center Related Links https://www.bridgewomenscenter.com/ |
edtsum3180 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: --(BUSINESS WIRE)--Consumer Energy Alliance: What: Consumer Energy Alliance (CEA) hosts Fuels Institute Executive Director John Eichberger for a webinar regarding the impact of transportation-related environmental initiatives on energy consumers. Who: CEAs virtual event will begin with a welcome from David Holt, CEA President, followed by remarks from John Eichberger on recent findings from the Institutes report which provides valuable context to guide governments considering strategies to reduce emissions from transportation. When: Tuesday, January 12, 2020 at 2:00 p.m. ET Contact: Credentialed media interested in attending should RSVP to Kristin Marcell at [email protected]. About Consumer Energy Alliance Consumer Energy Alliance (CEA) is the leading voice for sensible energy and environmental policies for consumers, bringing together families, farmers, small businesses, distributors, producers, and manufacturers to support America's environmentally sustainable energy future. With more than 550,000 members nationwide, we are committed to leading the nations dialogue around energy and the environment, its critical role in the economy, and how it supports the vital supply chains for the families and businesses that depend on them. CEA works daily to encourage communities across the nation to seek sensible, realistic, and environmentally responsible solutions to meet our nations energy needs.
Answer: | Consumer Energy Alliance Hosts Fuels Institute Executive Director John Eichberger to Discuss Impact of Transportation-Related Environmental Initiatives | --(BUSINESS WIRE)--Consumer Energy Alliance: What: Consumer Energy Alliance (CEA) hosts Fuels Institute Executive Director John Eichberger for a webinar regarding the impact of transportation-related environmental initiatives on energy consumers. Who: CEAs virtual event will begin with a welcome from David Holt, CEA President, followed by remarks from John Eichberger on recent findings from the Institutes report which provides valuable context to guide governments considering strategies to reduce emissions from transportation. When: Tuesday, January 12, 2020 at 2:00 p.m. ET Contact: Credentialed media interested in attending should RSVP to Kristin Marcell at [email protected]. About Consumer Energy Alliance Consumer Energy Alliance (CEA) is the leading voice for sensible energy and environmental policies for consumers, bringing together families, farmers, small businesses, distributors, producers, and manufacturers to support America's environmentally sustainable energy future. With more than 550,000 members nationwide, we are committed to leading the nations dialogue around energy and the environment, its critical role in the economy, and how it supports the vital supply chains for the families and businesses that depend on them. CEA works daily to encourage communities across the nation to seek sensible, realistic, and environmentally responsible solutions to meet our nations energy needs. |
edtsum3184 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ZUG, Switzerland--(BUSINESS WIRE)--Regulatory News: LafargeHolcim (Paris:LHN) has signed an agreement to acquire Firestone Building Products (FSBP), a leader in commercial roofing and building envelope solutions based in the United States (US), with 2020 (est.) net sales of USD 1.8 billion and EBITDA of USD 270 million. This acquisition is a milestone in LafargeHolcims transformation to become the global leader in innovative and sustainable building solutions. This transaction is valued at USD 3.4 billion, to be financed with cash and debt while maintaining net debt below 2x. Synergies of USD 110 million per year are expected on a run-rate basis within two years of closing, which is expected in the second quarter. The acquisition is earnings per share (EPS) accretive from the first year. Jan Jenisch, LafargeHolcim CEO: I am excited to be entering the highly attractive roofing business. With Firestone Building Products we are strengthening our biggest market, the US, while also building a global growth and innovation platform for the company. Todays milestone is a strategic leap on our journey to become the global leader in innovative and sustainable building solutions, to build a world that works for people and the planet. I have great respect for the high-caliber leadership and expertise of the Firestone Building Products team and look forward to welcoming them into the LafargeHolcim family. Paolo Ferrari, Bridgestone Americas President, CEO & COO: This transaction will create new growth opportunities for Firestone Building Products and allow Bridgestone to focus its resources to further invest in the companys tire business and rapidly growing mobility solutions business. Like Bridgestone, LafargeHolcim is a global company with a strong financial position and thriving culture. We know they will take great care of our Firestone Building Products employees and customers, and ensure the business enjoys growth and success for many years to come. Taylor Cole, Firestone Building Products President: Today is a big moment for the Firestone Building Products team as we look forward to becoming part of the global leader in building materials and solutions. Together, we are in a prime position to accelerate our growth by combining Firestone Building Products advanced technologies and know-how with LafargeHolcims global scale and reach. Founded in 1980, Firestone Building Products (FSBP) is a business unit of Bridgestone Americas and part of Tokyo-based Bridgestone Corporation, a global leader providing tires and sustainable mobility solutions that create social and customer value. The acquisition of FSBP will strengthen LafargeHolcims biggest market, the US, establishing a new growth profile, reaching USD 6 billion in annual net sales. Building on FSBPs strong organic growth, LafargeHolcim expects to accelerate its leadership through cross-selling opportunities and further bolt-on acquisitions. LafargeHolcim also aims to swiftly globalize the business, leveraging its European and Latin American footprint. Urbanization trends are accelerating the development of the flat roof market, currently estimated at around USD 50 billion globally. By entering this attractive new business, LafargeHolcim will deliver above-market growth, driven by innovative technologies and branding. It will also benefit from FSBPs position in the high-growth repair and refurbishment segment, accounting for the majority of its sales today. With up to 60% of buildings energy lost through roofs, FSBP plays an instrumental role in mitigating this process, with its industry-leading technologies, including cool roofs, insulation and waterproofing systems. In addition, its green roofs contribute to more sustainable urban environments. These technologies complement LafargeHolcims sustainable building solutions, from its ECOPact green concrete to its EcoLabel range, accelerating the companys net zero commitment. With this acquisition LafargeHolcim will add 15 manufacturing facilities, 1,800 distribution points, and three R&D laboratories to its network. Upon completion of the sale, FSBP will continue to be headquartered in Nashville, Tennessee, and all 1,900 FSBP employees will transition to LafargeHolcim. Additional information Presentation A presentation of the acquisition with further details is available on our website at www.lafargeholcim.com Analyst and Media Conference An analyst and media conference will be held on Thursday, January 7th at 08:30am CET. Participants may pre-register and will receive dedicated Dial-in details to easily and quickly access the call. Click here to pre-register. ABOUT LAFARGEHOLCIM As the worlds global leader in building solutions, LafargeHolcim is reinventing how the world builds to make it greener and smarter for all. On its way to becoming a net zero company, LafargeHolcim offers global solutions such as ECOPact, enabling carbon-neutral construction. With its circular business model, the company is a global leader in recycling waste as a source of energy and raw materials through products like Susteno, its leading circular cement. Innovation and digitalization are at the core of the companys strategy, with more than half of its R&D projects dedicated to greener solutions. LafargeHolcims 70,000 employees are committed to improving quality of life across more than 70 markets through its four business segments: Cement, Ready-Mix Concrete, Aggregates and Solutions & Products. More information is available on www.lafargeholcim.com ABOUT Bridgestone Americas Nashville, Tennessee-based Bridgestone Americas, Inc. is a subsidiary of Bridgestone Corporation, a global leader providing sustainable mobility and advanced solutions. Bridgestone Americas develops, manufactures and markets a diverse portfolio of original equipment and replacement tires, tire-centric solutions, mobility solutions, and other rubber-associated and diversified products that deliver social value and customer value. Guided by its global corporate social responsibility commitment, Our Way to Serve, Bridgestone is dedicated to shaping a sustainable future of mobility and improving the way people move, live, work and play. ABOUT Firestone Building Products Firestone Building Products Company, LLC is a leading manufacturer and supplier of trusted roofing and building envelope solutions. By taking the entire building envelope into consideration, Firestone Building Products meets individual customer and project needs for roofing, wall and lining solutions. Headquartered in Nashville, Tennessee, the company also offers outstanding technical services, an international network of roofing contractors, distributors and field sales representatives, and exceptional warranty protection. Products include commercial roofing systems, roofing accessories, green roofing systems and daylighting systems, vegetative roofing systems, metal wall panels, insulation, cavity wall construction, pond liners, geomembranes and silicone and acrylic liquid coatings. Firestone Building Products Company, LLC is a subsidiary of Bridgestone Americas, Inc. Important disclaimer forward-looking statements: This document contains forward-looking statements. Such forward-looking statements do not constitute forecasts regarding results or any other performance indicator, but rather trends or targets, as the case may be, including with respect to plans, initiatives, events, products, solutions and services, their development and potential. Although LafargeHolcim believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions as at the time of publishing this document, investors are cautioned that these statements are not guarantees of future performance. Actual results may differ materially from the forward-looking statements as a result of a number of risks and uncertainties, many of which are difficult to predict and generally beyond the control of LafargeHolcim, including but not limited to the risks described in the LafargeHolcim's annual report available on its website (www.lafargeholcim.com) and uncertainties related to the market conditions and the implementation of our plans. Accordingly, we caution you against relying on forward-looking statements. LafargeHolcim does not undertake to provide updates of these forward-looking statements. This document contains inside information within the meaning of the Market Abuse Regulation (EU) (No 596/2014).
Answer: | LafargeHolcim to Acquire Firestone Building Products from Bridgestone Americas Acquiring industry leader in commercial roofing and building envelope solutions to position it for continued growth A milestone in the transformation of LafargeHolcim to become the global leader in innovative and sustainable building materials and solutions Strengthening LafargeHolcims biggest market, the US, with annual sales to exceed USD 6bn Plans to expand in Europe and Latin America to become the global leader in flat roofing systems Sale to enable Bridgestone to strengthen investments in companys tire business and fast-growing mobility solutions business | ZUG, Switzerland--(BUSINESS WIRE)--Regulatory News: LafargeHolcim (Paris:LHN) has signed an agreement to acquire Firestone Building Products (FSBP), a leader in commercial roofing and building envelope solutions based in the United States (US), with 2020 (est.) net sales of USD 1.8 billion and EBITDA of USD 270 million. This acquisition is a milestone in LafargeHolcims transformation to become the global leader in innovative and sustainable building solutions. This transaction is valued at USD 3.4 billion, to be financed with cash and debt while maintaining net debt below 2x. Synergies of USD 110 million per year are expected on a run-rate basis within two years of closing, which is expected in the second quarter. The acquisition is earnings per share (EPS) accretive from the first year. Jan Jenisch, LafargeHolcim CEO: I am excited to be entering the highly attractive roofing business. With Firestone Building Products we are strengthening our biggest market, the US, while also building a global growth and innovation platform for the company. Todays milestone is a strategic leap on our journey to become the global leader in innovative and sustainable building solutions, to build a world that works for people and the planet. I have great respect for the high-caliber leadership and expertise of the Firestone Building Products team and look forward to welcoming them into the LafargeHolcim family. Paolo Ferrari, Bridgestone Americas President, CEO & COO: This transaction will create new growth opportunities for Firestone Building Products and allow Bridgestone to focus its resources to further invest in the companys tire business and rapidly growing mobility solutions business. Like Bridgestone, LafargeHolcim is a global company with a strong financial position and thriving culture. We know they will take great care of our Firestone Building Products employees and customers, and ensure the business enjoys growth and success for many years to come. Taylor Cole, Firestone Building Products President: Today is a big moment for the Firestone Building Products team as we look forward to becoming part of the global leader in building materials and solutions. Together, we are in a prime position to accelerate our growth by combining Firestone Building Products advanced technologies and know-how with LafargeHolcims global scale and reach. Founded in 1980, Firestone Building Products (FSBP) is a business unit of Bridgestone Americas and part of Tokyo-based Bridgestone Corporation, a global leader providing tires and sustainable mobility solutions that create social and customer value. The acquisition of FSBP will strengthen LafargeHolcims biggest market, the US, establishing a new growth profile, reaching USD 6 billion in annual net sales. Building on FSBPs strong organic growth, LafargeHolcim expects to accelerate its leadership through cross-selling opportunities and further bolt-on acquisitions. LafargeHolcim also aims to swiftly globalize the business, leveraging its European and Latin American footprint. Urbanization trends are accelerating the development of the flat roof market, currently estimated at around USD 50 billion globally. By entering this attractive new business, LafargeHolcim will deliver above-market growth, driven by innovative technologies and branding. It will also benefit from FSBPs position in the high-growth repair and refurbishment segment, accounting for the majority of its sales today. With up to 60% of buildings energy lost through roofs, FSBP plays an instrumental role in mitigating this process, with its industry-leading technologies, including cool roofs, insulation and waterproofing systems. In addition, its green roofs contribute to more sustainable urban environments. These technologies complement LafargeHolcims sustainable building solutions, from its ECOPact green concrete to its EcoLabel range, accelerating the companys net zero commitment. With this acquisition LafargeHolcim will add 15 manufacturing facilities, 1,800 distribution points, and three R&D laboratories to its network. Upon completion of the sale, FSBP will continue to be headquartered in Nashville, Tennessee, and all 1,900 FSBP employees will transition to LafargeHolcim. Additional information Presentation A presentation of the acquisition with further details is available on our website at www.lafargeholcim.com Analyst and Media Conference An analyst and media conference will be held on Thursday, January 7th at 08:30am CET. Participants may pre-register and will receive dedicated Dial-in details to easily and quickly access the call. Click here to pre-register. ABOUT LAFARGEHOLCIM As the worlds global leader in building solutions, LafargeHolcim is reinventing how the world builds to make it greener and smarter for all. On its way to becoming a net zero company, LafargeHolcim offers global solutions such as ECOPact, enabling carbon-neutral construction. With its circular business model, the company is a global leader in recycling waste as a source of energy and raw materials through products like Susteno, its leading circular cement. Innovation and digitalization are at the core of the companys strategy, with more than half of its R&D projects dedicated to greener solutions. LafargeHolcims 70,000 employees are committed to improving quality of life across more than 70 markets through its four business segments: Cement, Ready-Mix Concrete, Aggregates and Solutions & Products. More information is available on www.lafargeholcim.com ABOUT Bridgestone Americas Nashville, Tennessee-based Bridgestone Americas, Inc. is a subsidiary of Bridgestone Corporation, a global leader providing sustainable mobility and advanced solutions. Bridgestone Americas develops, manufactures and markets a diverse portfolio of original equipment and replacement tires, tire-centric solutions, mobility solutions, and other rubber-associated and diversified products that deliver social value and customer value. Guided by its global corporate social responsibility commitment, Our Way to Serve, Bridgestone is dedicated to shaping a sustainable future of mobility and improving the way people move, live, work and play. ABOUT Firestone Building Products Firestone Building Products Company, LLC is a leading manufacturer and supplier of trusted roofing and building envelope solutions. By taking the entire building envelope into consideration, Firestone Building Products meets individual customer and project needs for roofing, wall and lining solutions. Headquartered in Nashville, Tennessee, the company also offers outstanding technical services, an international network of roofing contractors, distributors and field sales representatives, and exceptional warranty protection. Products include commercial roofing systems, roofing accessories, green roofing systems and daylighting systems, vegetative roofing systems, metal wall panels, insulation, cavity wall construction, pond liners, geomembranes and silicone and acrylic liquid coatings. Firestone Building Products Company, LLC is a subsidiary of Bridgestone Americas, Inc. Important disclaimer forward-looking statements: This document contains forward-looking statements. Such forward-looking statements do not constitute forecasts regarding results or any other performance indicator, but rather trends or targets, as the case may be, including with respect to plans, initiatives, events, products, solutions and services, their development and potential. Although LafargeHolcim believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions as at the time of publishing this document, investors are cautioned that these statements are not guarantees of future performance. Actual results may differ materially from the forward-looking statements as a result of a number of risks and uncertainties, many of which are difficult to predict and generally beyond the control of LafargeHolcim, including but not limited to the risks described in the LafargeHolcim's annual report available on its website (www.lafargeholcim.com) and uncertainties related to the market conditions and the implementation of our plans. Accordingly, we caution you against relying on forward-looking statements. LafargeHolcim does not undertake to provide updates of these forward-looking statements. This document contains inside information within the meaning of the Market Abuse Regulation (EU) (No 596/2014). |
edtsum3186 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OAKLAND, Calif., Feb. 9, 2021 /PRNewswire/ --The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.11 per share on the company's common stock. The dividend is payable May 7, 2021, to stockholders of record as of the close of business on April 21, 2021. Clorox has a long history of providing value to its shareholders through regular dividend increases. This is the 52nd consecutive year Clorox has paid an annual dividend ever since it became independent again following a decade of outside ownership. The Clorox Company TheClorox Company(NYSE:CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of$6.7 billion. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products; Pine-Solcleaners; Liquid-Plumrclog removers; Poetthome care products; Fresh Stepcat litter; Gladbags and wraps; Kingsford grilling products;Hidden Valleydressings and sauces; Britawater-filtration products;Burt's Beesnatural personal care products; and RenewLife, Rainbow Light, Natural Vitality Calm, NeoCell and Stop Aging Now vitamins, minerals and supplements. The company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro and Clorox Healthcare brand names. More than 80% of the company's sales are generated from brands that hold theNo. 1or No. 2 market share positions in their categories. Clorox is a signatory of the United Nations Global Compact and the Ellen MacArthur Foundation's New Plastics Economy Global Commitment. The company has been broadly recognized for its corporate responsibility efforts, listed No. 1 on the 2020 Axios Harris Poll 100 reputation rankings and included on the Barron's 2020 100 Most Sustainable Companies list, 2021 Bloomberg Gender-Equality Index and the Human Rights Campaign's 2021 Corporate Equality Index, among others. In support of its communities, The Clorox Company and its foundations contributed more than $25 millionin combined cash grants, productdonationsand cause marketing infiscal year2020. For more information, visit TheCloroxCompany.com, including theGood Growth blog, and follow the company on Twitter at @CloroxCo. CLX-F SOURCE The Clorox Company
Answer: | Clorox Declares Regular Quarterly Dividend of $1.11 Per Share | OAKLAND, Calif., Feb. 9, 2021 /PRNewswire/ --The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.11 per share on the company's common stock. The dividend is payable May 7, 2021, to stockholders of record as of the close of business on April 21, 2021. Clorox has a long history of providing value to its shareholders through regular dividend increases. This is the 52nd consecutive year Clorox has paid an annual dividend ever since it became independent again following a decade of outside ownership. The Clorox Company TheClorox Company(NYSE:CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of$6.7 billion. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products; Pine-Solcleaners; Liquid-Plumrclog removers; Poetthome care products; Fresh Stepcat litter; Gladbags and wraps; Kingsford grilling products;Hidden Valleydressings and sauces; Britawater-filtration products;Burt's Beesnatural personal care products; and RenewLife, Rainbow Light, Natural Vitality Calm, NeoCell and Stop Aging Now vitamins, minerals and supplements. The company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro and Clorox Healthcare brand names. More than 80% of the company's sales are generated from brands that hold theNo. 1or No. 2 market share positions in their categories. Clorox is a signatory of the United Nations Global Compact and the Ellen MacArthur Foundation's New Plastics Economy Global Commitment. The company has been broadly recognized for its corporate responsibility efforts, listed No. 1 on the 2020 Axios Harris Poll 100 reputation rankings and included on the Barron's 2020 100 Most Sustainable Companies list, 2021 Bloomberg Gender-Equality Index and the Human Rights Campaign's 2021 Corporate Equality Index, among others. In support of its communities, The Clorox Company and its foundations contributed more than $25 millionin combined cash grants, productdonationsand cause marketing infiscal year2020. For more information, visit TheCloroxCompany.com, including theGood Growth blog, and follow the company on Twitter at @CloroxCo. CLX-F SOURCE The Clorox Company |
edtsum3192 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB:CYTR) (CytRx or the Company), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today congratulated Orphazyme A/S (ORPHA.CO) (NASDAQ:ORPH) (Orphazyme) on the September 29, 2020 pricing of its global offering, consisting of an initial public offering of American Depositary Shares in the U.S. and a concurrent private placement of ordinary shares in Europe. According to Orphazyme, the aggregate gross proceeds from its global offering will amount to approximately DKK 534,534,637 ($83,777,606 using a DKK/USD exchange rate of 6.3804) (assuming no exercise of the option to purchase additional shares) and DKK 614,714,770 ($96,344,237 using a DKK/USD exchange rate of 6.3804) (assuming full exercise of the option to purchase additional shares). CytRx has an agreement with Orphazyme that can yield milestone payments and royalties based on potential future sales of arimoclomol. In connection with Orphazymes global offering, it disclosed receipt of a filing communication from the U.S. Food and Drug Administration (FDA) relating to the agencys ordinary course review of its new drug application (NDA) for arimoclomol in the treatment of Niemann-Pick disease Type C (NPC). The filing communication follows acceptance on a Priority Review basis by the FDA of Orphazymes NDA for arimoclomol in NPC and the agencys establishment of the Prescription Drug User Fee Act (PDUFA) target action date of March 17, 2021. Orphazyme stated that its receipt of the filing communication does not impact the FDAs acceptance of its NDA, the target PDUFA action date or the Priority Review determination. Orphazymes disclosure notes that the filing communication constitutes preliminary notice from the FDA of potential review issues as part of its ordinary course review of the NDA and is not necessarily indicative of deficiencies that may be identified during the review. Orphazyme has stated that it intends to discuss the filing communication with the FDA. In accordance with applicable securities laws, Orphazyme amended the registration statement on Form F-1 on file with the U.S. Securities and Exchange Commission. For further information concerning the FDA filing communication, we refer you to the Recent Developments section on Page 6 of Orphazymes amended Form F-1 filed on September 28, 2020. CytRx will continue to provide updates that are relevant to its agreement with Orphazyme. About CytRx Corporation CytRx Corporation (OTCQB:CYTR) is a biopharmaceutical company with expertise in discovering and developing new therapeutics principally to treat patients with cancer and neurodegenerative diseases. CytRx's drug candidate, arimoclomol, was sold to Orphazyme A/S (Nasdaq Copenhagen exchange: ORPHA.CO) in exchange for milestone payments and royalties. Orphazyme is developing arimoclomol in four indications including amyotrophic lateral sclerosis (ALS), Niemann-Pick disease Type C (NPC), Gaucher disease and sporadic Inclusion Body Myositis (sIBM). Learn more at www.cytrx.com. About Orphazyme Orphazyme is a biopharmaceutical company focused on bringing novel treatments to patients living with life threatening or debilitating rare diseases. Their research focuses on developing therapies for diseases caused by misfolding of proteins including lysosomal storage diseases. Arimoclomol, the companys lead candidate, is in clinical development for four orphan diseases: Niemann-Pick disease Type C, Gaucher disease, sporadic Inclusion Body Myositis, and Amyotrophic Lateral Sclerosis. The Denmark-based company is listed on Nasdaq Copenhagen (ORPHA.CO). For more information, please visit www.orphazyme.com. About NPC Niemann-Pick disease Type C (NPC) is a rare, genetic and progressive disease that impairs the ability of the body to move cholesterol and other fatty substances (lipids) inside the cells. The result is an accumulation of lipids within the bodys tissue, including the brain tissue, causing damage to the affected 2 areas. The symptoms upon onset of NPC vary from fatality during the first months after birth to a progressive disorder not diagnosed until adulthood. The disease affects neurologic and psychiatric functions as well as various internal organs. Systemic symptoms of NPC are more common in infancy or childhood and the rate of progression is usually much slower in individuals with onset of symptoms during adulthood. NPC is usually fatal and the majority of individuals with the disease die before the age of 20. NPC has been granted Orphan Drug Designation (EU and U.S.) for the treatment of NPC. It is estimated the incidence of NPC to be one in 100,000 live births and the number of NPC patients in the United States and in Europe to be approximately 1,800 individuals. There are no approved treatments for NPC in the U.S. and only one approved product in Europe called miglustat. About Arimoclomol Arimoclomol is an investigational drug candidate that amplifies the production of heat-shock proteins (HSPs). HSPs can rescue defective misfolded proteins, clear protein aggregates, and improve the function of lysosomes. Arimoclomol is administered orally, crosses the blood brain barrier, and has been studied in seven Phase 1, four Phase 2 and one pivotal Phase 2/3 clinical trial. Arimoclomol is in clinical development at Orphazyme for the treatment of NPC, Gaucher disease, sIBM and ALS. Arimoclomol has received orphan drug designation for NPC, sIBM and ALS in the US and EU, as well as fast-track designation from the US Food and Drug Administration (FDA) for NPC, sIBM and ALS. In addition, arimoclomol has received breakthrough therapy designation and rare-pediatric disease designation from the FDA for NPC. Forward-Looking Statements This press release contains forward-looking statements, including statements relating to the Companys receipt of future milestone and royalty payments from Orphazyme and the achievement of long-term value for the Companys stockholders. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including risks and uncertainties relating to the ability of Orphazyme to obtain regulatory approval for, manufacture and commercialize its products and therapies that use arimoclomol; the results of future clinical trials involving arimoclomol; the amount, if any, of future milestone and royalty payments that we may receive from Orphazyme; and other risks and uncertainties described in the most recent annual and quarterly reports filed by the Company with the SEC and current reports filed since the date of the Companys most recent annual report. All forward-looking statements are based upon information available to the Company on the date the statements are first published. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Answer: | CytRx Issues Statement Regarding Orphazymes Global Offering | LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB:CYTR) (CytRx or the Company), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today congratulated Orphazyme A/S (ORPHA.CO) (NASDAQ:ORPH) (Orphazyme) on the September 29, 2020 pricing of its global offering, consisting of an initial public offering of American Depositary Shares in the U.S. and a concurrent private placement of ordinary shares in Europe. According to Orphazyme, the aggregate gross proceeds from its global offering will amount to approximately DKK 534,534,637 ($83,777,606 using a DKK/USD exchange rate of 6.3804) (assuming no exercise of the option to purchase additional shares) and DKK 614,714,770 ($96,344,237 using a DKK/USD exchange rate of 6.3804) (assuming full exercise of the option to purchase additional shares). CytRx has an agreement with Orphazyme that can yield milestone payments and royalties based on potential future sales of arimoclomol. In connection with Orphazymes global offering, it disclosed receipt of a filing communication from the U.S. Food and Drug Administration (FDA) relating to the agencys ordinary course review of its new drug application (NDA) for arimoclomol in the treatment of Niemann-Pick disease Type C (NPC). The filing communication follows acceptance on a Priority Review basis by the FDA of Orphazymes NDA for arimoclomol in NPC and the agencys establishment of the Prescription Drug User Fee Act (PDUFA) target action date of March 17, 2021. Orphazyme stated that its receipt of the filing communication does not impact the FDAs acceptance of its NDA, the target PDUFA action date or the Priority Review determination. Orphazymes disclosure notes that the filing communication constitutes preliminary notice from the FDA of potential review issues as part of its ordinary course review of the NDA and is not necessarily indicative of deficiencies that may be identified during the review. Orphazyme has stated that it intends to discuss the filing communication with the FDA. In accordance with applicable securities laws, Orphazyme amended the registration statement on Form F-1 on file with the U.S. Securities and Exchange Commission. For further information concerning the FDA filing communication, we refer you to the Recent Developments section on Page 6 of Orphazymes amended Form F-1 filed on September 28, 2020. CytRx will continue to provide updates that are relevant to its agreement with Orphazyme. About CytRx Corporation CytRx Corporation (OTCQB:CYTR) is a biopharmaceutical company with expertise in discovering and developing new therapeutics principally to treat patients with cancer and neurodegenerative diseases. CytRx's drug candidate, arimoclomol, was sold to Orphazyme A/S (Nasdaq Copenhagen exchange: ORPHA.CO) in exchange for milestone payments and royalties. Orphazyme is developing arimoclomol in four indications including amyotrophic lateral sclerosis (ALS), Niemann-Pick disease Type C (NPC), Gaucher disease and sporadic Inclusion Body Myositis (sIBM). Learn more at www.cytrx.com. About Orphazyme Orphazyme is a biopharmaceutical company focused on bringing novel treatments to patients living with life threatening or debilitating rare diseases. Their research focuses on developing therapies for diseases caused by misfolding of proteins including lysosomal storage diseases. Arimoclomol, the companys lead candidate, is in clinical development for four orphan diseases: Niemann-Pick disease Type C, Gaucher disease, sporadic Inclusion Body Myositis, and Amyotrophic Lateral Sclerosis. The Denmark-based company is listed on Nasdaq Copenhagen (ORPHA.CO). For more information, please visit www.orphazyme.com. About NPC Niemann-Pick disease Type C (NPC) is a rare, genetic and progressive disease that impairs the ability of the body to move cholesterol and other fatty substances (lipids) inside the cells. The result is an accumulation of lipids within the bodys tissue, including the brain tissue, causing damage to the affected 2 areas. The symptoms upon onset of NPC vary from fatality during the first months after birth to a progressive disorder not diagnosed until adulthood. The disease affects neurologic and psychiatric functions as well as various internal organs. Systemic symptoms of NPC are more common in infancy or childhood and the rate of progression is usually much slower in individuals with onset of symptoms during adulthood. NPC is usually fatal and the majority of individuals with the disease die before the age of 20. NPC has been granted Orphan Drug Designation (EU and U.S.) for the treatment of NPC. It is estimated the incidence of NPC to be one in 100,000 live births and the number of NPC patients in the United States and in Europe to be approximately 1,800 individuals. There are no approved treatments for NPC in the U.S. and only one approved product in Europe called miglustat. About Arimoclomol Arimoclomol is an investigational drug candidate that amplifies the production of heat-shock proteins (HSPs). HSPs can rescue defective misfolded proteins, clear protein aggregates, and improve the function of lysosomes. Arimoclomol is administered orally, crosses the blood brain barrier, and has been studied in seven Phase 1, four Phase 2 and one pivotal Phase 2/3 clinical trial. Arimoclomol is in clinical development at Orphazyme for the treatment of NPC, Gaucher disease, sIBM and ALS. Arimoclomol has received orphan drug designation for NPC, sIBM and ALS in the US and EU, as well as fast-track designation from the US Food and Drug Administration (FDA) for NPC, sIBM and ALS. In addition, arimoclomol has received breakthrough therapy designation and rare-pediatric disease designation from the FDA for NPC. Forward-Looking Statements This press release contains forward-looking statements, including statements relating to the Companys receipt of future milestone and royalty payments from Orphazyme and the achievement of long-term value for the Companys stockholders. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including risks and uncertainties relating to the ability of Orphazyme to obtain regulatory approval for, manufacture and commercialize its products and therapies that use arimoclomol; the results of future clinical trials involving arimoclomol; the amount, if any, of future milestone and royalty payments that we may receive from Orphazyme; and other risks and uncertainties described in the most recent annual and quarterly reports filed by the Company with the SEC and current reports filed since the date of the Companys most recent annual report. All forward-looking statements are based upon information available to the Company on the date the statements are first published. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. |
edtsum3211 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of SolarWinds Corporation (SolarWinds or the Company) (NYSE: SWI) on behalf of investors concerning the Companys possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On December 13, 2020, Reuters reported hackers alleged to be working for Russia have been monitoring email traffic at the U.S. Treasury and Commerce departments. The alleged hackers are believed to have breached the emails by deceptively interfering with updates released by SolarWinds, which services various government vendors in the executive branch, the military, and the intelligence services. On December 14, 2020, SolarWinds stated it has evidence that the weakness was introduced in its Orion monitoring products and existed in updates released between March and June 2020. On this news, the price of SolarWinds shares fell $3.93, or 17%, to close at $19.62 per share on December 14, 2020, thereby injuring investors. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased SolarWinds securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Answer: | The Law Offices of Frank R. Cruz Announces Investigation of SolarWinds Corporation (SWI) on Behalf of Investors | LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of SolarWinds Corporation (SolarWinds or the Company) (NYSE: SWI) on behalf of investors concerning the Companys possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On December 13, 2020, Reuters reported hackers alleged to be working for Russia have been monitoring email traffic at the U.S. Treasury and Commerce departments. The alleged hackers are believed to have breached the emails by deceptively interfering with updates released by SolarWinds, which services various government vendors in the executive branch, the military, and the intelligence services. On December 14, 2020, SolarWinds stated it has evidence that the weakness was introduced in its Orion monitoring products and existed in updates released between March and June 2020. On this news, the price of SolarWinds shares fell $3.93, or 17%, to close at $19.62 per share on December 14, 2020, thereby injuring investors. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased SolarWinds securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. |
edtsum3212 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN CLEMENTE, Calif., May 12, 2020 /PRNewswire/ --The Surfrider Foundation today released its annual Clean Water Report to protect public health and clean water as beaches across the nation start to reopen during the current phase of the COVID-19 pandemic. The report features case studies and the collective results from Surfrider's Blue Water Task Force, the largest volunteer-run beach water testing program in the country. It also highlights outcomes from Surfrider's Ocean Friendly Gardens program, which provides landscaping solutions to protect clean water and support resilient coasts. Each year, an estimated 180 million people visit beaches across the U.S. to enjoy some of the nation's most outstanding public areas. Surfrider's goal is to ensure that coastal waters are safe for recreation and that beachgoers have the necessary information to protect their health. To achieve that goal, more than 50 Blue Water Task Force labs across the country monitor water quality year-round so the public can find out where it's safe to surf, swim or play in the water. Last year, the Surfrider network processed 7,707 water samples collected from 484 sampling sites. Due to the ongoing pandemic, many beaches across the U.S. have been closed in recent weeks and are slowly beginning to reopen with new guidelines in place. While Surfrider has temporarily suspended its Blue Water Task Force operations to protect the health of volunteers and the public, these closures have highlighted the important intersection between beachgoing and public health. In fact, more than 20,000 health advisories are issued annually in the U.S. to protect beachgoers from exposure to bacteria and other illness-causing pathogens in the water. "In areas like Chicago, Illinois, where industrial discharges are polluting important recreational areas in Lake Michigan, and Florida, where toxic algae blooms are devastating the coasts, Surfrider's work to protect clean water is more critical than ever," said Surfrider's Water Quality Manager, Mara Dias. "Our chapters tackle regional water quality issues by testing for pollution, building ocean-friendly solutions, and informing the public of where it's safe to surf, swim and play in the ocean. We look forward to continuing our water testing programs as soon as health officials deem it safe to resume these efforts." Surfrider's Clean Water Report also highlights case studies of regional efforts to solve water pollution issues in Chicago, Illinois; Isla Vista, California; and Miami and St. Petersburg, Florida. These studies provide valuable examples of how communities can drive solutions to pollution problems and protect public health. They also show how local action can support the ocean recreation and tourism sector, which contributes $126 billion annually to our nation's GDP and provides 2.4 million jobs. The Surfrider network is not only testing the water, but it's also leading theOcean Friendly Gardens program across the nation. This program provides easy ways to transform yards and public spaces into idyllic gardens that protect water quality. With many Americans under some form of stay-at-home order because of COVID-19, it also offers a safe way for individuals to take positive action in their own yards. Last year, more than 75 Ocean Friendly Gardens were installed in coastal communities by the Surfrider network to reduce urban runoff pollution and protect clean water. Visit Surfrider.org to read Surfrider's Clean Water Report and learn how you can get involved in helping to protect clean water and healthy beaches. About the Surfrider Foundation The Surfrider Foundation is a nonprofit grassroots organization dedicated to the protection and enjoyment of our world's ocean, waves and beaches through a powerful network. Founded in 1984 by a handful of visionary surfers in Malibu, California, the Surfrider Foundation now maintains over one million supporters, activists and members, with more than 170 volunteer-led chapters and student clubs in the U.S., and more than 700 victories protecting our coasts. Learn more atsurfrider.org. SOURCE Surfrider Foundation Related Links http://www.surfrider.org
Answer: | Surfrider Foundation Releases Clean Water Report as America's Beaches Start to Reopen | SAN CLEMENTE, Calif., May 12, 2020 /PRNewswire/ --The Surfrider Foundation today released its annual Clean Water Report to protect public health and clean water as beaches across the nation start to reopen during the current phase of the COVID-19 pandemic. The report features case studies and the collective results from Surfrider's Blue Water Task Force, the largest volunteer-run beach water testing program in the country. It also highlights outcomes from Surfrider's Ocean Friendly Gardens program, which provides landscaping solutions to protect clean water and support resilient coasts. Each year, an estimated 180 million people visit beaches across the U.S. to enjoy some of the nation's most outstanding public areas. Surfrider's goal is to ensure that coastal waters are safe for recreation and that beachgoers have the necessary information to protect their health. To achieve that goal, more than 50 Blue Water Task Force labs across the country monitor water quality year-round so the public can find out where it's safe to surf, swim or play in the water. Last year, the Surfrider network processed 7,707 water samples collected from 484 sampling sites. Due to the ongoing pandemic, many beaches across the U.S. have been closed in recent weeks and are slowly beginning to reopen with new guidelines in place. While Surfrider has temporarily suspended its Blue Water Task Force operations to protect the health of volunteers and the public, these closures have highlighted the important intersection between beachgoing and public health. In fact, more than 20,000 health advisories are issued annually in the U.S. to protect beachgoers from exposure to bacteria and other illness-causing pathogens in the water. "In areas like Chicago, Illinois, where industrial discharges are polluting important recreational areas in Lake Michigan, and Florida, where toxic algae blooms are devastating the coasts, Surfrider's work to protect clean water is more critical than ever," said Surfrider's Water Quality Manager, Mara Dias. "Our chapters tackle regional water quality issues by testing for pollution, building ocean-friendly solutions, and informing the public of where it's safe to surf, swim and play in the ocean. We look forward to continuing our water testing programs as soon as health officials deem it safe to resume these efforts." Surfrider's Clean Water Report also highlights case studies of regional efforts to solve water pollution issues in Chicago, Illinois; Isla Vista, California; and Miami and St. Petersburg, Florida. These studies provide valuable examples of how communities can drive solutions to pollution problems and protect public health. They also show how local action can support the ocean recreation and tourism sector, which contributes $126 billion annually to our nation's GDP and provides 2.4 million jobs. The Surfrider network is not only testing the water, but it's also leading theOcean Friendly Gardens program across the nation. This program provides easy ways to transform yards and public spaces into idyllic gardens that protect water quality. With many Americans under some form of stay-at-home order because of COVID-19, it also offers a safe way for individuals to take positive action in their own yards. Last year, more than 75 Ocean Friendly Gardens were installed in coastal communities by the Surfrider network to reduce urban runoff pollution and protect clean water. Visit Surfrider.org to read Surfrider's Clean Water Report and learn how you can get involved in helping to protect clean water and healthy beaches. About the Surfrider Foundation The Surfrider Foundation is a nonprofit grassroots organization dedicated to the protection and enjoyment of our world's ocean, waves and beaches through a powerful network. Founded in 1984 by a handful of visionary surfers in Malibu, California, the Surfrider Foundation now maintains over one million supporters, activists and members, with more than 170 volunteer-led chapters and student clubs in the U.S., and more than 700 victories protecting our coasts. Learn more atsurfrider.org. SOURCE Surfrider Foundation Related Links http://www.surfrider.org |
edtsum3216 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: VICTOR, NY and SMITHS FALLS, ON, May 1, 2020 /PRNewswire/ - Constellation Brands, Inc. ("Constellation Brands") (NYSE: STZ) and (NYSE: STZ.B), a leading beverage alcohol company, and Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC), a leading diversified cannabis company, today announced the exercise by Greenstar Canada Investment Limited Partnership, an indirect, wholly-owned subsidiary of Constellation Brands, of an aggregate of 18,876,901 warrants to purchase common shares of Canopy Growth. The warrants, which were originally issued on November 2, 2017, were exercised at an exercise price of C$12.9783 per common share for an aggregate of approximately C$245 million. Upon issuance, the common shares represented approximately 5.1% of the issued and outstanding common shares of Canopy Growth. As a result of the acquisition of new common shares, Constellation Brands now indirectly holds, in the aggregate, 142,253,802 common shares, 139,745,453 warrants to purchase common shares and C$200,000,000 principal amount of senior notes. Collectively, the common shares increase Constellation Brands' ownership of Canopy Growth to 38.6% of the issued and outstanding common shares.Assuming full exercise of all remaining warrants and full conversion of the notes (but for these purposes excluding any effect from a Canopy Growth exercise of its right to acquire Acreage Holdings, Inc. pursuant to its option under the plan of arrangement previously announced on June 27, 2019) Constellation Brands would own approximately 55.8% of the issued and outstanding common shares of Canopy Growth. "While global legalization of cannabis is still in its infancy, we continue to believe the long-term opportunity in this evolving market is substantial," said Bill Newlands, president and chief executive officer, Constellation Brands. "Canopy is best positioned to win in the emerging cannabis space and we are confident in the strategic direction of the company under David Klein and his team." "This additional investment validates the work our team has done since attracting the initial investment in 2017. It also strengthens our ability to pursue the immense market and product opportunities available to Canopy in Canada, the U.S. and other key global markets," said David Klein, chief executive officer, Canopy Growth.Constellation Brands may from time to time acquire or dispose of common shares or other securities of Canopy Growth or exercise its warrants in the future, either on the open market or in private transactions, in each case, depending on a number of factors, including general market and economic conditions and other available investment opportunities. Depending on market conditions, general economic and industry conditions, Canopy Growth's business and financial condition and/or other relevant factors, Constellation Brands may develop other plans or intentions in the future.A copy of the early warning report filed in connection with this press release will be available on Canopy Growth's profile on SEDAR at www.sedar.comor may be obtained by contacting Constellation Brands' Investor Center at 1-888-922-2150.About Constellation Brands At Constellation Brands (NYSE: STZ and STZ.B), our mission is to build brands that people love because we believe sharing a toast, unwinding after a day, celebrating milestones, and helping people connect, are Worth Reaching For. It's worth our dedication, hard work, and the bold calculated risks we take to deliver more for our consumers, trade partners, shareholders, and communities in which we live and work. It's what has made us one of the fastest-growing large CPG companies in the U.S. at retail, and it drives our pursuit to deliver what's next.Today, we are a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Every day, people reach for our high-end, iconic imported beer brands such as Corona Extra, Corona Light, Corona Premier, Modelo Especial, Modelo Negra, and Pacifico, and our high-quality premium wine and spirits brands, including the Robert Mondavi brand family, Kim Crawford, Meiomi, The Prisoner brand family, SVEDKA Vodka, Casa Noble Tequila, and High West Whiskey.But we won't stop here. Our visionary leadership team and passionate employees from barrel room to boardroom are reaching for the next level, to explore the boundaries of the beverage alcohol industry and beyond. Join us in discovering what's Worth Reaching For.To learn more, follow us on Twitter @cbrands and visit www.cbrands.com.About Canopy Growth Corporation Canopy Growth (TSX:WEED,NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth's subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.Canopy Growth's medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visitwww.canopygrowth.com.Forward-Looking Statements This news release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, including statements about Constellation Brands' future ownership of shares of Canopy Growth, the possibility that Canopy Growth might exercise its right to acquire Acreage Holdings, Inc. and Canopy Growth's ability to continue its pursuit of market opportunities and success. The words "if", "expect," "intend" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These statements may relate to business strategy, future operations, prospects, plans and objectives of management, as well as information concerning expected actions of third parties. All forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those set forth in, or implied by, such forward-looking statements. The forward-looking statements are based on management's current expectations and should not be construed in any manner as a guarantee that such results will in fact occur or will occur on the timetable contemplated hereby. All forward-looking statements speak only as of the date of this news release and neither Constellation Brands nor Canopy Growth undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition to risks and uncertainties associated with ordinary business operations, the forward-looking statements contained in this news release are subject to other risks and uncertainties and other factors and uncertainties disclosed from time-to-time in Constellation Brands's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended February 29, 2020 and in Canopy Growth'sfilings with the Canadian Securities Administration, including in Canopy Growth's Annual Information Form filed on SEDAR on June 25, 2019 under the heading "Risk Factors", or with the United States Securities Exchange Commission, which could cause actual future performance to differ from current expectations.SOURCE Canopy Growth Corporation Related Links canopygrowth.com
Answer: | Constellation Brands Exercises Warrants to Acquire Shares in Canopy Growth, Reinforcing Confidence in Canopy Growth's Ability to Win Long-Term in Emerging Cannabis Industry | VICTOR, NY and SMITHS FALLS, ON, May 1, 2020 /PRNewswire/ - Constellation Brands, Inc. ("Constellation Brands") (NYSE: STZ) and (NYSE: STZ.B), a leading beverage alcohol company, and Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC), a leading diversified cannabis company, today announced the exercise by Greenstar Canada Investment Limited Partnership, an indirect, wholly-owned subsidiary of Constellation Brands, of an aggregate of 18,876,901 warrants to purchase common shares of Canopy Growth. The warrants, which were originally issued on November 2, 2017, were exercised at an exercise price of C$12.9783 per common share for an aggregate of approximately C$245 million. Upon issuance, the common shares represented approximately 5.1% of the issued and outstanding common shares of Canopy Growth. As a result of the acquisition of new common shares, Constellation Brands now indirectly holds, in the aggregate, 142,253,802 common shares, 139,745,453 warrants to purchase common shares and C$200,000,000 principal amount of senior notes. Collectively, the common shares increase Constellation Brands' ownership of Canopy Growth to 38.6% of the issued and outstanding common shares.Assuming full exercise of all remaining warrants and full conversion of the notes (but for these purposes excluding any effect from a Canopy Growth exercise of its right to acquire Acreage Holdings, Inc. pursuant to its option under the plan of arrangement previously announced on June 27, 2019) Constellation Brands would own approximately 55.8% of the issued and outstanding common shares of Canopy Growth. "While global legalization of cannabis is still in its infancy, we continue to believe the long-term opportunity in this evolving market is substantial," said Bill Newlands, president and chief executive officer, Constellation Brands. "Canopy is best positioned to win in the emerging cannabis space and we are confident in the strategic direction of the company under David Klein and his team." "This additional investment validates the work our team has done since attracting the initial investment in 2017. It also strengthens our ability to pursue the immense market and product opportunities available to Canopy in Canada, the U.S. and other key global markets," said David Klein, chief executive officer, Canopy Growth.Constellation Brands may from time to time acquire or dispose of common shares or other securities of Canopy Growth or exercise its warrants in the future, either on the open market or in private transactions, in each case, depending on a number of factors, including general market and economic conditions and other available investment opportunities. Depending on market conditions, general economic and industry conditions, Canopy Growth's business and financial condition and/or other relevant factors, Constellation Brands may develop other plans or intentions in the future.A copy of the early warning report filed in connection with this press release will be available on Canopy Growth's profile on SEDAR at www.sedar.comor may be obtained by contacting Constellation Brands' Investor Center at 1-888-922-2150.About Constellation Brands At Constellation Brands (NYSE: STZ and STZ.B), our mission is to build brands that people love because we believe sharing a toast, unwinding after a day, celebrating milestones, and helping people connect, are Worth Reaching For. It's worth our dedication, hard work, and the bold calculated risks we take to deliver more for our consumers, trade partners, shareholders, and communities in which we live and work. It's what has made us one of the fastest-growing large CPG companies in the U.S. at retail, and it drives our pursuit to deliver what's next.Today, we are a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Every day, people reach for our high-end, iconic imported beer brands such as Corona Extra, Corona Light, Corona Premier, Modelo Especial, Modelo Negra, and Pacifico, and our high-quality premium wine and spirits brands, including the Robert Mondavi brand family, Kim Crawford, Meiomi, The Prisoner brand family, SVEDKA Vodka, Casa Noble Tequila, and High West Whiskey.But we won't stop here. Our visionary leadership team and passionate employees from barrel room to boardroom are reaching for the next level, to explore the boundaries of the beverage alcohol industry and beyond. Join us in discovering what's Worth Reaching For.To learn more, follow us on Twitter @cbrands and visit www.cbrands.com.About Canopy Growth Corporation Canopy Growth (TSX:WEED,NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth's subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.Canopy Growth's medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visitwww.canopygrowth.com.Forward-Looking Statements This news release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, including statements about Constellation Brands' future ownership of shares of Canopy Growth, the possibility that Canopy Growth might exercise its right to acquire Acreage Holdings, Inc. and Canopy Growth's ability to continue its pursuit of market opportunities and success. The words "if", "expect," "intend" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These statements may relate to business strategy, future operations, prospects, plans and objectives of management, as well as information concerning expected actions of third parties. All forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those set forth in, or implied by, such forward-looking statements. The forward-looking statements are based on management's current expectations and should not be construed in any manner as a guarantee that such results will in fact occur or will occur on the timetable contemplated hereby. All forward-looking statements speak only as of the date of this news release and neither Constellation Brands nor Canopy Growth undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition to risks and uncertainties associated with ordinary business operations, the forward-looking statements contained in this news release are subject to other risks and uncertainties and other factors and uncertainties disclosed from time-to-time in Constellation Brands's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended February 29, 2020 and in Canopy Growth'sfilings with the Canadian Securities Administration, including in Canopy Growth's Annual Information Form filed on SEDAR on June 25, 2019 under the heading "Risk Factors", or with the United States Securities Exchange Commission, which could cause actual future performance to differ from current expectations.SOURCE Canopy Growth Corporation Related Links canopygrowth.com |
edtsum3224 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OMAHA, Neb.--(BUSINESS WIRE)--driverDOC, a supply chain technology company, today announced it has closed a $400K seed round led by The Pearl Fund with additional co-investments from angel investors. The SaaS startup plans to use the funds to accelerate growth for its cloud-based platform, currently available on Android and iOS. From the driver's cab to the supply chain's back office, the industry's manual processes and paper documents waste time and money. driverDOC is addressing the inefficiencies of the logistics supply chain by creating a better driver experience and integrated data flow. Founded in 2019 by Josh Kolar, who brings over a decade of experience in the transportation and financial data management industries with past roles at companies including UPS, Union Pacific, Werner and KPMGdriverDOC believes drivers are the greatestyet most underutilized asset in simplifying the supply chain's back office. While the largest transportation companies have sophisticated, automated supply chain tracking which enables accurate data flow and efficient billings and collections, an estimated 97% of companies in the trucking industry have fleet sizes of 20 or fewer trucksand these companies rely heavily on paper documents and manual processes which lead to delays in invoicing and distracting status calls to drivers over the road. Additionally, the manual collection of freight data results in delayed communication to the supply chain including time-sensitive shippers and receivers. We couldnt be more pleased to have the confidence of our investors as we simplify the overall driver experience, automate data aggregation and provide shipment visibility throughout the supply chain, said Kolar. As our platform grows and evolves, we look forward to ensuring drivers health while in transit and reducing distractions in the cab, which ultimately protects the safety of American highways. driverDOC starts with the driverthe most knowledgeable participant in the supply chainand focuses on automating manual processes that prohibit the flow of shipment data. Its platform arms drivers with a simple, low-touch application that reduces some of the most frustrating aspects of their jobs, including completing and delivering paperwork, unnecessary wait times, and potentially unsafe communication requirements while in transit. With a five-minute adoption, driverDOC provides real-time ETA, location visibility, digital documents and other critical data to the entire supply chain. American highways are safer when automated data replace phone, email and text communications to truck drivers. Brian Phillips, managing partner of The Pearl Fund, the first Opportunity Zone venture capital fund in the U.S. and ranked one of the Top 10 Opportunity Zone Funds by Forbes, stated: As the industry moves towards autonomous vehicles, it must first address that true autonomy will be achieved only if the data flow does not rely on paper documents and driver conversations. driverDOC is well-positioned to be a major player in the trucking and transportation ecosystem as it is facilitating a more efficient data flow that is accessible to the shipper, receiver and logistics provider. Through its partnership with Truckers Against Trafficking (TAT), a nonprofit organization working to combat sex trafficking through the trucking, bus and energy industries, driverDOC is joining in the effort to empower and equip the trucking industry to fight against human trafficking along our roadways. In addition, driverDOCs app will soon include a way to help more trucking companies and their drivers become TAT certified. January is National Slavery and Human Trafficking Prevention Month and driverDOC is proud to support the work of TAT. About driverDOC driverDoc is a supply chain, SaaS company focused on the driver experience. We simplify logistics in the hand of the driver. Visit https://www.driverdoc.io/ for more information. About The Pearl Fund Led by serial entrepreneur and global economic development expert Brian Phillips, who has been a founding member of over a dozen startups (two IPOs, two acquisitions and one sold via an MBO), The Pearl Fund focuses on high-potential businesses that can yield a 10X+ tax-free return along with positive social and economic impact in OZ communities. As a pioneer in OZ investing beyond real estate, The Pearl Fund has also developed a growing network of affiliated business-focused Pearl Funds, each with a particular geographic and industry lens. For more information, visit www.thepearl.fund.
Answer: | driverDOC Announces $400K Seed Round to Digitize the Trucking Experience and Make U.S. Highways Safer Funding marks the first Opportunity Zone startup in transportation and trucking to raise capital in the region | OMAHA, Neb.--(BUSINESS WIRE)--driverDOC, a supply chain technology company, today announced it has closed a $400K seed round led by The Pearl Fund with additional co-investments from angel investors. The SaaS startup plans to use the funds to accelerate growth for its cloud-based platform, currently available on Android and iOS. From the driver's cab to the supply chain's back office, the industry's manual processes and paper documents waste time and money. driverDOC is addressing the inefficiencies of the logistics supply chain by creating a better driver experience and integrated data flow. Founded in 2019 by Josh Kolar, who brings over a decade of experience in the transportation and financial data management industries with past roles at companies including UPS, Union Pacific, Werner and KPMGdriverDOC believes drivers are the greatestyet most underutilized asset in simplifying the supply chain's back office. While the largest transportation companies have sophisticated, automated supply chain tracking which enables accurate data flow and efficient billings and collections, an estimated 97% of companies in the trucking industry have fleet sizes of 20 or fewer trucksand these companies rely heavily on paper documents and manual processes which lead to delays in invoicing and distracting status calls to drivers over the road. Additionally, the manual collection of freight data results in delayed communication to the supply chain including time-sensitive shippers and receivers. We couldnt be more pleased to have the confidence of our investors as we simplify the overall driver experience, automate data aggregation and provide shipment visibility throughout the supply chain, said Kolar. As our platform grows and evolves, we look forward to ensuring drivers health while in transit and reducing distractions in the cab, which ultimately protects the safety of American highways. driverDOC starts with the driverthe most knowledgeable participant in the supply chainand focuses on automating manual processes that prohibit the flow of shipment data. Its platform arms drivers with a simple, low-touch application that reduces some of the most frustrating aspects of their jobs, including completing and delivering paperwork, unnecessary wait times, and potentially unsafe communication requirements while in transit. With a five-minute adoption, driverDOC provides real-time ETA, location visibility, digital documents and other critical data to the entire supply chain. American highways are safer when automated data replace phone, email and text communications to truck drivers. Brian Phillips, managing partner of The Pearl Fund, the first Opportunity Zone venture capital fund in the U.S. and ranked one of the Top 10 Opportunity Zone Funds by Forbes, stated: As the industry moves towards autonomous vehicles, it must first address that true autonomy will be achieved only if the data flow does not rely on paper documents and driver conversations. driverDOC is well-positioned to be a major player in the trucking and transportation ecosystem as it is facilitating a more efficient data flow that is accessible to the shipper, receiver and logistics provider. Through its partnership with Truckers Against Trafficking (TAT), a nonprofit organization working to combat sex trafficking through the trucking, bus and energy industries, driverDOC is joining in the effort to empower and equip the trucking industry to fight against human trafficking along our roadways. In addition, driverDOCs app will soon include a way to help more trucking companies and their drivers become TAT certified. January is National Slavery and Human Trafficking Prevention Month and driverDOC is proud to support the work of TAT. About driverDOC driverDoc is a supply chain, SaaS company focused on the driver experience. We simplify logistics in the hand of the driver. Visit https://www.driverdoc.io/ for more information. About The Pearl Fund Led by serial entrepreneur and global economic development expert Brian Phillips, who has been a founding member of over a dozen startups (two IPOs, two acquisitions and one sold via an MBO), The Pearl Fund focuses on high-potential businesses that can yield a 10X+ tax-free return along with positive social and economic impact in OZ communities. As a pioneer in OZ investing beyond real estate, The Pearl Fund has also developed a growing network of affiliated business-focused Pearl Funds, each with a particular geographic and industry lens. For more information, visit www.thepearl.fund. |
edtsum3231 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, Feb. 22, 2021 /PRNewswire/ -- The "Geopolymer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global geopolymer market reached a value of US$ 4.56 Billion in 2020. Looking forward, the publisher expects the global geopolymer market to exhibit strong growth during the next five yearsGeopolymers are inorganic ceramic materials characterized by networks of mineral molecules linked with covalent bonds. They can be classified into two groups, namely, pure inorganic and hybrid (organic-inorganic) geopolymers. Although geopolymers like obsidian occur naturally, they can also be synthesized chemically. Geopolymers have an amorphous microstructure at room temperature owing to which they have high heat resistance and can be used for thermal insulation. Commercially produced geopolymers are currently used in fire and heat resistant coatings and adhesives, medicinal applications, high-temperature ceramics, and toxic and radioactive waste encapsulation. Global Geopolymer Market Drivers Geopolymers offer advantages such as high strength, ultra-porosity, low drying shrinkage, low creep and acid resistance. On account of these properties, they are used to substitute Portland cement as a binder in concrete. They are also utilized for repairing bridges, tunnels, roads, and in the rehabilitation of pipes and structures in the civil infrastructure, oil and gas, and chemical industries. Moreover, geopolymers are cheaper than Portland cement, and their production emits lesser carbon dioxide. With rising environmental regulations and emission strain on the cement industry, the demand for geopolymers is increasing. Furthermore, factors such as technological developments and innovations in the construction sector are also contributing to the growth of the global geopolymer market. Market Summary: Based on the application, the market has been segmented into cement and concrete, furnace and reactor insulators, composites, and decorative artifacts. The cement and concrete segment currently accounts for the largest share. On the basis of end-use industries, the market has been segmented into building construction, infrastructure, industrial, art and decoration, and others. Region-wise, the market has been segmented into Asia Pacific, Europe, North America, Middle East and Africa, and Latin America. Amongst these, Asia Pacific is the biggest market, accounting for the majority of the global share. The competitive landscape of the market has also been examined with some of the key players being Imerys Group / Ags Argil's & Mineraux, Milliken & Company Inc., PCI Augsburg GMBH, DowDuPont, Rocla, Wagners, Universal Enterprise, Schlumberger Ltd, Murray & Roberts Cementation Co. Ltd, Banah UK Ltd, Zeobond Pty Ltd, Uretek, BASF, Corning Inc., Nu-Core and Pyromeral Systems. Key Questions Answered in This Report: How has the global geopolymer market performed so far and how will it perform in the coming years? What are the key regional markets in the global geopolymer industry? What has been the impact of COVID-19 on the global geopolymer market? What is the breakup of the global geopolymer market on the basis of application? What is the breakup of the global geopolymer market on the basis of end-use industry? What are the various stages in the value chain of the global geopolymer market? What are the key driving factors and challenges in the global geopolymer market? What is the structure of the global geopolymer market and who are the key players? What is the degree of competition in the global geopolymer market? How are geopolymers manufactured? Key Topics Covered: 1 Preface2 Scope and Methodology2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.4 Market Estimation2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Properties4.3 Key Industry Trends5 Global Geopolymer Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Breakup by Application5.5 Market Breakup by End-Use Industry5.6 Market Breakup by Region5.7 Market Forecast6 Market Breakup by Application6.1 Cement and Concrete6.2 Furnace and Reactor Insulators6.3 Composites6.4 Decorative Artifacts7 Market Breakup by End-Use Industry7.1 Building Construction7.2 Infrastructure7.3 Industrial7.4 Art and Decoration7.5 Others8 Market Breakup by Region8.1 Asia Pacific8.2 Europe8.3 North America8.4 Middle East and Africa8.5 Latin America9 Global Geopolymer Industry: SWOT Analysis9.1 Overview9.2 Strengths9.3 Weaknesses9.4 Opportunities9.5 Threats10 Global Geopolymer Industry: Value Chain Analysis10.1 Overview10.2 Research and Development10.3 Raw Material Procurement10.4 Manufacturing10.5 Marketing10.6 Distribution10.7 End-Use11 Global Geopolymer Industry: Porters Five Forces Analysis11.1 Overview11.2 Bargaining Power of Buyers11.3 Bargaining Power of Suppliers11.4 Degree of Competition11.5 Threat of New Entrants11.6 Threat of Substitutes12 Global Geopolymer Industry: Price Analysis12.1 Price Indicators12.2 Price Structure12.3 Margin Analysis13 Geopolymer Manufacturing Process13.1 Product Overview13.2 Raw Material Requirements13.3 Manufacturing Process13.4 Key Success and Risk Factors14 Competitive Landscape14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players Imerys Group / Ags Argil's & Mineraux Milliken & Company Inc. PCI Augsburg GMBH DowDuPont Rocla Wagners Universal Enterprise Schlumberger Ltd Murray & Roberts Cementation Co. Ltd Banah UK Ltd Zeobond Pty Ltd Uretek BASF Corning Inc. Nu-Core and Pyromeral Systems For more information about this report visit https://www.researchandmarkets.com/r/nq22to Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | Global Geopolymer Markets, 2021-2026: Technological Developments and Innovations in Construction are Contributing to Growth | DUBLIN, Feb. 22, 2021 /PRNewswire/ -- The "Geopolymer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global geopolymer market reached a value of US$ 4.56 Billion in 2020. Looking forward, the publisher expects the global geopolymer market to exhibit strong growth during the next five yearsGeopolymers are inorganic ceramic materials characterized by networks of mineral molecules linked with covalent bonds. They can be classified into two groups, namely, pure inorganic and hybrid (organic-inorganic) geopolymers. Although geopolymers like obsidian occur naturally, they can also be synthesized chemically. Geopolymers have an amorphous microstructure at room temperature owing to which they have high heat resistance and can be used for thermal insulation. Commercially produced geopolymers are currently used in fire and heat resistant coatings and adhesives, medicinal applications, high-temperature ceramics, and toxic and radioactive waste encapsulation. Global Geopolymer Market Drivers Geopolymers offer advantages such as high strength, ultra-porosity, low drying shrinkage, low creep and acid resistance. On account of these properties, they are used to substitute Portland cement as a binder in concrete. They are also utilized for repairing bridges, tunnels, roads, and in the rehabilitation of pipes and structures in the civil infrastructure, oil and gas, and chemical industries. Moreover, geopolymers are cheaper than Portland cement, and their production emits lesser carbon dioxide. With rising environmental regulations and emission strain on the cement industry, the demand for geopolymers is increasing. Furthermore, factors such as technological developments and innovations in the construction sector are also contributing to the growth of the global geopolymer market. Market Summary: Based on the application, the market has been segmented into cement and concrete, furnace and reactor insulators, composites, and decorative artifacts. The cement and concrete segment currently accounts for the largest share. On the basis of end-use industries, the market has been segmented into building construction, infrastructure, industrial, art and decoration, and others. Region-wise, the market has been segmented into Asia Pacific, Europe, North America, Middle East and Africa, and Latin America. Amongst these, Asia Pacific is the biggest market, accounting for the majority of the global share. The competitive landscape of the market has also been examined with some of the key players being Imerys Group / Ags Argil's & Mineraux, Milliken & Company Inc., PCI Augsburg GMBH, DowDuPont, Rocla, Wagners, Universal Enterprise, Schlumberger Ltd, Murray & Roberts Cementation Co. Ltd, Banah UK Ltd, Zeobond Pty Ltd, Uretek, BASF, Corning Inc., Nu-Core and Pyromeral Systems. Key Questions Answered in This Report: How has the global geopolymer market performed so far and how will it perform in the coming years? What are the key regional markets in the global geopolymer industry? What has been the impact of COVID-19 on the global geopolymer market? What is the breakup of the global geopolymer market on the basis of application? What is the breakup of the global geopolymer market on the basis of end-use industry? What are the various stages in the value chain of the global geopolymer market? What are the key driving factors and challenges in the global geopolymer market? What is the structure of the global geopolymer market and who are the key players? What is the degree of competition in the global geopolymer market? How are geopolymers manufactured? Key Topics Covered: 1 Preface2 Scope and Methodology2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.4 Market Estimation2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Properties4.3 Key Industry Trends5 Global Geopolymer Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Breakup by Application5.5 Market Breakup by End-Use Industry5.6 Market Breakup by Region5.7 Market Forecast6 Market Breakup by Application6.1 Cement and Concrete6.2 Furnace and Reactor Insulators6.3 Composites6.4 Decorative Artifacts7 Market Breakup by End-Use Industry7.1 Building Construction7.2 Infrastructure7.3 Industrial7.4 Art and Decoration7.5 Others8 Market Breakup by Region8.1 Asia Pacific8.2 Europe8.3 North America8.4 Middle East and Africa8.5 Latin America9 Global Geopolymer Industry: SWOT Analysis9.1 Overview9.2 Strengths9.3 Weaknesses9.4 Opportunities9.5 Threats10 Global Geopolymer Industry: Value Chain Analysis10.1 Overview10.2 Research and Development10.3 Raw Material Procurement10.4 Manufacturing10.5 Marketing10.6 Distribution10.7 End-Use11 Global Geopolymer Industry: Porters Five Forces Analysis11.1 Overview11.2 Bargaining Power of Buyers11.3 Bargaining Power of Suppliers11.4 Degree of Competition11.5 Threat of New Entrants11.6 Threat of Substitutes12 Global Geopolymer Industry: Price Analysis12.1 Price Indicators12.2 Price Structure12.3 Margin Analysis13 Geopolymer Manufacturing Process13.1 Product Overview13.2 Raw Material Requirements13.3 Manufacturing Process13.4 Key Success and Risk Factors14 Competitive Landscape14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players Imerys Group / Ags Argil's & Mineraux Milliken & Company Inc. PCI Augsburg GMBH DowDuPont Rocla Wagners Universal Enterprise Schlumberger Ltd Murray & Roberts Cementation Co. Ltd Banah UK Ltd Zeobond Pty Ltd Uretek BASF Corning Inc. Nu-Core and Pyromeral Systems For more information about this report visit https://www.researchandmarkets.com/r/nq22to Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum3236 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: VANCOUVER, Wash., April 3, 2020 /PRNewswire/ --Bridge Chiropractic is offering free chiropractic care to physicians, physician's assistants and registered nurses working on the front lines of healthcare in hospital emergency rooms and urgent care centers during this critical and demanding time for healthcare professionals. Typically, hospital staff members spend 10-12 hours on their feet during each shift, a number that is likely much greater during times like these when hospital emergency departments and urgent care centers are experiencing an influx of patients. Standing for several hours can take a toll on anyone's spine, which can cause muscle soreness, headaches, and back and neck pain. At Bridge Chiropractic, we specialize in helping patients find relief from pain and discomfort through a unique combination of chiropractic adjustments and therapies. With four locations in Salmon Creek, Fisher's Landing, Mill Plain and Downtown Vancouver, we are able to serve a widespread population of healthcare professionals in Vancouver, WA, and the surrounding area. "Our community's front-line medical workers are a critical piece in helping us combat our current COVID-19 crisis.These teams are under extreme amounts of mental and physical stress while providing the necessary care. The doctors and support staff of the Bridge Chiropractic Clinics want to help all of the front liners stay healthy so they can continue to focus on helping our community recover from this crisis as quickly as possible. Extraordinary times call for extraordinary actions.That's why we are offering complimentary chiropractic care to support the hardworking men and women serving in our hospitals and healthcare centers," says Dr. Paul Reed, Owner and Founder of Bridge Chiropractic. We're thrilled to be able to support healthcare professionals serving on the front lines during the COVID-19 pandemic. Any physician, physician's assistant or registered nurse who currently works in a hospital emergency department or urgent care center is eligible to receive complimentary care at Bridge Chiropractic. About Bridge Chiropractic At Vancouver Washington's Bridge Chiropractic, we are a family chiropractic practice proudly serving 4 Washington locations for your convenience. We are a place for both children and adults of all ages. Under our chiropractic care, we have built specialized techniques for 20+ years. All of these techniques are focused on reducing and eliminating your pain. To learn more visit us at: bridgechiropractic.com Contact: Amanda RoszkowskiTelephone: 630-399-9047Email: [emailprotected] SOURCE Bridge Chiropractic Related Links https://bridgechiropractic.com
Answer: | Bridge Chiropractic Offers Free Care to Frontline Healthcare Professionals During COVID-19, physicians, PA's and RN's receive complimentary chiropractic care | VANCOUVER, Wash., April 3, 2020 /PRNewswire/ --Bridge Chiropractic is offering free chiropractic care to physicians, physician's assistants and registered nurses working on the front lines of healthcare in hospital emergency rooms and urgent care centers during this critical and demanding time for healthcare professionals. Typically, hospital staff members spend 10-12 hours on their feet during each shift, a number that is likely much greater during times like these when hospital emergency departments and urgent care centers are experiencing an influx of patients. Standing for several hours can take a toll on anyone's spine, which can cause muscle soreness, headaches, and back and neck pain. At Bridge Chiropractic, we specialize in helping patients find relief from pain and discomfort through a unique combination of chiropractic adjustments and therapies. With four locations in Salmon Creek, Fisher's Landing, Mill Plain and Downtown Vancouver, we are able to serve a widespread population of healthcare professionals in Vancouver, WA, and the surrounding area. "Our community's front-line medical workers are a critical piece in helping us combat our current COVID-19 crisis.These teams are under extreme amounts of mental and physical stress while providing the necessary care. The doctors and support staff of the Bridge Chiropractic Clinics want to help all of the front liners stay healthy so they can continue to focus on helping our community recover from this crisis as quickly as possible. Extraordinary times call for extraordinary actions.That's why we are offering complimentary chiropractic care to support the hardworking men and women serving in our hospitals and healthcare centers," says Dr. Paul Reed, Owner and Founder of Bridge Chiropractic. We're thrilled to be able to support healthcare professionals serving on the front lines during the COVID-19 pandemic. Any physician, physician's assistant or registered nurse who currently works in a hospital emergency department or urgent care center is eligible to receive complimentary care at Bridge Chiropractic. About Bridge Chiropractic At Vancouver Washington's Bridge Chiropractic, we are a family chiropractic practice proudly serving 4 Washington locations for your convenience. We are a place for both children and adults of all ages. Under our chiropractic care, we have built specialized techniques for 20+ years. All of these techniques are focused on reducing and eliminating your pain. To learn more visit us at: bridgechiropractic.com Contact: Amanda RoszkowskiTelephone: 630-399-9047Email: [emailprotected] SOURCE Bridge Chiropractic Related Links https://bridgechiropractic.com |
edtsum3238 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the future regulation and detection of dioxins. Dioxins are a group of chemical compounds that are considered persistent environmental pollutants and subsequently find their way into the food chain. These chemicals are listed as persistent organic pollutants under the United Nations Stockholm Convention and are therefore regulated globally, meaning that accurate, reliable testing methods for dioxins are essential. The previous US EPA dioxin testing method, EPA 1613B, required the use of magnetic sector instruments. These aging platforms are both difficult and expensive to use and maintain and therefore suffer from decreasing vendor and instrument availability. There was a crucial need for an alternative testing method as the current promulgated method of testing relies on 30-year-old mass spectrometry technology which is no longer being supported by most instrument manufacturers, said Coreen Hamilton, a senior scientist with SGS Environmental, Health, and Safety who worked on the project. We have worked in close collaboration over the past two years with the EPA and equipment manufacturers, including Agilent, to find a new method that would take advantage of the latest technological advancements such as modern tandem mass spectrometers. This new technology is already widely used in contract testing labs and is less expensive to purchase, operate, and maintain, increasing the number of laboratories able to perform this testing. This collaboration between Agilent, SGS AXYS, and the US EPA shows our commitment to provide the tools for labs to ensure a safer and healthier environment for all, stated Tarun Anumol, Director, Global Environment & Food Markets, at Agilent. The creation of this new method to analyze dioxins and furans using a GC/TQ allows environmental labs the ability to employ the newest technology to measure these contaminants more accurately and reliably while allowing them to reduce operational and laboratory costs at the same time. This effort also shows Agilents continued commitment to support environmental testing as a market leader in this space for over 40 years, Anumol added. The newly approved Agilent SGS AXYS Method 16130 is set to become a key testing solution for environmental laboratories testing regulated contaminants. This new method will greatly reduce exposure to dioxins found in soil, agricultural land, and water. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. In its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.
Answer: | Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ Expanding laboratory dioxin testing with the latest technology | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the future regulation and detection of dioxins. Dioxins are a group of chemical compounds that are considered persistent environmental pollutants and subsequently find their way into the food chain. These chemicals are listed as persistent organic pollutants under the United Nations Stockholm Convention and are therefore regulated globally, meaning that accurate, reliable testing methods for dioxins are essential. The previous US EPA dioxin testing method, EPA 1613B, required the use of magnetic sector instruments. These aging platforms are both difficult and expensive to use and maintain and therefore suffer from decreasing vendor and instrument availability. There was a crucial need for an alternative testing method as the current promulgated method of testing relies on 30-year-old mass spectrometry technology which is no longer being supported by most instrument manufacturers, said Coreen Hamilton, a senior scientist with SGS Environmental, Health, and Safety who worked on the project. We have worked in close collaboration over the past two years with the EPA and equipment manufacturers, including Agilent, to find a new method that would take advantage of the latest technological advancements such as modern tandem mass spectrometers. This new technology is already widely used in contract testing labs and is less expensive to purchase, operate, and maintain, increasing the number of laboratories able to perform this testing. This collaboration between Agilent, SGS AXYS, and the US EPA shows our commitment to provide the tools for labs to ensure a safer and healthier environment for all, stated Tarun Anumol, Director, Global Environment & Food Markets, at Agilent. The creation of this new method to analyze dioxins and furans using a GC/TQ allows environmental labs the ability to employ the newest technology to measure these contaminants more accurately and reliably while allowing them to reduce operational and laboratory costs at the same time. This effort also shows Agilents continued commitment to support environmental testing as a market leader in this space for over 40 years, Anumol added. The newly approved Agilent SGS AXYS Method 16130 is set to become a key testing solution for environmental laboratories testing regulated contaminants. This new method will greatly reduce exposure to dioxins found in soil, agricultural land, and water. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. In its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook. |
edtsum3239 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO--(BUSINESS WIRE)--Oomnitza, the worlds leading provider of IT asset tracking software, deployed its Fall 20 Release, giving enterprise businesses a fully-integrated, real-time view into their entire IT estate, covering hardware, software, cloud and virtual solutions. This updated capability dramatically simplifies regulatory compliance, cybersecurity and procurement, saving customers time and providing the information needed to optimize business processes. Amid a work-from-home reality, companies globally are dealing with an accelerated digital transformation across their business. Traditional IT asset management systems provide incomplete, siloed data by tracking IT assets by category. Oomnitza delivers customers a fully integrated, real-time understanding of all assets, entirely automating and significantly simplifying asset tracking across all categories and workflows. Oomnitzas Fall 20 Release is a major milestone for our customers, providing them with a complete picture of how their hardware, software, cloud and IoT devices are used, said Oomnitza CTO Udo Waibel. The biggest and most successful companies in the world work with Oomnitza, and its more critical than ever for our customers to treat their IT infrastructure as a strategic asset. Oomnitza helps them do that. Oomnitza enables teams to do their work more efficiently and accurately. With bidirectional information flow between assets and the systems that track and manage them, customers can far more easily comply with compliance requirements with ready and on-demand data and secure IT infrastructure. Tracking assets is the first step in securing them, and this enables business teams with real-time access to finance, procurement, HR, and other essential information to business processes. For more information about Oomnitzas Fall 20 Release, visit our website. About Oomnitza Oomnitza provides the first enterprise-wide view of your entire IT estate. By connecting hardware, software, cloud, and IoT, we empower our customers to create and automate workflows to improve security, compliance, audit, and employee experience, accelerating time to value. Customers range from the worlds largest enterprises to pre-IPO companies, across every sector including technology, healthcare, e-Commerce and government. Oomnitza is based in San Francisco. For more information, visit us at www.oomnitza.com.
Answer: | Oomnitzas Fall 20 Software Release Delivers Customers Industry-First View into Their Complete IT Infrastructure | SAN FRANCISCO--(BUSINESS WIRE)--Oomnitza, the worlds leading provider of IT asset tracking software, deployed its Fall 20 Release, giving enterprise businesses a fully-integrated, real-time view into their entire IT estate, covering hardware, software, cloud and virtual solutions. This updated capability dramatically simplifies regulatory compliance, cybersecurity and procurement, saving customers time and providing the information needed to optimize business processes. Amid a work-from-home reality, companies globally are dealing with an accelerated digital transformation across their business. Traditional IT asset management systems provide incomplete, siloed data by tracking IT assets by category. Oomnitza delivers customers a fully integrated, real-time understanding of all assets, entirely automating and significantly simplifying asset tracking across all categories and workflows. Oomnitzas Fall 20 Release is a major milestone for our customers, providing them with a complete picture of how their hardware, software, cloud and IoT devices are used, said Oomnitza CTO Udo Waibel. The biggest and most successful companies in the world work with Oomnitza, and its more critical than ever for our customers to treat their IT infrastructure as a strategic asset. Oomnitza helps them do that. Oomnitza enables teams to do their work more efficiently and accurately. With bidirectional information flow between assets and the systems that track and manage them, customers can far more easily comply with compliance requirements with ready and on-demand data and secure IT infrastructure. Tracking assets is the first step in securing them, and this enables business teams with real-time access to finance, procurement, HR, and other essential information to business processes. For more information about Oomnitzas Fall 20 Release, visit our website. About Oomnitza Oomnitza provides the first enterprise-wide view of your entire IT estate. By connecting hardware, software, cloud, and IoT, we empower our customers to create and automate workflows to improve security, compliance, audit, and employee experience, accelerating time to value. Customers range from the worlds largest enterprises to pre-IPO companies, across every sector including technology, healthcare, e-Commerce and government. Oomnitza is based in San Francisco. For more information, visit us at www.oomnitza.com. |
edtsum3244 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HOUSTON--(BUSINESS WIRE)--Crestwood Equity Partners LP (NYSE: CEQP) (Crestwood) today announced that it and Crestwood Holdings LLC (Crestwood Holdings) have executed a series of definitive agreements whereby Crestwood will acquire approximately 11.5 million common units and the general partner interest from Crestwood Holdings for total consideration of approximately $268 million. In addition, in a separate press release issued today, Crestwood announced that First Reserve priced a private placement of six million common units for total proceeds of $132 million. With the combination of these transactions, First Reserve expects to have fully exited its investment in Crestwood. Crestwood will retire the approximate 11.5 million outstanding common units currently held by First Reserve, and transition to a publicly elected Board of Directors. Additionally, the Board of Directors has authorized a $175 million opportunistic common and preferred unit repurchase program. Highlights of the Transactions and Updated Strategic Initiatives: Today marks a great milestone in the history of Crestwood with the buy-in of First Reserves interest in a transaction that enhances our alignment with common unitholders, improves our financial flexibility, and advances our strategic objectives to be a best-in-class midstream infrastructure company and maximize returns to our unitholders, stated Robert G. Phillips, Chairman, President and Chief Executive Officer of Crestwoods general partner. I would like to thank the First Reserve organization for their support, guidance and partnership over the last ten years as they helped us tremendously to build Crestwood into a premier midstream company. Crestwood has established a track record of solid execution, disciplined capital allocation and a commitment to embracing a best-in-class MLP sustainability program. Todays announcements are the next logical steps in our strategy to drive peer leading governance and set the stage for future growth by simplifying our organizational structure, increasing our public float and liquidity, and enhancing our financial flexibility as we strive to generate long-term value for our unitholders. Gary D. Reaves, Managing Director of First Reserve said, First Reserve would like to thank the Crestwood organization for its partnership over the past ten years. While today marks the culmination of over a decade of First Reserves ownership of Crestwood, we will certainly maintain our long-standing relationships with the Crestwood team and all Crestwood stakeholders, and we exit this investment proud of all that Crestwood has achieved in the past decade including its leadership role in MLP sustainability initiatives. We continue to believe the outlook is bright for the Crestwood organization and look forward to watching its future success in the years to come. Transaction Details Under the terms of the transactions, First Reserve will exit its investment in Crestwood which included 17.5 million common units, approximately 24% of total common units outstanding, and control of the general partner. In a series of transactions, First Reserve has entered into agreements with third parties to sell six million common units representing limited partner interests in Crestwood, with expected total proceeds of $132 million. In addition, Crestwood expects to repurchase the general partner interest and the remaining 11.5 million units held by First Reserve with $268 million drawn on its existing $1.25 billion revolving credit facility. Following completion of the transactions, Crestwood will have approximately 62.8 million common units outstanding, representing an approximate 15% reduction in total common unit count. Crestwoods buyback of First Reserves common units results in annual cash distribution savings of approximately $29 million based on the current annual distribution rate of $2.50 per common unit. The closing of the repurchase of First Reserves common units is expected to occur on March 30, 2021 and the closing of the acquisition of the general partner interest is expected to occur in the coming months and is not subject to any closing conditions. The transactions between Crestwood and First Reserve were unanimously approved by the Conflicts Committee of the Board of Directors of the general partner of Crestwood following review with legal counsel Akin Gump Strauss Hauer & Feld LLP and rendering of a fairness opinion to the Conflicts Committee from Evercore. Following the approval by the Conflicts Committee, these transactions were unanimously approved by the Board of Directors of the general partner, with First Reserve affiliated directors abstaining. Todays announcement does not affect Crestwoods nor First Reserves ownership in Crestwood Permian Basin Holdings LLC (CPJV). CPJV was formed in November 2016 to develop, own, and operate vital midstream infrastructure assets in the Delaware Basin and is held in a separate 10-year fund that First Reserve formed in 2014. Crestwood to Transition to an Elected Board Gary D. Reaves and William R. Brown will resign from the Board of Directors at closing of the initial transaction, which is scheduled for March 30, 2021. Going forward, to enhance its corporate governance sustainability initiatives, Crestwood will transition to a fully elected board with traditional public company oversight that includes a staggered board feature, term limits, and a continued commitment to board diversity. Crestwood will maintain a board composed of seven directors until such time as it can appoint two independent replacements. Revised 2021 Outlook Based on preliminary results, Crestwood estimates it will exceed its first quarter 2021 budget as a result of outperformance driven by stronger than expected commodity prices. Based on Crestwoods preliminary first quarter 2021 results, todays announced transactions, and a favorable commodity price outlook for the remainder of 2021, Crestwood is revising its full-year financial outlook as it no longer expects the previous Adjusted EBITDA range of $550 million to $610 million to accurately reflect business performance in 2021. These projections are subject to risks and uncertainties as described in the Forward-Looking Statements section at the end of this release. $US millions Adj. EBITDA Range Operating Segment Low High Gathering & Processing $450 - $490 Storage & Transportation 80 - 85 Marketing, Supply & Logistics 100 - 105 Less: Corporate G&A (55) (55) FY 2021 Totals $575 - $625 Common and Preferred Unit Repurchase Program Crestwood announced that its Board of Directors has authorized a $175 million common unit and preferred unit repurchase program effective immediately through December 31, 2022. This program is intended to supplement the companys deleveraging goals and utilize additional free cash flow to optimize its long-term cost of capital and generate value for common unitholders. Crestwood plans to continue to prioritize its capital allocation strategies towards first achieving its long-term leverage target of 3.5x to 4.0x, but believes that the unit repurchase program is an incremental tool that can be used for allocation of strong free cash flow generation going forward to accomplish its chief objective of maximizing value for its investors. Crestwood may purchase common and preferred units from time to time in the open market in accordance with applicable securities laws at current market prices, in privately negotiated transactions or pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934. The timing and amount of purchases under the program will be determined based on ongoing assessments of leverage goals, growth capital opportunities, financial performance and outlook, and other factors, including acquisition opportunities and market conditions. The unit repurchase program does not obligate Crestwood to purchase any specific dollar amount or number of units and may be suspended or discontinued at any time. Advisors Citi served as Crestwoods financial advisor and Hunton Andrews Kurth LLP and Vinson & Elkins LLP served as legal advisors. Evercore served as financial advisor to Crestwoods Conflicts Committee and Akin Gump Strauss Hauer & Feld LLP served as legal advisor. Simpson Thacher & Bartlett LLP served as legal advisor to First Reserve. Baker Botts L.L.P. served as legal advisor to Citi. Non-GAAP Financial Measures Adjusted EBITDA, distributable cash flow and free cash flow are non-GAAP financial measures. The accompanying schedules of this news release provide reconciliations of these non-GAAP financial measures to their most directly comparable financial measures calculated and presented in accordance with GAAP. Our non-GAAP financial measures should not be considered as alternatives to GAAP measures such as net income or operating income or any other GAAP measure of liquidity or financial performance. Forward-Looking Statements This news release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities and Exchange Act of 1934. The words expects, believes, anticipates, plans, will, shall, estimates, and similar expressions identify forward-looking statements, which are generally not historical in nature. Forward-looking statements, including statements regarding our revised 2021 outlook, are subject to risks and uncertainties and are based on the beliefs and assumptions of management, based on information currently available to them. Although Crestwood believes that these forward-looking statements are based on reasonable assumptions, it can give no assurance that any such forward-looking statements will materialize. Important factors that could cause actual results to differ materially from those expressed in or implied from these forward-looking statements include the risks and uncertainties described in Crestwoods reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its subsequent reports, which are available through the SECs EDGAR system at www.sec.gov and on our website. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect managements view only as of the date made, and Crestwood assumes no obligation to update these forward-looking statements. About First Reserve First Reserve is a leading global private equity investment firm exclusively focused on energy, including related industrial markets. With over 35 years of industry insight, investment expertise and operational excellence, the firm has cultivated an enduring network of global relationships and raised more than $32 billion of aggregate capital since inception. First Reserve has completed approximately 700 transactions (including platform investments and add-on acquisitions), creating several notable energy companies throughout the firms history. Its portfolio companies have operated on six continents, spanning the energy spectrum from upstream oil and gas to midstream and downstream, including resources, equipment and services, and associated infrastructure. Please visit www.firstreserve.com for further information. About Crestwood Equity Partners LP Houston, Texas, based Crestwood Equity Partners LP (NYSE: CEQP) is a master limited partnership that owns and operates midstream businesses in multiple shale resource plays across the United States. Crestwood Equity is engaged in the gathering, processing, treating, compression, storage and transportation of natural gas; storage, transportation, terminalling and marketing of NGLs; gathering, storage, terminalling and marketing of crude oil; and gathering and disposal of produced water. Visit Crestwood Equity Partners LP at www.crestwoodlp.com; and to learn more about Crestwoods sustainability efforts, please visit https://esg.crestwoodlp.com. CRESTWOOD EQUITY PARTNERS LP Full Year 2021 Adjusted EBITDA, Distributable Cash Flow and Free Cash Flow Guidance Reconciliation of Non-GAAP Financial Measures (in millions) (unaudited) Expected 2021 Range Low - High Net Income Reconciliation Net income (b) $100 - $150 Interest and debt expense, net (a) 160 - 165 Depreciation, amortization and accretion 235 - 240 Unit-based compensation charges 25 - 30 Earnings from unconsolidated affiliates (b) (40) - (45) Adjusted EBITDA from unconsolidated affiliates 85 - 90 Adjusted EBITDA $575 - $625 Cash interest expense (c) (145) - (150) Maintenance capital expenditures (d) (20) - (25) PRB cash received in excess of recognized revenues (e) 25 - 30 Adjusted EBITDA from unconsolidated affiliates (85) - (90) Distributable cash flow from unconsolidated affiliates 80 - 85 Cash distributions to preferred unitholders (f) (100) Distributable cash flow attributable to CEQP (g) $335 - $385 Cash Flows from Operating Activities Reconciliation Net cash provided by operating activities, net $410 - $460 Interest and debt expense, net (a) 160 - 165 Adjusted EBITDA from unconsolidated affiliates 85 - 90 Earnings from unconsolidated affiliates (b) (40) - (45) Amortization of debt-related deferred costs (5) - (10) Changes in operating assets and liabilities, net (35) - (40) Adjusted EBITDA $575 - $625 Cash interest expense (c) (145) - (150) Maintenance capital expenditures (d) (20) - (25) PRB cash received in excess of recognized revenues (e) 25 - 30 Adjusted EBITDA from unconsolidated affiliates (85) - (90) Distributable cash flow from unconsolidated affiliates 80 - 85 Cash distributions to preferred unitholders (f) (100) Distributable cash flow attributable to CEQP (g) $335 - $385 Less: Growth capital expenditures 35 - 45 Less: Distributions to common unitholders 165 Free cash flow after distributions (h) $130 - $180
Answer: | Crestwood Equity Partners LP Announces Strategic Transactions with Crestwood Holdings and Provides Update to 2021 Strategic Outlook Crestwood and First Reserve have agreed to a series of transactions that provide First Reserve a complete exit from its investment in Crestwood Equity Partners LP, transferring control of the general partner interest to Crestwood and transitioning Crestwood to a publicly elected board of directors in accordance with ESG strategy Transaction results in greater than 15% accretion to distributable cash flow per unit, increased free cash flow, larger public trading float and enhanced credit profile Strong performance year-to-date and favorable full-year 2021 outlook drive an increased full-year 2021 Adjusted EBITDA estimate of $575 million to $625 million | HOUSTON--(BUSINESS WIRE)--Crestwood Equity Partners LP (NYSE: CEQP) (Crestwood) today announced that it and Crestwood Holdings LLC (Crestwood Holdings) have executed a series of definitive agreements whereby Crestwood will acquire approximately 11.5 million common units and the general partner interest from Crestwood Holdings for total consideration of approximately $268 million. In addition, in a separate press release issued today, Crestwood announced that First Reserve priced a private placement of six million common units for total proceeds of $132 million. With the combination of these transactions, First Reserve expects to have fully exited its investment in Crestwood. Crestwood will retire the approximate 11.5 million outstanding common units currently held by First Reserve, and transition to a publicly elected Board of Directors. Additionally, the Board of Directors has authorized a $175 million opportunistic common and preferred unit repurchase program. Highlights of the Transactions and Updated Strategic Initiatives: Today marks a great milestone in the history of Crestwood with the buy-in of First Reserves interest in a transaction that enhances our alignment with common unitholders, improves our financial flexibility, and advances our strategic objectives to be a best-in-class midstream infrastructure company and maximize returns to our unitholders, stated Robert G. Phillips, Chairman, President and Chief Executive Officer of Crestwoods general partner. I would like to thank the First Reserve organization for their support, guidance and partnership over the last ten years as they helped us tremendously to build Crestwood into a premier midstream company. Crestwood has established a track record of solid execution, disciplined capital allocation and a commitment to embracing a best-in-class MLP sustainability program. Todays announcements are the next logical steps in our strategy to drive peer leading governance and set the stage for future growth by simplifying our organizational structure, increasing our public float and liquidity, and enhancing our financial flexibility as we strive to generate long-term value for our unitholders. Gary D. Reaves, Managing Director of First Reserve said, First Reserve would like to thank the Crestwood organization for its partnership over the past ten years. While today marks the culmination of over a decade of First Reserves ownership of Crestwood, we will certainly maintain our long-standing relationships with the Crestwood team and all Crestwood stakeholders, and we exit this investment proud of all that Crestwood has achieved in the past decade including its leadership role in MLP sustainability initiatives. We continue to believe the outlook is bright for the Crestwood organization and look forward to watching its future success in the years to come. Transaction Details Under the terms of the transactions, First Reserve will exit its investment in Crestwood which included 17.5 million common units, approximately 24% of total common units outstanding, and control of the general partner. In a series of transactions, First Reserve has entered into agreements with third parties to sell six million common units representing limited partner interests in Crestwood, with expected total proceeds of $132 million. In addition, Crestwood expects to repurchase the general partner interest and the remaining 11.5 million units held by First Reserve with $268 million drawn on its existing $1.25 billion revolving credit facility. Following completion of the transactions, Crestwood will have approximately 62.8 million common units outstanding, representing an approximate 15% reduction in total common unit count. Crestwoods buyback of First Reserves common units results in annual cash distribution savings of approximately $29 million based on the current annual distribution rate of $2.50 per common unit. The closing of the repurchase of First Reserves common units is expected to occur on March 30, 2021 and the closing of the acquisition of the general partner interest is expected to occur in the coming months and is not subject to any closing conditions. The transactions between Crestwood and First Reserve were unanimously approved by the Conflicts Committee of the Board of Directors of the general partner of Crestwood following review with legal counsel Akin Gump Strauss Hauer & Feld LLP and rendering of a fairness opinion to the Conflicts Committee from Evercore. Following the approval by the Conflicts Committee, these transactions were unanimously approved by the Board of Directors of the general partner, with First Reserve affiliated directors abstaining. Todays announcement does not affect Crestwoods nor First Reserves ownership in Crestwood Permian Basin Holdings LLC (CPJV). CPJV was formed in November 2016 to develop, own, and operate vital midstream infrastructure assets in the Delaware Basin and is held in a separate 10-year fund that First Reserve formed in 2014. Crestwood to Transition to an Elected Board Gary D. Reaves and William R. Brown will resign from the Board of Directors at closing of the initial transaction, which is scheduled for March 30, 2021. Going forward, to enhance its corporate governance sustainability initiatives, Crestwood will transition to a fully elected board with traditional public company oversight that includes a staggered board feature, term limits, and a continued commitment to board diversity. Crestwood will maintain a board composed of seven directors until such time as it can appoint two independent replacements. Revised 2021 Outlook Based on preliminary results, Crestwood estimates it will exceed its first quarter 2021 budget as a result of outperformance driven by stronger than expected commodity prices. Based on Crestwoods preliminary first quarter 2021 results, todays announced transactions, and a favorable commodity price outlook for the remainder of 2021, Crestwood is revising its full-year financial outlook as it no longer expects the previous Adjusted EBITDA range of $550 million to $610 million to accurately reflect business performance in 2021. These projections are subject to risks and uncertainties as described in the Forward-Looking Statements section at the end of this release. $US millions Adj. EBITDA Range Operating Segment Low High Gathering & Processing $450 - $490 Storage & Transportation 80 - 85 Marketing, Supply & Logistics 100 - 105 Less: Corporate G&A (55) (55) FY 2021 Totals $575 - $625 Common and Preferred Unit Repurchase Program Crestwood announced that its Board of Directors has authorized a $175 million common unit and preferred unit repurchase program effective immediately through December 31, 2022. This program is intended to supplement the companys deleveraging goals and utilize additional free cash flow to optimize its long-term cost of capital and generate value for common unitholders. Crestwood plans to continue to prioritize its capital allocation strategies towards first achieving its long-term leverage target of 3.5x to 4.0x, but believes that the unit repurchase program is an incremental tool that can be used for allocation of strong free cash flow generation going forward to accomplish its chief objective of maximizing value for its investors. Crestwood may purchase common and preferred units from time to time in the open market in accordance with applicable securities laws at current market prices, in privately negotiated transactions or pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934. The timing and amount of purchases under the program will be determined based on ongoing assessments of leverage goals, growth capital opportunities, financial performance and outlook, and other factors, including acquisition opportunities and market conditions. The unit repurchase program does not obligate Crestwood to purchase any specific dollar amount or number of units and may be suspended or discontinued at any time. Advisors Citi served as Crestwoods financial advisor and Hunton Andrews Kurth LLP and Vinson & Elkins LLP served as legal advisors. Evercore served as financial advisor to Crestwoods Conflicts Committee and Akin Gump Strauss Hauer & Feld LLP served as legal advisor. Simpson Thacher & Bartlett LLP served as legal advisor to First Reserve. Baker Botts L.L.P. served as legal advisor to Citi. Non-GAAP Financial Measures Adjusted EBITDA, distributable cash flow and free cash flow are non-GAAP financial measures. The accompanying schedules of this news release provide reconciliations of these non-GAAP financial measures to their most directly comparable financial measures calculated and presented in accordance with GAAP. Our non-GAAP financial measures should not be considered as alternatives to GAAP measures such as net income or operating income or any other GAAP measure of liquidity or financial performance. Forward-Looking Statements This news release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities and Exchange Act of 1934. The words expects, believes, anticipates, plans, will, shall, estimates, and similar expressions identify forward-looking statements, which are generally not historical in nature. Forward-looking statements, including statements regarding our revised 2021 outlook, are subject to risks and uncertainties and are based on the beliefs and assumptions of management, based on information currently available to them. Although Crestwood believes that these forward-looking statements are based on reasonable assumptions, it can give no assurance that any such forward-looking statements will materialize. Important factors that could cause actual results to differ materially from those expressed in or implied from these forward-looking statements include the risks and uncertainties described in Crestwoods reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its subsequent reports, which are available through the SECs EDGAR system at www.sec.gov and on our website. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect managements view only as of the date made, and Crestwood assumes no obligation to update these forward-looking statements. About First Reserve First Reserve is a leading global private equity investment firm exclusively focused on energy, including related industrial markets. With over 35 years of industry insight, investment expertise and operational excellence, the firm has cultivated an enduring network of global relationships and raised more than $32 billion of aggregate capital since inception. First Reserve has completed approximately 700 transactions (including platform investments and add-on acquisitions), creating several notable energy companies throughout the firms history. Its portfolio companies have operated on six continents, spanning the energy spectrum from upstream oil and gas to midstream and downstream, including resources, equipment and services, and associated infrastructure. Please visit www.firstreserve.com for further information. About Crestwood Equity Partners LP Houston, Texas, based Crestwood Equity Partners LP (NYSE: CEQP) is a master limited partnership that owns and operates midstream businesses in multiple shale resource plays across the United States. Crestwood Equity is engaged in the gathering, processing, treating, compression, storage and transportation of natural gas; storage, transportation, terminalling and marketing of NGLs; gathering, storage, terminalling and marketing of crude oil; and gathering and disposal of produced water. Visit Crestwood Equity Partners LP at www.crestwoodlp.com; and to learn more about Crestwoods sustainability efforts, please visit https://esg.crestwoodlp.com. CRESTWOOD EQUITY PARTNERS LP Full Year 2021 Adjusted EBITDA, Distributable Cash Flow and Free Cash Flow Guidance Reconciliation of Non-GAAP Financial Measures (in millions) (unaudited) Expected 2021 Range Low - High Net Income Reconciliation Net income (b) $100 - $150 Interest and debt expense, net (a) 160 - 165 Depreciation, amortization and accretion 235 - 240 Unit-based compensation charges 25 - 30 Earnings from unconsolidated affiliates (b) (40) - (45) Adjusted EBITDA from unconsolidated affiliates 85 - 90 Adjusted EBITDA $575 - $625 Cash interest expense (c) (145) - (150) Maintenance capital expenditures (d) (20) - (25) PRB cash received in excess of recognized revenues (e) 25 - 30 Adjusted EBITDA from unconsolidated affiliates (85) - (90) Distributable cash flow from unconsolidated affiliates 80 - 85 Cash distributions to preferred unitholders (f) (100) Distributable cash flow attributable to CEQP (g) $335 - $385 Cash Flows from Operating Activities Reconciliation Net cash provided by operating activities, net $410 - $460 Interest and debt expense, net (a) 160 - 165 Adjusted EBITDA from unconsolidated affiliates 85 - 90 Earnings from unconsolidated affiliates (b) (40) - (45) Amortization of debt-related deferred costs (5) - (10) Changes in operating assets and liabilities, net (35) - (40) Adjusted EBITDA $575 - $625 Cash interest expense (c) (145) - (150) Maintenance capital expenditures (d) (20) - (25) PRB cash received in excess of recognized revenues (e) 25 - 30 Adjusted EBITDA from unconsolidated affiliates (85) - (90) Distributable cash flow from unconsolidated affiliates 80 - 85 Cash distributions to preferred unitholders (f) (100) Distributable cash flow attributable to CEQP (g) $335 - $385 Less: Growth capital expenditures 35 - 45 Less: Distributions to common unitholders 165 Free cash flow after distributions (h) $130 - $180 |
edtsum3253 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, Jan. 14, 2021 /PRNewswire/ -- The "Crohn's Disease Forecast and Market Analysis to 2027" report has been added to ResearchAndMarkets.com's offering. As specialty products, therapies for Crohn's disease (CD) can be expensive, and formulary positioning is paramount to product uptake. Payers are settled in vital contracts that lead them to prioritize broad immunology drugs Humira and Remicade. This has posed a high barrier to newer entrants to the market, which cannot compete in volume and rebates. Biosimilar and generic competition will further undermine the likely premium pricing of newer drugs and pipeline products. Over the next decade, all key marketed brands for CD will have faced patent expiry. Thus far, the European market has taken the brunt of biosimilar erosion, with earlier launches and more acceptance compared to other countries. In the US, biosimilars will face challenges in usurping branded anti-TNFs, with adalimumab biosimilars not expected until 2023, substantial originator rebates, and exclusive contracting with payers. Over time, biosimilar penetration is anticipated to gain more momentum as international real-world evidence accumulates and long-term data support biosimilar efficacy and safety. This should allow physicians and patients to grow their confidence and familiarity with biosimilars and encourage uptake. Nevertheless, the CD market is projected to expand, propelled by a growing patient caseload and the introduction of pipeline products. The publisher estimates that in 2018, there were 6.1 million prevalent cases of CD worldwide, and forecasts that number to increase to 6.5 million prevalent cases by 2027. The entry of novel drug classes will drive growth of the CD market, despite facing cost-related barriers to uptake. The pipeline holds distinct prospects that aim to treat non-responders, including the oral JAK inhibitors Jyseleca and Rinvoq. These will be welcomed for their distinguished mechanisms of action, and their oral formulation will further offer unprecedented convenience in the CD treatment algorithm. Targeting global markets broadens their commercial potential as they are being investigated across the US, Japan, and Europe. Advantageously, over the forecast period, Rinvoq and Jyseleca will not encounter the increasing biosimilar competition that will directly erode sales of already marketed drugs. On the other hand, newer premium-priced entrants will likely be relegated to later lines of therapy after cheaper conventional drugs and biosimilars. Significant unmet needs include targeting inadequate responders to biologic and conventional therapies, as well as underserved patients with fistulas. In terms of clinical trials, active comparators and the endoscopic endpoints should be prioritized as there is a stark absence of head-to-head data and the field is moving towards endoscopic treatment goals. Additionally, new mechanisms of action and convenient oral therapies that are safe and effective are desirable. Pricing will be critical to secure favorable positioning in formularies and maximize commercial opportunities. Key Topics Covered: OVERVIEW Latest key takeaways DISEASE BACKGROUND Definition Symptoms Patient segmentation TREATMENT ACG treatment guidelines ECCO treatment guidelines NICE treatment guidelines EPIDEMIOLOGY Prevalence methodology MARKETED DRUGSPIPELINE DRUGSKEY REGULATORY EVENTS Japan Nods Include Global Firsts For Duvroq, Vafseo And First Local Biosimilar Humira EU Approves Takeda's Injectable Entyvio for IBD Part B Drugs At Home: Medicare Policy Responds To COVID-Driven Access Concerns Alberta Is Second Canadian Province To Switch To Biosimilars CHMP Positive On Pfizer's Adalimumab Keeping Track Of Approvals: Two Novel Drugs (Givlaari And Xcopri), A Project Orbis Collaboration (Calquence) And Another Humira Biosimilar PROBABILITY OF SUCCESSLICENSING AND ASSET ACQUISITION DEALS Cytocom Goes Public Via Merger With Cleveland BioLabs UCB, Ferring Will Co-Promote Cimzia Syringe For Crohn's In US Gilead Moves Into Microbiome In Deal With Second Genome Beximco And Mylan Strike Biosimilars Deal Asia Deal Watch: Mundipharma Will Sell Samsung Bioepis' Biosimilars In Taiwan, Hong Kong AZ Gets IBD Drug Back From Allergan CLINICAL TRIAL LANDSCAPE Sponsors by status Sponsors by phase Recent events DRUG ASSESSMENT MODEL Biologic DMARDs Non-biologic DMARDs Stem cell therapy Antibiotics MARKET DYNAMICSFUTURE TRENDS Despite formulary constraints, novel pipeline drugs will expand the market Biosimilar erosion of key brands will intensify over the next 10 years CONSENSUS FORECASTSRECENT EVENTS AND ANALYST OPINION Tremfya for Crohn's Disease (October 12, 2020) Stelara for Crohn's Disease (February 13, 2020) PRV-6527 for Crohn's Disease (October 22, 2019) Inflectra for Crohn's Disease (September 19, 2019) Multiple Drugs for Crohn's Disease (June 25, 2019) Mirikizumab for Crohn's Disease (May 21, 2019) KEY UPCOMING EVENTSUNMET NEEDS There is critical unmet need for predictive biomarkers Biologics with rapid onset and sustained remission Novel oral treatments Diverse head-to-head trials and trials for fistulas BIBLIOGRAPHY Prescription information APPENDIXFor more information about this report visit https://www.researchandmarkets.com/r/wtgqa3 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | Global Crohn's Disease Market Analysis & Forecasts, 2020-2027: Treatment, Epidemiology, Pipeline, Key Regulatory Events, Licensing & Asset Acquisitions, Trends and Upcoming Events | DUBLIN, Jan. 14, 2021 /PRNewswire/ -- The "Crohn's Disease Forecast and Market Analysis to 2027" report has been added to ResearchAndMarkets.com's offering. As specialty products, therapies for Crohn's disease (CD) can be expensive, and formulary positioning is paramount to product uptake. Payers are settled in vital contracts that lead them to prioritize broad immunology drugs Humira and Remicade. This has posed a high barrier to newer entrants to the market, which cannot compete in volume and rebates. Biosimilar and generic competition will further undermine the likely premium pricing of newer drugs and pipeline products. Over the next decade, all key marketed brands for CD will have faced patent expiry. Thus far, the European market has taken the brunt of biosimilar erosion, with earlier launches and more acceptance compared to other countries. In the US, biosimilars will face challenges in usurping branded anti-TNFs, with adalimumab biosimilars not expected until 2023, substantial originator rebates, and exclusive contracting with payers. Over time, biosimilar penetration is anticipated to gain more momentum as international real-world evidence accumulates and long-term data support biosimilar efficacy and safety. This should allow physicians and patients to grow their confidence and familiarity with biosimilars and encourage uptake. Nevertheless, the CD market is projected to expand, propelled by a growing patient caseload and the introduction of pipeline products. The publisher estimates that in 2018, there were 6.1 million prevalent cases of CD worldwide, and forecasts that number to increase to 6.5 million prevalent cases by 2027. The entry of novel drug classes will drive growth of the CD market, despite facing cost-related barriers to uptake. The pipeline holds distinct prospects that aim to treat non-responders, including the oral JAK inhibitors Jyseleca and Rinvoq. These will be welcomed for their distinguished mechanisms of action, and their oral formulation will further offer unprecedented convenience in the CD treatment algorithm. Targeting global markets broadens their commercial potential as they are being investigated across the US, Japan, and Europe. Advantageously, over the forecast period, Rinvoq and Jyseleca will not encounter the increasing biosimilar competition that will directly erode sales of already marketed drugs. On the other hand, newer premium-priced entrants will likely be relegated to later lines of therapy after cheaper conventional drugs and biosimilars. Significant unmet needs include targeting inadequate responders to biologic and conventional therapies, as well as underserved patients with fistulas. In terms of clinical trials, active comparators and the endoscopic endpoints should be prioritized as there is a stark absence of head-to-head data and the field is moving towards endoscopic treatment goals. Additionally, new mechanisms of action and convenient oral therapies that are safe and effective are desirable. Pricing will be critical to secure favorable positioning in formularies and maximize commercial opportunities. Key Topics Covered: OVERVIEW Latest key takeaways DISEASE BACKGROUND Definition Symptoms Patient segmentation TREATMENT ACG treatment guidelines ECCO treatment guidelines NICE treatment guidelines EPIDEMIOLOGY Prevalence methodology MARKETED DRUGSPIPELINE DRUGSKEY REGULATORY EVENTS Japan Nods Include Global Firsts For Duvroq, Vafseo And First Local Biosimilar Humira EU Approves Takeda's Injectable Entyvio for IBD Part B Drugs At Home: Medicare Policy Responds To COVID-Driven Access Concerns Alberta Is Second Canadian Province To Switch To Biosimilars CHMP Positive On Pfizer's Adalimumab Keeping Track Of Approvals: Two Novel Drugs (Givlaari And Xcopri), A Project Orbis Collaboration (Calquence) And Another Humira Biosimilar PROBABILITY OF SUCCESSLICENSING AND ASSET ACQUISITION DEALS Cytocom Goes Public Via Merger With Cleveland BioLabs UCB, Ferring Will Co-Promote Cimzia Syringe For Crohn's In US Gilead Moves Into Microbiome In Deal With Second Genome Beximco And Mylan Strike Biosimilars Deal Asia Deal Watch: Mundipharma Will Sell Samsung Bioepis' Biosimilars In Taiwan, Hong Kong AZ Gets IBD Drug Back From Allergan CLINICAL TRIAL LANDSCAPE Sponsors by status Sponsors by phase Recent events DRUG ASSESSMENT MODEL Biologic DMARDs Non-biologic DMARDs Stem cell therapy Antibiotics MARKET DYNAMICSFUTURE TRENDS Despite formulary constraints, novel pipeline drugs will expand the market Biosimilar erosion of key brands will intensify over the next 10 years CONSENSUS FORECASTSRECENT EVENTS AND ANALYST OPINION Tremfya for Crohn's Disease (October 12, 2020) Stelara for Crohn's Disease (February 13, 2020) PRV-6527 for Crohn's Disease (October 22, 2019) Inflectra for Crohn's Disease (September 19, 2019) Multiple Drugs for Crohn's Disease (June 25, 2019) Mirikizumab for Crohn's Disease (May 21, 2019) KEY UPCOMING EVENTSUNMET NEEDS There is critical unmet need for predictive biomarkers Biologics with rapid onset and sustained remission Novel oral treatments Diverse head-to-head trials and trials for fistulas BIBLIOGRAPHY Prescription information APPENDIXFor more information about this report visit https://www.researchandmarkets.com/r/wtgqa3 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum3254 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MEMPHIS, Tenn., April 27, 2021 /PRNewswire/ --St. Jude Children's Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases. St. Jude Children's Research Hospital announces a strategic plan to accelerate its impact on an international scale, continuing its quest to find cures and save children with catastrophic diseases. The Six-Year St. Jude Strategic Plan, approved March 25, 2021, by the St. Jude Board of Governors, focuses on the expansion of patient care and clinical and laboratory-based research related to pediatric catastrophic illnesses, including work in cancer, blood disorders, neurological diseases and infectious diseases. The plan calls for an additional 1,400 jobs; the expenditure of $1.9 billion in new construction, renovation and capital needs; and the development of new research areas. "The plan is ambitious, and its goals are far-reaching," said James R. Downing, M.D., St. Jude president and CEO. "We're committing substantial resources to broaden scientific understanding, raise survival rates, improve quality of life, and connect researchers worldwide in the quest to find cures and save children with cancer and other deadly diseases." The endeavor builds on the research hospital's prior strategic plan, which at the time was the largest expansion in the institution's history and resulted in $7 billion in investments. Within the past six years, St. Jude has advanced fundamental, clinical and translational research, among its many milestones. Globally, access to quality careonce a dream for children in low- and middle-income countriesis beginning to be realized through its reimagined international outreach efforts that reach seven regions of the world. On campus, St. Jude accepted nearly 20% more new cancer patients; increased faculty by 30% and staff by 23%; and embarked on several large-scale construction projects.The new plan continues this momentum by concentrating on five areas: fundamental science, childhood cancer, pediatric catastrophic diseases, global impact and workforce and workplace culture. Highlights across these areas include the following:Building a workforce to speed cures for children Under the plan, St. Jude will hire nearly 70 new faculty members, plus supporting laboratory staff, to work in basic, translational and clinical research across 22 departments. These investigators will have the freedom to pursue the type of conceptually driven research that leads to tomorrow's clinical advances. Investing in the intersection of science and technology During the next six years, St. Jude will invest more than $250 million to expand state-of-the-art technology and resources available to scientists and clinicians in their search to understand why pediatric catastrophic diseases arise, spread and resist treatments. These investments will include: Creating a Cryo-Electron Tomography Center to determine the atomic structure of molecules in their native states within human cells Establishing a Center of Excellence in Advanced Microscopy to build the next generation of microscopes that explore cells in ways previously unimaginable Expanding data science staff and the digital infrastructure necessary to become a world leader in the application of data science to biological discovery in normal and disease states Creating a brighter future for children with cancer St. Jude will invest $3.7 billion during the next six years to expand cancer-focused research and related clinical care. These efforts will center on raising survival rates for the highest-risk cancers and for children with relapsed diseases, while simultaneously improving quality of life for pediatric cancer survivors. The investments will include: Accelerating preclinical and clinical testing of new therapeutic agents so the most promising agents can rapidly move from clinical investigation to standard of care Expanding large-scale, collaborative trials to reach more childhood cancer patients across the U.S. and around the world Creating a new Translational Immunology and Immunotherapy Initiative (TI3)an inter-departmental collaboration focused on expanding the use of cellular-based cancer immunotherapy as curative treatments for pediatric solid tumors and brain tumors Finding cures and saving children everywhereIn the U.S., more than 80% of children diagnosed with cancer will be cured. In contrast, 80% of children with cancer live in limited-resource countries, where a mere 20% survive their disease. To address this, St. Jude will more than triple its investment in its international efforts coordinated through St. Jude Globaland the St. Jude Global Allianceduring the next six years. This represents an investment of more than $470 million. Global initiatives include: Expanding educational programs to train the workforce needed to treat childhood cancer worldwide; strengthening the health care systems required to deliver that care; and bolstering regional and global programs to create the research infrastructure necessary to continually improve the quality of care in resource-limited settings Creating seven international operational hubs staffed by St. Jude workers to effectively manage the St. Jude Global Alliance, a network of more than 140 institutions across 50-plus countries Developing a multimillion-dollar Pediatric Cancer Global Drug Access Programin collaboration with World Health Organization, other U.N. agencies and international organizationsto distribute an uninterrupted supply of anti-cancer drugs for childhood cancer treatment in low- and middle-income countries Beyond cancer: Investing in other pediatric catastrophic diseasesUnder theplan, St. Jude will expand research and treatment programs to advance cures for childhood catastrophic diseases. The $1.1 billion, six-year investment includes work in nonmalignant diseases, such as sickle cell disease; a new laboratory-based research program in infectious diseases that affect children worldwide; and a new research and clinical program to better understand and treat pediatric neurological diseases. Fostering a culture and environment that propel progressThe plan outlines several strategies to ensure St. Jude remains a place where teamwork flourishes; internal and external collaboration thrives; and employees can make a difference in the lives of children. These will include: Expanding the St. Jude Research Collaboratives program from funding five to 11 teams of scientists worldwide through a more than $100 million investment Enriching future biomedical research pipelines for potential employees by creating experiences for high school and college students in science Expanding the established St. Jude blue-sky process, which solicits mission-related, game-changing ideas outside of the strategic plan, by $180 million Building and supporting best-in-class environments that help employees advance the institution's life-saving work and offer patients and their families a home away from home The $1.3 billion in new construction and renovations will include completion of The Domino's Village, a family housing facility with one-, two- and three-bedroom units; Family Commons, a quality of life space with patient family services from school to tech support; and the Advanced Research Centerand construction of outpatient, clinical office and administrative buildings and parking garages. The multi-phase expansion plan is fueled almost entirely by steadily increasing donor contributions generated by ALSAC, the fundraising and awareness organization for St. Jude. "We are making our biggest financial investment everduring a pandemicbecause the public, our donors, have demonstrated their commitment to us," said Richard C. Shadyac Jr., ALSAC president and CEO. "It's an incredible display of loyalty and purpose, and the power of people coming together to help the most vulnerable in our society: sick children."Private fundraising conducted by ALSAC is the organization's lifeline because pediatric cancer research typically receives a disproportionately low share of government research dollars. Of the approximately $6 billion distributed annually by the National Cancer Institute, only an estimated 4% targets pediatric cancers. It is estimated that 87% of funds to sustain and grow St. Jude over the next six years will come from public donations. The St. Jude model is unique in that patients never receive a bill for treatment, travel, housing or food. That model was established by ALSAC and St. Jude founder Danny Thomas, who believed in equal access to medical care and driving research advances. "As we move forward with this strategic plan, our missionto advance cures and means of prevention for pediatric catastrophic diseases through research and treatmentremains at the forefront of everything we do," Downing said. "The mission serves as our compass, and the plan serves as our guide for the journey ahead."St. Jude Children's Research HospitalSt. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude on social media at @stjuderesearch.SOURCE St. Jude Children's Research Hospital Related Links http://www.stjude.org
Answer: | St. Jude Children's Research Hospital announces largest strategic expansion in its history targeting pediatric catastrophic diseases globally Six-year plan to invest $11.5 billion with donor support to accelerate research and treatment worldwide | MEMPHIS, Tenn., April 27, 2021 /PRNewswire/ --St. Jude Children's Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases. St. Jude Children's Research Hospital announces a strategic plan to accelerate its impact on an international scale, continuing its quest to find cures and save children with catastrophic diseases. The Six-Year St. Jude Strategic Plan, approved March 25, 2021, by the St. Jude Board of Governors, focuses on the expansion of patient care and clinical and laboratory-based research related to pediatric catastrophic illnesses, including work in cancer, blood disorders, neurological diseases and infectious diseases. The plan calls for an additional 1,400 jobs; the expenditure of $1.9 billion in new construction, renovation and capital needs; and the development of new research areas. "The plan is ambitious, and its goals are far-reaching," said James R. Downing, M.D., St. Jude president and CEO. "We're committing substantial resources to broaden scientific understanding, raise survival rates, improve quality of life, and connect researchers worldwide in the quest to find cures and save children with cancer and other deadly diseases." The endeavor builds on the research hospital's prior strategic plan, which at the time was the largest expansion in the institution's history and resulted in $7 billion in investments. Within the past six years, St. Jude has advanced fundamental, clinical and translational research, among its many milestones. Globally, access to quality careonce a dream for children in low- and middle-income countriesis beginning to be realized through its reimagined international outreach efforts that reach seven regions of the world. On campus, St. Jude accepted nearly 20% more new cancer patients; increased faculty by 30% and staff by 23%; and embarked on several large-scale construction projects.The new plan continues this momentum by concentrating on five areas: fundamental science, childhood cancer, pediatric catastrophic diseases, global impact and workforce and workplace culture. Highlights across these areas include the following:Building a workforce to speed cures for children Under the plan, St. Jude will hire nearly 70 new faculty members, plus supporting laboratory staff, to work in basic, translational and clinical research across 22 departments. These investigators will have the freedom to pursue the type of conceptually driven research that leads to tomorrow's clinical advances. Investing in the intersection of science and technology During the next six years, St. Jude will invest more than $250 million to expand state-of-the-art technology and resources available to scientists and clinicians in their search to understand why pediatric catastrophic diseases arise, spread and resist treatments. These investments will include: Creating a Cryo-Electron Tomography Center to determine the atomic structure of molecules in their native states within human cells Establishing a Center of Excellence in Advanced Microscopy to build the next generation of microscopes that explore cells in ways previously unimaginable Expanding data science staff and the digital infrastructure necessary to become a world leader in the application of data science to biological discovery in normal and disease states Creating a brighter future for children with cancer St. Jude will invest $3.7 billion during the next six years to expand cancer-focused research and related clinical care. These efforts will center on raising survival rates for the highest-risk cancers and for children with relapsed diseases, while simultaneously improving quality of life for pediatric cancer survivors. The investments will include: Accelerating preclinical and clinical testing of new therapeutic agents so the most promising agents can rapidly move from clinical investigation to standard of care Expanding large-scale, collaborative trials to reach more childhood cancer patients across the U.S. and around the world Creating a new Translational Immunology and Immunotherapy Initiative (TI3)an inter-departmental collaboration focused on expanding the use of cellular-based cancer immunotherapy as curative treatments for pediatric solid tumors and brain tumors Finding cures and saving children everywhereIn the U.S., more than 80% of children diagnosed with cancer will be cured. In contrast, 80% of children with cancer live in limited-resource countries, where a mere 20% survive their disease. To address this, St. Jude will more than triple its investment in its international efforts coordinated through St. Jude Globaland the St. Jude Global Allianceduring the next six years. This represents an investment of more than $470 million. Global initiatives include: Expanding educational programs to train the workforce needed to treat childhood cancer worldwide; strengthening the health care systems required to deliver that care; and bolstering regional and global programs to create the research infrastructure necessary to continually improve the quality of care in resource-limited settings Creating seven international operational hubs staffed by St. Jude workers to effectively manage the St. Jude Global Alliance, a network of more than 140 institutions across 50-plus countries Developing a multimillion-dollar Pediatric Cancer Global Drug Access Programin collaboration with World Health Organization, other U.N. agencies and international organizationsto distribute an uninterrupted supply of anti-cancer drugs for childhood cancer treatment in low- and middle-income countries Beyond cancer: Investing in other pediatric catastrophic diseasesUnder theplan, St. Jude will expand research and treatment programs to advance cures for childhood catastrophic diseases. The $1.1 billion, six-year investment includes work in nonmalignant diseases, such as sickle cell disease; a new laboratory-based research program in infectious diseases that affect children worldwide; and a new research and clinical program to better understand and treat pediatric neurological diseases. Fostering a culture and environment that propel progressThe plan outlines several strategies to ensure St. Jude remains a place where teamwork flourishes; internal and external collaboration thrives; and employees can make a difference in the lives of children. These will include: Expanding the St. Jude Research Collaboratives program from funding five to 11 teams of scientists worldwide through a more than $100 million investment Enriching future biomedical research pipelines for potential employees by creating experiences for high school and college students in science Expanding the established St. Jude blue-sky process, which solicits mission-related, game-changing ideas outside of the strategic plan, by $180 million Building and supporting best-in-class environments that help employees advance the institution's life-saving work and offer patients and their families a home away from home The $1.3 billion in new construction and renovations will include completion of The Domino's Village, a family housing facility with one-, two- and three-bedroom units; Family Commons, a quality of life space with patient family services from school to tech support; and the Advanced Research Centerand construction of outpatient, clinical office and administrative buildings and parking garages. The multi-phase expansion plan is fueled almost entirely by steadily increasing donor contributions generated by ALSAC, the fundraising and awareness organization for St. Jude. "We are making our biggest financial investment everduring a pandemicbecause the public, our donors, have demonstrated their commitment to us," said Richard C. Shadyac Jr., ALSAC president and CEO. "It's an incredible display of loyalty and purpose, and the power of people coming together to help the most vulnerable in our society: sick children."Private fundraising conducted by ALSAC is the organization's lifeline because pediatric cancer research typically receives a disproportionately low share of government research dollars. Of the approximately $6 billion distributed annually by the National Cancer Institute, only an estimated 4% targets pediatric cancers. It is estimated that 87% of funds to sustain and grow St. Jude over the next six years will come from public donations. The St. Jude model is unique in that patients never receive a bill for treatment, travel, housing or food. That model was established by ALSAC and St. Jude founder Danny Thomas, who believed in equal access to medical care and driving research advances. "As we move forward with this strategic plan, our missionto advance cures and means of prevention for pediatric catastrophic diseases through research and treatmentremains at the forefront of everything we do," Downing said. "The mission serves as our compass, and the plan serves as our guide for the journey ahead."St. Jude Children's Research HospitalSt. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude on social media at @stjuderesearch.SOURCE St. Jude Children's Research Hospital Related Links http://www.stjude.org |
edtsum3259 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens has been selected by the Centers for Disease Control and Prevention (CDC) and U.S. Department of Health and Human Services to provide a limited number of COVID-19 vaccinations across 15 states and jurisdictions as part of the Federal Retail Pharmacy Program. Vaccinations will begin in stores Feb. 12 to eligible individuals based on state and jurisdiction guidelines, and may include healthcare workers, people ages 65 and older, and individuals with pre-existing conditions. Walgreens was one of the first pharmacies to begin administering COVID-19 vaccinations in December to long-term care facility staff and residents, and we look forward to leveraging our experience to support the federal government and CDC in expanding access to these vaccines, said John Standley, president, Walgreens. Our pharmacy teams have already provided nearly two million COVID-19 vaccinations and stand ready with their expertise to help educate and vaccinate additional Americans, including those in rural and underserved communities. The CDC selected Walgreens as a pharmacy partner in specific states and jurisdictions to optimize vaccine access in medically underserved areas and areas with a high social vulnerability index score. A defined number of vaccine doses will be allocated from the CDC directly to Walgreens in each geography. Those states and local jurisdictions include: Walgreens Continues to Work Directly with States to Support Local Vaccination Efforts In addition to supporting distribution of federal vaccine allocation, Walgreens continues to assist several states and jurisdictions with administration of COVID-19 vaccines in select stores to eligible populations. Walgreens has administered over 300,000 vaccinations through these efforts to date, as determined by state and jurisdiction guidelines. Areas include: Available Appointments Vaccine inventory is still limited and available to eligible individuals by appointment only at select Walgreens stores. Appointments can be made through Walgreens updated appointment scheduler at Walgreens.com/ScheduleVaccine when vaccine becomes available. Walgreens will not provide vaccinations on a walk-in basis at this time. Long-term care update Walgreens continues efforts to support vaccinations across long-term care facilities. The company has completed first dose vaccinations in more than 75 percent of long-term care facilities that selected Walgreens as their vaccine provider and remains on track to complete remaining first doses by mid-February. More information on Walgreens efforts to support communities during the COVID-19 pandemic is available here. Additional imagery, b-roll and multimedia assets are available on the Walgreens newsroom. About Walgreens Walgreens (www.walgreens.com) is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a global leader in retail and wholesale pharmacy. As Americas most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and well-being of every community in America. Operating more than 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 8 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with platforms bringing together physical and digital, supported by the latest technology to deliver high-quality products and services in local communities nationwide.
Answer: | Walgreens to Expand COVID-19 Vaccinations in Stores as Part of Federal Retail Pharmacy Partnership Program Walgreens selected by Centers for Disease Control and Prevention to administer COVID-19 vaccines in 15 states and jurisdictions under federal program; focusing on high-risk, socially vulnerable populations | DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens has been selected by the Centers for Disease Control and Prevention (CDC) and U.S. Department of Health and Human Services to provide a limited number of COVID-19 vaccinations across 15 states and jurisdictions as part of the Federal Retail Pharmacy Program. Vaccinations will begin in stores Feb. 12 to eligible individuals based on state and jurisdiction guidelines, and may include healthcare workers, people ages 65 and older, and individuals with pre-existing conditions. Walgreens was one of the first pharmacies to begin administering COVID-19 vaccinations in December to long-term care facility staff and residents, and we look forward to leveraging our experience to support the federal government and CDC in expanding access to these vaccines, said John Standley, president, Walgreens. Our pharmacy teams have already provided nearly two million COVID-19 vaccinations and stand ready with their expertise to help educate and vaccinate additional Americans, including those in rural and underserved communities. The CDC selected Walgreens as a pharmacy partner in specific states and jurisdictions to optimize vaccine access in medically underserved areas and areas with a high social vulnerability index score. A defined number of vaccine doses will be allocated from the CDC directly to Walgreens in each geography. Those states and local jurisdictions include: Walgreens Continues to Work Directly with States to Support Local Vaccination Efforts In addition to supporting distribution of federal vaccine allocation, Walgreens continues to assist several states and jurisdictions with administration of COVID-19 vaccines in select stores to eligible populations. Walgreens has administered over 300,000 vaccinations through these efforts to date, as determined by state and jurisdiction guidelines. Areas include: Available Appointments Vaccine inventory is still limited and available to eligible individuals by appointment only at select Walgreens stores. Appointments can be made through Walgreens updated appointment scheduler at Walgreens.com/ScheduleVaccine when vaccine becomes available. Walgreens will not provide vaccinations on a walk-in basis at this time. Long-term care update Walgreens continues efforts to support vaccinations across long-term care facilities. The company has completed first dose vaccinations in more than 75 percent of long-term care facilities that selected Walgreens as their vaccine provider and remains on track to complete remaining first doses by mid-February. More information on Walgreens efforts to support communities during the COVID-19 pandemic is available here. Additional imagery, b-roll and multimedia assets are available on the Walgreens newsroom. About Walgreens Walgreens (www.walgreens.com) is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a global leader in retail and wholesale pharmacy. As Americas most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and well-being of every community in America. Operating more than 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 8 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with platforms bringing together physical and digital, supported by the latest technology to deliver high-quality products and services in local communities nationwide. |
edtsum3272 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SANTA ANA, Calif., June 10, 2020 /PRNewswire/ --TENACORE announced that they have named Barbara Bitzer as the new chief financial officer effective May 18, 2020. In this role, Bitzer will lead the financial team to manage and execute the business financial plan and strategy. She will serve as a member of the Tenacore executive leadership team reporting to Chief Executive Officer James Willett. Barbara Bitzer named Chief Financial Officer at Tenacore LLC Bitzer and her team will manage day to day financial operations and ensure alignment with the core business expansion strategy. Additionally, Barbara and her team will lead the company's transition to entirely new service operations and enterprise resource planning (ERP) platforms. This effort will enable Tenacore to fully reengineer current service and repair processes and transform the service line capabilities. This transformation will position Tenacore with best-in-class service and repair systems infrastructure, enabling customers to better manage asset repair costs. "We are incredibly fortunate to have Barb join the Tenacore team and lead our financial initiatives that will help transform this business into a leading force within medical device depot service," says James Willett, chief executive officer. "Her experience in both large and small business environments combined with leading multiple acquisitions and integrations make Barb a tremendously important addition to our team." Bitzer most recently served as chief accounting officer and senior controller for Foundation Building Materials, Inc., located in Santa Ana, CA. In this role she was responsible for all accounting, SEC and external reporting. She also led the audit committee reporting to the Board of Directors and established a SOX compliant internal control structure in the newly established public company. Barbara has also served as vice president and controller for both Calumet Specialty Products, L.P. and Remy International, where she led accounting and treasury functions, as well as leading accounting due diligence for acquisition projects."I'm looking forward to joining the Tenacore organization and the leadership team that will move Tenacore to the next level of growth within the medical device service and repair industry," said Bitzer. "This is a tremendous market where I am confident that Tenacore will grow to become an even more important provider of new asset management and repair solutions for our clients and the patients that they serve."Bitzer earned a Bachelor of Science degree from The University of Evansville, Evansville, IN. She is a CPA and volunteer board member with the Pretend City Children's Museum in Irvine, CA. About Tenacore Tenacore LLC is a healthcare technology management company specializing in the depot based service and repair of a broad range of medical equipment. The company's ongoing expansion across the United States, paired with its depot model, multi-vendor service expertise and scalability, uniquely positions Tenacore to offer a cost effective and quality alternative to site-based service. In February of 2020, The Courtney Group based in Newport, CA collaborated with Indianapolis based Centerfield Capital Partners to invest in the acquisition of Tenacore LLC.Press Contact: Brandon Anaya800.297.2241[emailprotected] SOURCE Tenacore LLC Related Links https://www.tenacore.com
Answer: | Barbara Bitzer named Chief Financial Officer at Tenacore LLC Top healthcare technology repair and medical equipment service provider, Tenacore, has named Barbara Bitzer as its new CFO, effective May 18, 2020. | SANTA ANA, Calif., June 10, 2020 /PRNewswire/ --TENACORE announced that they have named Barbara Bitzer as the new chief financial officer effective May 18, 2020. In this role, Bitzer will lead the financial team to manage and execute the business financial plan and strategy. She will serve as a member of the Tenacore executive leadership team reporting to Chief Executive Officer James Willett. Barbara Bitzer named Chief Financial Officer at Tenacore LLC Bitzer and her team will manage day to day financial operations and ensure alignment with the core business expansion strategy. Additionally, Barbara and her team will lead the company's transition to entirely new service operations and enterprise resource planning (ERP) platforms. This effort will enable Tenacore to fully reengineer current service and repair processes and transform the service line capabilities. This transformation will position Tenacore with best-in-class service and repair systems infrastructure, enabling customers to better manage asset repair costs. "We are incredibly fortunate to have Barb join the Tenacore team and lead our financial initiatives that will help transform this business into a leading force within medical device depot service," says James Willett, chief executive officer. "Her experience in both large and small business environments combined with leading multiple acquisitions and integrations make Barb a tremendously important addition to our team." Bitzer most recently served as chief accounting officer and senior controller for Foundation Building Materials, Inc., located in Santa Ana, CA. In this role she was responsible for all accounting, SEC and external reporting. She also led the audit committee reporting to the Board of Directors and established a SOX compliant internal control structure in the newly established public company. Barbara has also served as vice president and controller for both Calumet Specialty Products, L.P. and Remy International, where she led accounting and treasury functions, as well as leading accounting due diligence for acquisition projects."I'm looking forward to joining the Tenacore organization and the leadership team that will move Tenacore to the next level of growth within the medical device service and repair industry," said Bitzer. "This is a tremendous market where I am confident that Tenacore will grow to become an even more important provider of new asset management and repair solutions for our clients and the patients that they serve."Bitzer earned a Bachelor of Science degree from The University of Evansville, Evansville, IN. She is a CPA and volunteer board member with the Pretend City Children's Museum in Irvine, CA. About Tenacore Tenacore LLC is a healthcare technology management company specializing in the depot based service and repair of a broad range of medical equipment. The company's ongoing expansion across the United States, paired with its depot model, multi-vendor service expertise and scalability, uniquely positions Tenacore to offer a cost effective and quality alternative to site-based service. In February of 2020, The Courtney Group based in Newport, CA collaborated with Indianapolis based Centerfield Capital Partners to invest in the acquisition of Tenacore LLC.Press Contact: Brandon Anaya800.297.2241[emailprotected] SOURCE Tenacore LLC Related Links https://www.tenacore.com |
edtsum3275 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SHANGHAI, March 11, 2021 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform in China, today announced that its Board of Directors has approved and declared a special cash dividend of US$1.00 per American depositary share (or US$0.50 per ordinary share) on its outstanding shares, to be paid on April 8, 2021 (Eastern Time) to shareholders of record as of the close of trading on March 22, 2021 (Eastern Time). About Cango Inc. Cango Inc. (NYSE: CANG) is a leading automotive transaction service platform in China connecting dealers, financial institutions, car buyers, and other industry participants. Founded in 2010 by a group of pioneers in China's automotive finance industry, the Company is headquartered in Shanghai and engages car buyers through a nationwide dealer network. The Company's services primarily consist of automotive financing facilitation, automotive transaction facilitation, and after-market services facilitation. By utilizing its competitive advantages in technology, data insights, and cloud-based infrastructure, Cango is able to connect its platform participants while bringing them a premium user experience. Cango's platform model puts it in a unique position to add value for its platform participants and business partners as the automotive and mobility markets in China continue to grow and evolve. For more information, please visit: www.cangoonline.com. Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the "Business Outlook" section and quotations from management in this announcement, contain forward-looking statements. Cango may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Cango's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Cango's goal and strategies; Cango's expansion plans; Cango's future business development, financial condition and results of operations; Cango's expectations regarding demand for, and market acceptance of, its solutions and services; Cango's expectations regarding keeping and strengthening its relationships with dealers, financial institutions, car buyers and other platform participants; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in Cango's filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Cango does not undertake any obligation to update any forward-looking statement, except as required under applicable law. Investor Relations Contact Caesar CaoCango Inc.Tel: +86 21 3183 5088 ext.5581Email: [emailprotected] Emilie WuThe Piacente Group, Inc.Tel: +86 21 6039 8363Email: [emailprotected] SOURCE Cango Inc. Related Links www.cangoonline.com
Answer: | Cango Inc. Declares Special Cash Dividend | SHANGHAI, March 11, 2021 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform in China, today announced that its Board of Directors has approved and declared a special cash dividend of US$1.00 per American depositary share (or US$0.50 per ordinary share) on its outstanding shares, to be paid on April 8, 2021 (Eastern Time) to shareholders of record as of the close of trading on March 22, 2021 (Eastern Time). About Cango Inc. Cango Inc. (NYSE: CANG) is a leading automotive transaction service platform in China connecting dealers, financial institutions, car buyers, and other industry participants. Founded in 2010 by a group of pioneers in China's automotive finance industry, the Company is headquartered in Shanghai and engages car buyers through a nationwide dealer network. The Company's services primarily consist of automotive financing facilitation, automotive transaction facilitation, and after-market services facilitation. By utilizing its competitive advantages in technology, data insights, and cloud-based infrastructure, Cango is able to connect its platform participants while bringing them a premium user experience. Cango's platform model puts it in a unique position to add value for its platform participants and business partners as the automotive and mobility markets in China continue to grow and evolve. For more information, please visit: www.cangoonline.com. Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the "Business Outlook" section and quotations from management in this announcement, contain forward-looking statements. Cango may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Cango's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Cango's goal and strategies; Cango's expansion plans; Cango's future business development, financial condition and results of operations; Cango's expectations regarding demand for, and market acceptance of, its solutions and services; Cango's expectations regarding keeping and strengthening its relationships with dealers, financial institutions, car buyers and other platform participants; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in Cango's filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Cango does not undertake any obligation to update any forward-looking statement, except as required under applicable law. Investor Relations Contact Caesar CaoCango Inc.Tel: +86 21 3183 5088 ext.5581Email: [emailprotected] Emilie WuThe Piacente Group, Inc.Tel: +86 21 6039 8363Email: [emailprotected] SOURCE Cango Inc. Related Links www.cangoonline.com |
edtsum3277 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Several Nuveen Closed-End Funds today announced that the Board of Trustees of the Funds has approved the adoption of a level distribution policy. Under the new policy, the Funds are increasing their current distribution rates as outlined below. The following dates apply to todays declaration: Record Date March 15, 2021 Ex-Dividend Date March 12, 2021 Payable Date April 1, 2021 Ticker Exchange Fund Name Monthly Distribution Per Share Amount Change From Previous Month Market Distribution Rate NAV Distribution Rate JGH NYSE Nuveen Global High Income Fund 0.1130 +0.0275 8.92% 7.98% JFR NYSE Nuveen Floating Rate Income Fund 0.0580 +0.0095 7.46% 6.74% JRO NYSE Nuveen Floating Rate Income Opportunity Fund 0.0575 +0.0100 7.50% 6.74% JSD NYSE Nuveen Short Duration Credit Opportunities Fund 0.0865 +0.0130 7.53% 6.72% NSL NYSE Nuveen Senior Income Fund 0.0340 +0.0035 7.39% 6.72% JLS NYSE Nuveen Mortgage and Income Fund 0.0830 +0.0150 4.88% 4.41% JMM NYSE Nuveen Multi-Market Income Fund 0.0300 +0.0055 4.96% 4.60% The level distribution policy is intended to provide shareholders with stable, but not guaranteed, cash flow, independent of the amount or timing of income earned or capital gains realized by a Fund. Each Fund intends to distribute all or substantially all of its net investment income through its regular monthly distribution and to distribute realized capital gains at least annually. In addition, in any monthly period, in order to maintain its level distribution amount, each Fund may pay out more or less than its net investment income during the period. As a result, distribution sources may include net investment income, realized gains and return of capital. If a Funds distribution includes anything other than net investment income, the Fund will provide a notice of its best estimate of the distribution sources at that time, which may be viewed at www.nuveen.com/CEFdistributions. These estimates may not match the final tax characterization (for the full years distributions) contained in shareholders 1099-DIV forms delivered after the end of the calendar year. Each Funds ability to maintain a level distribution amount will depend on a number of factors, including the amount and stability of investment income earned by the Fund, underlying market conditions, and the Funds expenses, including expenses associated with the Funds use of leverage. You should not draw any conclusions about the Funds investment performance from the amount of the distribution or from the terms of the Level Distribution Policy. A return of capital is a non-taxable distribution of a portion of a Funds capital. A return of capital distribution does not necessarily reflect a Funds investment performance and should not be confused with yield or income. For more information, please visit Nuveens Closed-End Fund homepage at https://www.nuveen.com/CEF. About Nuveen Nuveen, the investment manager of TIAA, offers a comprehensive range of outcome-focused investment solutions designed to secure the long-term financial goals of institutional and individual investors. Nuveen has $1.2 trillion in assets under management as of 31 Dec 2020 and operations in 27 countries. Its investment specialists offer deep expertise across a comprehensive range of traditional and alternative investments through a wide array of vehicles and customized strategies. For more information, please visit www.nuveen.com. Nuveen Securities, LLC, member FINRA and SIPC. The information contained on the Nuveen website is not a part of this press release. FORWARD LOOKING STATEMENTS Certain statements made in this release are forward-looking statements. Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements due to numerous factors. These include, but are not limited to: Nuveen and the closed-end funds managed by Nuveen and its affiliates undertake no responsibility to update publicly or revise any forward-looking statement. EPS-1539414PR-E0221X
Answer: | Nuveen Closed-End Funds Announce Distribution Increases and Adoption of Level Distribution Policy | NEW YORK--(BUSINESS WIRE)--Several Nuveen Closed-End Funds today announced that the Board of Trustees of the Funds has approved the adoption of a level distribution policy. Under the new policy, the Funds are increasing their current distribution rates as outlined below. The following dates apply to todays declaration: Record Date March 15, 2021 Ex-Dividend Date March 12, 2021 Payable Date April 1, 2021 Ticker Exchange Fund Name Monthly Distribution Per Share Amount Change From Previous Month Market Distribution Rate NAV Distribution Rate JGH NYSE Nuveen Global High Income Fund 0.1130 +0.0275 8.92% 7.98% JFR NYSE Nuveen Floating Rate Income Fund 0.0580 +0.0095 7.46% 6.74% JRO NYSE Nuveen Floating Rate Income Opportunity Fund 0.0575 +0.0100 7.50% 6.74% JSD NYSE Nuveen Short Duration Credit Opportunities Fund 0.0865 +0.0130 7.53% 6.72% NSL NYSE Nuveen Senior Income Fund 0.0340 +0.0035 7.39% 6.72% JLS NYSE Nuveen Mortgage and Income Fund 0.0830 +0.0150 4.88% 4.41% JMM NYSE Nuveen Multi-Market Income Fund 0.0300 +0.0055 4.96% 4.60% The level distribution policy is intended to provide shareholders with stable, but not guaranteed, cash flow, independent of the amount or timing of income earned or capital gains realized by a Fund. Each Fund intends to distribute all or substantially all of its net investment income through its regular monthly distribution and to distribute realized capital gains at least annually. In addition, in any monthly period, in order to maintain its level distribution amount, each Fund may pay out more or less than its net investment income during the period. As a result, distribution sources may include net investment income, realized gains and return of capital. If a Funds distribution includes anything other than net investment income, the Fund will provide a notice of its best estimate of the distribution sources at that time, which may be viewed at www.nuveen.com/CEFdistributions. These estimates may not match the final tax characterization (for the full years distributions) contained in shareholders 1099-DIV forms delivered after the end of the calendar year. Each Funds ability to maintain a level distribution amount will depend on a number of factors, including the amount and stability of investment income earned by the Fund, underlying market conditions, and the Funds expenses, including expenses associated with the Funds use of leverage. You should not draw any conclusions about the Funds investment performance from the amount of the distribution or from the terms of the Level Distribution Policy. A return of capital is a non-taxable distribution of a portion of a Funds capital. A return of capital distribution does not necessarily reflect a Funds investment performance and should not be confused with yield or income. For more information, please visit Nuveens Closed-End Fund homepage at https://www.nuveen.com/CEF. About Nuveen Nuveen, the investment manager of TIAA, offers a comprehensive range of outcome-focused investment solutions designed to secure the long-term financial goals of institutional and individual investors. Nuveen has $1.2 trillion in assets under management as of 31 Dec 2020 and operations in 27 countries. Its investment specialists offer deep expertise across a comprehensive range of traditional and alternative investments through a wide array of vehicles and customized strategies. For more information, please visit www.nuveen.com. Nuveen Securities, LLC, member FINRA and SIPC. The information contained on the Nuveen website is not a part of this press release. FORWARD LOOKING STATEMENTS Certain statements made in this release are forward-looking statements. Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements due to numerous factors. These include, but are not limited to: Nuveen and the closed-end funds managed by Nuveen and its affiliates undertake no responsibility to update publicly or revise any forward-looking statement. EPS-1539414PR-E0221X |
edtsum3287 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOSTON, Jan. 21, 2021 /PRNewswire/ -- COVID-19 vaccines continue to be administered across the country, and Black Pastors will be publicly vaccinated at Whittier Street Health Center on Jan. 22, 2021, from 10 a.m.-12 p.m. Whittier has a deep commitment to addressing racial and ethnic disparities in health and health care, economic equity, and social justice in the Boston inner city. The vaccine will be administered by Whittier staff Dr. Stephen Wright, Medical Director for Primary Care Services, and Melissa Leaston, RN, Director of Nursing and Infection Control Officer. "We deeply value our strategic and community partnerships, which includes our faith-based institutions and leaders. We believe that as key influencers in the communities we serve, they play a critical role in the engagement of our patients and community residents in health education and services that will address the high rates of mortality and morbidity in the communities we serve. Our minority populations have been negatively impacted by many issues including the COVID-19 virus. Our faith leaders have done an excellent job supporting our testing activities during the pandemicand our mission to address wellness, prevention, health disparities and overall well-being," said Frederica M. Williams, President and CEO of Whittier Street Health Center. "At Whittier, our goal is to build a culture of wellness in the communities servedand we hope to launch a mobile COVID-19 vaccination program, meeting people where they are and providing health and social services." "Whittier Street Health Center, for over 85 years, has been a stalwart for premier community-focused health care for inner-city Boston," said Pastor Gerald Bell, Board Chair, Whittier Street Health Center. "I personally acknowledge and have lived my entire life experiencing how Black Americans have been mistreated on many levels by the institutions which were meant to serve and help them. Therefore, without doubt or question, I will follow the lead of my primary care physician at Whittier and take the life-saving vaccination. I will lead my parishioners to do the same, follow the science and put your trust in the Lord above." Reverend Miniard Culpepper, Senior Pastor, Pleasant Hill Missionary Baptist Church and head of the COVID-19 Clergy Committee of Boston, stated that "Dr. Martin Luther King, Jr. said 'science investigates; religion interprets.' After much prayer, I interpret what the scientists are saying to mean that we can't wait. I agree with Dr. King when he said, 'We are caught in an inescapable network of mutuality tied in a single garment of destiny. What affects one directly affects all indirectly.' I hope and pray that by taking the vaccine, I can positively impact many to do the same." Whittier launched several COVID-19 vaccination focus groups and listening sessions to solicit feedback from community residents, community leaders and faith-based leaders from minority communities, and these have informed the culturally sensitive vaccination education outreach activities being launched. CONTACT:[emailprotected] 617 989 3220 SOURCE Whittier Street Health Center
Answer: | Black Pastors Taking the Lead Receiving COVID-19 Vaccine to Educate and Reassure the Minority Communities | BOSTON, Jan. 21, 2021 /PRNewswire/ -- COVID-19 vaccines continue to be administered across the country, and Black Pastors will be publicly vaccinated at Whittier Street Health Center on Jan. 22, 2021, from 10 a.m.-12 p.m. Whittier has a deep commitment to addressing racial and ethnic disparities in health and health care, economic equity, and social justice in the Boston inner city. The vaccine will be administered by Whittier staff Dr. Stephen Wright, Medical Director for Primary Care Services, and Melissa Leaston, RN, Director of Nursing and Infection Control Officer. "We deeply value our strategic and community partnerships, which includes our faith-based institutions and leaders. We believe that as key influencers in the communities we serve, they play a critical role in the engagement of our patients and community residents in health education and services that will address the high rates of mortality and morbidity in the communities we serve. Our minority populations have been negatively impacted by many issues including the COVID-19 virus. Our faith leaders have done an excellent job supporting our testing activities during the pandemicand our mission to address wellness, prevention, health disparities and overall well-being," said Frederica M. Williams, President and CEO of Whittier Street Health Center. "At Whittier, our goal is to build a culture of wellness in the communities servedand we hope to launch a mobile COVID-19 vaccination program, meeting people where they are and providing health and social services." "Whittier Street Health Center, for over 85 years, has been a stalwart for premier community-focused health care for inner-city Boston," said Pastor Gerald Bell, Board Chair, Whittier Street Health Center. "I personally acknowledge and have lived my entire life experiencing how Black Americans have been mistreated on many levels by the institutions which were meant to serve and help them. Therefore, without doubt or question, I will follow the lead of my primary care physician at Whittier and take the life-saving vaccination. I will lead my parishioners to do the same, follow the science and put your trust in the Lord above." Reverend Miniard Culpepper, Senior Pastor, Pleasant Hill Missionary Baptist Church and head of the COVID-19 Clergy Committee of Boston, stated that "Dr. Martin Luther King, Jr. said 'science investigates; religion interprets.' After much prayer, I interpret what the scientists are saying to mean that we can't wait. I agree with Dr. King when he said, 'We are caught in an inescapable network of mutuality tied in a single garment of destiny. What affects one directly affects all indirectly.' I hope and pray that by taking the vaccine, I can positively impact many to do the same." Whittier launched several COVID-19 vaccination focus groups and listening sessions to solicit feedback from community residents, community leaders and faith-based leaders from minority communities, and these have informed the culturally sensitive vaccination education outreach activities being launched. CONTACT:[emailprotected] 617 989 3220 SOURCE Whittier Street Health Center |
edtsum3294 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ENGLEWOOD, Colo.--(BUSINESS WIRE)--Qurate Retail, Inc. (Qurate Retail) (Nasdaq: QRTEA, QRTEB, QRTEP) announced Mike George, President and CEO of Qurate Retail, will be presenting at the Bank of America Consumer & Retail Technology Conference on Wednesday, March 10th at 10:30 a.m. E.S.T. During his presentation, Mr. George may make observations regarding the company's financial performance and outlook, as well as other forward looking matters. The presentation will be broadcast live via the Internet. All interested persons should visit the Qurate Retail website at http://qurateretail.com/events to register for the webcast. An archive of the webcast will also be available on this website for 180 days after appropriate filings have been made with the SEC. About Qurate Retail, Inc. Qurate Retail, Inc. operates and owns interests in a broad range of digital commerce businesses. Qurate Retail, Inc.s businesses and assets consist of QVC (and its subsidiaries, including HSN), Zulily and the Cornerstone Brands (collectively, the Qurate Retail Group) as well as various green energy and other investments.
Answer: | Qurate Retail, Inc. to Present at Bank of America Consumer & Retail Technology Conference | ENGLEWOOD, Colo.--(BUSINESS WIRE)--Qurate Retail, Inc. (Qurate Retail) (Nasdaq: QRTEA, QRTEB, QRTEP) announced Mike George, President and CEO of Qurate Retail, will be presenting at the Bank of America Consumer & Retail Technology Conference on Wednesday, March 10th at 10:30 a.m. E.S.T. During his presentation, Mr. George may make observations regarding the company's financial performance and outlook, as well as other forward looking matters. The presentation will be broadcast live via the Internet. All interested persons should visit the Qurate Retail website at http://qurateretail.com/events to register for the webcast. An archive of the webcast will also be available on this website for 180 days after appropriate filings have been made with the SEC. About Qurate Retail, Inc. Qurate Retail, Inc. operates and owns interests in a broad range of digital commerce businesses. Qurate Retail, Inc.s businesses and assets consist of QVC (and its subsidiaries, including HSN), Zulily and the Cornerstone Brands (collectively, the Qurate Retail Group) as well as various green energy and other investments. |
edtsum3299 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious medical conditions, today announced positive interim results from the ongoing 24-patient Phase 1/2a clinical study of Lineages lead product candidate, OpRegen. OpRegen is an investigational cell therapy consisting of allogeneic retinal pigment epithelium (RPE) cells administered to the subretinal space for the treatment of dry age-related macular degeneration (AMD) with geographic atrophy (GA). At AAO, new data were presented on 20 patients, including 8 patients treated in Cohort 4, which feature better baseline vision and smaller areas of GA. All 8 of these patients were treated with a new thaw-and-inject formulation of OpRegen and 4 were treated using the Gyroscope Orbit Subretinal Delivery System (Gyroscope SDS). Data presented at AAO showed improvements in visual acuity in Cohort 4 patients, with treated versus fellow eye comparisons reaching statistical significance at 9 and 12 months following OpRegen administration. These improvements were maintained for up to 24 months in some patients. A trend towards slower GA growth was observed in the first 6 Cohort 4 patients, a trend maintained for as long as 24 months in patients with 24-month data available. Previously reported structural improvements in the retina and decreases in drusen density have continued with evidence of durable engraftment of OpRegen cells in treated patients, some more than 4 years following administration, with no immunosuppression utilized beyond the perioperative period. Overall, OpRegen appears to be well-tolerated in all patients treated to date. The final four patients in the study were treated during November and will provide additional visual acuity data in the coming months. These new data increasingly suggest to us that treatment with OpRegen can provide clinically meaningful outcomes in dry AMD patients with GA, particularly for those with earlier-stage disease, stated Brian M. Culley, Lineage CEO. According to a recent survey published in Investigative Ophthalmology & Visual Science, only 27% percent of retinal specialists believed patients with visual acuity of 20/200 or worse could benefit from treatment with an agent which slows the growth of GA, while 93-99% of them believed patients with visual acuity of 20/200 or better could benefit from this approach. This is consistent with our belief that recent data from our Cohort 4 patients, which have less advanced disease and better baseline vision, are more exciting and provide a better surrogate for the potential clinical and commercial opportunity for OpRegen. Mr. Culley added, In addition to reporting the first known finding of anatomical restoration of retinal tissue, which has persisted below baseline for 23 months and counting, treatment with OpRegen continues to demonstrate other benefits in some patients, including increases in visual acuity, reductions in the growth rate of GA and increases in reading speed. These are additive to the improvements we previously reported in retinal architecture and drusen reduction. Further, the multi-year durability of transplants without rejection is notable for our allogeneic cell therapy approach, especially as patients did not require long-term immunosuppression. With enrollment recently completed, our focus turns next toward collecting safety and efficacy data on the most recently treated patients, advancing partnership and investor discussions weve been having, exploring our options for later-stage clinical development, and speaking with the FDA about next steps. Our objective is to position the OpRegen program as a front-runner in the race to address an unmet need in what is widely expected to be a multi-billion-dollar dry AMD therapeutic market and to drive Lineage forward as the pre-eminent allogeneic cell therapy company. OpRegen Data Update & Highlights from the AAO Presentation (data presented on 20 patients, dosed through October 5, 2020): The results were presented at the 2020 American Academy of Ophthalmology Annual Meeting (AAO 2020). The presentation, Phase 1/2a Study of Subretinally Transplanted hESC-Derived RPE Cells in Advanced Dry-Form AMD Patients was featured as part of the Original Paper Session, OP02V Retina, Vitreous Original Papers on November 15, 2020 and was presented by Christopher Riemann, M.D. KOL Call and Webcast Lineage will host a therapeutic area expert call with Christopher D. Riemann, M.D., Vitreoretinal Surgeon and Fellowship Director, Cincinnati Eye Institute and University of Cincinnati School of Medicine, to discuss the interim results on November 17, 2020 at 4:00 pm Eastern Time / 1:00 p.m. Pacific Time. Interested parties can access the event on the Events and Presentations section of Lineages website. About OpRegen OpRegen is currently being evaluated in a Phase 1/2a open-label, dose escalation safety and efficacy study of a single injection of human retinal pigment epithelium cells derived from an established pluripotent cell line and transplanted subretinally in patients with advanced dry AMD with GA. The study enrolled 24 patients into 4 cohorts. The first 3 cohorts enrolled only legally blind patients with best corrected visual acuity (BCVA) of 20/200 or worse. The fourth cohort enrolled 12 better vision patients (vision from 20/65 to 20/250 with smaller areas of GA). Cohort 4 also included patients treated with a new thaw-and-inject formulation of OpRegen, which can be shipped directly to sites and used immediately upon thawing, removing the complications and logistics of having to use a dose preparation facility. In total, 17 patients were treated via PPV, while 7 were treated with the Gyroscope SDS. The primary objective of the study is to evaluate the safety and tolerability of OpRegen as assessed by the incidence and frequency of treatment emergent adverse events. Secondary objectives are to evaluate the preliminary efficacy of OpRegen treatment by assessing the changes in ophthalmological parameters measured by various methods of primary clinical relevance. Additionally, for the patients in Cohort 4 that receive subretinal delivery of OpRegen utilizing the Gyroscope SDS, objectives will include the evaluation of the safety of delivery of OpRegen using the Gyroscope SDS. OpRegen is a registered trademark of Cell Cure Neurosciences Ltd., a majority-owned subsidiary of Lineage Cell Therapeutics, Inc. About Dry AMD Dry age-related macular degeneration (AMD) is a leading cause of adult blindness in the developed world. There are two forms of AMD: wet AMD and dry AMD. Dry AMD is the more common of the two types, accounting for approximately 85-90% of cases. Wet AMD is the less common of the two types, accounting for approximately 10-15% of cases. Global sales of the two leading wet AMD therapies were in excess of $10 billion in 2019. Nearly all cases of wet AMD begin as dry AMD. Dry AMD typically affects both eyes. There are currently no U.S. Food and Drug Administration (FDA) or European Medicines Agency (EMA) approved treatment options available for patients with dry AMD. About Lineage Cell Therapeutics, Inc. Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineages programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineages clinical programs are in markets with billion dollar opportunities and include three allogeneic (off-the-shelf) product candidates: (i) OpRegen, a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in clinical development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com or follow the Company on Twitter @LineageCell. Forward-Looking Statements Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as believe, may, will, estimate, continue, anticipate, design, intend, expect, could, plan, potential, predict, seek, should, would, contemplate, project, target, tend to, or the negative version of these words and similar expressions. Such statements include, but are not limited to, statements relating to the development plans for OpRegen and post-enrollment timing expectations. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineages actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including risks and uncertainties inherent in Lineages business and other risks in Lineages filings with the Securities and Exchange Commission (the SEC). Lineages forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. Further information regarding these and other risks is included under the heading Risk Factors in Lineages periodic reports with the SEC, including Lineages Annual Report on Form 10-K filed with the SEC on March 12, 2020 and its other reports, which are available from the SECs website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.
Answer: | Lineage Cell Therapeutics Presents New OpRegen Data for Dry AMD With GA at 2020 American Academy of Ophthalmology Annual Meeting Improved Visual Acuity Continues to be Observed in Cohort 4 Patients First Known Clinical Report of Retinal Tissue Regeneration Persisted to 23 Months with Further Improvement in Visual Acuity Patient Enrollment Recently Completed Therapeutic Expert Call with Principal Investigator Christopher D. Riemann, M.D. Scheduled for November 17, 2020 at 4:00 pm Eastern Time | CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious medical conditions, today announced positive interim results from the ongoing 24-patient Phase 1/2a clinical study of Lineages lead product candidate, OpRegen. OpRegen is an investigational cell therapy consisting of allogeneic retinal pigment epithelium (RPE) cells administered to the subretinal space for the treatment of dry age-related macular degeneration (AMD) with geographic atrophy (GA). At AAO, new data were presented on 20 patients, including 8 patients treated in Cohort 4, which feature better baseline vision and smaller areas of GA. All 8 of these patients were treated with a new thaw-and-inject formulation of OpRegen and 4 were treated using the Gyroscope Orbit Subretinal Delivery System (Gyroscope SDS). Data presented at AAO showed improvements in visual acuity in Cohort 4 patients, with treated versus fellow eye comparisons reaching statistical significance at 9 and 12 months following OpRegen administration. These improvements were maintained for up to 24 months in some patients. A trend towards slower GA growth was observed in the first 6 Cohort 4 patients, a trend maintained for as long as 24 months in patients with 24-month data available. Previously reported structural improvements in the retina and decreases in drusen density have continued with evidence of durable engraftment of OpRegen cells in treated patients, some more than 4 years following administration, with no immunosuppression utilized beyond the perioperative period. Overall, OpRegen appears to be well-tolerated in all patients treated to date. The final four patients in the study were treated during November and will provide additional visual acuity data in the coming months. These new data increasingly suggest to us that treatment with OpRegen can provide clinically meaningful outcomes in dry AMD patients with GA, particularly for those with earlier-stage disease, stated Brian M. Culley, Lineage CEO. According to a recent survey published in Investigative Ophthalmology & Visual Science, only 27% percent of retinal specialists believed patients with visual acuity of 20/200 or worse could benefit from treatment with an agent which slows the growth of GA, while 93-99% of them believed patients with visual acuity of 20/200 or better could benefit from this approach. This is consistent with our belief that recent data from our Cohort 4 patients, which have less advanced disease and better baseline vision, are more exciting and provide a better surrogate for the potential clinical and commercial opportunity for OpRegen. Mr. Culley added, In addition to reporting the first known finding of anatomical restoration of retinal tissue, which has persisted below baseline for 23 months and counting, treatment with OpRegen continues to demonstrate other benefits in some patients, including increases in visual acuity, reductions in the growth rate of GA and increases in reading speed. These are additive to the improvements we previously reported in retinal architecture and drusen reduction. Further, the multi-year durability of transplants without rejection is notable for our allogeneic cell therapy approach, especially as patients did not require long-term immunosuppression. With enrollment recently completed, our focus turns next toward collecting safety and efficacy data on the most recently treated patients, advancing partnership and investor discussions weve been having, exploring our options for later-stage clinical development, and speaking with the FDA about next steps. Our objective is to position the OpRegen program as a front-runner in the race to address an unmet need in what is widely expected to be a multi-billion-dollar dry AMD therapeutic market and to drive Lineage forward as the pre-eminent allogeneic cell therapy company. OpRegen Data Update & Highlights from the AAO Presentation (data presented on 20 patients, dosed through October 5, 2020): The results were presented at the 2020 American Academy of Ophthalmology Annual Meeting (AAO 2020). The presentation, Phase 1/2a Study of Subretinally Transplanted hESC-Derived RPE Cells in Advanced Dry-Form AMD Patients was featured as part of the Original Paper Session, OP02V Retina, Vitreous Original Papers on November 15, 2020 and was presented by Christopher Riemann, M.D. KOL Call and Webcast Lineage will host a therapeutic area expert call with Christopher D. Riemann, M.D., Vitreoretinal Surgeon and Fellowship Director, Cincinnati Eye Institute and University of Cincinnati School of Medicine, to discuss the interim results on November 17, 2020 at 4:00 pm Eastern Time / 1:00 p.m. Pacific Time. Interested parties can access the event on the Events and Presentations section of Lineages website. About OpRegen OpRegen is currently being evaluated in a Phase 1/2a open-label, dose escalation safety and efficacy study of a single injection of human retinal pigment epithelium cells derived from an established pluripotent cell line and transplanted subretinally in patients with advanced dry AMD with GA. The study enrolled 24 patients into 4 cohorts. The first 3 cohorts enrolled only legally blind patients with best corrected visual acuity (BCVA) of 20/200 or worse. The fourth cohort enrolled 12 better vision patients (vision from 20/65 to 20/250 with smaller areas of GA). Cohort 4 also included patients treated with a new thaw-and-inject formulation of OpRegen, which can be shipped directly to sites and used immediately upon thawing, removing the complications and logistics of having to use a dose preparation facility. In total, 17 patients were treated via PPV, while 7 were treated with the Gyroscope SDS. The primary objective of the study is to evaluate the safety and tolerability of OpRegen as assessed by the incidence and frequency of treatment emergent adverse events. Secondary objectives are to evaluate the preliminary efficacy of OpRegen treatment by assessing the changes in ophthalmological parameters measured by various methods of primary clinical relevance. Additionally, for the patients in Cohort 4 that receive subretinal delivery of OpRegen utilizing the Gyroscope SDS, objectives will include the evaluation of the safety of delivery of OpRegen using the Gyroscope SDS. OpRegen is a registered trademark of Cell Cure Neurosciences Ltd., a majority-owned subsidiary of Lineage Cell Therapeutics, Inc. About Dry AMD Dry age-related macular degeneration (AMD) is a leading cause of adult blindness in the developed world. There are two forms of AMD: wet AMD and dry AMD. Dry AMD is the more common of the two types, accounting for approximately 85-90% of cases. Wet AMD is the less common of the two types, accounting for approximately 10-15% of cases. Global sales of the two leading wet AMD therapies were in excess of $10 billion in 2019. Nearly all cases of wet AMD begin as dry AMD. Dry AMD typically affects both eyes. There are currently no U.S. Food and Drug Administration (FDA) or European Medicines Agency (EMA) approved treatment options available for patients with dry AMD. About Lineage Cell Therapeutics, Inc. Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineages programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineages clinical programs are in markets with billion dollar opportunities and include three allogeneic (off-the-shelf) product candidates: (i) OpRegen, a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in clinical development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com or follow the Company on Twitter @LineageCell. Forward-Looking Statements Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as believe, may, will, estimate, continue, anticipate, design, intend, expect, could, plan, potential, predict, seek, should, would, contemplate, project, target, tend to, or the negative version of these words and similar expressions. Such statements include, but are not limited to, statements relating to the development plans for OpRegen and post-enrollment timing expectations. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineages actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including risks and uncertainties inherent in Lineages business and other risks in Lineages filings with the Securities and Exchange Commission (the SEC). Lineages forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. Further information regarding these and other risks is included under the heading Risk Factors in Lineages periodic reports with the SEC, including Lineages Annual Report on Form 10-K filed with the SEC on March 12, 2020 and its other reports, which are available from the SECs website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. |
edtsum3308 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SOLON, Ohio, June 1, 2020 /PRNewswire/ -- Efficient Collaborative Retail Marketing (ECRM), the global leader in driving long-term, critical business relationships for retail, foodservice and pharmacy/medical markets, announced the successful launch of its first Virtual Session on the ECRM Connect proprietary platform, developed to enable buyers and sellers to engage in live, interactive digital meetings at scale. Continue Reading Across Categories, Across Platforms, Across the Globe for 25 Years! Whether you're a retailer, supplier, owner/operator or service provider, we drive efficiency and effectiveness for your business. Through an innovative digital platform and face-to-face interaction, ECRM brings planning, knowledge, guidance and networking together, unlike anyone in the industry. We're in the discovery business, helping bring innovative products and services to the world. More than 70 retail buyers participated in 630 digital face-to-face meetings with suppliers of vitamins, supplements and nutritional products during ECRM's Healthy Living, Vitamin & Nutrition Program, the first session to go live on the new virtual platform. The efficiency, effectiveness and usability of the platform was noted by users on both sides of the virtual meeting table. "ECRM has completely transformed the way they are doing business, quickly pivoting into an easy-to-use, convenient online platform for both buyers and sellers," said Jeff Currie, Category Manager - Health & Beauty for Wakefern Food Corp. "It was definitely a valuable experience for me, and I look forward to attending future digital sessions with ECRM soon." In addition to the face to face video engagement, buyers and sellers took full advantage of the platform's technology, which provided users with the ability to take meeting notes, review products and supplier capabilities, rank meetings with a one- to five-star rating, and communicate follow-up timelines - all this activity automatically recorded in each user's profile to access following the meetings. Each user also had the ability to share presentations that further explain how their products could fit in each retailers' stores. "I used the notes really heavily," said Kate Soffe, Category Manager, Beauty & Wellness for Overstock.com. "It was really easy to review them afterwards because it was all in one place on the follow up site. The star ratings were also helpful, and they enabled me to sort and locate my top opportunities, and in our case, we were able to send follow up emails the day after we were finished."Soffe also noted that having the sessions in a virtual format means she will be able to participate in additional Programs, which will result in increased opportunities for product discovery. "I was impressed with the number of qualified vendors I was able to meet with, and I do see the benefits of in-person sessions, but it's not easy to travel a lot for work. The virtual will enable me to participate in more sessions, so a healthy mix of both in the future will be ideal."To ensure that all buyers and sellers had an optimal experience, ECRM's Customer Success team worked closely with each participant toensure each felt comfortable using the platform, including building their company profile, buyer needs and objectives, supplier products and capabilities, and loading up any presentations they may want to share. Each was then taken through a dry run on the platform so they could familiarize themselves with its tools. The result was a smooth live experience for all involved."It was seamless," says Bob Richardson, Director of Customer & Industry Development for The Clorox Company, one of the seller participants in the session. "The benefit of being able to take the notes, me typing instead of writing, was great. And then the transition from one meeting to the next is quick. That actually went quite well."Suppliers also loved the quick follow-up of the buyers. More than 165 follow-up timelines were indicated, and with no need to pack up and travel home at the end of the session, many reached out to suppliers as soon as the meetings concluded. "We had 35 buyer meetings, and 17 buyers indicated specific follow up timelines," said Alisa Shakespeare, Founder of Total Cluster Fudge. "The best part is that six of them actually reached out to me directly within a day!"ECRM will be hosting more than 50 virtual sessionsacross the Food & beverage, Health & Beauty Care, General Merchandise and Pharmacy/Medical Markets categories throughout the remainder of the year. In this time of uncertainty and travel restrictions, ECRM seeks to continue delivering value to buyers and sellers by providing solutions that help them continue moving forward with their business, as the company has done for the past 25 years."We're thrilled we were able to deliver on our promise of a virtual solution that would enable buyers and sellers to continue conducting business during this time of restricted travel," said Craig Chmielowicz, SVP of Health & Beauty Care for ECRM. "Based on participant feedback, these Virtual Sessions, in combination with our in-person Sessions and Efficient Supplier Introductions, will enable our customers to engage each other when, where and how it best suits their needs."About ECRM:ECRM brings efficiencies and effectiveness to the buying and selling process by propelling connections between buyers and suppliers through key programs that utilize virtual and face-to-face platforms. With 25 years of experience, ECRM's programs promote relationships, forward thinking insights along with process efficiencies. ECRM works with companies around with world in a variety of different categories including food & beverage, general merchandise, health & beauty care, pharmacy & medical markets and foodservice.Rachel Mayfield440-498-0500 x1253[emailprotected]www.ECRM.MarketGate.comSOURCE ECRM Related Links https://ecrm.marketgate.com
Answer: | ECRM's First Virtual Session Exceeds Buyer and Seller Expectations | SOLON, Ohio, June 1, 2020 /PRNewswire/ -- Efficient Collaborative Retail Marketing (ECRM), the global leader in driving long-term, critical business relationships for retail, foodservice and pharmacy/medical markets, announced the successful launch of its first Virtual Session on the ECRM Connect proprietary platform, developed to enable buyers and sellers to engage in live, interactive digital meetings at scale. Continue Reading Across Categories, Across Platforms, Across the Globe for 25 Years! Whether you're a retailer, supplier, owner/operator or service provider, we drive efficiency and effectiveness for your business. Through an innovative digital platform and face-to-face interaction, ECRM brings planning, knowledge, guidance and networking together, unlike anyone in the industry. We're in the discovery business, helping bring innovative products and services to the world. More than 70 retail buyers participated in 630 digital face-to-face meetings with suppliers of vitamins, supplements and nutritional products during ECRM's Healthy Living, Vitamin & Nutrition Program, the first session to go live on the new virtual platform. The efficiency, effectiveness and usability of the platform was noted by users on both sides of the virtual meeting table. "ECRM has completely transformed the way they are doing business, quickly pivoting into an easy-to-use, convenient online platform for both buyers and sellers," said Jeff Currie, Category Manager - Health & Beauty for Wakefern Food Corp. "It was definitely a valuable experience for me, and I look forward to attending future digital sessions with ECRM soon." In addition to the face to face video engagement, buyers and sellers took full advantage of the platform's technology, which provided users with the ability to take meeting notes, review products and supplier capabilities, rank meetings with a one- to five-star rating, and communicate follow-up timelines - all this activity automatically recorded in each user's profile to access following the meetings. Each user also had the ability to share presentations that further explain how their products could fit in each retailers' stores. "I used the notes really heavily," said Kate Soffe, Category Manager, Beauty & Wellness for Overstock.com. "It was really easy to review them afterwards because it was all in one place on the follow up site. The star ratings were also helpful, and they enabled me to sort and locate my top opportunities, and in our case, we were able to send follow up emails the day after we were finished."Soffe also noted that having the sessions in a virtual format means she will be able to participate in additional Programs, which will result in increased opportunities for product discovery. "I was impressed with the number of qualified vendors I was able to meet with, and I do see the benefits of in-person sessions, but it's not easy to travel a lot for work. The virtual will enable me to participate in more sessions, so a healthy mix of both in the future will be ideal."To ensure that all buyers and sellers had an optimal experience, ECRM's Customer Success team worked closely with each participant toensure each felt comfortable using the platform, including building their company profile, buyer needs and objectives, supplier products and capabilities, and loading up any presentations they may want to share. Each was then taken through a dry run on the platform so they could familiarize themselves with its tools. The result was a smooth live experience for all involved."It was seamless," says Bob Richardson, Director of Customer & Industry Development for The Clorox Company, one of the seller participants in the session. "The benefit of being able to take the notes, me typing instead of writing, was great. And then the transition from one meeting to the next is quick. That actually went quite well."Suppliers also loved the quick follow-up of the buyers. More than 165 follow-up timelines were indicated, and with no need to pack up and travel home at the end of the session, many reached out to suppliers as soon as the meetings concluded. "We had 35 buyer meetings, and 17 buyers indicated specific follow up timelines," said Alisa Shakespeare, Founder of Total Cluster Fudge. "The best part is that six of them actually reached out to me directly within a day!"ECRM will be hosting more than 50 virtual sessionsacross the Food & beverage, Health & Beauty Care, General Merchandise and Pharmacy/Medical Markets categories throughout the remainder of the year. In this time of uncertainty and travel restrictions, ECRM seeks to continue delivering value to buyers and sellers by providing solutions that help them continue moving forward with their business, as the company has done for the past 25 years."We're thrilled we were able to deliver on our promise of a virtual solution that would enable buyers and sellers to continue conducting business during this time of restricted travel," said Craig Chmielowicz, SVP of Health & Beauty Care for ECRM. "Based on participant feedback, these Virtual Sessions, in combination with our in-person Sessions and Efficient Supplier Introductions, will enable our customers to engage each other when, where and how it best suits their needs."About ECRM:ECRM brings efficiencies and effectiveness to the buying and selling process by propelling connections between buyers and suppliers through key programs that utilize virtual and face-to-face platforms. With 25 years of experience, ECRM's programs promote relationships, forward thinking insights along with process efficiencies. ECRM works with companies around with world in a variety of different categories including food & beverage, general merchandise, health & beauty care, pharmacy & medical markets and foodservice.Rachel Mayfield440-498-0500 x1253[emailprotected]www.ECRM.MarketGate.comSOURCE ECRM Related Links https://ecrm.marketgate.com |
edtsum3317 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: COLUMBUS, Ga., Oct. 29, 2020 /PRNewswire/ --Last year, 461 Aflac employees logged more than 16,450 hours of volunteer work for a variety of charities, including the American Cancer Society, the Girl Scouts of Historic Georgia, Giving Tree and Minor in Business. Now Aflac is publicly recognizing its top-12 employee volunteers for service to their local communities. Recipients will be honored with a customized sign placed in their yards and a contribution to their charity of choice. "These 12 honorees illustrate how at Aflac, doing good for the community and giving back have been ingrained in our culture for 65 years," said Aflac Chairman and CEO Dan Amos. "We are proud of all of our remarkable employees who illustrate selfless giving in their communities across the country, and are pleased that the number of volunteers as well as the number of hours they dedicate to making the world a better place are on the rise. That is truly the Aflac Way." Each year, Aflac asks employees across the company to track and log volunteer hours. In 2019, 461 employees 2% more than 2018 signed up. They logged 16,450 hours of service, a 7% increase from the year prior. Aflac is proud to announce the following recipients of the 2019 Outstanding Employee Volunteer Award: Theresa Aderhold Americus, Georgia. Chelsea Arrington Phenix City, Alabama. David Bailey Woodstock, Georgia. Keith Banks Opelika, Alabama. Michaela Coleson Columbus, Georgia. Lea Craig LaGrange, Georgia. Sherricka Day Columbus, Georgia. Mike Frank Phenix City, Alabama. Jamie Landers Cataula, Georgia. Julie Maggard Columbia, South Carolina. Tara Rotthoff - Columbia, South Carolina. Mark Shreve Ellerslie, Georgia. Aflac, a leading provider of supplemental insurance and products in the U.S., encourages employees to choose opportunities that align with company-supported charitable organizations as well as employees' interests and passions. In September, goBeyondProfit named Aflac a 2020 goBeyondProfit Champion, an award honoring exemplary approaches in corporate generosity. To learn more about Aflac and its commitment to community, please visit Aflac.com/CSRReport. About Aflac IncorporatedAflac Incorporated (NYSE: AFL) is a Fortune 500 company, helping provide protection to more than 50 million people through its subsidiaries inJapanand the U.S., where it is a leading supplemental insurer by paying cash fast when policyholders get sick or injured. For more than six decades, insurance policies of Aflac Incorporated's subsidiaries have given policyholders the opportunity to focus on recovery, not financial stress. Aflac Life Insurance Japan is the leading provider of medical and cancer insurance inJapanwhere it insures 1 in 4 households. For 14 consecutive years, Aflac Incorporated has been recognized byEthisphereas one of the World's Most Ethical Companies. In 2020, Fortune included Aflac Incorporated on its list of World's Most Admired Companies for the 19th time, and Bloomberg added Aflac Incorporated to its Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation and transparency. To find out how to get help with expenses health insurance doesn't cover, get to know us ataflac.comoraflac.com/espanol. Aflac | Aflac New York | WWHQ | 1932 Wynnton Road | Columbus, GA 31999. Media contact: Jon Sullivan, 706.573.7610 or [emailprotected] Analyst and investor contact: David A. Young, 706.596.3264 or [emailprotected] SOURCE Aflac
Answer: | Aflac Employees Honored for Doing Good and Giving Back Employees logged more than 16,000 hours of volunteer work in 2019, up 7% from 2018. | COLUMBUS, Ga., Oct. 29, 2020 /PRNewswire/ --Last year, 461 Aflac employees logged more than 16,450 hours of volunteer work for a variety of charities, including the American Cancer Society, the Girl Scouts of Historic Georgia, Giving Tree and Minor in Business. Now Aflac is publicly recognizing its top-12 employee volunteers for service to their local communities. Recipients will be honored with a customized sign placed in their yards and a contribution to their charity of choice. "These 12 honorees illustrate how at Aflac, doing good for the community and giving back have been ingrained in our culture for 65 years," said Aflac Chairman and CEO Dan Amos. "We are proud of all of our remarkable employees who illustrate selfless giving in their communities across the country, and are pleased that the number of volunteers as well as the number of hours they dedicate to making the world a better place are on the rise. That is truly the Aflac Way." Each year, Aflac asks employees across the company to track and log volunteer hours. In 2019, 461 employees 2% more than 2018 signed up. They logged 16,450 hours of service, a 7% increase from the year prior. Aflac is proud to announce the following recipients of the 2019 Outstanding Employee Volunteer Award: Theresa Aderhold Americus, Georgia. Chelsea Arrington Phenix City, Alabama. David Bailey Woodstock, Georgia. Keith Banks Opelika, Alabama. Michaela Coleson Columbus, Georgia. Lea Craig LaGrange, Georgia. Sherricka Day Columbus, Georgia. Mike Frank Phenix City, Alabama. Jamie Landers Cataula, Georgia. Julie Maggard Columbia, South Carolina. Tara Rotthoff - Columbia, South Carolina. Mark Shreve Ellerslie, Georgia. Aflac, a leading provider of supplemental insurance and products in the U.S., encourages employees to choose opportunities that align with company-supported charitable organizations as well as employees' interests and passions. In September, goBeyondProfit named Aflac a 2020 goBeyondProfit Champion, an award honoring exemplary approaches in corporate generosity. To learn more about Aflac and its commitment to community, please visit Aflac.com/CSRReport. About Aflac IncorporatedAflac Incorporated (NYSE: AFL) is a Fortune 500 company, helping provide protection to more than 50 million people through its subsidiaries inJapanand the U.S., where it is a leading supplemental insurer by paying cash fast when policyholders get sick or injured. For more than six decades, insurance policies of Aflac Incorporated's subsidiaries have given policyholders the opportunity to focus on recovery, not financial stress. Aflac Life Insurance Japan is the leading provider of medical and cancer insurance inJapanwhere it insures 1 in 4 households. For 14 consecutive years, Aflac Incorporated has been recognized byEthisphereas one of the World's Most Ethical Companies. In 2020, Fortune included Aflac Incorporated on its list of World's Most Admired Companies for the 19th time, and Bloomberg added Aflac Incorporated to its Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation and transparency. To find out how to get help with expenses health insurance doesn't cover, get to know us ataflac.comoraflac.com/espanol. Aflac | Aflac New York | WWHQ | 1932 Wynnton Road | Columbus, GA 31999. Media contact: Jon Sullivan, 706.573.7610 or [emailprotected] Analyst and investor contact: David A. Young, 706.596.3264 or [emailprotected] SOURCE Aflac |
edtsum3322 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OMAHA, Neb.--(BUSINESS WIRE)--Today insurance and financial services giant Mutual of Omaha unveiled a new corporate logo, featuring the image of a lion. Inspired by its heritage and customer-centric mission and values, this updated logo reflects the protection and strength that Mutual of Omaha has represented for more than a century. It also delivers a strong brand connection based on the companys longtime sponsorship of the groundbreaking wildlife program Mutual of Omahas Wild Kingdom. Our new logo reflects our companys mission and values while representing the commitment weve made for more than a century to helping people protect whats important to them, said Keith Clark, senior vice president of marketing at Mutual of Omaha. We chose the symbol of a lion not only as a nod to our Wild Kingdom heritage, but to represent the strong company weve always been. In July, Mutual announced the removal of Native American imagery from its corporate logo. For additional information about Mutual of Omahas new logo, visit www.mutualofomaha.com. Founded in 1909, Mutual of Omaha is a highly-rated, Fortune 500 organization offering a variety of insurance and financial products for individuals, businesses and groups throughout the United States. As a mutual company, Mutual of Omaha is owned by its policyholders and committed to providing outstanding service to its customers.
Answer: | Mutual of Omaha Announces New Corporate Logo | OMAHA, Neb.--(BUSINESS WIRE)--Today insurance and financial services giant Mutual of Omaha unveiled a new corporate logo, featuring the image of a lion. Inspired by its heritage and customer-centric mission and values, this updated logo reflects the protection and strength that Mutual of Omaha has represented for more than a century. It also delivers a strong brand connection based on the companys longtime sponsorship of the groundbreaking wildlife program Mutual of Omahas Wild Kingdom. Our new logo reflects our companys mission and values while representing the commitment weve made for more than a century to helping people protect whats important to them, said Keith Clark, senior vice president of marketing at Mutual of Omaha. We chose the symbol of a lion not only as a nod to our Wild Kingdom heritage, but to represent the strong company weve always been. In July, Mutual announced the removal of Native American imagery from its corporate logo. For additional information about Mutual of Omahas new logo, visit www.mutualofomaha.com. Founded in 1909, Mutual of Omaha is a highly-rated, Fortune 500 organization offering a variety of insurance and financial products for individuals, businesses and groups throughout the United States. As a mutual company, Mutual of Omaha is owned by its policyholders and committed to providing outstanding service to its customers. |
edtsum3324 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SHANGHAI, Aug. 8, 2020 /PRNewswire/ -- LONGi Green Energy Technology Co., Ltd, or LONGi Group, a leading global solar technology company, announces an 8-year roadmap to achieve 100% renewable energy use for its global operations by 2028. The world's largest mono-crystalline PV products manufacturer made the announcement at the 14th SNEC PV Power EXPO in Shanghai. (PRNewsfoto/LONGi Green Energy Technology C) (PRNewsfoto/LONGi Green Energy Technology C) According to the roadmap, LONGi will achieve 70% renewable electricity use by 2027 and ultimately reach 100% for its global operations by 2028. In 2019 alone, LONGi Group consumed 189,243,000 kWh of electricity globally, with 47.14% of which came from renewable sources. LONGi focused on manufacturing PV products and providing solar power technology solutions. Its product offering ranges from wafers, cells, modules, PV solar power equipment, to solar power systems. LONGi Group has evolved into a global company with approximately 8.38 billion USD of assets andmore than 4.65 billion USD of annual revenues in 2019. For more:en.longigroup.com In the next 8 years, LONGi Group will follow a 5-stage roadmap, including solid actions like improving energy use efficiency among its factories in and outside China, building new factories that have access to green electricity, building more PV power stations for self-use, and prioritizing green electricity use and influencing stakeholders. "We are proud to announce our RE100 roadmap for 100% renewable energy use. LONGi Group, as a global company dedicated to solar technology and manufacturing, will work closely with The Climate Group and our partners to deliver this green commitment. We hope to shoulder more responsibilities for global energy transition", says Mr. Zhong Baoshen, Chairman of LONGi Group. "Through this process, LONGi can fully influence our supply chain partners and our customers by delivering the RE100 initiative. LONGi will play by example to promote more industries to focus on clean energy, and LONGi is happy to provide technology solutions and support for those who have the same ambition", adds Mr. Li Zhenguo, founder and president of LONGi Group.LONGi has always been practicing the concept of 'using clean energy to produce clean energy products.' Since 2015, LONGi Group has relocated some of their manufacturing facilities to Yunnan Province in southwestern China, from the regions mainly powered by fossil-fuel generated electricity, to areas that are mostly powered by hydropower. LONGi built factories in China's Yunnan Province and Malaysia's Kuching, where hydropower was abundant and cheap. Using hydropower, LONGi produces PV products, including the mono-crystalline silicon ingots, wafers, cells, and modules with lower production costs. LONGi has also installed solar power systems on the roof of Wuxi LONGi and Taizhou LONGi Factory to increase clean energy use. Earlier this March, the Xi'an City headquartered solar technology giant joined the RE100 initiative, a global corporate leadership initiative led by The Climate Group in partnership with Carbon Disclosure Project. The RE100 initiative brings together influential businesses committed to 100% renewable electricity. Also, at the SNEC PV Power EXPO, LONGi Group, together with Sungrow Power, Envision, Chinese Renewable Energy Industries Association (CREIA), and PV Committee of China Green Supply Chain Alliance (ECOPV), launched the RE100 China Initiative.LONGi President Li Zhenguo says initiating such platform is aimed to promote the transition of China's energy sector to a clean and low-carbon future and help resolve climate change issues and global energy crisis. Li adds these renewable energy companies and industry associations will set an example for China's energy transition and play their role as China trying to deliver its commitment to the Paris Climate Agreement. RE100RE100 is the global corporate renewable energy initiativebringing together hundreds oflarge and ambitious businessescommitted to 100% renewable electricity.Led byThe Climate Groupin partnership withCDP,RE100's mission is to accelerate a global shift to clean energyand zero carbon grids delivering a cleaner, healthier future for all.For more information, visit: https://www.there100.org/SOURCE LONGi Green Energy Technology Co., Ltd Related Links https://en.longigroup.com/
Answer: | LONGi unveils RE100 roadmap to achieve 100% green energy use by 2028 English English English Latin America - espaol Jointly launches RE100 China Initiative with renewable energy leaders in China | SHANGHAI, Aug. 8, 2020 /PRNewswire/ -- LONGi Green Energy Technology Co., Ltd, or LONGi Group, a leading global solar technology company, announces an 8-year roadmap to achieve 100% renewable energy use for its global operations by 2028. The world's largest mono-crystalline PV products manufacturer made the announcement at the 14th SNEC PV Power EXPO in Shanghai. (PRNewsfoto/LONGi Green Energy Technology C) (PRNewsfoto/LONGi Green Energy Technology C) According to the roadmap, LONGi will achieve 70% renewable electricity use by 2027 and ultimately reach 100% for its global operations by 2028. In 2019 alone, LONGi Group consumed 189,243,000 kWh of electricity globally, with 47.14% of which came from renewable sources. LONGi focused on manufacturing PV products and providing solar power technology solutions. Its product offering ranges from wafers, cells, modules, PV solar power equipment, to solar power systems. LONGi Group has evolved into a global company with approximately 8.38 billion USD of assets andmore than 4.65 billion USD of annual revenues in 2019. For more:en.longigroup.com In the next 8 years, LONGi Group will follow a 5-stage roadmap, including solid actions like improving energy use efficiency among its factories in and outside China, building new factories that have access to green electricity, building more PV power stations for self-use, and prioritizing green electricity use and influencing stakeholders. "We are proud to announce our RE100 roadmap for 100% renewable energy use. LONGi Group, as a global company dedicated to solar technology and manufacturing, will work closely with The Climate Group and our partners to deliver this green commitment. We hope to shoulder more responsibilities for global energy transition", says Mr. Zhong Baoshen, Chairman of LONGi Group. "Through this process, LONGi can fully influence our supply chain partners and our customers by delivering the RE100 initiative. LONGi will play by example to promote more industries to focus on clean energy, and LONGi is happy to provide technology solutions and support for those who have the same ambition", adds Mr. Li Zhenguo, founder and president of LONGi Group.LONGi has always been practicing the concept of 'using clean energy to produce clean energy products.' Since 2015, LONGi Group has relocated some of their manufacturing facilities to Yunnan Province in southwestern China, from the regions mainly powered by fossil-fuel generated electricity, to areas that are mostly powered by hydropower. LONGi built factories in China's Yunnan Province and Malaysia's Kuching, where hydropower was abundant and cheap. Using hydropower, LONGi produces PV products, including the mono-crystalline silicon ingots, wafers, cells, and modules with lower production costs. LONGi has also installed solar power systems on the roof of Wuxi LONGi and Taizhou LONGi Factory to increase clean energy use. Earlier this March, the Xi'an City headquartered solar technology giant joined the RE100 initiative, a global corporate leadership initiative led by The Climate Group in partnership with Carbon Disclosure Project. The RE100 initiative brings together influential businesses committed to 100% renewable electricity. Also, at the SNEC PV Power EXPO, LONGi Group, together with Sungrow Power, Envision, Chinese Renewable Energy Industries Association (CREIA), and PV Committee of China Green Supply Chain Alliance (ECOPV), launched the RE100 China Initiative.LONGi President Li Zhenguo says initiating such platform is aimed to promote the transition of China's energy sector to a clean and low-carbon future and help resolve climate change issues and global energy crisis. Li adds these renewable energy companies and industry associations will set an example for China's energy transition and play their role as China trying to deliver its commitment to the Paris Climate Agreement. RE100RE100 is the global corporate renewable energy initiativebringing together hundreds oflarge and ambitious businessescommitted to 100% renewable electricity.Led byThe Climate Groupin partnership withCDP,RE100's mission is to accelerate a global shift to clean energyand zero carbon grids delivering a cleaner, healthier future for all.For more information, visit: https://www.there100.org/SOURCE LONGi Green Energy Technology Co., Ltd Related Links https://en.longigroup.com/ |
edtsum3328 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, April 29, 2020 /PRNewswire/ -- ResearchAndMarkets.com published a new article on the food and beverage industry, "Nut & Seed Butters Rise by 163% During COVID-19 Outbreak as Consumers Demand Shelf-Stable Products" Several factors have influenced the soaring demand for nut and seed butters during the COVID-19 outbreak. Products like peanut butter are often considered a comfort food by consumers and the concern over possible food shortages has caused many to stock up on familiar brands such as Smucker's, Jif and Skippy.The coronavirus has also brought travel restrictions to most countries and many consumers are worried about what effect this will have on their ability to get fresh food. As a result, there has been a great increase in demand for shelf-stable products. Nut and seed butters can last many months unopened so they are an ideal choice for consumers preparing for quarantine.The growing trend towards meat-free products has also influenced demand for nut and seed butters as they are an excellent source of plant-based protein and are widely available in most supermarkets. As a result, sales of products like peanut, almond and cashew butters as well as sunflower and pumpkin seed butter have greatly increased among consumers looking for an easily-available alternative protein source.To see the full article and a list of related reports on the market, visit "Nut & Seed Butters Rise by 163% During COVID-19 Outbreak as Consumers Demand Shelf-Stable Products" About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | Nut & Seed Butters Rise by 163% During COVID-19 Outbreak as Consumers Demand Shelf-Stable Products | DUBLIN, April 29, 2020 /PRNewswire/ -- ResearchAndMarkets.com published a new article on the food and beverage industry, "Nut & Seed Butters Rise by 163% During COVID-19 Outbreak as Consumers Demand Shelf-Stable Products" Several factors have influenced the soaring demand for nut and seed butters during the COVID-19 outbreak. Products like peanut butter are often considered a comfort food by consumers and the concern over possible food shortages has caused many to stock up on familiar brands such as Smucker's, Jif and Skippy.The coronavirus has also brought travel restrictions to most countries and many consumers are worried about what effect this will have on their ability to get fresh food. As a result, there has been a great increase in demand for shelf-stable products. Nut and seed butters can last many months unopened so they are an ideal choice for consumers preparing for quarantine.The growing trend towards meat-free products has also influenced demand for nut and seed butters as they are an excellent source of plant-based protein and are widely available in most supermarkets. As a result, sales of products like peanut, almond and cashew butters as well as sunflower and pumpkin seed butter have greatly increased among consumers looking for an easily-available alternative protein source.To see the full article and a list of related reports on the market, visit "Nut & Seed Butters Rise by 163% During COVID-19 Outbreak as Consumers Demand Shelf-Stable Products" About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum3337 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PLANO, Texas, May 12, 2020 /PRNewswire/ -- In a time when uncertainty and concern for public health limit the industry's ability to gather data, Dynamic Weather Solutions (DWS) is the only company to offer source-derived hail data which both adheres to the strictest CDC, federal, state and local guidelines, but is able to be retrieved with the increased safety, reliability and efficiency of remote access. Continue Reading HailStrike All DWS storm data is geo-referenced for use at a highly specific level. Coverage includes the entire Continental United States for a period of 10 years, and is also available for large data requests via an interface designed to handle thousands of requests or more, per minute. Daron Sneed Chief Executive Officer at DWS in Plano, Texas recently commented: "We are tactically and practically different from most weather reporting companies in that we collect, store and analyze historical storm details recorded directly by the weather radars. As a result of this approach, we are able to respond to vast requests from those who need verification of activity relative to specific locations." In addition to weather, DWS users can access county record data including ownership, taxes and other parcel information. Overlays of zip codes, counties, area codes, property values and demographic information can also be referenced. With these various sets of data, an individual can remotely manage unique cases without having to leave one's desk."By accessing our database, hail activity can be analyzed against a clients' portfolio for intersecting values which could show potentially damaging activity; on certain dates at specific locations." Sneed continues: "This can be useful for anything from underwriting to processing a single day event."Dynamic Weather Solutions was granted a Utility Patent in 2017 for their unique Systems and methods for inferring localized hail intensity in addition to the traditionally referenced but limited size of hail. Their 'heat map' of the storms' footprint defines areas of higher hail intensity regardless of the varying sizes of hail that may be present in a single storm cell. "I believe it is rather short sighted to limit investigations to "maximum, possible, probable" hail size when there may have been a deluge of slightly smaller reported hail sizes that were still capable of causing significant damage."Founded in 2011, Dynamic Weather Solutions is an advanced weather forensics company offering the most innovative and cross-referenced analytic data available in the historical storm market today. Contact DWS for more information regarding access, bulk pricing, corporate discounts, and complete integration of our data into your processes.Media Contact:Daron Sneed(972) 638-7225 x101[emailprotected]SOURCE Dynamic Weather Solutions, Inc.
Answer: | Dynamic Weather Solutions, Inc. Offers Pandemic-Optimal Access to Comprehensive, Historic Hail Data DURING COVID-19, MAINTAINING REMOTE ACCESS TO SOURCE-DERIVED STORM DATA IS MORE VITAL THAN EVER. | PLANO, Texas, May 12, 2020 /PRNewswire/ -- In a time when uncertainty and concern for public health limit the industry's ability to gather data, Dynamic Weather Solutions (DWS) is the only company to offer source-derived hail data which both adheres to the strictest CDC, federal, state and local guidelines, but is able to be retrieved with the increased safety, reliability and efficiency of remote access. Continue Reading HailStrike All DWS storm data is geo-referenced for use at a highly specific level. Coverage includes the entire Continental United States for a period of 10 years, and is also available for large data requests via an interface designed to handle thousands of requests or more, per minute. Daron Sneed Chief Executive Officer at DWS in Plano, Texas recently commented: "We are tactically and practically different from most weather reporting companies in that we collect, store and analyze historical storm details recorded directly by the weather radars. As a result of this approach, we are able to respond to vast requests from those who need verification of activity relative to specific locations." In addition to weather, DWS users can access county record data including ownership, taxes and other parcel information. Overlays of zip codes, counties, area codes, property values and demographic information can also be referenced. With these various sets of data, an individual can remotely manage unique cases without having to leave one's desk."By accessing our database, hail activity can be analyzed against a clients' portfolio for intersecting values which could show potentially damaging activity; on certain dates at specific locations." Sneed continues: "This can be useful for anything from underwriting to processing a single day event."Dynamic Weather Solutions was granted a Utility Patent in 2017 for their unique Systems and methods for inferring localized hail intensity in addition to the traditionally referenced but limited size of hail. Their 'heat map' of the storms' footprint defines areas of higher hail intensity regardless of the varying sizes of hail that may be present in a single storm cell. "I believe it is rather short sighted to limit investigations to "maximum, possible, probable" hail size when there may have been a deluge of slightly smaller reported hail sizes that were still capable of causing significant damage."Founded in 2011, Dynamic Weather Solutions is an advanced weather forensics company offering the most innovative and cross-referenced analytic data available in the historical storm market today. Contact DWS for more information regarding access, bulk pricing, corporate discounts, and complete integration of our data into your processes.Media Contact:Daron Sneed(972) 638-7225 x101[emailprotected]SOURCE Dynamic Weather Solutions, Inc. |
edtsum3338 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: KANSAS CITY, Mo.--(BUSINESS WIRE)--Kansas City Southern (KCS) (NYSE:KSU) reported revenues of $706.0 million, a decrease of 4% from first quarter 2020. Overall, carload volumes were down 1% compared to prior year. First Quarter 2021 First quarter revenues were $706.0 million, a decrease of 4% primarily resulting from lower volumes, lower fuel surcharge, and fluctuations in foreign currency. First quarter operating expenses were $453.0 million. Operating income was $253.0 million and the reported operating ratio was 64.2%. First quarter net income was $153.4 million, or $1.68 per diluted share. Adjusted first quarter operating income, net income and diluted earnings per share were as follows: (in millions, except operating ratio and diluted earnings per share) Three Months Ended March 31, 2021 Operating Income Operating Ratio Net Income Diluted Earnings per Share GAAP Operating Results $ 253.0 64.2 % $ 153.4 $ 1.68 Merger Costs 19.3 (2.8) 15.2 0.17 Other Adjustments, Net 6.0 0.06 Adjusted Operating Results (non-GAAP) $ 272.3 61.4 % $ 174.6 $ 1.91 See following pages for reconciliations to GAAP "Although our first quarter performance was impacted by several unique and challenging events, including the Polar Vortex, and lingering network congestion, our operating team is focused on improving operating metrics and customer service through PSR phase III, stated president and chief executive officer, Patrick J. Ottensmeyer. Based on an outlook for improvement in volume growth and operational trends, we can confidently confirm our 2021 guidance. During the first quarter, we also announced an exciting and historic combination with Canadian Pacific, creating the first rail network connecting the U.S., Mexico, and Canada. This combination is expected to provide an enhanced competitive alternative to existing rail service providers, resulting in improved service to customers of all sizes. This transaction represents an exciting opportunity for KCS and CP stakeholders, and we look forward to delivering the benefits to our customers, employees, investors, and communities. For more information on the transaction and the benefits it is expected to bring to the full range of stakeholders, visit FutureForFreight.com. Statement Regarding Non-GAAP Financial Measures In addition to disclosing financial results in accordance with U.S. GAAP, the accompanying first quarter 2021 earnings release contains non-GAAP financial measures. KCS management believes that certain non-GAAP financial measures used to review and in certain cases manage the Company's business fall within the meaning of Regulation G (Disclosure of non-GAAP financial measures) and may provide its users of the financial information with additional meaningful comparison when reviewing the Company's results. KCS management uses non-GAAP information in its planning and forecasting processes and to further analyze its own financial trends and operational performance, as well as making financial comparisons to prior periods presented on a similar basis. Management believes investors and users of the Company's financial information should consider all of the above factors when evaluating KCS's results. These non-GAAP measures should be viewed as a supplement and not considered a substitute for GAAP measures. Some of KCS's non-GAAP measures may differ from similar measures used by other companies, even if similar terms are used to identify such measures. GAAP Reconciliations ($ in millions, except per share amounts) Reconciliation of Diluted Earnings per Share to Adjusted Diluted Earnings per Share Three Months Ended March 31, 2021 Income Before Income Taxes Income Tax Expense Net Income Diluted Earnings per Share As reported $ 211.9 $ 58.5 $ 153.4 $ 1.68 Adjustments for: Merger costs 19.3 4.1 15.2 0.17 Foreign exchange loss 7.3 2.2 5.1 0.05 Foreign exchange component of income taxes (0.9) 0.9 0.01 Adjusted $ 238.5 $ 63.9 174.6 Less: Noncontrolling interest and preferred stock dividends (0.4) Adjusted net income available to common stockholders - see (a) below $ 174.2 $ 1.91 GAAP Reconciliations (continued) ($ in millions, except per share amounts) Three Months Ended March 31, 2020 Income Before Income Taxes Income Tax Expense Net Income Diluted Earnings per Share As reported $ 197.5 $ 45.2 $ 152.3 $ 1.58 Adjustments for: Restructuring charges 6.0 1.7 4.3 0.05 Foreign exchange loss 59.5 17.8 41.7 0.43 Foreign exchange component of income taxes 9.5 (9.5 ) (0.10 ) Adjusted $ 263.0 $ 74.2 188.8 Less: Noncontrolling interest and preferred stock dividends (0.6 ) Adjusted net income available to common stockholders - see (a) below $ 188.2 $ 1.96 Reconciliation of Operating Expenses to Adjusted Three Months Ended Operating Expenses March 31, 2021 2020 Operating expenses as reported $ 453.0 $ 442.9 Adjustment for merger costs (19.3 ) Adjustment for restructuring charges (6.0 ) Adjusted operating expenses - see (b) below $ 433.7 $ 436.9 Operating income as reported $ 253.0 $ 288.8 Adjusted operating income - see (b) below 272.3 294.8 Operating ratio (c) as reported 64.2 % 60.5 % Adjusted operating ratio - see (b) and (c) below 61.4 % 59.7 % (a) The Company believes adjusted diluted earnings per share is meaningful as it allows investors to evaluate the Companys performance for different periods on a more comparable basis by adjusting for the impact of changes in foreign currency exchange rates, and items that are not directly related to the ongoing operations of the Company. The income tax expense impacts related to these adjustments are calculated at the applicable statutory tax rate. (b) The Company believes adjusted operating expenses, operating income and operating ratio are meaningful as they allow investors to evaluate the Company's performance for different periods on a more comparable basis by adjusting for items that are not directly related to the ongoing operations of the Company. Operating ratio is calculated by dividing operating expenses by revenues; or in the case of adjusted operating ratio, adjusted operating expenses divided by revenues. Investor Conference Call and Webcast KCS will also hold its first quarter 2021 earnings conference call on Friday, April 16, 2021 at 8:45 a.m. eastern time. Shareholders and other interested parties are invited to participate via live webcast or telephone. To participate in the live webcast and to view accompanying presentation materials, please log into investors.kcsouthern.com immediately prior to the presentation. To join the teleconference, please call (844) 308-6428 from the U.S., or (412) 317-5409 from all other countries. A replay of the presentation will be available by calling (877) 344-7529 from the U.S., (855) 669-9658 from Canada or (412) 317-0088 from all other countries and entering conference ID 10152592. The webcast replay and presentation materials will be archived on the companys website. About Kansas City Southern Headquartered in Kansas City, Mo., Kansas City Southern (KCS) (NYSE: KSU) is a transportation holding company that has railroad investments in the U.S., Mexico and Panama. Its primary U.S. holding is The Kansas City Southern Railway Company, serving the central and south central U.S. Its international holdings include Kansas City Southern de Mexico, S.A. de C.V., serving northeastern and central Mexico and the port cities of Lzaro Crdenas, Tampico and Veracruz, and a 50 percent interest in Panama Canal Railway Company, providing ocean-to-ocean freight and passenger service along the Panama Canal. KCS' North American rail holdings and strategic alliances with other North American rail partners are primary components of a unique railway system, linking the commercial and industrial centers of the U.S., Mexico and Canada. More information about KCS can be found at www.kcsouthern.com Forward-Looking Information This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Private Securities Litigation Reform Act of 1995. In addition, management may make forward-looking statements orally or in other writing, including, but not limited to, in press releases, quarterly earnings calls, executive presentations, in the annual report to stockholders and in other filings with the Securities and Exchange Commission. Readers can usually identify these forward-looking statements by the use of such words as "may," "will," "should," "likely," "plans," "projects," "expects," "anticipates," "believes" or similar words. These statements involve a number of risks and uncertainties. Actual results could materially differ from those anticipated by such forward-looking statements as a result of a number of factors or combination of factors including, but not limited: the merger with Canadian Pacific Railway Limited ("CP") is subject to various closing conditions and there can be no assurances as to whether and when it may be completed; failure to complete the Companys merger with CP could negatively impact the Companys stock price and future business and financial results; Companys stockholders cannot be sure of the value of the merger consideration they will receive from CP in the merger; lawsuits may be filed against the Company and/or CP challenging the transactions contemplated by the merger between, among others, the Company and CP; the shares of CP common stock to be received by the Companys stockholders upon completion of the merger will have different rights from shares of the Companys common stock; after completion of the merger, CP may fail to realize the projected benefits and cost savings of the merger; public health threats or outbreaks of communicable diseases, such as the ongoing COVID-19 pandemic and its impact on KCSs business, suppliers, consumers, customers, employees and supply chains; rail accidents or other incidents or accidents on KCSs rail network or at KCSs facilities or customer facilities involving the release of hazardous materials, including toxic inhalation hazards; legislative and regulatory developments and disputes, including environmental regulations; loss of the rail concession of Kansas City Southerns subsidiary, Kansas City Southern de Mxico, S.A. de C.V.; domestic and international economic, political and social conditions; disruptions to the Companys technology infrastructure, including its computer systems; increased demand and traffic congestion; the level of trade between the United States and Asia or Mexico; fluctuations in the peso-dollar exchange rate; natural events such as severe weather, hurricanes and floods; the outcome of claims and litigation involving the Company or its subsidiaries; competition and consolidation within the transportation industry; the business environment in industries that produce and use items shipped by rail; the termination of, or failure to renew, agreements with customers, other railroads and third parties; fluctuation in prices or availability of key materials, in particular diesel fuel; access to capital; climate change and the market and regulatory responses to climate change; dependency on certain key suppliers of core rail equipment; changes in securities and capital markets; unavailability of qualified personnel; labor difficulties, including strikes and work stoppages; acts of terrorism or risk of terrorist activities, war or other acts of violence; and other factors affecting the operation of the business; and other risks identified in this news release, in KCS's Annual Report on Form 10-K for the year ended December 31, 2020, and in other reports filed by KCS with the Securities and Exchange Commission. Forward-looking statements reflect the information only as of the date on which they are made. KCS does not undertake any obligation to update any forward-looking statements to reflect future events, developments, or other information. Kansas City Southern and Subsidiaries Consolidated Statements of Income (In millions, except share and per share amounts) (Unaudited) Three Months Ended March 31, 2021 2020 Revenues $ 706.0 $ 731.7 Operating expenses: Compensation and benefits 129.5 133.4 Purchased services 53.8 53.3 Fuel 70.9 74.9 Equipment costs 21.1 21.9 Depreciation and amortization 92.0 89.4 Materials and other 66.4 64.0 Merger costs 19.3 Restructuring charges 6.0 Total operating expenses 453.0 442.9 Operating income 253.0 288.8 Equity in net earnings of affiliates 6.0 1.0 Interest expense (39.0 ) (34.2 ) Foreign exchange loss (7.3 ) (59.5 ) Other income (expense), net (0.8 ) 1.4 Income before income taxes 211.9 197.5 Income tax expense 58.5 45.2 Net income 153.4 152.3 Less: Net income attributable to noncontrolling interest 0.4 0.5 Net income attributable to Kansas City Southern and subsidiaries 153.0 151.8 Preferred stock dividends 0.1 Net income available to common stockholders $ 153.0 $ 151.7 Earnings per share: Basic earnings per share $ 1.69 $ 1.59 Diluted earnings per share $ 1.68 $ 1.58 Average shares outstanding (in thousands): Basic 90,757 95,662 Effect of dilution 529 509 Diluted 91,286 96,171 Kansas City Southern and Subsidiaries Revenue & Carload/Units by Commodity - First Quarter 2021 and 2020 Revenues Carloads and Units Revenue per (in millions) (in thousands) Carload/Unit First Quarter % First Quarter % First Quarter % 2021 2020 Change 2021 2020 Change 2021 2020 Change Chemical & Petroleum Chemicals $ 60.6 $ 62.5 (3 %) 24.9 24.6 1 % $ 2,434 $ 2,541 (4 %) Petroleum 135.2 95.8 41 % 59.2 46.5 27 % 2,284 2,060 11 % Plastics 35.5 40.3 (12 %) 17.5 19.8 (12 %) 2,029 2,035 Total 231.3 198.6 16 % 101.6 90.9 12 % 2,277 2,185 4 % Industrial & Consumer Products Forest Products 57.7 68.9 (16 %) 23.5 27.4 (14 %) 2,455 2,515 (2 %) Metals & Scrap 46.3 62.3 (26 %) 26.5 32.2 (18 %) 1,747 1,935 (10 %) Other 30.0 27.8 8 % 22.3 23.8 (6 %) 1,345 1,168 15 % Total 134.0 159.0 (16 %) 72.3 83.4 (13 %) 1,853 1,906 (3 %) Agriculture & Minerals Grain 74.7 77.8 (4 %) 35.7 35.4 1 % 2,092 2,198 (5 %) Food Products 37.0 42.7 (13 %) 14.7 16.5 (11 %) 2,517 2,588 (3 %) Ores & Minerals 5.2 5.8 (10 %) 7.2 7.7 (6 %) 722 753 (4 %) Stone, Clay & Glass 7.5 8.2 (9 %) 3.1 3.5 (11 %) 2,419 2,343 3 % Total 124.4 134.5 (8 %) 60.7 63.1 (4 %) 2,049 2,132 (4 %) Energy Utility Coal 31.7 23.6 34 % 37.9 29.2 30 % 836 808 3 % Coal & Petroleum Coke 10.4 11.6 (10 %) 12.5 15.0 (17 %) 832 773 8 % Frac Sand 3.4 3.8 (11 %) 2.9 3.1 (6 %) 1,172 1,226 (4 %) Crude Oil 12.0 17.3 (31 %) 8.3 10.3 (19 %) 1,446 1,680 (14 %) Total 57.5 56.3 2 % 61.6 57.6 7 % 933 977 (5 %) Intermodal 81.3 88.7 (8 %) 232.8 233.6 349 380 (8 %) Automotive 44.1 53.9 (18 %) 26.4 32.2 (18 %) 1,670 1,674 TOTAL FOR COMMODITY GROUPS 672.6 691.0 (3 %) 555.4 560.8 (1 %) $ 1,211 $ 1,232 (2 %) Other Revenue 33.4 40.7 (18 %) TOTAL $ 706.0 $ 731.7 (4 %)
Answer: | Kansas City Southern Reports First Quarter Results | KANSAS CITY, Mo.--(BUSINESS WIRE)--Kansas City Southern (KCS) (NYSE:KSU) reported revenues of $706.0 million, a decrease of 4% from first quarter 2020. Overall, carload volumes were down 1% compared to prior year. First Quarter 2021 First quarter revenues were $706.0 million, a decrease of 4% primarily resulting from lower volumes, lower fuel surcharge, and fluctuations in foreign currency. First quarter operating expenses were $453.0 million. Operating income was $253.0 million and the reported operating ratio was 64.2%. First quarter net income was $153.4 million, or $1.68 per diluted share. Adjusted first quarter operating income, net income and diluted earnings per share were as follows: (in millions, except operating ratio and diluted earnings per share) Three Months Ended March 31, 2021 Operating Income Operating Ratio Net Income Diluted Earnings per Share GAAP Operating Results $ 253.0 64.2 % $ 153.4 $ 1.68 Merger Costs 19.3 (2.8) 15.2 0.17 Other Adjustments, Net 6.0 0.06 Adjusted Operating Results (non-GAAP) $ 272.3 61.4 % $ 174.6 $ 1.91 See following pages for reconciliations to GAAP "Although our first quarter performance was impacted by several unique and challenging events, including the Polar Vortex, and lingering network congestion, our operating team is focused on improving operating metrics and customer service through PSR phase III, stated president and chief executive officer, Patrick J. Ottensmeyer. Based on an outlook for improvement in volume growth and operational trends, we can confidently confirm our 2021 guidance. During the first quarter, we also announced an exciting and historic combination with Canadian Pacific, creating the first rail network connecting the U.S., Mexico, and Canada. This combination is expected to provide an enhanced competitive alternative to existing rail service providers, resulting in improved service to customers of all sizes. This transaction represents an exciting opportunity for KCS and CP stakeholders, and we look forward to delivering the benefits to our customers, employees, investors, and communities. For more information on the transaction and the benefits it is expected to bring to the full range of stakeholders, visit FutureForFreight.com. Statement Regarding Non-GAAP Financial Measures In addition to disclosing financial results in accordance with U.S. GAAP, the accompanying first quarter 2021 earnings release contains non-GAAP financial measures. KCS management believes that certain non-GAAP financial measures used to review and in certain cases manage the Company's business fall within the meaning of Regulation G (Disclosure of non-GAAP financial measures) and may provide its users of the financial information with additional meaningful comparison when reviewing the Company's results. KCS management uses non-GAAP information in its planning and forecasting processes and to further analyze its own financial trends and operational performance, as well as making financial comparisons to prior periods presented on a similar basis. Management believes investors and users of the Company's financial information should consider all of the above factors when evaluating KCS's results. These non-GAAP measures should be viewed as a supplement and not considered a substitute for GAAP measures. Some of KCS's non-GAAP measures may differ from similar measures used by other companies, even if similar terms are used to identify such measures. GAAP Reconciliations ($ in millions, except per share amounts) Reconciliation of Diluted Earnings per Share to Adjusted Diluted Earnings per Share Three Months Ended March 31, 2021 Income Before Income Taxes Income Tax Expense Net Income Diluted Earnings per Share As reported $ 211.9 $ 58.5 $ 153.4 $ 1.68 Adjustments for: Merger costs 19.3 4.1 15.2 0.17 Foreign exchange loss 7.3 2.2 5.1 0.05 Foreign exchange component of income taxes (0.9) 0.9 0.01 Adjusted $ 238.5 $ 63.9 174.6 Less: Noncontrolling interest and preferred stock dividends (0.4) Adjusted net income available to common stockholders - see (a) below $ 174.2 $ 1.91 GAAP Reconciliations (continued) ($ in millions, except per share amounts) Three Months Ended March 31, 2020 Income Before Income Taxes Income Tax Expense Net Income Diluted Earnings per Share As reported $ 197.5 $ 45.2 $ 152.3 $ 1.58 Adjustments for: Restructuring charges 6.0 1.7 4.3 0.05 Foreign exchange loss 59.5 17.8 41.7 0.43 Foreign exchange component of income taxes 9.5 (9.5 ) (0.10 ) Adjusted $ 263.0 $ 74.2 188.8 Less: Noncontrolling interest and preferred stock dividends (0.6 ) Adjusted net income available to common stockholders - see (a) below $ 188.2 $ 1.96 Reconciliation of Operating Expenses to Adjusted Three Months Ended Operating Expenses March 31, 2021 2020 Operating expenses as reported $ 453.0 $ 442.9 Adjustment for merger costs (19.3 ) Adjustment for restructuring charges (6.0 ) Adjusted operating expenses - see (b) below $ 433.7 $ 436.9 Operating income as reported $ 253.0 $ 288.8 Adjusted operating income - see (b) below 272.3 294.8 Operating ratio (c) as reported 64.2 % 60.5 % Adjusted operating ratio - see (b) and (c) below 61.4 % 59.7 % (a) The Company believes adjusted diluted earnings per share is meaningful as it allows investors to evaluate the Companys performance for different periods on a more comparable basis by adjusting for the impact of changes in foreign currency exchange rates, and items that are not directly related to the ongoing operations of the Company. The income tax expense impacts related to these adjustments are calculated at the applicable statutory tax rate. (b) The Company believes adjusted operating expenses, operating income and operating ratio are meaningful as they allow investors to evaluate the Company's performance for different periods on a more comparable basis by adjusting for items that are not directly related to the ongoing operations of the Company. Operating ratio is calculated by dividing operating expenses by revenues; or in the case of adjusted operating ratio, adjusted operating expenses divided by revenues. Investor Conference Call and Webcast KCS will also hold its first quarter 2021 earnings conference call on Friday, April 16, 2021 at 8:45 a.m. eastern time. Shareholders and other interested parties are invited to participate via live webcast or telephone. To participate in the live webcast and to view accompanying presentation materials, please log into investors.kcsouthern.com immediately prior to the presentation. To join the teleconference, please call (844) 308-6428 from the U.S., or (412) 317-5409 from all other countries. A replay of the presentation will be available by calling (877) 344-7529 from the U.S., (855) 669-9658 from Canada or (412) 317-0088 from all other countries and entering conference ID 10152592. The webcast replay and presentation materials will be archived on the companys website. About Kansas City Southern Headquartered in Kansas City, Mo., Kansas City Southern (KCS) (NYSE: KSU) is a transportation holding company that has railroad investments in the U.S., Mexico and Panama. Its primary U.S. holding is The Kansas City Southern Railway Company, serving the central and south central U.S. Its international holdings include Kansas City Southern de Mexico, S.A. de C.V., serving northeastern and central Mexico and the port cities of Lzaro Crdenas, Tampico and Veracruz, and a 50 percent interest in Panama Canal Railway Company, providing ocean-to-ocean freight and passenger service along the Panama Canal. KCS' North American rail holdings and strategic alliances with other North American rail partners are primary components of a unique railway system, linking the commercial and industrial centers of the U.S., Mexico and Canada. More information about KCS can be found at www.kcsouthern.com Forward-Looking Information This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Private Securities Litigation Reform Act of 1995. In addition, management may make forward-looking statements orally or in other writing, including, but not limited to, in press releases, quarterly earnings calls, executive presentations, in the annual report to stockholders and in other filings with the Securities and Exchange Commission. Readers can usually identify these forward-looking statements by the use of such words as "may," "will," "should," "likely," "plans," "projects," "expects," "anticipates," "believes" or similar words. These statements involve a number of risks and uncertainties. Actual results could materially differ from those anticipated by such forward-looking statements as a result of a number of factors or combination of factors including, but not limited: the merger with Canadian Pacific Railway Limited ("CP") is subject to various closing conditions and there can be no assurances as to whether and when it may be completed; failure to complete the Companys merger with CP could negatively impact the Companys stock price and future business and financial results; Companys stockholders cannot be sure of the value of the merger consideration they will receive from CP in the merger; lawsuits may be filed against the Company and/or CP challenging the transactions contemplated by the merger between, among others, the Company and CP; the shares of CP common stock to be received by the Companys stockholders upon completion of the merger will have different rights from shares of the Companys common stock; after completion of the merger, CP may fail to realize the projected benefits and cost savings of the merger; public health threats or outbreaks of communicable diseases, such as the ongoing COVID-19 pandemic and its impact on KCSs business, suppliers, consumers, customers, employees and supply chains; rail accidents or other incidents or accidents on KCSs rail network or at KCSs facilities or customer facilities involving the release of hazardous materials, including toxic inhalation hazards; legislative and regulatory developments and disputes, including environmental regulations; loss of the rail concession of Kansas City Southerns subsidiary, Kansas City Southern de Mxico, S.A. de C.V.; domestic and international economic, political and social conditions; disruptions to the Companys technology infrastructure, including its computer systems; increased demand and traffic congestion; the level of trade between the United States and Asia or Mexico; fluctuations in the peso-dollar exchange rate; natural events such as severe weather, hurricanes and floods; the outcome of claims and litigation involving the Company or its subsidiaries; competition and consolidation within the transportation industry; the business environment in industries that produce and use items shipped by rail; the termination of, or failure to renew, agreements with customers, other railroads and third parties; fluctuation in prices or availability of key materials, in particular diesel fuel; access to capital; climate change and the market and regulatory responses to climate change; dependency on certain key suppliers of core rail equipment; changes in securities and capital markets; unavailability of qualified personnel; labor difficulties, including strikes and work stoppages; acts of terrorism or risk of terrorist activities, war or other acts of violence; and other factors affecting the operation of the business; and other risks identified in this news release, in KCS's Annual Report on Form 10-K for the year ended December 31, 2020, and in other reports filed by KCS with the Securities and Exchange Commission. Forward-looking statements reflect the information only as of the date on which they are made. KCS does not undertake any obligation to update any forward-looking statements to reflect future events, developments, or other information. Kansas City Southern and Subsidiaries Consolidated Statements of Income (In millions, except share and per share amounts) (Unaudited) Three Months Ended March 31, 2021 2020 Revenues $ 706.0 $ 731.7 Operating expenses: Compensation and benefits 129.5 133.4 Purchased services 53.8 53.3 Fuel 70.9 74.9 Equipment costs 21.1 21.9 Depreciation and amortization 92.0 89.4 Materials and other 66.4 64.0 Merger costs 19.3 Restructuring charges 6.0 Total operating expenses 453.0 442.9 Operating income 253.0 288.8 Equity in net earnings of affiliates 6.0 1.0 Interest expense (39.0 ) (34.2 ) Foreign exchange loss (7.3 ) (59.5 ) Other income (expense), net (0.8 ) 1.4 Income before income taxes 211.9 197.5 Income tax expense 58.5 45.2 Net income 153.4 152.3 Less: Net income attributable to noncontrolling interest 0.4 0.5 Net income attributable to Kansas City Southern and subsidiaries 153.0 151.8 Preferred stock dividends 0.1 Net income available to common stockholders $ 153.0 $ 151.7 Earnings per share: Basic earnings per share $ 1.69 $ 1.59 Diluted earnings per share $ 1.68 $ 1.58 Average shares outstanding (in thousands): Basic 90,757 95,662 Effect of dilution 529 509 Diluted 91,286 96,171 Kansas City Southern and Subsidiaries Revenue & Carload/Units by Commodity - First Quarter 2021 and 2020 Revenues Carloads and Units Revenue per (in millions) (in thousands) Carload/Unit First Quarter % First Quarter % First Quarter % 2021 2020 Change 2021 2020 Change 2021 2020 Change Chemical & Petroleum Chemicals $ 60.6 $ 62.5 (3 %) 24.9 24.6 1 % $ 2,434 $ 2,541 (4 %) Petroleum 135.2 95.8 41 % 59.2 46.5 27 % 2,284 2,060 11 % Plastics 35.5 40.3 (12 %) 17.5 19.8 (12 %) 2,029 2,035 Total 231.3 198.6 16 % 101.6 90.9 12 % 2,277 2,185 4 % Industrial & Consumer Products Forest Products 57.7 68.9 (16 %) 23.5 27.4 (14 %) 2,455 2,515 (2 %) Metals & Scrap 46.3 62.3 (26 %) 26.5 32.2 (18 %) 1,747 1,935 (10 %) Other 30.0 27.8 8 % 22.3 23.8 (6 %) 1,345 1,168 15 % Total 134.0 159.0 (16 %) 72.3 83.4 (13 %) 1,853 1,906 (3 %) Agriculture & Minerals Grain 74.7 77.8 (4 %) 35.7 35.4 1 % 2,092 2,198 (5 %) Food Products 37.0 42.7 (13 %) 14.7 16.5 (11 %) 2,517 2,588 (3 %) Ores & Minerals 5.2 5.8 (10 %) 7.2 7.7 (6 %) 722 753 (4 %) Stone, Clay & Glass 7.5 8.2 (9 %) 3.1 3.5 (11 %) 2,419 2,343 3 % Total 124.4 134.5 (8 %) 60.7 63.1 (4 %) 2,049 2,132 (4 %) Energy Utility Coal 31.7 23.6 34 % 37.9 29.2 30 % 836 808 3 % Coal & Petroleum Coke 10.4 11.6 (10 %) 12.5 15.0 (17 %) 832 773 8 % Frac Sand 3.4 3.8 (11 %) 2.9 3.1 (6 %) 1,172 1,226 (4 %) Crude Oil 12.0 17.3 (31 %) 8.3 10.3 (19 %) 1,446 1,680 (14 %) Total 57.5 56.3 2 % 61.6 57.6 7 % 933 977 (5 %) Intermodal 81.3 88.7 (8 %) 232.8 233.6 349 380 (8 %) Automotive 44.1 53.9 (18 %) 26.4 32.2 (18 %) 1,670 1,674 TOTAL FOR COMMODITY GROUPS 672.6 691.0 (3 %) 555.4 560.8 (1 %) $ 1,211 $ 1,232 (2 %) Other Revenue 33.4 40.7 (18 %) TOTAL $ 706.0 $ 731.7 (4 %) |
edtsum3340 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHARLESTON, S.C., April 3, 2020 /PRNewswire/ --Blackbaud(NASDAQ: BLKB),the world's leading cloud softwarecompany powering social good, is rallying behind its customers and empowering them with the technology needed to make quick shifts and take critical action during the global COVID-19 crisis. In the weeks since the crisis came to the forefront, Blackbaud customers have creatively pivoted to switch in-person events to virtual fundraisers, established virtual volunteering options for employees, galvanized lobbying efforts for legislation to protect at-risk patient populations and created an array of COVID-19 funds and grant opportunities. K12 schools are swiftly moving classes online as they've been forced to shut their doors. Religious organizations are providing online resources while coordinating support, given the increased need for offerings. Zoos, aquariums and other cultural organizations, which have lost revenue from in-person attendance, have graciously provided content for all to enjoy online, while reminding of ways to donate toward their continued operating costs. "Our customers have always inspired us, but the levels they are rising to during this pandemic are truly extraordinary," said Blackbaud President and CEO Mike Gianoni. "In the face of adversity and the incredible challenges brought on by COVID-19, they are creating innovative solutions and using technology in new ways to contribute to the ecosystem of good. We are proud to stand with our customers and support them with critical technology so they can continue focusing on their missions during this time of global crisis." The isolating nature of the pandemic means many organizations are relying even more on virtual and online solutions for fundraising, relationship management, payment services and grantmaking as well as other platforms tailored to their sectors. Blackbaud solutions are purpose-built for the unique needs of arts and cultural organizations, nonprots, companies, higher education, faith communities, healthcare organizations, K12 schools and foundations. HealthcareThe rare-disease Alpha-1 Foundation used Blackbaud tools to successfully advocate for emergency federal legislation that is a matter of life and death for Alpha-1 patients. A primary victory will temporarily allow treatments for the Alpha-1 disease at home, rather than forcing "Alphas," many of whom have compromised lungs, to get those treatments at medical facilities where they might be exposed to COVID-19. One of the Blackbaud tools that has proven especially helpful is Blackbaud Luminate Online, which allows the foundation to strategically mobilize Alpha-1 advocates in lobbying legislators. "We are able to leverage our Blackbaud systems to find constituents in key districts in order to be able to have their story and issue heard. As time is not on our side, to have the ability to pull this information quickly is extremely helpful," said Director of Development Linda Rodriguez. FoundationsCommitted to the welfare of the Aurora community, the Dunham Fund in Illinois worked with four local funding partners to pool resources and address the most urgent needs in quality healthcare, human services and educational opportunities. "As money starts to filter to states and communities, and we learn how federal and state dollars will be allocated, we are also discovering how we can fill that gap," said President and CEO Vicki Morcos. "In recognition of nonprofits' resources being strained, we effortlessly modified our grant application so that it is easier and quicker for them to submit. This allows the Dunham Fund to respond more swiftly to their needs for general operating support and funding for services related to COVID-19." With Blackbaud Grantmaking, the Dunham Fund's staff made those changes so seamlessly, according to Morcos, it felt like "business as usual" despite the extraordinary circumstances. NonprofitPancreatic Cancer Action Network (PanCAN) transitioned upcoming PurpleStride fundraising walks through the end of May into virtual events to protect the health and safety of their vulnerable population of pancreatic cancer patients, as well as supporters, volunteers and staff. "Because PanCAN utilizes Blackbaud Luminate Online for all peer-to-peer fundraising and digital marketing, we were able to quickly and efficiently pivot our in-person PurpleStride walks to a virtual fundraising campaign," said Lori Stevens, chief development and community engagement officer, PanCAN. The nonprofit is providing "virtual striders" tips and tricks on online fundraising and other DIY opportunities, and some are doing their walks solo. "Even in these challenging times, our mission to improve outcomes for pancreatic cancer patients does not slow down or stop. Our fundraising goals have not changed," Stevens said. "While we may not be able to come together physically, we can come together virtually to fight this disease." Arts & Cultural Cincinnati Zoo & Botanical Garden, which typically welcomes 1.8 million guests per year, has opened its virtual doors to tens of millions of viewers in the span of a few short weeks through its Home Safari. The daily live and on-demand videos feature a zookeeper and an animal, plus an at-home activity for viewers. With Blackbaud as a partner for fundraising and marketing, Cincinnati Zoo quickly set up a donation program to support its operations while the attraction remains closed. In that time, the zoo has experienced a 487% increase in donors, while active views for Home Safari stretch to nearly 20 million. "It's been so successful, and it really speaks to the opportunity to creatively fulfill our mission while meeting a need for the community right now," said Director of Donor Engagement Krista Powers. "We believe in hope. We want to provide a little seed of joy and brightness in people's lives, and this is allowing us to do that." Corporate Social ResponsibilityWith Blackbaud's YourCause corporate social responsibility solution, Umpqua Bank in the Pacific Northwest selected charity organizations to meet the most urgent needs, providing a three-to-one match on employee gifts. The bank focused first on COVID-19 response funds, has transitioned to food access organizations, and will shift to small business support, culturally specific organizations and then employee resource groups in the coming weeks. Umpqua Bank also set up virtual volunteering through YourCause, connecting its employees with nonprofits that previously received funding from the bank. Partner organizations have surfaced 25 virtual volunteering opportunities in the first two weeks alone, and Umpqua associates are sewing medical masks, doing data entry, reading to children, and more. "We're working to fill urgent needs first," said Operations Manager Jordan Bowen. "We had our program ready to go in the YourCause platform before we even had funding approval from our foundation. The platform has been so responsive, and really helped advance our ability to help our people and communities during this challenging time." Higher EducationIndiana University of Pennsylvania (IUP)immediately moved to establish an online emergency response fund for students, faculty and staff impacted by COVID-19. By March's end, alumni and friends contributed more than $130,000 to the online fund, which staff could easily manage while working remotely, thanks to Blackbaud Raiser's Edge NXT and Blackbaud Financial Edge NXT. The public research university's adoption of the cloud-based solutions in 2019 "couldn't have happened at a better time, given the circumstances we are now in," said Heather Andring, director of advancement services at the university, which enrolls more than 10,000 students. K-12 SchoolsBased outside of Seattle, International Baccalaureate World School Annie Wright Schools, which includes day and boarding options, began preparing for COVID-19 months ago and put technology plans in place to maintain education from a distance. Annie Wright has relied on Blackbaud's total school solution as its communication partner leveraging the platform to provide weekly newsletters and regular updates to parents, teachers and faculty as the COVID-19 pandemic as evolved. Being able to communicate quickly and effectively to the entire school has been crucial for Annie Wright during these times. Additionally, Annie Wright has been using key features of Blackbaud's Student Management System, such as gradebook and attendance platforms, which has provided much-needed consistency with the in-person classroom experience. "It has been seamless in this entire transition," said Jen Willey, communications director, Annie Wright Schools. Faith CommunitiesWith Blackbaud Online Express, the Catholic Community Foundation of the Diocese of Richmond spun up an online donation portal for more than 140 individual parishes. Within the first day, more than 170 people donated, and one-third of donors made their gifts recurring. With the approach of Easter seasona critical giving time for the dioceseCatholic Community Foundation continues to drive awareness about the digital offertory and drive parishioners to engage and support online. "Everything but e-giving stopped when the churches closed," said Executive Director Margaret Keightley. "Without money, we cannot provide ministryand so many people are in need. If we can't stay open, we can't assist the poor." Through it all, Blackbaud customer support, customer success, professional services and managed services teams have been on call to assist customers, helping more than 10,000 customers in one week as the month of March came to a close. "The intersection of technology and social good has never been more important than it is today," said Walter Loiselle, senior vice president of customer operations, Blackbaud. "We're committed to supporting all our customers as quickly and creatively as possible, while helping new customers achieve the time to value and time to ROI they need during this unprecedented time." About BlackbaudBlackbaud(NASDAQ: BLKB) is the world's leading cloud software company powering social good. Serving the entire social good communitynonprofits, higher education institutions, K12 schools, healthcare organizations, faith communities, arts and cultural organizations, foundations, companies and individual change agentsBlackbaud connects and empowers organizations to increase their impact through cloud software, services, expertise and data intelligence. The Blackbaud portfolio is tailored to the unique needs of vertical markets, with solutions for fundraising and CRM, marketing, advocacy, peer-to-peer fundraising, corporate social responsibility, school management, ticketing, grantmaking, financial management, payment processing and analytics. Serving the industry for more than three decades, Blackbaud is headquartered in Charleston, South Carolina, and has operations in the United States, Australia, Canada, Costa Rica and the United Kingdom. For more information, visit www.blackbaud.comor follow us onTwitter, LinkedIn,Instagram andFacebook. Media Inquiries[emailprotected] Forward-looking StatementsExcept for historical information, all of the statements, expectations, and assumptions contained in this news release are forward-looking statements that involve a number of risks and uncertainties, including statements regarding expected benefits of products and product features. Although Blackbaud attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors that could cause results to differ materially include the following: general economic risks; uncertainty regarding increased business and renewals from existing customers; continued success in sales growth; management of integration of acquired companies and other risks associated with acquisitions; risks associated with successful implementation of multiple integrated software products; the ability to attract and retain key personnel; risks associated with management of growth; lengthy sales and implementation cycles, particularly in larger organization; technological changes that make our products and services less competitive; and the other risk factors set forth from time to time in the SEC filings for Blackbaud, copies of which are available free of charge at the SEC's website at www.sec.gov or upon request from Blackbaud's investor relations department. All Blackbaud product names appearing herein are trademarks or registered trademarks of Blackbaud, Inc. SOURCE Blackbaud Related Links http://www.blackbaud.com
Answer: | Blackbaud's Social Good Customers Share Stories of Resilience During COVID-19 Nonprofits, foundations, healthcare organizations, education institutions, corporate social responsibility teams share how cloud technology has been instrumental in helping them quickly pivot amid pandemic | CHARLESTON, S.C., April 3, 2020 /PRNewswire/ --Blackbaud(NASDAQ: BLKB),the world's leading cloud softwarecompany powering social good, is rallying behind its customers and empowering them with the technology needed to make quick shifts and take critical action during the global COVID-19 crisis. In the weeks since the crisis came to the forefront, Blackbaud customers have creatively pivoted to switch in-person events to virtual fundraisers, established virtual volunteering options for employees, galvanized lobbying efforts for legislation to protect at-risk patient populations and created an array of COVID-19 funds and grant opportunities. K12 schools are swiftly moving classes online as they've been forced to shut their doors. Religious organizations are providing online resources while coordinating support, given the increased need for offerings. Zoos, aquariums and other cultural organizations, which have lost revenue from in-person attendance, have graciously provided content for all to enjoy online, while reminding of ways to donate toward their continued operating costs. "Our customers have always inspired us, but the levels they are rising to during this pandemic are truly extraordinary," said Blackbaud President and CEO Mike Gianoni. "In the face of adversity and the incredible challenges brought on by COVID-19, they are creating innovative solutions and using technology in new ways to contribute to the ecosystem of good. We are proud to stand with our customers and support them with critical technology so they can continue focusing on their missions during this time of global crisis." The isolating nature of the pandemic means many organizations are relying even more on virtual and online solutions for fundraising, relationship management, payment services and grantmaking as well as other platforms tailored to their sectors. Blackbaud solutions are purpose-built for the unique needs of arts and cultural organizations, nonprots, companies, higher education, faith communities, healthcare organizations, K12 schools and foundations. HealthcareThe rare-disease Alpha-1 Foundation used Blackbaud tools to successfully advocate for emergency federal legislation that is a matter of life and death for Alpha-1 patients. A primary victory will temporarily allow treatments for the Alpha-1 disease at home, rather than forcing "Alphas," many of whom have compromised lungs, to get those treatments at medical facilities where they might be exposed to COVID-19. One of the Blackbaud tools that has proven especially helpful is Blackbaud Luminate Online, which allows the foundation to strategically mobilize Alpha-1 advocates in lobbying legislators. "We are able to leverage our Blackbaud systems to find constituents in key districts in order to be able to have their story and issue heard. As time is not on our side, to have the ability to pull this information quickly is extremely helpful," said Director of Development Linda Rodriguez. FoundationsCommitted to the welfare of the Aurora community, the Dunham Fund in Illinois worked with four local funding partners to pool resources and address the most urgent needs in quality healthcare, human services and educational opportunities. "As money starts to filter to states and communities, and we learn how federal and state dollars will be allocated, we are also discovering how we can fill that gap," said President and CEO Vicki Morcos. "In recognition of nonprofits' resources being strained, we effortlessly modified our grant application so that it is easier and quicker for them to submit. This allows the Dunham Fund to respond more swiftly to their needs for general operating support and funding for services related to COVID-19." With Blackbaud Grantmaking, the Dunham Fund's staff made those changes so seamlessly, according to Morcos, it felt like "business as usual" despite the extraordinary circumstances. NonprofitPancreatic Cancer Action Network (PanCAN) transitioned upcoming PurpleStride fundraising walks through the end of May into virtual events to protect the health and safety of their vulnerable population of pancreatic cancer patients, as well as supporters, volunteers and staff. "Because PanCAN utilizes Blackbaud Luminate Online for all peer-to-peer fundraising and digital marketing, we were able to quickly and efficiently pivot our in-person PurpleStride walks to a virtual fundraising campaign," said Lori Stevens, chief development and community engagement officer, PanCAN. The nonprofit is providing "virtual striders" tips and tricks on online fundraising and other DIY opportunities, and some are doing their walks solo. "Even in these challenging times, our mission to improve outcomes for pancreatic cancer patients does not slow down or stop. Our fundraising goals have not changed," Stevens said. "While we may not be able to come together physically, we can come together virtually to fight this disease." Arts & Cultural Cincinnati Zoo & Botanical Garden, which typically welcomes 1.8 million guests per year, has opened its virtual doors to tens of millions of viewers in the span of a few short weeks through its Home Safari. The daily live and on-demand videos feature a zookeeper and an animal, plus an at-home activity for viewers. With Blackbaud as a partner for fundraising and marketing, Cincinnati Zoo quickly set up a donation program to support its operations while the attraction remains closed. In that time, the zoo has experienced a 487% increase in donors, while active views for Home Safari stretch to nearly 20 million. "It's been so successful, and it really speaks to the opportunity to creatively fulfill our mission while meeting a need for the community right now," said Director of Donor Engagement Krista Powers. "We believe in hope. We want to provide a little seed of joy and brightness in people's lives, and this is allowing us to do that." Corporate Social ResponsibilityWith Blackbaud's YourCause corporate social responsibility solution, Umpqua Bank in the Pacific Northwest selected charity organizations to meet the most urgent needs, providing a three-to-one match on employee gifts. The bank focused first on COVID-19 response funds, has transitioned to food access organizations, and will shift to small business support, culturally specific organizations and then employee resource groups in the coming weeks. Umpqua Bank also set up virtual volunteering through YourCause, connecting its employees with nonprofits that previously received funding from the bank. Partner organizations have surfaced 25 virtual volunteering opportunities in the first two weeks alone, and Umpqua associates are sewing medical masks, doing data entry, reading to children, and more. "We're working to fill urgent needs first," said Operations Manager Jordan Bowen. "We had our program ready to go in the YourCause platform before we even had funding approval from our foundation. The platform has been so responsive, and really helped advance our ability to help our people and communities during this challenging time." Higher EducationIndiana University of Pennsylvania (IUP)immediately moved to establish an online emergency response fund for students, faculty and staff impacted by COVID-19. By March's end, alumni and friends contributed more than $130,000 to the online fund, which staff could easily manage while working remotely, thanks to Blackbaud Raiser's Edge NXT and Blackbaud Financial Edge NXT. The public research university's adoption of the cloud-based solutions in 2019 "couldn't have happened at a better time, given the circumstances we are now in," said Heather Andring, director of advancement services at the university, which enrolls more than 10,000 students. K-12 SchoolsBased outside of Seattle, International Baccalaureate World School Annie Wright Schools, which includes day and boarding options, began preparing for COVID-19 months ago and put technology plans in place to maintain education from a distance. Annie Wright has relied on Blackbaud's total school solution as its communication partner leveraging the platform to provide weekly newsletters and regular updates to parents, teachers and faculty as the COVID-19 pandemic as evolved. Being able to communicate quickly and effectively to the entire school has been crucial for Annie Wright during these times. Additionally, Annie Wright has been using key features of Blackbaud's Student Management System, such as gradebook and attendance platforms, which has provided much-needed consistency with the in-person classroom experience. "It has been seamless in this entire transition," said Jen Willey, communications director, Annie Wright Schools. Faith CommunitiesWith Blackbaud Online Express, the Catholic Community Foundation of the Diocese of Richmond spun up an online donation portal for more than 140 individual parishes. Within the first day, more than 170 people donated, and one-third of donors made their gifts recurring. With the approach of Easter seasona critical giving time for the dioceseCatholic Community Foundation continues to drive awareness about the digital offertory and drive parishioners to engage and support online. "Everything but e-giving stopped when the churches closed," said Executive Director Margaret Keightley. "Without money, we cannot provide ministryand so many people are in need. If we can't stay open, we can't assist the poor." Through it all, Blackbaud customer support, customer success, professional services and managed services teams have been on call to assist customers, helping more than 10,000 customers in one week as the month of March came to a close. "The intersection of technology and social good has never been more important than it is today," said Walter Loiselle, senior vice president of customer operations, Blackbaud. "We're committed to supporting all our customers as quickly and creatively as possible, while helping new customers achieve the time to value and time to ROI they need during this unprecedented time." About BlackbaudBlackbaud(NASDAQ: BLKB) is the world's leading cloud software company powering social good. Serving the entire social good communitynonprofits, higher education institutions, K12 schools, healthcare organizations, faith communities, arts and cultural organizations, foundations, companies and individual change agentsBlackbaud connects and empowers organizations to increase their impact through cloud software, services, expertise and data intelligence. The Blackbaud portfolio is tailored to the unique needs of vertical markets, with solutions for fundraising and CRM, marketing, advocacy, peer-to-peer fundraising, corporate social responsibility, school management, ticketing, grantmaking, financial management, payment processing and analytics. Serving the industry for more than three decades, Blackbaud is headquartered in Charleston, South Carolina, and has operations in the United States, Australia, Canada, Costa Rica and the United Kingdom. For more information, visit www.blackbaud.comor follow us onTwitter, LinkedIn,Instagram andFacebook. Media Inquiries[emailprotected] Forward-looking StatementsExcept for historical information, all of the statements, expectations, and assumptions contained in this news release are forward-looking statements that involve a number of risks and uncertainties, including statements regarding expected benefits of products and product features. Although Blackbaud attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors that could cause results to differ materially include the following: general economic risks; uncertainty regarding increased business and renewals from existing customers; continued success in sales growth; management of integration of acquired companies and other risks associated with acquisitions; risks associated with successful implementation of multiple integrated software products; the ability to attract and retain key personnel; risks associated with management of growth; lengthy sales and implementation cycles, particularly in larger organization; technological changes that make our products and services less competitive; and the other risk factors set forth from time to time in the SEC filings for Blackbaud, copies of which are available free of charge at the SEC's website at www.sec.gov or upon request from Blackbaud's investor relations department. All Blackbaud product names appearing herein are trademarks or registered trademarks of Blackbaud, Inc. SOURCE Blackbaud Related Links http://www.blackbaud.com |
edtsum3357 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoHealth, Inc. (NASDAQ: GOCO) pursuant and/or traceable to the registration statement issued in connection with GoHealths July 2020 initial public offering (the IPO) of the important November 20, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoHealth investors under the federal securities laws. To join the GoHealth class action, go to http://www.rosenlegal.com/cases-register-1939.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. According to the lawsuit, the registration statement was negligently prepared and failed to disclose that at the time of the IPO: (1) the Medicare insurance industry was undergoing a period of elevated churn, which had begun in the first half of 2020; (2) GoHealth suffered from a higher risk of customer churn as a result of its unique business model and limited carrier base; (3) GoHealth suffered from degradations in customer persistency and retention as a result of elevated industry churn, vulnerabilities that arose from the Companys concentrated carrier business model, and GoHealths efforts to expand into new geographies, develop new carrier partnerships and worsening product mix; (4) GoHealth had entered into materially less favorable revenue sharing arrangements with its external sales agents; and (5) these adverse financial and operational trends were internally projected by GoHealth to continue and worsen following the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 20, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1939.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected]. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTORS ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firms attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com
Answer: | GOCO FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds GoHealth, Inc. Investors of Important Friday Deadline in Securities Class Action GOCO | NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoHealth, Inc. (NASDAQ: GOCO) pursuant and/or traceable to the registration statement issued in connection with GoHealths July 2020 initial public offering (the IPO) of the important November 20, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoHealth investors under the federal securities laws. To join the GoHealth class action, go to http://www.rosenlegal.com/cases-register-1939.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. According to the lawsuit, the registration statement was negligently prepared and failed to disclose that at the time of the IPO: (1) the Medicare insurance industry was undergoing a period of elevated churn, which had begun in the first half of 2020; (2) GoHealth suffered from a higher risk of customer churn as a result of its unique business model and limited carrier base; (3) GoHealth suffered from degradations in customer persistency and retention as a result of elevated industry churn, vulnerabilities that arose from the Companys concentrated carrier business model, and GoHealths efforts to expand into new geographies, develop new carrier partnerships and worsening product mix; (4) GoHealth had entered into materially less favorable revenue sharing arrangements with its external sales agents; and (5) these adverse financial and operational trends were internally projected by GoHealth to continue and worsen following the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 20, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1939.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected]. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTORS ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firms attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com |
edtsum3360 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: VIENNA, June 16, 2020 /PRNewswire/ -- In line with the increased focus on the medical market segment, Coveris is taking a gigantic leap forward to modernize their medical packaging production facilities. With an extensive EUR 10 m investment program, Coveris strives to become best in class when it comes to process transparency, cleanliness and quality. Coveris has recently modernized its production facilities for sterile grade medical packaging at the Halle site, Germany (PRNewsfoto/Coveris Management GmbH) After a two-year long phase of market research and careful planning with industry experts, Coveris has recently started the implementation phase of modernizing its production facilities for sterile grade medical packaging at the Halle site, Germany. The modernization is planned in all technology steps extrusion, printing, laminating and converting and is supposed to achieve industry 4.0 standards. Next to an upgrading of production equipment, it is planned to operate this machinery with industry leading safety-and cleanliness standards. To reduce the risk of any contamination to a minimum, Coveris will realize the printing and lamination in a white room environment. Core of the second phase in Q3 and Q4 this year it is planned to modernize the entire converting department of Halle under ISO Class 8 cleanroom conditions. The new cleanroom offers not only significantly upgraded cleanliness levels during production but also while packing and preparation for customer shipment. The full transition from the old to the new equipment is expected to be completed in Q1 2021. "Our high reputation in medical packaging is the result of a many decades long dedication to this market. This huge investment program is a serious commitment to support our customers to achieve the highest levels of quality and cleanliness also in the future," says Jakob A. Mosser, CEO of Coveris. ABOUT COVERIS Coveris is a leading European packaging company that manufactures flexible packaging solutions for some of the world's most respected brands. We develop packaging that protects all types of products - from food to pet food, from medical devices to industrial and agricultural products. Through our broad level of technical expertise, our high-quality packaging extends the shelf life of products hence helping to reduce waste and resource wastage. Together with our customers we are constantly working on new attractive and sustainable packaging solutions. Coveris operates 26 sites in the EMEA region with 4,300 employees. Coveris Group is headquartered in Vienna, Austria.www.coveris.com Photo - https://mma.prnewswire.com/media/1191492/Coveris_Halle.jpg Logo - https://mma.prnewswire.com/media/1095723/Coveris_Logo.jpg SOURCE Coveris Management GmbH
Answer: | Coveris Grows Medical Segment With Significant Investments Towards Industry 4.0 English Franais Deutsch espaol | VIENNA, June 16, 2020 /PRNewswire/ -- In line with the increased focus on the medical market segment, Coveris is taking a gigantic leap forward to modernize their medical packaging production facilities. With an extensive EUR 10 m investment program, Coveris strives to become best in class when it comes to process transparency, cleanliness and quality. Coveris has recently modernized its production facilities for sterile grade medical packaging at the Halle site, Germany (PRNewsfoto/Coveris Management GmbH) After a two-year long phase of market research and careful planning with industry experts, Coveris has recently started the implementation phase of modernizing its production facilities for sterile grade medical packaging at the Halle site, Germany. The modernization is planned in all technology steps extrusion, printing, laminating and converting and is supposed to achieve industry 4.0 standards. Next to an upgrading of production equipment, it is planned to operate this machinery with industry leading safety-and cleanliness standards. To reduce the risk of any contamination to a minimum, Coveris will realize the printing and lamination in a white room environment. Core of the second phase in Q3 and Q4 this year it is planned to modernize the entire converting department of Halle under ISO Class 8 cleanroom conditions. The new cleanroom offers not only significantly upgraded cleanliness levels during production but also while packing and preparation for customer shipment. The full transition from the old to the new equipment is expected to be completed in Q1 2021. "Our high reputation in medical packaging is the result of a many decades long dedication to this market. This huge investment program is a serious commitment to support our customers to achieve the highest levels of quality and cleanliness also in the future," says Jakob A. Mosser, CEO of Coveris. ABOUT COVERIS Coveris is a leading European packaging company that manufactures flexible packaging solutions for some of the world's most respected brands. We develop packaging that protects all types of products - from food to pet food, from medical devices to industrial and agricultural products. Through our broad level of technical expertise, our high-quality packaging extends the shelf life of products hence helping to reduce waste and resource wastage. Together with our customers we are constantly working on new attractive and sustainable packaging solutions. Coveris operates 26 sites in the EMEA region with 4,300 employees. Coveris Group is headquartered in Vienna, Austria.www.coveris.com Photo - https://mma.prnewswire.com/media/1191492/Coveris_Halle.jpg Logo - https://mma.prnewswire.com/media/1095723/Coveris_Logo.jpg SOURCE Coveris Management GmbH |
Subsets and Splits